data_2kt6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kt6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.776 ' C ' HD11 ' A' ' 7' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.42 -1.955 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.809 HD13 ' HA2' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -144.6 -177.41 5.48 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.566 -1.253 . . . . 0.0 113.78 -162.13 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.705 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 1.2 m-85 -118.21 104.13 10.51 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.535 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.442 ' HB1' ' HG ' ' A' ' 44' ' ' LEU . . . -102.91 143.34 32.64 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.955 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.442 HG12 ' CD1' ' A' ' 41' ' ' LEU . 10.1 mt -112.82 99.79 9.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.277 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.741 HD11 HG23 ' A' ' 65' ' ' VAL . 2.4 mm? -93.38 128.66 39.53 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.407 -173.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -135.44 131.59 36.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.188 -0.605 . . . . 0.0 112.37 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.603 HD21 ' SG ' ' A' ' 81' ' ' CYS . 3.3 mm? -53.96 142.08 25.83 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 167.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.92 -26.37 67.43 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.057 -1.428 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -65.79 -25.55 67.3 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.223 0.535 . . . . 0.0 110.842 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.23 10.97 19.26 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 22.9 t -97.16 -160.61 0.81 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.473 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.523 ' C ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -139.25 134.82 16.82 Favored Pre-proline 0 CA--C 1.5 -0.96 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -172.402 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.554 ' O ' HG23 ' A' ' 36' ' ' VAL . 42.3 Cg_endo -76.38 103.27 1.72 Allowed 'Trans proline' 0 N--CA 1.429 -2.303 0 N-CA-C 104.301 -3.0 . . . . 0.0 104.301 148.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 17.6 Cg_endo -98.65 -163.75 0.07 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.276 0 C-N-CA 122.773 2.315 . . . . 0.0 111.51 -161.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.582 ' HA ' HG12 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -48.56 109.61 0.26 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.079 0.466 . . . . 0.0 111.986 -172.304 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.9 3.17 26.7 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.701 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -65.29 95.73 0.2 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.214 0.531 . . . . 0.0 109.983 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.664 ' HB2' HD21 ' A' ' 56' ' ' ASN . 2.0 m -67.62 105.61 1.93 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.301 -1.772 . . . . 0.0 110.686 173.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.529 HG13 HG22 ' A' ' 55' ' ' VAL . 26.9 m -100.52 112.24 32.64 Favored 'Isoleucine or valine' 0 C--O 1.26 1.614 0 CA-C-O 121.857 0.837 . . . . 0.0 110.204 174.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -149.5 128.96 13.01 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.574 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . 7.1 p -62.83 171.3 2.18 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.594 -175.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -68.39 -7.59 32.85 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.942 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 48.5 tptt -93.72 -14.03 26.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.267 0.556 . . . . 0.0 109.65 172.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.456 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 100.7 31.57 5.71 Favored Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.625 ' O ' ' HA ' ' A' ' 26' ' ' THR . 26.6 tpt180 -73.9 89.22 1.86 Allowed 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 173.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.481 ' HG2' ' HB ' ' A' ' 26' ' ' THR . 25.6 mt-10 -86.11 94.86 9.37 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.066 -171.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.826 HD22 HD21 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -80.78 -37.61 29.97 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.077 -178.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.621 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . 167.26 -159.45 32.8 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 117.87 -2.11 . . . . 0.0 114.855 177.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.701 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 10.5 mtm -151.81 137.52 17.92 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.891 0.876 . . . . 0.0 109.683 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 21' ' ' PHE . 55.7 t -61.83 129.51 24.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 C-N-CA 120.006 -0.677 . . . . 0.0 109.841 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.67 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -130.73 55.02 1.85 Allowed 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.456 173.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.67 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 5.0 t70 148.98 122.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 125.306 1.628 . . . . 0.0 108.198 174.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 52.13 -102.2 0.12 Allowed 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.531 0.52 . . . . 0.0 111.297 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.8 29.34 2.66 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.442 ' CD1' HG12 ' A' ' 10' ' ' ILE . 11.8 tp -103.34 111.15 23.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.419 -0.391 . . . . 0.0 110.044 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.608 ' HB3' HD21 ' A' ' 44' ' ' LEU . . . -101.94 126.61 48.88 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.282 174.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -75.08 88.96 2.44 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.771 ' HB2' HD21 ' A' ' 7' ' ' LEU . 8.1 mt -83.26 177.32 8.58 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 117.403 -1.719 . . . . 0.0 110.079 -171.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.714 ' HA ' ' HB2' ' A' ' 6' ' ' ARG . 41.8 m -138.84 85.72 2.1 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.809 ' HA2' HD13 ' A' ' 7' ' ' LEU . . . 75.61 75.93 0.81 Allowed Glycine 0 C--O 1.223 -0.554 0 C-N-CA 119.914 -1.136 . . . . 0.0 115.421 174.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.464 HG13 HG11 ' A' ' 67' ' ' VAL . 3.9 t -81.65 134.41 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.239 -0.585 . . . . 0.0 109.637 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.541 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -86.55 127.88 58.98 Favored Pre-proline 0 C--N 1.326 -0.45 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.737 179.176 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.728 ' HB2' ' HA ' ' A' ' 69' ' ' GLU . 30.9 Cg_endo -64.71 115.21 3.1 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.326 2.018 . . . . 0.0 111.899 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.28 36.24 2.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.748 -1.215 . . . . 0.0 112.697 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 48' ' ' THR . 28.5 mt-10 -116.98 176.81 4.95 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 119.146 -1.022 . . . . 0.0 112.142 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 t -127.31 92.42 3.51 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.333 168.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.826 HD21 HD22 ' A' ' 33' ' ' LEU . 9.0 mt -58.86 158.86 7.62 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 114.222 -1.353 . . . . 0.0 111.764 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.577 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 24.8 m -125.23 121.44 34.12 Favored 'General case' 0 C--N 1.317 -0.812 0 O-C-N 123.58 0.55 . . . . 0.0 109.777 168.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 9.5 t -109.43 122.23 63.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-O 121.212 0.53 . . . . 0.0 111.466 -170.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.664 HD21 ' HB2' ' A' ' 24' ' ' SER . 0.8 OUTLIER -123.77 132.49 53.81 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.708 -170.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.657 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 6.7 p90 -147.23 -142.95 0.13 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 117.957 -1.497 . . . . 0.0 112.63 171.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.657 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 0.9 OUTLIER -37.5 -63.07 0.48 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.853 0.461 . . . . 0.0 111.298 167.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.609 ' HA3' ' NE2' ' A' ' 62' ' ' GLN . . . -80.18 0.45 83.81 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 119.126 -1.512 . . . . 0.0 110.691 176.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.619 ' C ' ' HA ' ' A' ' 56' ' ' ASN . 27.1 mttm 74.69 -140.31 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 113.898 -1.151 . . . . 0.0 113.165 173.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.67 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -77.9 98.78 2.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -174.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.609 ' NE2' ' HA3' ' A' ' 59' ' ' GLY . 1.5 mt-30 -118.92 -41.81 2.75 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 114.416 -1.266 . . . . 0.0 110.877 -173.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 17.2 p -118.24 158.1 25.77 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.73 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.706 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 24.0 mt-30 -126.9 156.53 41.3 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.741 HG23 HD11 ' A' ' 11' ' ' LEU . 2.7 t -106.75 131.92 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 114.433 -2.907 . . . . 0.0 112.562 -172.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -90.46 110.81 21.91 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.187 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.464 HG11 HG13 ' A' ' 47' ' ' VAL . 18.8 t -92.56 114.3 62.02 Favored Pre-proline 0 CA--C 1.513 -0.453 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.873 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 4.6 Cg_exo -81.51 172.7 12.2 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 124.324 3.35 . . . . 0.0 111.903 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.728 ' HA ' ' HB2' ' A' ' 49' ' ' PRO . 40.6 mt-10 -72.68 -6.87 47.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.814 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 68' ' ' PRO . 10.7 t -85.07 18.63 2.45 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.929 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.657 ' HA ' HD22 ' A' ' 77' ' ' LEU . . . -66.25 153.5 42.38 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.617 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.25 167.98 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.909 -173.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.464 ' HA ' HD12 ' A' ' 7' ' ' LEU . 47.5 t -101.29 143.33 31.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.787 -175.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 51.83 23.45 2.08 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -134.05 173.11 11.94 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.322 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.705 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 74.9 mt-30 -86.25 142.0 28.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.701 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.657 HD22 ' HA ' ' A' ' 71' ' ' ALA . 50.9 tp -150.74 116.6 5.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.644 HD11 ' H ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -82.72 141.7 32.2 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 118.332 -1.347 . . . . 0.0 109.454 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HB2' ' CD1' ' A' ' 11' ' ' LEU . 95.2 mt -131.46 147.84 67.71 Favored Pre-proline 0 C--O 1.247 0.97 0 CA-C-O 121.109 0.48 . . . . 0.0 111.962 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.0 109.91 2.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.576 2.851 . . . . 0.0 113.309 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.603 ' SG ' HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -91.06 93.46 9.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.279 172.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.5 m -97.3 126.29 42.36 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.397 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.12 148.68 92.17 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.758 2.305 . . . . 0.0 111.767 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.561 179.031 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 1.105 ' HB2' ' HB2' ' A' ' 45' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.418 -2.074 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.706 ' N ' ' HG3' ' A' ' 6' ' ' ARG . 1.7 tt -141.08 114.3 8.63 Favored 'General case' 0 N--CA 1.387 -3.62 0 C-N-CA 117.126 -1.829 . . . . 0.0 114.761 -144.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.688 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 2.1 m-85 -119.27 88.77 3.0 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.56 ' HB3' HD21 ' A' ' 79' ' ' LEU . . . -100.38 102.11 13.26 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -170.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 51.5 mt -80.93 98.28 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.565 HD12 ' HG2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -114.41 146.04 41.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.861 -172.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -137.11 147.93 46.36 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.104 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.525 HD12 ' SG ' ' A' ' 81' ' ' CYS . 4.5 mm? -66.15 146.85 54.17 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.71 -27.34 67.82 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.757 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.18 -18.84 63.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.536 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.17 -6.24 25.22 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.8 -163.65 0.75 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.153 -0.524 . . . . 0.0 110.741 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.55 ' HG2' ' HA3' ' A' ' 40' ' ' GLY . 2.8 mt-30 -136.81 145.24 50.06 Favored Pre-proline 0 CA--C 1.506 -0.747 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -172.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.672 ' O ' HG23 ' A' ' 36' ' ' VAL . 6.2 Cg_exo -74.53 103.62 1.73 Allowed 'Trans proline' 0 N--CA 1.431 -2.188 0 N-CA-C 104.796 -2.809 . . . . 0.0 104.796 148.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 19.4 Cg_endo -103.13 -177.69 0.11 Allowed 'Trans proline' 0 N--CA 1.43 -2.236 0 C-N-CA 123.277 2.651 . . . . 0.0 111.99 -165.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.655 ' HA ' HG13 ' A' ' 36' ' ' VAL . 31.0 t80 -41.65 117.43 0.92 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -168.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.67 8.46 57.19 Favored Glycine 0 N--CA 1.436 -1.367 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.74 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -59.0 94.76 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.789 -0.706 . . . . 0.0 109.393 171.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.781 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 3.8 m -57.46 93.01 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 113.341 -1.754 . . . . 0.0 111.546 172.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.973 HG23 ' C ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -89.04 95.18 5.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.634 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.722 ' HB ' ' HG2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -128.33 130.94 48.53 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.66 -174.021 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.5 p -65.42 172.07 3.51 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 118.567 -1.253 . . . . 0.0 109.553 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.61 -18.23 51.78 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.912 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -93.71 -8.79 39.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.839 0.352 . . . . 0.0 110.87 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.444 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 102.12 23.92 8.82 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.164 174.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.648 ' O ' ' HA ' ' A' ' 26' ' ' THR . 39.7 mtm105 -73.73 88.51 1.75 Allowed 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 118.212 -1.395 . . . . 0.0 108.57 170.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.722 ' HG2' ' HB ' ' A' ' 26' ' ' THR . 15.8 mt-10 -83.52 77.9 9.75 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.636 HD11 HH11 ' A' ' 31' ' ' ARG . 96.2 mt -121.11 12.39 11.08 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.816 -167.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 1.03 ' HA2' ' HB2' ' A' ' 44' ' ' LEU . . . -138.02 149.82 20.63 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.468 163.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.74 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 30.9 mtm -154.14 126.28 7.85 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 160.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 19' ' ' PRO . 32.3 t -60.89 135.32 25.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 O-C-N 123.649 0.593 . . . . 0.0 111.518 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -136.59 116.91 13.59 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 172.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 20.5 m-20 72.41 116.91 0.05 OUTLIER 'General case' 0 C--O 1.234 0.255 0 O-C-N 124.199 0.937 . . . . 0.0 111.101 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 62.87 -95.23 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.857 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.55 ' HA3' ' HG2' ' A' ' 18' ' ' GLN . . . -160.94 53.1 0.33 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 118.807 -1.663 . . . . 0.0 114.001 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.637 HD12 ' HE1' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -141.74 139.48 32.86 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.416 170.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.669 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -84.83 122.94 29.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.342 0.592 . . . . 0.0 111.719 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.637 ' HE1' HD12 ' A' ' 41' ' ' LEU . 58.9 m95 -97.03 88.13 4.42 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.268 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 1.03 ' HB2' ' HA2' ' A' ' 34' ' ' GLY . 1.2 mt -156.94 -166.65 2.14 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -169.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 1.105 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 1.1 t -153.57 106.38 2.91 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.281 -171.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.565 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 140.36 76.17 0.05 OUTLIER Glycine 0 CA--C 1.521 0.449 0 C-N-CA 119.707 -1.235 . . . . 0.0 113.93 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.552 ' HB ' HD12 ' A' ' 7' ' ' LEU . 12.9 p -120.84 143.64 32.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.895 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.2 m -117.08 129.48 25.29 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.82 0.343 . . . . 0.0 110.332 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.556 ' HA ' HG13 ' A' ' 67' ' ' VAL . 44.1 Cg_endo -68.56 129.01 18.07 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.569 2.179 . . . . 0.0 112.136 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.47 36.38 5.91 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.155 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -128.02 173.3 10.16 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 118.055 -1.458 . . . . 0.0 113.731 -170.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 p -121.09 89.8 3.2 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.089 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 25.6 mt -68.1 151.92 46.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.075 174.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.483 ' HB2' HD12 ' A' ' 61' ' ' ILE . 34.5 p -122.88 121.95 37.43 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.938 0.875 . . . . 0.0 110.593 170.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.781 ' HA ' ' O ' ' A' ' 24' ' ' SER . 4.8 t -120.08 117.95 55.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.465 -162.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.653 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 35.0 m-80 -103.51 148.75 25.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.922 -173.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 6.2 p90 -161.84 -138.21 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 120.263 -0.575 . . . . 0.0 112.528 161.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.676 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 30.8 t70 -41.72 -58.12 2.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.277 0.631 . . . . 0.0 111.495 168.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA3' ' NE2' ' A' ' 62' ' ' GLN . . . -80.55 -1.47 88.9 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 119.288 -1.434 . . . . 0.0 110.302 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 37.8 mtmt 71.18 -142.26 0.06 Allowed 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 113.938 -1.131 . . . . 0.0 110.74 173.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.483 HD12 ' HB2' ' A' ' 54' ' ' SER . 0.5 OUTLIER -67.98 95.35 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-O 123.414 1.578 . . . . 0.0 107.937 -177.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.554 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 4.7 pt20 -139.04 -37.3 0.52 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.434 -1.712 . . . . 0.0 111.129 -170.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.656 ' SG ' ' HG3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -87.56 142.85 27.54 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 166.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -140.09 124.64 18.07 Favored 'General case' 0 CA--C 1.478 -1.789 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 22.2 t -98.93 132.1 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.111 0 C-N-CA 114.639 -2.824 . . . . 0.0 112.278 -168.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -101.05 102.48 13.46 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 118.039 -1.464 . . . . 0.0 110.279 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.556 HG13 ' HA ' ' A' ' 49' ' ' PRO . 40.6 t -75.25 126.57 87.71 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.025 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.515 ' HB2' HG23 ' A' ' 70' ' ' THR . 9.8 Cg_endo -90.16 171.02 3.92 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.663 2.909 . . . . 0.0 111.93 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.32 0.26 22.92 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 111.596 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.515 HG23 ' HB2' ' A' ' 68' ' ' PRO . 8.8 t -93.42 16.03 14.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.192 0.52 . . . . 0.0 110.326 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.09 152.92 38.54 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.712 0.768 . . . . 0.0 111.711 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.1 mt -121.12 137.67 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.91 -174.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -88.53 140.39 29.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.382 -173.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.0 t70 71.76 -4.22 1.97 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.217 0.532 . . . . 0.0 112.246 170.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.857 HE21 ' HA ' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -112.7 -166.05 1.05 Allowed 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.34 0.591 . . . . 0.0 110.829 -177.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.688 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 30.0 pt20 -97.69 134.84 40.33 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.921 173.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 78' ' ' LEU . 1.6 tm? -142.9 141.91 31.62 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -88.16 132.81 34.19 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.393 -177.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.56 HD21 ' HB3' ' A' ' 9' ' ' ALA . 3.4 mm? -117.98 139.62 26.78 Favored Pre-proline 0 C--O 1.241 0.657 0 CA-C-O 121.233 0.539 . . . . 0.0 111.496 -176.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 73.3 Cg_endo -87.99 120.27 1.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.051 2.501 . . . . 0.0 112.278 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.525 ' SG ' HD12 ' A' ' 13' ' ' LEU . 8.8 t -89.04 120.31 30.33 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.853 176.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 m -97.52 134.78 22.14 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 170.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -63.17 152.14 81.2 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.46 2.107 . . . . 0.0 112.732 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.447 HE21 ' HB3' ' A' ' 84' ' ' GLN . 3.4 tt0 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.17 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.861 ' C ' HD22 ' A' ' 7' ' ' LEU . 90.7 mtt-85 . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.861 HD22 ' C ' ' A' ' 6' ' ' ARG . 0.9 OUTLIER -123.01 172.02 8.82 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 115.737 -2.385 . . . . 0.0 109.006 -170.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.786 ' HB2' ' HA ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -92.24 87.13 5.96 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.524 -1.67 . . . . 0.0 108.095 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.822 ' HB1' HD12 ' A' ' 44' ' ' LEU . . . -98.32 112.08 24.2 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 118.969 -1.093 . . . . 0.0 111.462 -173.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.43 HG12 ' HG ' ' A' ' 41' ' ' LEU . 59.2 mt -100.65 90.67 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.476 171.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.444 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -103.06 132.27 49.45 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.426 -175.335 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.78 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 58.7 mtm-85 -141.67 155.09 45.7 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.265 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.644 HD23 ' HD3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -89.99 135.23 33.77 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 117.888 -1.525 . . . . 0.0 109.028 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.53 -11.64 3.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.797 -169.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -67.29 -19.0 65.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.433 0.635 . . . . 0.0 110.596 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.7 -8.98 21.79 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -174.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.478 ' CB ' ' HG ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -82.61 -177.9 6.87 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 113.922 -1.139 . . . . 0.0 111.824 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.697 ' NE2' ' HB2' ' A' ' 39' ' ' GLU . 1.2 mt-30 -135.4 142.65 42.15 Favored Pre-proline 0 CA--C 1.503 -0.857 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.949 -176.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.78 ' HD3' ' HA ' ' A' ' 12' ' ' ARG . 3.6 Cg_endo -80.37 102.72 1.45 Allowed 'Trans proline' 0 N--CA 1.423 -2.668 0 N-CA-C 104.848 -2.789 . . . . 0.0 104.848 156.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.694 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 1.9 Cg_endo -101.63 175.76 0.23 Allowed 'Trans proline' 0 N--CA 1.422 -2.715 0 C-N-CA 122.836 2.357 . . . . 0.0 111.047 -162.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 37' ' ' ALA . 82.5 t80 -30.42 99.74 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 124.231 0.957 . . . . 0.0 113.306 -169.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.72 10.85 8.17 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.663 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.9 ' HB2' HG13 ' A' ' 36' ' ' VAL . . . -58.94 95.86 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.227 175.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -77.8 98.41 5.54 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.714 -1.585 . . . . 0.0 112.117 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.509 HG11 HG23 ' A' ' 55' ' ' VAL . 11.8 m -103.68 115.19 45.16 Favored 'Isoleucine or valine' 0 C--O 1.259 1.563 0 CA-C-O 121.319 0.581 . . . . 0.0 111.85 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.638 ' OG1' ' HA2' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -147.21 125.98 12.65 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.257 175.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.608 ' CB ' ' HE2' ' A' ' 29' ' ' LYS . 27.2 m -53.07 168.48 0.13 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 123.17 0.293 . . . . 0.0 111.385 -173.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.437 ' CD ' ' HG3' ' A' ' 29' ' ' LYS . 5.9 pm0 -59.75 -20.31 55.78 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.982 -0.448 . . . . 0.0 112.048 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.608 ' HE2' ' CB ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -103.03 4.55 37.38 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.686 176.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.638 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 86.15 43.06 6.42 Favored Glycine 0 N--CA 1.418 -2.541 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 174.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.966 ' HE ' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -94.7 97.34 10.0 Favored 'General case' 0 N--CA 1.421 -1.897 0 C-N-CA 117.521 -1.672 . . . . 0.0 107.12 166.028 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -96.15 111.18 23.3 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.16 -159.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.737 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 5.9 mp -84.64 -49.94 8.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.383 -174.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.6 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . 168.86 -155.93 26.84 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 117.041 -2.504 . . . . 0.0 114.888 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.797 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 17.1 mtp -149.84 128.28 12.22 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -173.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.9 HG13 ' HB2' ' A' ' 23' ' ' ALA . 6.3 m -71.37 130.04 35.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.105 -173.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.42 ' HA ' ' HD1' ' A' ' 21' ' ' PHE . . . -121.64 55.85 1.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.807 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 20.6 t0 150.31 139.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 O-C-N 125.36 1.662 . . . . 0.0 107.572 176.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.697 ' HB2' ' NE2' ' A' ' 18' ' ' GLN . 0.5 OUTLIER 28.12 -100.26 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 O-C-N 124.757 1.285 . . . . 0.0 111.781 -167.379 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.659 ' H ' ' CG ' ' A' ' 39' ' ' GLU . . . -136.07 48.84 0.9 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 173.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.43 ' HG ' HG12 ' A' ' 10' ' ' ILE . 2.6 tt -116.42 117.48 30.05 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.984 0.421 . . . . 0.0 111.039 -178.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.567 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . . . -125.57 154.75 41.74 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 171.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.588 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 64.6 m95 -84.21 88.11 7.2 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.822 HD12 ' HB1' ' A' ' 9' ' ' ALA . 6.3 mp -73.68 102.26 3.89 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.873 -169.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.798 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 6.4 m -56.71 87.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.086 0.866 . . . . 0.0 111.919 -176.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 56.58 91.35 0.01 OUTLIER Glycine 0 C--N 1.339 0.722 0 CA-C-N 114.683 -1.144 . . . . 0.0 114.341 175.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.751 HG22 HD12 ' A' ' 7' ' ' LEU . 4.6 t -72.02 145.72 11.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.569 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.3 118.52 72.26 Favored Pre-proline 0 N--CA 1.442 -0.847 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.967 ' HB2' ' HA ' ' A' ' 69' ' ' GLU . 73.1 Cg_endo -71.48 109.37 2.6 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.451 2.101 . . . . 0.0 112.197 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.44 34.95 1.04 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.098 -1.525 . . . . 0.0 113.524 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -164.66 179.99 6.26 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 117.477 -1.689 . . . . 0.0 114.121 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.813 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 21.0 p -111.63 124.98 53.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.823 -174.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.602 ' H ' HD23 ' A' ' 53' ' ' LEU . 1.1 mm? -83.14 134.79 34.98 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.57 ' HB3' HD13 ' A' ' 61' ' ' ILE . 3.1 m -72.33 103.51 3.44 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 24' ' ' SER . 46.3 t -103.18 94.42 3.2 Favored 'Isoleucine or valine' 0 C--O 1.249 1.058 0 CA-C-O 122.145 0.974 . . . . 0.0 111.278 -172.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.623 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 43.0 m-80 -73.65 131.67 41.91 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.271 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.64 ' HB3' ' HG3' ' A' ' 62' ' ' GLN . 1.7 t90 -148.39 134.56 19.34 Favored 'General case' 0 C--O 1.208 -1.125 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.666 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.614 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 2.6 p30 -12.58 -58.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -173.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.487 ' N ' ' NE2' ' A' ' 62' ' ' GLN . . . -61.05 -23.79 62.16 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 118.397 -1.859 . . . . 0.0 114.282 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.996 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 11.1 pttt 173.36 -141.83 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.732 0.777 . . . . 0.0 110.265 -170.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 11.8 tt -115.1 93.95 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 162.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.996 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 6.6 mt-30 -92.15 -19.51 22.2 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 117.289 -1.764 . . . . 0.0 113.285 -150.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.554 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 23.7 p -147.92 159.92 43.36 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.915 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 47.5 mt-30 -129.82 119.42 23.33 Favored 'General case' 0 CA--C 1.478 -1.824 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.813 ' O ' ' HA ' ' A' ' 52' ' ' THR . 2.6 t -78.19 123.47 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 C-N-CA 116.804 -1.958 . . . . 0.0 112.025 -167.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -91.32 133.21 35.62 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.023 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.691 HG23 HG11 ' A' ' 47' ' ' VAL . 62.1 t -121.53 134.54 24.59 Favored Pre-proline 0 N--CA 1.44 -0.966 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.768 -173.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 6.5 Cg_endo -92.26 172.76 2.38 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.393 3.395 . . . . 0.0 111.798 171.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.967 ' HA ' ' HB2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -63.6 -14.95 56.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.149 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.5 p -62.42 -21.55 65.49 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.27 138.71 33.47 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.366 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 mm -130.48 -82.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.888 -170.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.86 ' HA ' HD23 ' A' ' 7' ' ' LEU . 24.0 p -172.05 137.67 0.96 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.511 -175.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.795 ' N ' HD23 ' A' ' 7' ' ' LEU . 5.2 m-20 55.89 -163.23 0.15 Allowed 'General case' 0 C--N 1.362 1.142 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -172.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 8' ' ' PHE . 42.4 mt-30 65.73 150.3 0.05 OUTLIER 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.649 0.738 . . . . 0.0 112.3 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.786 ' HA ' ' HB2' ' A' ' 8' ' ' PHE . 22.1 mp0 -76.75 124.12 27.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.464 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.77 116.88 10.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.7 tt -85.98 127.13 34.57 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.018 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 81.9 mt -113.61 141.86 26.7 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 121.108 0.48 . . . . 0.0 111.704 -174.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 67.7 Cg_endo -91.38 120.39 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.349 2.699 . . . . 0.0 113.196 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.663 ' SG ' ' HG3' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -82.58 116.24 21.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.384 175.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.3 m -82.85 117.1 67.47 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.155 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.48 158.82 22.47 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.814 2.343 . . . . 0.0 112.268 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.421 178.022 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.814 ' C ' HD13 ' A' ' 7' ' ' LEU . 25.7 mtm180 . . . . . 0 N--CA 1.429 -1.487 0 N-CA-C 102.389 -3.189 . . . . 0.0 102.389 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.931 HD22 ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -149.67 177.68 9.55 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 117.714 -1.594 . . . . 0.0 113.164 -168.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 1.3 m-85 -126.78 89.64 3.02 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.697 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 77' ' ' LEU . . . -93.36 134.33 35.69 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.638 -170.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.589 ' HB ' ' HG ' ' A' ' 78' ' ' LEU . 4.2 mp -96.77 111.79 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.691 173.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.697 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 65.4 mt -92.51 131.29 37.77 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.543 -175.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HD3' ' O ' ' A' ' 17' ' ' SER . 6.2 tpp180 -137.81 123.56 19.92 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.477 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.69 HD12 ' SG ' ' A' ' 81' ' ' CYS . 4.2 mm? -53.99 144.27 19.56 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 168.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.07 -30.28 66.08 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.218 -1.356 . . . . 0.0 111.211 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -79.02 -13.01 60.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.668 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.25 -11.71 16.88 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.159 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.516 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 30.9 p -81.83 -164.58 0.82 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.465 0.632 . . . . 0.0 110.108 175.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.631 ' C ' HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -129.93 141.38 41.65 Favored Pre-proline 0 CA--C 1.504 -0.815 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -172.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.697 ' HG2' ' HB3' ' A' ' 11' ' ' LEU . 5.4 Cg_exo -78.41 103.66 1.71 Allowed 'Trans proline' 0 N--CA 1.436 -1.888 0 N-CA-C 105.617 -2.494 . . . . 0.0 105.617 153.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -104.27 -161.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 123.563 2.842 . . . . 0.0 111.799 -163.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.467 ' HA ' HG12 ' A' ' 36' ' ' VAL . 38.2 t80 -48.9 114.83 1.07 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.409 0.623 . . . . 0.0 112.585 -169.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.69 -18.86 14.66 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.653 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -53.3 96.43 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 124.505 0.768 . . . . 0.0 110.975 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.752 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -72.68 88.8 1.3 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.444 -1.707 . . . . 0.0 111.653 175.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.401 ' HB ' HD22 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -74.49 88.99 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.774 169.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.734 ' HB ' ' O ' ' A' ' 31' ' ' ARG . 7.2 p -148.27 143.89 27.26 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.794 ' HG ' ' HB2' ' A' ' 31' ' ' ARG . 96.3 p -71.39 178.3 3.5 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 116.953 -1.899 . . . . 0.0 109.913 -175.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 28' ' ' GLU . 2.1 mp0 -56.55 -28.69 60.7 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.849 0.357 . . . . 0.0 111.603 -171.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 1.9 mptp? -85.37 -15.48 43.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.197 0.522 . . . . 0.0 110.807 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.53 10.43 35.78 Favored Glycine 0 CA--C 1.485 -1.818 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.794 ' HB2' ' HG ' ' A' ' 27' ' ' SER . 93.2 mtt180 -63.95 -178.3 0.31 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.671 -1.265 . . . . 0.0 109.339 169.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 0.6 OUTLIER 87.27 -158.67 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 164.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.916 HD13 HD23 ' A' ' 53' ' ' LEU . 6.8 mp -83.84 -48.67 9.81 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -144.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.765 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . 154.53 -141.4 8.17 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.988 -175.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.765 ' HG3' ' C ' ' A' ' 34' ' ' GLY . 6.9 mtt -148.6 142.66 25.93 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 117.517 0.658 . . . . 0.0 111.529 -173.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.614 HG21 HD13 ' A' ' 11' ' ' LEU . 55.5 t -66.18 130.61 31.65 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.519 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.463 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . . . -121.17 58.5 0.97 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.635 0.731 . . . . 0.0 109.332 172.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.575 ' CG ' ' H ' ' A' ' 39' ' ' GLU . 25.6 t70 178.68 -167.7 0.07 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.182 -174.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.575 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 10.1 pt-20 -85.51 1.81 47.34 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 122.091 -0.381 . . . . 0.0 111.539 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.45 ' HA3' ' HG2' ' A' ' 18' ' ' GLN . . . 174.72 25.1 0.03 OUTLIER Glycine 0 C--N 1.332 0.31 0 C-N-CA 119.143 -1.503 . . . . 0.0 112.995 175.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.474 ' H ' HG11 ' A' ' 36' ' ' VAL . 35.0 tp -133.19 121.69 22.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.57 0.224 . . . . 0.0 111.017 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.675 ' CB ' HD22 ' A' ' 44' ' ' LEU . . . -111.13 128.93 56.05 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.167 176.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -85.12 100.16 11.54 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.931 ' HB2' HD22 ' A' ' 7' ' ' LEU . 35.7 mt -111.15 178.55 4.31 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 118.467 -1.293 . . . . 0.0 111.657 -163.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 21.1 p -132.22 88.56 2.56 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.4 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.728 ' CA ' HD12 ' A' ' 7' ' ' LEU . . . 86.78 142.56 7.21 Favored Glycine 0 N--CA 1.464 0.56 0 C-N-CA 119.102 -1.523 . . . . 0.0 113.619 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.618 HG11 HD22 ' A' ' 33' ' ' LEU . 16.2 m -122.3 152.61 26.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 120.575 0.226 . . . . 0.0 110.71 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -111.77 109.98 55.04 Favored Pre-proline 0 C--N 1.324 -0.526 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.741 170.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.6 133.93 27.06 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 123.902 3.068 . . . . 0.0 113.069 -173.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.86 34.9 17.27 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 119.507 -1.33 . . . . 0.0 112.474 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -127.32 -173.13 2.82 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 121.852 0.834 . . . . 0.0 112.476 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 22.7 m -130.94 108.58 9.92 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.986 170.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.916 HD23 HD13 ' A' ' 33' ' ' LEU . 5.0 mt -69.36 158.8 34.37 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.793 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.632 ' HB2' ' O ' ' A' ' 26' ' ' THR . 73.5 m -102.25 154.6 18.88 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 159.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.752 ' HA ' ' O ' ' A' ' 24' ' ' SER . 21.5 t -137.92 92.77 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.925 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.652 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.609 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -82.22 109.61 16.65 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.573 -177.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.858 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 1.2 t90 -119.47 153.34 35.44 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.79 -1.55 . . . . 0.0 110.172 -168.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.858 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 15.6 t70 -15.62 -68.23 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.905 1.282 . . . . 0.0 113.176 169.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.74 -41.49 99.07 Favored Glycine 0 C--N 1.346 1.097 0 C-N-CA 117.966 -2.064 . . . . 0.0 113.68 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 1.057 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 0.1 OUTLIER 172.91 -168.79 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.863 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -170.105 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -87.99 91.57 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 C-N-CA 117.678 -1.609 . . . . 0.0 107.224 173.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 1.057 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 3.7 mt-30 -99.39 -41.44 7.41 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.319 -159.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.583 ' SG ' ' HG3' ' A' ' 19' ' ' PRO . 9.1 m -94.95 152.45 18.33 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.239 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 89.4 mt-30 -133.48 134.8 43.96 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 161.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.6 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 78.2 t -100.0 143.56 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 C-N-CA 114.28 -2.968 . . . . 0.0 112.391 -168.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.401 HD21 ' HA ' ' A' ' 66' ' ' ASN . 0.5 OUTLIER -94.35 110.01 21.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 117.651 -1.619 . . . . 0.0 110.665 171.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 4.6 t -86.54 117.22 68.33 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.604 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 71' ' ' ALA . 6.0 Cg_exo -79.36 163.27 24.85 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.942 2.428 . . . . 0.0 111.839 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -80.16 -6.2 57.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.177 0.513 . . . . 0.0 110.398 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 p -92.16 -4.3 54.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.984 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . . . -74.21 157.24 36.25 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.221 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.4 tp -144.42 149.43 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.569 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.529 ' HA ' HD11 ' A' ' 7' ' ' LEU . 33.4 m -86.53 170.05 12.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.177 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t0 70.91 147.72 0.08 Allowed 'General case' 0 C--N 1.348 0.52 0 O-C-N 123.671 0.607 . . . . 0.0 109.557 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.413 ' HB3' ' H ' ' A' ' 76' ' ' GLN . 25.5 mp0 62.73 -166.96 0.22 Allowed 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.55 0.691 . . . . 0.0 111.824 -174.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 4.4 pt20 -90.88 143.56 26.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.692 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 39.6 tp -141.58 117.36 10.42 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -175.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.589 ' HG ' ' HB ' ' A' ' 10' ' ' ILE . 6.0 mp -84.79 128.72 34.75 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 118.864 -1.134 . . . . 0.0 109.8 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.582 ' HB3' HG12 ' A' ' 65' ' ' VAL . 83.2 mt -112.84 132.19 22.41 Favored Pre-proline 0 C--O 1.246 0.906 0 CA-C-O 121.212 0.53 . . . . 0.0 111.915 -176.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.435 ' O ' HG13 ' A' ' 65' ' ' VAL . 73.5 Cg_endo -83.57 113.3 1.96 Allowed 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 123.396 2.731 . . . . 0.0 112.675 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.69 ' SG ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -80.5 120.47 24.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.681 175.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 64.3 p -95.17 130.73 31.68 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 170.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.51 114.02 3.69 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.564 2.176 . . . . 0.0 111.264 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.4 HE21 ' HB2' ' A' ' 84' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 120.988 0.423 . . . . 0.0 111.445 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.795 ' HG3' ' H ' ' A' ' 45' ' ' SER . 0.6 OUTLIER . . . . . 0 C--O 1.259 1.553 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 1.036 ' HG ' ' HB3' ' A' ' 45' ' ' SER . 13.6 mt -114.43 167.56 10.62 Favored 'General case' 0 CA--C 1.483 -1.633 0 C-N-CA 116.668 -2.013 . . . . 0.0 114.676 -167.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 1.082 ' HB3' ' HA ' ' A' ' 76' ' ' GLN . 30.2 t80 -81.69 85.92 6.5 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 170.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.12 106.76 19.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.394 0.616 . . . . 0.0 111.886 -167.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.453 HD13 ' HG ' ' A' ' 78' ' ' LEU . 45.9 mt -98.12 96.88 5.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.246 170.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.755 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 71.6 mt -93.79 148.0 22.54 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.844 -174.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 17' ' ' SER . 18.8 ttt180 -160.59 142.49 12.52 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 118.566 -1.254 . . . . 0.0 112.348 172.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.654 HD22 ' C ' ' A' ' 18' ' ' GLN . 4.6 mm? -64.83 142.6 58.38 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.677 0.751 . . . . 0.0 109.209 174.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.71 -28.57 69.51 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.943 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.1 -16.35 61.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.298 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.71 -13.9 20.14 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.395 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.478 ' C ' ' HB2' ' A' ' 13' ' ' LEU . 13.2 t -75.74 -168.54 0.88 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.654 ' C ' HD22 ' A' ' 13' ' ' LEU . 1.4 mm-40 -142.45 148.1 45.82 Favored Pre-proline 0 CA--C 1.5 -0.955 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -173.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.755 ' HG2' ' HB3' ' A' ' 11' ' ' LEU . 1.2 Cg_endo -83.18 100.99 0.95 Allowed 'Trans proline' 0 N--CA 1.433 -2.074 0 N-CA-C 106.551 -2.134 . . . . 0.0 106.551 156.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.571 ' HD2' ' CD2' ' A' ' 57' ' ' TRP . 0.2 OUTLIER -106.75 -172.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.332 0 C-N-CA 124.017 3.145 . . . . 0.0 111.573 -167.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.447 ' HD1' ' H ' ' A' ' 38' ' ' ASP . 69.3 t80 -30.23 107.12 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -167.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.34 10.29 27.77 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.588 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.846 ' HB1' HG13 ' A' ' 36' ' ' VAL . . . -61.84 89.62 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 124.142 0.554 . . . . 0.0 111.615 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.848 ' OG ' ' HB3' ' A' ' 56' ' ' ASN . 48.2 p -62.04 131.68 50.38 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.124 0.89 . . . . 0.0 109.093 175.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.743 ' CG2' ' HA3' ' A' ' 34' ' ' GLY . 19.1 m -113.18 114.27 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 117.718 -1.593 . . . . 0.0 110.299 165.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.814 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 1.2 t -140.54 118.55 11.88 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.113 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.569 ' OG ' ' HB2' ' A' ' 31' ' ' ARG . 20.5 p -76.61 -171.69 1.95 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.801 -170.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -34.89 -62.63 0.36 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.087 0.955 . . . . 0.0 113.527 -171.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -75.39 -24.52 57.23 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.932 0.396 . . . . 0.0 111.479 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.645 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 119.88 42.81 0.51 Allowed Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 -172.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.814 ' O ' ' HA ' ' A' ' 26' ' ' THR . 8.8 tpp180 -69.99 99.04 1.37 Allowed 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -91.01 107.85 19.48 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.055 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.94 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -126.28 -16.64 5.4 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.671 -174.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 1.096 ' HA2' ' HB3' ' A' ' 44' ' ' LEU . . . -137.62 152.9 21.83 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 119.062 -1.542 . . . . 0.0 116.646 -169.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.784 ' N ' HD13 ' A' ' 44' ' ' LEU . 13.8 mtt -163.62 99.82 0.9 Allowed 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 125.446 1.499 . . . . 0.0 107.189 172.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.846 HG13 ' HB1' ' A' ' 23' ' ' ALA . 5.6 m -67.84 140.44 19.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 C-N-CA 118.616 -1.234 . . . . 0.0 110.811 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.88 113.67 19.44 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.441 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.447 ' H ' ' HD1' ' A' ' 21' ' ' PHE . 38.9 t70 72.81 125.38 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 O-C-N 124.371 1.044 . . . . 0.0 110.717 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 65.8 -85.14 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.684 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.516 ' HA3' ' OE1' ' A' ' 18' ' ' GLN . . . -174.0 37.67 0.12 Allowed Glycine 0 C--O 1.239 0.451 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.436 HD12 ' CH2' ' A' ' 43' ' ' TRP . 1.4 mm? -120.66 112.14 18.5 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.241 -0.479 . . . . 0.0 111.929 -172.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.584 ' HB1' ' HA ' ' A' ' 36' ' ' VAL . . . -116.53 125.93 52.6 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 171.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.692 ' CE3' ' HA ' ' A' ' 8' ' ' PHE . 8.9 m95 -86.68 81.51 8.2 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 112.603 -3.639 . . . . 0.0 105.494 167.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 1.096 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -149.7 131.1 14.71 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 -165.489 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 1.036 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . 8.6 t 171.2 -145.86 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.425 177.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.32 -0.47 8.14 Favored Glycine 0 C--N 1.3 -1.471 0 C-N-CA 117.704 -2.189 . . . . 0.0 110.338 -160.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.701 HG21 HG12 ' A' ' 67' ' ' VAL . 7.9 p -72.26 153.09 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.824 -0.688 . . . . 0.0 111.126 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.711 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 6.5 m -98.83 131.47 25.55 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.973 ' HB3' ' HA ' ' A' ' 69' ' ' GLU . 83.3 Cg_exo -41.24 127.98 3.05 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.737 2.958 . . . . 0.0 113.899 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.419 ' H ' HG23 ' A' ' 67' ' ' VAL . . . 97.15 36.27 5.0 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.148 174.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.711 ' HG3' ' O ' ' A' ' 48' ' ' THR . 30.3 mt-10 -122.37 -170.15 2.02 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 118.939 -1.104 . . . . 0.0 113.031 -175.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.4 m -132.83 112.86 12.28 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.89 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.858 HD23 HD12 ' A' ' 33' ' ' LEU . 18.6 mt -78.21 159.23 28.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.053 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.603 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 6.4 m -120.04 119.93 34.82 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 168.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.845 ' HA ' ' O ' ' A' ' 24' ' ' SER . 38.2 t -112.64 124.34 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 121.513 0.673 . . . . 0.0 111.916 -169.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.848 ' HB3' ' OG ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -120.02 146.45 45.86 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.067 -170.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.662 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 9.7 p90 -157.92 -139.26 0.07 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 119.499 -0.88 . . . . 0.0 112.754 168.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.662 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 1.5 m-20 -41.49 -60.0 1.43 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.348 0.659 . . . . 0.0 111.558 168.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.653 ' HA3' ' NE2' ' A' ' 62' ' ' GLN . . . -77.33 -3.2 81.82 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 118.882 -1.628 . . . . 0.0 110.581 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 10.7 mttp 76.45 -149.91 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 114.356 -0.922 . . . . 0.0 111.95 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.57 HG13 ' HB2' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -71.78 101.42 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -176.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.653 ' NE2' ' HA3' ' A' ' 59' ' ' GLY . 0.2 OUTLIER -129.65 -46.03 1.18 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.632 -175.055 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.508 ' HB3' HD11 ' A' ' 13' ' ' LEU . 16.3 p -99.66 148.07 24.74 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.658 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 27.7 mt-30 -133.24 141.67 48.15 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 1.5 t -96.15 146.41 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 C-N-CA 116.276 -2.17 . . . . 0.0 112.564 -164.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -98.3 116.17 29.96 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.1 171.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.701 HG12 HG21 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -93.54 123.14 61.06 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.316 -178.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -92.46 170.83 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.707 2.938 . . . . 0.0 113.268 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.973 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 1.8 mp0 -73.35 -13.34 61.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.52 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.7 p -82.89 24.86 0.72 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.332 0.494 . . . . 0.0 112.332 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.4 159.17 18.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.504 HG13 ' H ' ' A' ' 73' ' ' SER . 7.0 tp -169.08 168.09 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.263 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.504 ' H ' HG13 ' A' ' 72' ' ' ILE . 4.1 p -52.82 135.35 35.98 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 62.51 4.6 1.39 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.43 ' HG2' ' H ' ' A' ' 76' ' ' GLN . 11.4 tt0 -86.23 155.59 20.64 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 122.19 -0.319 . . . . 0.0 111.324 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 1.082 ' HA ' ' HB3' ' A' ' 8' ' ' PHE . 14.9 pt20 -82.77 130.2 35.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.051 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.634 HD21 HD11 ' A' ' 7' ' ' LEU . 3.0 mm? -137.88 118.45 13.92 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.453 ' HG ' HD13 ' A' ' 10' ' ' ILE . 6.3 mp -86.08 96.63 9.94 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 118.759 -1.176 . . . . 0.0 108.115 174.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.562 HD12 HG12 ' A' ' 65' ' ' VAL . 96.2 mt -90.9 132.13 35.43 Favored Pre-proline 0 C--O 1.249 1.048 0 CA-C-O 121.582 0.706 . . . . 0.0 112.703 -167.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.41 117.99 3.85 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 123.544 2.829 . . . . 0.0 111.784 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.463 ' SG ' HG22 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -99.74 99.13 9.91 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.59 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 93.3 m -90.22 123.03 66.83 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.576 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.25 123.62 10.11 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.361 2.041 . . . . 0.0 111.066 175.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 . . . . . 0 C--N 1.323 -0.562 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.493 -177.503 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 1.002 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.404 -2.73 1 N-CA-C 99.692 -4.188 . . . . 0.0 99.692 . . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.891 HD11 ' HA3' ' A' ' 46' ' ' GLY . 0.4 OUTLIER -168.44 169.28 10.62 Favored 'General case' 0 N--CA 1.408 -2.537 0 C-N-CA 114.803 -2.759 . . . . 0.0 114.295 -159.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.646 ' HB2' ' HA ' ' A' ' 76' ' ' GLN . 77.4 m-85 -98.32 89.58 4.51 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.84 174.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.26 103.92 15.89 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.543 -174.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.1 mt -89.22 102.25 12.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.475 175.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -106.08 126.25 51.98 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.138 0.971 . . . . 0.0 110.559 -173.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -127.31 156.06 42.56 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.91 -1.496 . . . . 0.0 108.479 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.63 HD23 ' C ' ' A' ' 18' ' ' GLN . 1.1 pp -105.97 137.52 43.73 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 117.96 -1.496 . . . . 0.0 109.531 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.27 -9.96 0.78 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -166.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.503 ' HB3' HD13 ' A' ' 13' ' ' LEU . 6.5 t70 -66.74 -22.23 66.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.505 0.669 . . . . 0.0 110.216 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.3 -6.85 32.25 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t -96.91 -175.2 3.2 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.61 -0.795 . . . . 0.0 109.729 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.63 ' C ' HD23 ' A' ' 13' ' ' LEU . 1.6 tt0 -120.31 138.29 27.06 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.631 -171.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.538 ' N ' HD23 ' A' ' 13' ' ' LEU . 2.8 Cg_endo -80.73 103.96 1.54 Allowed 'Trans proline' 0 N--CA 1.428 -2.329 0 N-CA-C 105.646 -2.482 . . . . 0.0 105.646 156.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 1.1 Cg_endo -103.49 175.98 0.16 Allowed 'Trans proline' 0 N--CA 1.431 -2.199 0 C-N-CA 123.111 2.541 . . . . 0.0 112.545 -161.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.577 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 24.8 t80 -23.94 104.48 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -168.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.404 ' H ' HG13 ' A' ' 36' ' ' VAL . . . 113.72 0.23 24.51 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.083 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.784 ' HB2' HG11 ' A' ' 36' ' ' VAL . . . -60.69 99.63 0.09 Allowed 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.424 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.924 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 68.4 p -66.82 99.32 0.61 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.418 173.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.8 HG21 ' CA ' ' A' ' 34' ' ' GLY . 5.1 m -82.37 101.41 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 C-N-CA 115.762 -2.375 . . . . 0.0 107.982 166.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.683 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 1.1 t -138.51 120.0 14.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.926 -171.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.1 t -83.15 160.64 21.8 Favored 'General case' 0 C--O 1.211 -0.941 0 C-N-CA 119.317 -0.953 . . . . 0.0 108.988 -171.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -15.6 -70.86 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -164.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -65.47 -20.81 66.51 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.3 0.571 . . . . 0.0 112.069 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.549 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 119.67 40.36 0.62 Allowed Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.683 ' O ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -77.24 93.41 3.97 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.073 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -90.57 95.89 10.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.204 0.526 . . . . 0.0 110.478 -172.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.776 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -106.06 3.71 28.46 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.332 -176.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.868 ' HA2' ' CB ' ' A' ' 44' ' ' LEU . . . -157.13 149.67 20.46 Favored Glycine 0 C--O 1.221 -0.672 0 O-C-N 124.585 1.178 . . . . 0.0 112.884 172.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.763 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 42.8 mtp -150.82 107.91 3.58 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 165.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.784 HG11 ' HB2' ' A' ' 23' ' ' ALA . 1.9 p -60.67 123.89 14.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.567 -170.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.414 ' HA ' ' HD1' ' A' ' 21' ' ' PHE . . . -107.5 129.79 54.92 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 170.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.494 ' OD1' ' HG3' ' A' ' 39' ' ' GLU . 3.4 t0 73.59 -150.44 0.05 Allowed 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.902 0.751 . . . . 0.0 109.418 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HG3' ' OD1' ' A' ' 38' ' ' ASP . 32.6 mt-10 -84.24 81.95 8.59 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -171.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.3 -17.66 46.46 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 114.804 0.681 . . . . 0.0 114.804 165.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.655 HD11 ' H ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -85.78 113.09 21.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 118.045 0.922 . . . . 0.0 113.101 175.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.54 ' HB3' ' N ' ' A' ' 35' ' ' MET . . . -95.64 103.47 15.34 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.723 ' HA ' ' CE3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -82.83 89.58 6.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.868 ' CB ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -140.29 -165.23 1.87 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -163.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 1.002 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.7 p -122.51 113.7 19.67 Favored 'General case' 0 N--CA 1.424 -1.731 0 C-N-CA 117.462 -1.695 . . . . 0.0 109.243 -167.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.891 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -59.4 173.21 4.33 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 118.829 2.292 . . . . 0.0 118.829 -161.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.431 ' HB ' HD21 ' A' ' 33' ' ' LEU . 8.0 p -121.1 172.78 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 112.984 -1.608 . . . . 0.0 110.577 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.413 HG21 ' HD2' ' A' ' 49' ' ' PRO . 6.4 m -71.29 148.12 93.48 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.257 0.623 . . . . 0.0 110.209 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.61 ' HA ' HG12 ' A' ' 67' ' ' VAL . 4.5 Cg_exo -77.82 161.82 30.05 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.479 2.119 . . . . 0.0 112.189 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.27 35.24 27.24 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 119.454 -1.355 . . . . 0.0 112.216 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -132.0 -168.29 2.01 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.818 -175.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.2 m -139.84 99.05 3.6 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.72 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.756 HD12 ' HB ' ' A' ' 25' ' ' VAL . 30.9 mt -57.91 155.44 10.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.015 168.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.545 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 48.8 m -121.75 119.88 33.02 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 170.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.924 ' HA ' ' O ' ' A' ' 24' ' ' SER . 48.8 t -109.55 110.81 33.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-O 122.023 0.916 . . . . 0.0 112.435 -166.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.847 ' HB3' ' OG ' ' A' ' 24' ' ' SER . 0.4 OUTLIER -97.26 149.32 22.18 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.412 -174.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.737 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 0.1 OUTLIER -158.71 155.09 27.42 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.918 -167.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.737 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 0.1 OUTLIER -19.78 -57.37 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.721 1.208 . . . . 0.0 114.16 174.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.34 -44.4 95.47 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 117.249 -2.405 . . . . 0.0 113.479 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.543 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 1.2 pttt 174.25 -176.25 0.08 Allowed 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -167.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.836 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 4.2 tt -87.9 97.06 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 169.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -103.92 -50.02 3.49 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 118.938 -1.105 . . . . 0.0 112.795 -158.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 29.0 p -104.87 158.08 16.77 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.567 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 51.0 mt-30 -133.09 138.89 46.87 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 2.7 t -91.44 130.55 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 C-N-CA 115.013 -2.675 . . . . 0.0 112.117 -169.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.435 ' N ' HD21 ' A' ' 66' ' ' ASN . 0.9 OUTLIER -93.29 116.12 28.69 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 118.494 -1.282 . . . . 0.0 110.06 177.134 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.61 HG12 ' HA ' ' A' ' 49' ' ' PRO . 13.8 t -93.55 116.16 66.07 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.585 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -92.03 169.23 2.93 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.051 2.501 . . . . 0.0 111.818 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -90.25 15.05 11.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.192 0.52 . . . . 0.0 110.776 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.5 m -106.78 2.6 25.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.589 0.709 . . . . 0.0 110.1 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.38 174.85 7.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.75 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.653 HG13 ' H ' ' A' ' 73' ' ' SER . 11.1 tp -136.66 170.33 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.111 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.653 ' H ' HG13 ' A' ' 72' ' ' ILE . 15.1 m -146.04 -178.58 6.2 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 23.7 t70 71.33 -41.95 0.52 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.106 0.562 . . . . 0.0 110.645 -173.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -89.73 -163.56 1.02 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.864 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.646 ' HA ' ' HB2' ' A' ' 8' ' ' PHE . 25.6 tt0 -86.55 133.62 33.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.536 174.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.596 ' HG ' ' H ' ' A' ' 72' ' ' ILE . 3.1 tm? -150.87 133.04 15.34 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.617 ' H ' HD22 ' A' ' 78' ' ' LEU . 2.4 pt? -94.41 134.74 36.6 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.557 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 93.5 mt -106.43 137.24 19.37 Favored Pre-proline 0 C--O 1.24 0.557 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.281 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 59.8 Cg_endo -90.28 114.51 0.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.189 2.593 . . . . 0.0 113.027 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.87 107.31 18.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.106 177.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.9 m -78.39 130.5 71.43 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.705 175.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.93 129.55 21.02 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.402 2.068 . . . . 0.0 110.998 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.408 HE21 ' HB2' ' A' ' 84' ' ' GLN . 8.3 tt0 . . . . . 0 C--N 1.328 -0.343 0 O-C-N 123.429 0.455 . . . . 0.0 110.938 -178.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.833 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 2.1 tmm_? . . . . . 0 N--CA 1.42 -1.951 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.761 HD12 ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -140.56 175.41 9.63 Favored 'General case' 0 N--CA 1.403 -2.816 0 CA-C-N 112.312 -2.222 . . . . 0.0 111.007 -158.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.68 ' HD2' ' HB3' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -110.91 87.43 2.53 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 173.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 41' ' ' LEU . . . -90.59 115.16 27.49 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.5 -167.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 57.0 mt -95.38 98.4 7.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.932 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 3.4 mm? -90.13 134.29 34.36 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 119.559 -0.857 . . . . 0.0 109.411 -174.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -144.05 126.54 15.9 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.055 175.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.778 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . 0.9 OUTLIER -90.48 113.54 25.52 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 117.347 -1.741 . . . . 0.0 109.602 174.295 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.48 -7.98 1.65 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 113.73 -1.577 . . . . 0.0 113.734 -169.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -63.32 -13.73 42.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.219 0.533 . . . . 0.0 110.668 174.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.51 27.75 2.98 Favored Glycine 0 CA--C 1.502 -0.724 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.694 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.7 m -142.03 170.68 15.26 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 114.906 -0.647 . . . . 0.0 110.219 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.82 142.47 31.85 Favored Pre-proline 0 CA--C 1.495 -1.14 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.657 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.932 ' HG2' ' HB3' ' A' ' 11' ' ' LEU . 5.6 Cg_exo -75.29 105.38 2.07 Favored 'Trans proline' 0 N--CA 1.424 -2.562 0 N-CA-C 105.027 -2.72 . . . . 0.0 105.027 156.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -105.96 -165.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.155 0 C-N-CA 123.078 2.519 . . . . 0.0 112.198 -164.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.74 100.16 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -170.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.84 22.8 7.79 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.868 ' HB3' HG13 ' A' ' 36' ' ' VAL . . . -64.94 89.62 0.08 Allowed 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.694 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.702 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -70.45 87.91 0.65 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.578 -1.646 . . . . 0.0 111.622 178.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.781 HG23 ' CA ' ' A' ' 34' ' ' GLY . 3.2 m -82.28 112.36 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.173 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -140.53 121.22 14.32 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.795 -178.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.727 ' OG ' HD21 ' A' ' 53' ' ' LEU . 64.0 m -84.85 -171.98 3.93 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.723 -168.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -23.93 -67.85 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -169.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -88.71 -6.97 57.09 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -171.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.563 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 114.39 35.87 1.39 Allowed Glycine 0 CA--C 1.487 -1.672 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -177.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.697 ' O ' HD23 ' A' ' 33' ' ' LEU . 68.3 mtp180 -76.01 100.06 4.78 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -91.9 96.05 10.17 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.06 -169.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.872 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -109.01 4.42 23.19 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.712 -170.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.891 ' N ' HD11 ' A' ' 44' ' ' LEU . . . -166.72 154.76 25.45 Favored Glycine 0 N--CA 1.467 0.764 0 C-N-CA 119.079 -1.534 . . . . 0.0 114.406 176.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.702 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 31.8 mtt -149.88 99.67 2.87 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 164.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.868 HG13 ' HB3' ' A' ' 23' ' ' ALA . 2.2 m -72.09 106.59 2.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 118.899 -1.121 . . . . 0.0 111.176 -169.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.43 120.84 37.47 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 118.659 -1.216 . . . . 0.0 110.328 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 t70 70.6 119.69 0.04 OUTLIER 'General case' 0 C--O 1.237 0.398 0 O-C-N 124.348 1.03 . . . . 0.0 110.968 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 66.63 -98.93 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.309 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.83 47.65 0.33 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.084 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 9' ' ' ALA . 3.9 tt -133.96 125.07 27.43 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.626 ' HB3' ' H ' ' A' ' 35' ' ' MET . . . -113.08 129.23 56.57 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.75 0.31 . . . . 0.0 110.659 177.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.406 ' O ' HD23 ' A' ' 44' ' ' LEU . 91.2 m95 -90.48 83.46 5.88 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.891 HD11 ' N ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -145.46 -170.37 3.43 Favored 'General case' 0 C--O 1.195 -1.764 0 CA-C-O 118.973 -0.537 . . . . 0.0 110.002 -157.338 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.833 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 37.3 p -116.76 85.81 2.39 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -163.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.761 ' N ' HD12 ' A' ' 7' ' ' LEU . . . -62.12 -177.82 3.12 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 116.395 1.318 . . . . 0.0 116.395 -162.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.572 HG12 ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -103.78 177.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.153 -0.523 . . . . 0.0 111.79 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 m -82.47 139.52 44.58 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.029 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.675 ' HA ' HG13 ' A' ' 67' ' ' VAL . 59.0 Cg_exo -52.73 120.91 8.28 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.808 2.338 . . . . 0.0 112.833 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.68 36.3 0.92 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.023 -1.084 . . . . 0.0 112.677 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -138.43 -160.94 1.11 Allowed 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 119.244 -0.982 . . . . 0.0 112.175 -174.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 58.3 m -142.73 129.78 20.76 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.4 172.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.727 HD21 ' OG ' ' A' ' 27' ' ' SER . 45.3 mt -88.13 151.47 22.69 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 173.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.06 106.93 14.31 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 171.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.702 ' HA ' ' O ' ' A' ' 24' ' ' SER . 20.0 t -112.32 109.69 29.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.892 -159.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 41.5 m-80 -77.68 146.16 36.19 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.549 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.792 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -150.41 149.82 30.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.415 -174.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.792 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 5.2 m-20 -25.18 -55.62 0.05 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 173.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.88 -40.62 98.55 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 117.071 -2.49 . . . . 0.0 113.778 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.775 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER 169.12 -168.96 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -169.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.4 tt -86.12 115.16 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 169.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.775 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 1.1 mt-30 -130.73 -48.78 1.05 Allowed 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 117.663 -1.615 . . . . 0.0 111.207 -165.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.583 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . 38.1 t -72.95 129.29 37.78 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.343 -1.298 . . . . 0.0 107.772 174.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -136.11 114.66 11.84 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 167.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.726 HG11 ' HB2' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -93.75 147.09 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.167 0 C-N-CA 115.04 -2.664 . . . . 0.0 112.346 -160.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 77.1 m-20 -100.5 108.92 21.0 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.568 174.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.675 HG13 ' HA ' ' A' ' 49' ' ' PRO . 22.1 t -79.99 112.49 30.44 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.074 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 66' ' ' ASN . 94.4 Cg_endo -89.01 171.45 4.7 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.445 2.763 . . . . 0.0 112.141 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.523 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 2.4 mp0 -67.34 -15.37 63.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.72 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.4 m -79.83 -3.89 49.79 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.039 0.447 . . . . 0.0 111.115 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.62 156.87 36.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.4 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.45 HD13 ' H ' ' A' ' 73' ' ' SER . 0.4 OUTLIER -158.93 160.16 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.654 ' CB ' HD11 ' A' ' 7' ' ' LEU . 22.0 p -120.28 174.27 6.61 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.578 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.8 t70 68.78 8.16 6.59 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.371 0.605 . . . . 0.0 110.802 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -138.06 172.5 12.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.797 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.68 ' HB3' ' HD2' ' A' ' 8' ' ' PHE . 11.0 pt20 -94.13 124.74 38.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 172.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.6 tp -150.27 149.04 29.6 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.529 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.0 pt? -98.48 132.27 44.06 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.492 -1.283 . . . . 0.0 109.915 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 11' ' ' LEU . 3.1 mm? -110.66 143.73 28.8 Favored Pre-proline 0 C--O 1.248 0.994 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.33 -176.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 4.9 Cg_exo -79.8 100.36 1.28 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.727 2.951 . . . . 0.0 112.864 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.778 ' SG ' ' HB3' ' A' ' 13' ' ' LEU . 5.1 t -82.62 146.2 29.26 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.212 173.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.4 m -126.12 136.34 28.39 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.45 152.67 31.85 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.019 1.813 . . . . 0.0 111.04 174.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 121.011 0.434 . . . . 0.0 111.717 -176.153 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.8 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.249 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 1.04 HD12 ' HG ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -157.99 172.09 19.07 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 115.797 1.776 . . . . 0.0 115.797 -157.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.565 ' HB2' ' HA ' ' A' ' 76' ' ' GLN . 92.4 m-85 -114.65 90.18 3.28 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 112.739 -2.028 . . . . 0.0 107.542 174.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.48 98.55 11.83 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.503 -0.479 . . . . 0.0 112.0 -171.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 40.5 mt -87.73 103.0 13.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.954 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -117.85 150.33 39.35 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.651 -175.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.497 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 13.8 mmm180 -140.3 155.42 46.84 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.821 HD23 ' SG ' ' A' ' 63' ' ' CYS . 1.8 mt -78.69 151.0 32.43 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 116.87 -1.932 . . . . 0.0 107.092 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.34 -40.34 67.95 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.684 -172.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 -74.68 -10.46 59.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.811 0.339 . . . . 0.0 111.686 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.22 24.72 4.07 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.557 -1.306 . . . . 0.0 111.754 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.64 ' HB2' ' CG ' ' A' ' 13' ' ' LEU . 16.2 m -106.33 -155.32 0.54 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.673 ' C ' HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -140.35 137.82 18.25 Favored Pre-proline 0 CA--C 1.51 -0.564 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -170.466 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.954 ' HG2' ' HB2' ' A' ' 11' ' ' LEU . 3.6 Cg_exo -78.59 102.14 1.52 Allowed 'Trans proline' 0 N--CA 1.438 -1.792 0 N-CA-C 104.773 -2.818 . . . . 0.0 104.773 149.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.534 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . 9.8 Cg_endo -107.78 160.88 0.1 Allowed 'Trans proline' 0 N--CA 1.431 -2.201 0 C-N-CA 123.455 2.77 . . . . 0.0 112.683 -164.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -18.64 103.7 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -168.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.413 ' H ' HG13 ' A' ' 36' ' ' VAL . . . 103.63 4.36 46.12 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.837 ' HA ' ' O ' ' A' ' 56' ' ' ASN . . . -61.78 100.03 0.14 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.851 169.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.756 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -72.57 100.07 2.67 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 112.395 -2.184 . . . . 0.0 111.453 173.243 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.737 HG23 ' CA ' ' A' ' 34' ' ' GLY . 19.9 m -89.61 113.78 26.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 C-N-CA 117.645 -1.622 . . . . 0.0 109.668 174.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.94 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . 3.2 p -148.79 133.83 18.17 Favored 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.081 170.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.593 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -78.52 162.7 26.14 Favored 'General case' 0 C--O 1.207 -1.139 0 C-N-CA 117.221 -1.792 . . . . 0.0 108.181 -172.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -18.61 -62.67 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -165.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -87.13 3.49 46.05 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -171.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.89 27.03 5.57 Favored Glycine 0 CA--C 1.488 -1.614 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.906 ' HG3' HG12 ' A' ' 47' ' ' VAL . 8.5 tpt180 -68.15 176.92 2.46 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.94 ' HB3' ' HA ' ' A' ' 26' ' ' THR . 23.2 tp10 82.06 -120.56 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 169.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.683 ' C ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER 98.21 93.01 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.186 0 O-C-N 124.512 1.133 . . . . 0.0 109.623 -159.047 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 1.066 ' HA2' ' HB2' ' A' ' 44' ' ' LEU . . . -159.94 102.19 0.21 Allowed Glycine 0 C--O 1.216 -1.014 0 CA-C-N 112.362 -2.199 . . . . 0.0 112.216 164.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.749 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 14.3 mtm -111.08 125.67 54.01 Favored 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 121.0 -1.294 . . . . 0.0 109.911 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.699 HG11 ' HB1' ' A' ' 23' ' ' ALA . 2.1 p -73.59 139.29 19.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.727 -174.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.87 71.14 0.73 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 171.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.3 t70 72.65 151.91 0.12 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.239 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.524 ' HB2' HD21 ' A' ' 41' ' ' LEU . 13.5 mm-40 71.8 -27.65 0.18 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.841 0.857 . . . . 0.0 112.889 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.464 ' HA2' HG22 ' A' ' 36' ' ' VAL . . . 116.99 12.81 8.15 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.354 175.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -90.0 107.31 19.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.678 -0.409 . . . . 0.0 112.002 173.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.716 ' HB3' ' C ' ' A' ' 34' ' ' GLY . . . -95.8 92.45 6.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.499 0.666 . . . . 0.0 110.45 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.579 ' HA ' ' CE3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -83.33 110.85 18.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.424 -177.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 1.066 ' HB2' ' HA2' ' A' ' 34' ' ' GLY . 4.2 mt -167.47 -169.93 1.33 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -167.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.8 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 26.5 p -127.47 79.36 1.88 Allowed 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 -168.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.725 ' H ' ' CD1' ' A' ' 7' ' ' LEU . . . -87.04 -150.49 18.1 Favored Glycine 0 C--N 1.306 -1.111 0 CA-C-N 114.44 -1.255 . . . . 0.0 113.529 -161.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.906 HG12 ' HG3' ' A' ' 31' ' ' ARG . 15.5 m -121.2 174.57 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.503 0.668 . . . . 0.0 112.162 174.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 11.4 t -77.79 139.19 62.08 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.692 -175.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HB3' HG23 ' A' ' 67' ' ' VAL . 87.5 Cg_exo -49.06 153.2 4.25 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.941 3.094 . . . . 0.0 114.155 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.884 ' H ' HG11 ' A' ' 67' ' ' VAL . . . 119.44 26.74 2.33 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.332 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.46 ' H ' ' CG1' ' A' ' 67' ' ' VAL . 23.2 mt-10 -143.36 -168.45 2.82 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.763 0.792 . . . . 0.0 112.946 -173.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 16.7 p -126.69 122.36 34.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.912 167.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.7 ' HB2' HG13 ' A' ' 65' ' ' VAL . 19.2 mt -93.37 121.01 34.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.302 -173.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.54 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 13.3 m -77.62 109.37 11.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.607 0.718 . . . . 0.0 110.583 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.756 ' HA ' ' O ' ' A' ' 24' ' ' SER . 59.3 t -116.57 116.72 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.537 -167.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.837 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 37.6 m-80 -99.33 157.53 16.34 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.812 -176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 2.4 p90 -161.62 -144.5 0.1 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.887 159.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.673 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 1.0 OUTLIER -41.49 -55.0 2.98 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.746 0.703 . . . . 0.0 111.076 166.216 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.656 ' HA3' ' NE2' ' A' ' 62' ' ' GLN . . . -80.68 2.3 79.6 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 118.886 -1.626 . . . . 0.0 111.079 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.6 ' C ' ' HA ' ' A' ' 56' ' ' ASN . 11.2 mtpt 67.13 -151.59 0.19 Allowed 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 114.482 -0.859 . . . . 0.0 111.771 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.461 HD11 ' HB3' ' A' ' 54' ' ' SER . 0.1 OUTLIER -64.09 106.97 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-O 122.648 1.213 . . . . 0.0 108.656 -177.001 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.656 ' NE2' ' HA3' ' A' ' 59' ' ' GLY . 2.3 pt20 -146.62 -39.33 0.21 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.759 -1.564 . . . . 0.0 111.614 -174.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.821 ' SG ' HD23 ' A' ' 13' ' ' LEU . 1.6 t -96.75 135.04 39.26 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.528 174.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.613 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 49.7 mt-30 -126.36 137.75 53.49 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 169.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.7 HG13 ' HB2' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -97.41 129.95 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 C-N-CA 115.985 -2.286 . . . . 0.0 110.185 -170.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -89.56 98.46 11.78 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.216 -0.994 . . . . 0.0 109.332 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.884 HG11 ' H ' ' A' ' 50' ' ' GLY . 9.0 p -92.11 115.98 65.64 Favored Pre-proline 0 N--CA 1.44 -0.939 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.525 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.53 152.68 15.47 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.352 2.701 . . . . 0.0 111.565 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -75.84 13.39 0.85 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.828 0.346 . . . . 0.0 111.875 -174.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 m -73.75 -42.45 61.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.986 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.11 -173.14 2.24 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.821 -173.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.409 ' O ' HD11 ' A' ' 77' ' ' LEU . 12.6 tt -140.93 155.68 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.35 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 1.04 ' HG ' HD12 ' A' ' 7' ' ' LEU . 33.3 t -84.85 -166.51 1.5 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.886 -175.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 73' ' ' SER . 38.8 t70 75.76 10.07 3.39 Favored 'General case' 0 C--N 1.359 1.012 0 CA-C-O 121.717 0.77 . . . . 0.0 110.195 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -153.24 -171.97 4.09 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.154 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.565 ' HA ' ' HB2' ' A' ' 8' ' ' PHE . 14.1 pt20 -86.11 140.39 30.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.409 HD11 ' O ' ' A' ' 72' ' ' ILE . 96.1 mt -138.47 157.0 47.03 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.594 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -111.03 132.96 53.79 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 117.757 -1.577 . . . . 0.0 109.528 173.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.423 HD13 HG22 ' A' ' 67' ' ' VAL . 2.7 mm? -122.9 140.98 34.41 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -169.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 57.8 Cg_endo -88.57 110.01 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.846 3.031 . . . . 0.0 112.467 176.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.512 ' HB3' ' HA ' ' A' ' 13' ' ' LEU . 1.8 t -93.43 122.45 35.86 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.345 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 8.6 t -130.35 133.5 24.98 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.737 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 82' ' ' THR . 5.0 Cg_endo -88.02 98.89 0.42 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.952 2.435 . . . . 0.0 110.823 171.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 121.715 0.769 . . . . 0.0 109.622 -176.916 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.461 -2.476 0 N-CA-C 101.724 -3.435 . . . . 0.0 101.724 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.99 HD12 ' H ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -163.17 -179.32 6.56 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 111.762 -3.975 . . . . 0.0 115.987 -151.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.918 ' HE1' ' HB2' ' A' ' 41' ' ' LEU . 6.2 t80 -127.17 105.39 8.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.41 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 77' ' ' LEU . . . -100.74 131.61 46.55 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.877 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.474 HG22 ' HG2' ' A' ' 12' ' ' ARG . 4.1 mp -100.28 97.02 5.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.865 HD11 HG22 ' A' ' 65' ' ' VAL . 2.7 mm? -85.48 107.57 17.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.359 -173.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.862 ' HD3' ' HG2' ' A' ' 18' ' ' GLN . 18.1 mmt180 -126.47 139.75 53.0 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.063 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' A' ' 17' ' ' SER . 2.3 mt -80.62 144.32 32.43 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 117.774 -1.57 . . . . 0.0 107.694 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 -15.39 59.24 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.673 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -75.17 -30.1 60.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.827 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.16 -11.14 20.06 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -174.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.642 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 8.7 p -87.35 165.26 15.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.939 -0.631 . . . . 0.0 110.834 175.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.862 ' HG2' ' HD3' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -159.01 -91.14 0.0 OUTLIER Pre-proline 0 C--O 1.22 -0.484 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.386 171.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 21.3 Cg_exo -23.64 100.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 124.321 3.347 . . . . 0.0 115.114 -133.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.707 ' HB2' ' HB1' ' A' ' 23' ' ' ALA . 91.4 Cg_endo -111.3 96.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.895 0 C-N-CA 124.678 3.586 . . . . 0.0 111.902 163.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.99 111.4 23.73 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 118.641 -1.224 . . . . 0.0 109.401 -171.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.24 12.86 28.19 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 -163.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.751 ' HA ' ' O ' ' A' ' 56' ' ' ASN . . . -60.14 93.74 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.887 -0.656 . . . . 0.0 110.107 174.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.655 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -68.63 94.62 0.6 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.77 174.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.616 ' HB ' HD13 ' A' ' 53' ' ' LEU . 28.5 m -82.3 108.9 15.71 Favored 'Isoleucine or valine' 0 C--O 1.261 1.662 0 C-N-CA 119.031 -1.068 . . . . 0.0 108.691 173.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.686 ' HB ' ' OE1' ' A' ' 32' ' ' GLU . 5.0 t -134.11 129.7 36.31 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.867 -175.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.64 131.14 35.9 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 117.624 -1.63 . . . . 0.0 108.33 -173.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -14.72 -52.6 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -158.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -65.83 -17.27 64.52 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.31 0.959 . . . . 0.0 111.885 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.627 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 113.36 36.46 1.46 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.7 mtp85 -81.75 86.97 6.36 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 171.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.686 ' OE1' ' HB ' ' A' ' 26' ' ' THR . 4.9 mm-40 -72.35 104.8 3.85 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.03 -173.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.618 HD21 ' O ' ' A' ' 46' ' ' GLY . 24.7 mt -85.84 -35.05 20.87 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.067 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.667 ' HA3' HD21 ' A' ' 44' ' ' LEU . . . 175.9 -171.29 44.34 Favored Glycine 0 C--N 1.349 1.258 0 C-N-CA 119.258 -1.449 . . . . 0.0 114.209 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.7 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 24.8 mtt -149.0 135.99 19.87 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.854 0.327 . . . . 0.0 111.516 -173.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 54.7 t -69.41 148.56 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.238 0.336 . . . . 0.0 111.055 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -138.84 57.28 1.68 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.106 172.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.736 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 9.0 p-10 167.09 -154.32 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.579 -176.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 62.6 mm-40 -49.74 -52.55 30.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.774 169.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.52 57.93 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 118.59 -1.767 . . . . 0.0 113.982 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.918 ' HB2' ' HE1' ' A' ' 8' ' ' PHE . 4.5 pp -132.09 131.71 42.63 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.608 0.718 . . . . 0.0 110.341 169.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB2' HD22 ' A' ' 44' ' ' LEU . . . -124.05 114.87 20.31 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.827 173.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.42 ' CZ3' ' HB2' ' A' ' 8' ' ' PHE . 50.7 m95 -72.97 88.81 1.39 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.699 ' HB2' ' CD1' ' A' ' 7' ' ' LEU . 5.9 mt -79.24 178.06 8.36 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 118.547 -1.261 . . . . 0.0 108.538 -174.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 65.7 p -147.13 88.83 1.75 Allowed 'General case' 0 N--CA 1.427 -1.575 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.387 172.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.99 ' H ' HD12 ' A' ' 7' ' ' LEU . . . 107.33 92.87 2.28 Favored Glycine 0 C--O 1.222 -0.615 0 C-N-CA 119.011 -1.566 . . . . 0.0 112.248 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.512 HG22 HD12 ' A' ' 33' ' ' LEU . 10.3 p -120.39 137.46 54.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.425 ' HB ' ' OE2' ' A' ' 51' ' ' GLU . 28.8 m -101.22 129.44 27.04 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.899 ' HB2' ' HA ' ' A' ' 69' ' ' GLU . 60.3 Cg_endo -72.99 135.38 23.08 Favored 'Trans proline' 0 C--N 1.331 -0.367 0 C-N-CA 122.907 2.405 . . . . 0.0 112.897 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.48 ' H ' HG11 ' A' ' 67' ' ' VAL . . . 96.94 35.66 5.26 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 119.46 -1.352 . . . . 0.0 113.176 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HB2' HG12 ' A' ' 67' ' ' VAL . 31.6 mt-10 -121.89 177.69 5.19 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.879 -176.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 p -122.86 90.98 3.39 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.664 165.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.616 HD13 ' HB ' ' A' ' 25' ' ' VAL . 19.6 mt -51.43 152.82 2.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.484 171.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.481 ' HB2' HD11 ' A' ' 61' ' ' ILE . 21.4 p -120.61 125.14 47.01 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 165.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.655 ' HA ' ' O ' ' A' ' 24' ' ' SER . 20.3 t -112.68 107.93 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.497 0.665 . . . . 0.0 111.275 -167.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.751 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 45.8 m-80 -76.42 139.8 41.04 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.624 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.873 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 2.4 t90 -144.59 149.66 36.16 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.503 -166.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.873 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 4.3 m-20 -19.41 -64.74 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.758 1.223 . . . . 0.0 113.243 166.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 60' ' ' LYS . . . -62.76 -36.46 93.36 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 117.719 -2.181 . . . . 0.0 113.864 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.779 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 13.1 pttp 167.77 -169.7 0.02 OUTLIER 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -172.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.3 tt -81.96 118.31 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 167.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.779 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 1.4 mt-30 -125.18 -63.06 1.18 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 115.555 -2.458 . . . . 0.0 112.511 -166.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.51 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 27.5 p -92.89 149.21 21.41 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 117.304 -1.758 . . . . 0.0 108.116 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.598 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 25.5 mt-30 -127.13 133.82 50.31 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.865 HG22 HD11 ' A' ' 11' ' ' LEU . 4.4 t -94.99 140.74 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 C-N-CA 115.522 -2.471 . . . . 0.0 113.015 -164.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -95.48 113.58 25.25 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 118.736 -1.185 . . . . 0.0 110.261 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.48 HG11 ' H ' ' A' ' 50' ' ' GLY . 8.8 p -101.8 124.22 41.19 Favored Pre-proline 0 C--O 1.219 -0.507 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.823 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 91.8 Cg_endo -88.67 171.8 4.93 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.853 3.035 . . . . 0.0 112.916 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.899 ' HA ' ' HB2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -68.78 -25.19 64.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.651 -177.51 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -76.81 28.7 0.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.127 0.489 . . . . 0.0 111.811 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.54 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -69.36 135.28 50.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.394 0.616 . . . . 0.0 110.908 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.456 HG13 ' H ' ' A' ' 73' ' ' SER . 10.7 tp -96.08 157.92 3.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.067 -173.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.456 ' H ' HG13 ' A' ' 72' ' ' ILE . 3.3 m -107.52 129.92 54.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.442 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.677 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 58.4 m-20 56.08 30.09 15.68 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -146.02 -167.7 2.79 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.282 0.563 . . . . 0.0 112.208 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.578 ' HA ' ' HB3' ' A' ' 8' ' ' PHE . 26.9 tt0 -93.32 140.51 29.47 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.606 -175.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 71' ' ' ALA . 55.0 tp -153.98 123.01 6.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.655 ' H ' HD22 ' A' ' 78' ' ' LEU . 2.3 pt? -85.5 137.0 33.19 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 118.426 -1.309 . . . . 0.0 109.549 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.544 ' HB2' HD13 ' A' ' 11' ' ' LEU . 55.5 mt -122.81 134.83 25.23 Favored Pre-proline 0 C--O 1.245 0.818 0 CA-C-O 121.7 0.762 . . . . 0.0 111.85 -175.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 92.1 Cg_endo -87.68 121.86 1.6 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.192 2.595 . . . . 0.0 112.846 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 63' ' ' CYS . 1.1 m -81.52 97.82 7.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.054 173.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.426 ' HB ' ' CD ' ' A' ' 83' ' ' PRO . 17.2 p -83.92 171.31 11.6 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.029 176.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.426 ' CD ' ' HB ' ' A' ' 82' ' ' THR . 22.6 Cg_exo -65.69 -172.31 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.564 2.176 . . . . 0.0 112.848 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.471 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 27.2 mt-30 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.564 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.811 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 7.7 ptp180 . . . . . 0 N--CA 1.448 -0.561 0 CA-C-O 117.299 -1.334 . . . . 0.0 108.645 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.673 HD12 ' HA ' ' A' ' 74' ' ' ASP 0.317 10.6 mt 172.13 -165.36 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 156.294 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 0.7 OUTLIER -66.62 127.76 33.61 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.6 -166.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.589 ' HB3' HD11 ' A' ' 44' ' ' LEU . . . -127.19 144.14 51.1 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.587 -175.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.1 mt -90.21 106.67 17.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.555 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.608 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -102.41 154.65 18.88 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.605 ' HA ' ' HG3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -142.89 154.08 43.76 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.05 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.812 HD23 HE21 ' A' ' 18' ' ' GLN . 1.7 mm? -64.07 -175.8 0.17 Allowed 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.623 0.725 . . . . 0.0 109.748 172.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.2 -27.35 66.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.025 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.95 -20.66 61.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.557 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.38 33.64 7.94 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.732 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.732 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 74.8 p -154.75 148.76 25.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.189 -0.505 . . . . 0.0 110.698 -174.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.812 HE21 HD23 ' A' ' 13' ' ' LEU . 5.6 mt-30 -167.71 132.37 1.53 Allowed Pre-proline 0 CA--C 1.503 -0.843 0 C-N-CA 123.068 0.547 . . . . 0.0 109.782 170.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -113.95 91.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.161 0 CA-C-N 119.382 0.815 . . . . 0.0 111.306 140.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.763 ' HD3' ' CB ' ' A' ' 18' ' ' GLN . 22.0 Cg_endo -116.4 94.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.781 0 C-N-CA 123.291 2.66 . . . . 0.0 113.256 163.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.51 108.57 19.47 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.887 0.851 . . . . 0.0 109.566 -174.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.48 -0.66 12.57 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -169.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -56.75 95.21 0.02 OUTLIER 'General case' 0 C--N 1.345 0.411 0 CA-C-O 121.575 0.702 . . . . 0.0 109.891 174.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -70.98 96.92 1.35 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.423 -1.717 . . . . 0.0 113.082 179.005 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.666 HG21 ' HG ' ' A' ' 44' ' ' LEU . 27.6 m -84.41 113.9 23.9 Favored 'Isoleucine or valine' 0 C--O 1.251 1.183 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.752 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -143.4 130.74 20.95 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.337 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.661 ' HA ' ' HA ' ' A' ' 53' ' ' LEU . 59.7 p -69.96 176.37 3.78 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.437 -173.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.536 ' HG2' HG22 ' A' ' 52' ' ' THR . 11.8 mm-40 -58.79 -20.34 49.09 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.018 0.437 . . . . 0.0 111.393 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.425 ' HZ2' ' CD ' ' A' ' 51' ' ' GLU . 37.5 mtmm -86.98 -17.29 33.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.0 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 98.99 18.72 23.91 Favored Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.653 ' HB2' ' OG ' ' A' ' 27' ' ' SER . 32.0 mtt180 -63.88 91.17 0.06 Allowed 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 168.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.492 ' HA ' ' HB ' ' A' ' 26' ' ' THR . 19.3 mt-10 -81.32 89.67 6.09 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.192 -177.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.513 HD23 ' HB3' ' A' ' 44' ' ' LEU . 11.1 mp -66.56 -48.79 68.54 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.696 -175.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.537 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . -177.22 -161.77 26.38 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 117.932 -2.08 . . . . 0.0 114.051 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.553 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 19.4 mtt -149.69 140.99 23.17 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -176.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 20' ' ' PRO . 43.8 t -70.03 129.05 34.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.324 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.88 92.89 3.89 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 171.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 74.73 136.22 0.06 Allowed 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.296 0.997 . . . . 0.0 111.316 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 58.24 -145.15 0.58 Allowed 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.425 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.43 61.3 0.32 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.425 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 8' ' ' PHE . 3.8 tt -134.14 112.01 10.78 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.183 -177.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.42 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -106.87 161.29 14.83 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.392 173.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.51 ' CD2' ' HB3' ' A' ' 8' ' ' PHE . 22.6 m95 -95.71 87.98 4.85 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.486 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.666 ' HG ' HG21 ' A' ' 25' ' ' VAL . 6.6 mp -90.27 88.69 7.32 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 116.857 -1.937 . . . . 0.0 111.191 -167.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.811 ' HA ' ' HB2' ' A' ' 6' ' ' ARG . 6.3 p -86.09 86.91 7.35 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 122.012 0.91 . . . . 0.0 109.179 171.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.564 ' N ' ' HB2' ' A' ' 6' ' ' ARG . . . 150.85 26.59 0.05 OUTLIER Glycine 0 C--N 1.308 -0.976 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.176 176.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.532 HG13 ' HA ' ' A' ' 6' ' ' ARG . 6.2 p -84.72 115.31 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.97 -176.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.0 m -115.8 124.81 29.37 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 172.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HA ' HG13 ' A' ' 67' ' ' VAL . 10.2 Cg_endo -53.5 133.94 55.58 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.147 2.565 . . . . 0.0 112.708 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.28 35.8 5.62 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.583 -1.294 . . . . 0.0 112.605 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' CD ' ' HZ2' ' A' ' 29' ' ' LYS . 4.5 mm-40 -116.31 179.4 4.0 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 122.298 1.047 . . . . 0.0 111.943 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.536 HG22 ' HG2' ' A' ' 28' ' ' GLU . 14.3 t -134.12 143.2 47.82 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.352 -1.749 . . . . 0.0 108.548 165.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 4.5 tp -121.72 160.0 25.43 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.065 -166.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.488 ' HB3' HD11 ' A' ' 61' ' ' ILE . 36.8 m -129.55 129.94 45.11 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 123.787 0.679 . . . . 0.0 111.214 172.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.656 HG21 ' SG ' ' A' ' 81' ' ' CYS . 14.4 t -119.33 106.15 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.152 -167.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.621 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 8.5 m-20 -76.92 85.62 3.47 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.55 177.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.806 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -82.24 147.11 29.13 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.899 176.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.806 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 18.1 m-20 -12.08 -64.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 170.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.11 -42.65 99.73 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 117.895 -2.098 . . . . 0.0 114.42 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 1.084 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 9.0 ptpt -178.8 -166.29 0.1 Allowed 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -169.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 12.7 tt -90.4 87.92 2.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 173.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 1.084 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 2.1 mt-30 -96.2 -51.93 4.21 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.896 -158.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' CYS . . . . . 0.412 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 20.5 p -105.33 158.16 16.82 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 118.185 -1.406 . . . . 0.0 108.145 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.642 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 97.1 mt-30 -132.45 142.5 49.28 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -97.54 151.55 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 C-N-CA 114.825 -2.75 . . . . 0.0 112.196 -169.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.59 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 12.7 m120 -112.09 113.42 25.69 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.357 174.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.406 HG13 ' HA ' ' A' ' 49' ' ' PRO . 56.1 t -96.82 106.75 32.65 Favored Pre-proline 0 C--O 1.224 -0.244 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.075 -177.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.22 156.08 52.76 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.208 2.605 . . . . 0.0 112.449 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -77.26 5.98 7.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.62 -170.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.7 t -130.23 -4.08 4.4 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.552 -0.459 . . . . 0.0 112.153 -172.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.557 ' HB1' HD12 ' A' ' 77' ' ' LEU . . . -94.79 152.69 18.21 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.751 -0.779 . . . . 0.0 112.675 -172.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.453 HG13 ' H ' ' A' ' 73' ' ' SER . 10.9 tp -158.16 161.9 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.803 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.453 ' H ' HG13 ' A' ' 72' ' ' ILE . 19.3 m -118.1 -105.34 0.39 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 119.182 -1.007 . . . . 0.0 113.459 -173.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.673 ' HA ' HD12 ' A' ' 7' ' ' LEU . 29.1 t70 72.13 8.23 5.86 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.284 1.04 . . . . 0.0 109.092 -165.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -169.87 -146.63 0.05 Allowed 'General case' 0 C--O 1.245 0.816 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.738 -173.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.618 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 24.9 mt-30 -78.93 136.86 37.38 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.086 0.866 . . . . 0.0 110.672 171.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.723 ' HG ' ' H ' ' A' ' 78' ' ' LEU . 37.7 tp -129.96 -179.03 4.98 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 169.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.723 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 3.2 pp -140.81 139.32 34.52 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 117.722 -1.591 . . . . 0.0 110.721 174.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 2.8 mm? -133.58 142.2 43.04 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-O 121.567 0.699 . . . . 0.0 112.699 -175.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.59 ' HG2' ' HB2' ' A' ' 66' ' ' ASN . 74.2 Cg_endo -82.47 122.13 3.54 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.892 2.394 . . . . 0.0 111.594 171.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.656 ' SG ' HG21 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -106.67 87.65 2.58 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.2 t -68.79 143.91 95.36 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.983 -175.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.34 152.39 67.34 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.725 2.283 . . . . 0.0 111.939 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.536 -177.607 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 2' ' ' LEU . 31.2 mt -119.65 66.28 0.8 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.608 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -98.28 -48.26 5.13 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 157.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.63 ' HA2' ' HB2' ' A' ' 73' ' ' SER . . . -168.07 -169.31 31.39 Favored Glycine 0 CA--C 1.48 -2.147 0 CA-C-N 113.477 -1.692 . . . . 0.0 111.287 155.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 28.8 mmtt -153.73 -140.38 0.09 Allowed 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 111.484 -2.358 . . . . 0.0 104.667 -168.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.776 ' C ' HD11 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -114.66 156.19 25.21 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 -177.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.809 HD13 ' HA2' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -144.6 -177.41 5.48 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.566 -1.253 . . . . 0.0 113.78 -162.13 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.705 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 1.2 m-85 -118.21 104.13 10.51 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.535 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.442 ' HB1' ' HG ' ' A' ' 44' ' ' LEU . . . -102.91 143.34 32.64 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.955 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.442 HG12 ' CD1' ' A' ' 41' ' ' LEU . 10.1 mt -112.82 99.79 9.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.277 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.741 HD11 HG23 ' A' ' 65' ' ' VAL . 2.4 mm? -93.38 128.66 39.53 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.407 -173.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -135.44 131.59 36.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.188 -0.605 . . . . 0.0 112.37 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.603 HD21 ' SG ' ' A' ' 81' ' ' CYS . 3.3 mm? -53.96 142.08 25.83 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 167.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.92 -26.37 67.43 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.057 -1.428 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -65.79 -25.55 67.3 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.223 0.535 . . . . 0.0 110.842 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.23 10.97 19.26 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.466 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 22.9 t -97.16 -160.61 0.81 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.473 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.523 ' C ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -139.25 134.82 16.82 Favored Pre-proline 0 CA--C 1.5 -0.96 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -172.402 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.554 ' O ' HG23 ' A' ' 36' ' ' VAL . 42.3 Cg_endo -76.38 103.27 1.72 Allowed 'Trans proline' 0 N--CA 1.429 -2.303 0 N-CA-C 104.301 -3.0 . . . . 0.0 104.301 148.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 17.6 Cg_endo -98.65 -163.75 0.07 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.276 0 C-N-CA 122.773 2.315 . . . . 0.0 111.51 -161.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.582 ' HA ' HG12 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -48.56 109.61 0.26 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.079 0.466 . . . . 0.0 111.986 -172.304 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.9 3.17 26.7 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.701 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -65.29 95.73 0.2 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.214 0.531 . . . . 0.0 109.983 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.664 ' HB2' HD21 ' A' ' 56' ' ' ASN . 2.0 m -67.62 105.61 1.93 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.301 -1.772 . . . . 0.0 110.686 173.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.529 HG13 HG22 ' A' ' 55' ' ' VAL . 26.9 m -100.52 112.24 32.64 Favored 'Isoleucine or valine' 0 C--O 1.26 1.614 0 CA-C-O 121.857 0.837 . . . . 0.0 110.204 174.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.625 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -149.5 128.96 13.01 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.574 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.449 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . 7.1 p -62.83 171.3 2.18 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.594 -175.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -68.39 -7.59 32.85 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.942 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 48.5 tptt -93.72 -14.03 26.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.267 0.556 . . . . 0.0 109.65 172.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.456 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 100.7 31.57 5.71 Favored Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.625 ' O ' ' HA ' ' A' ' 26' ' ' THR . 26.6 tpt180 -73.9 89.22 1.86 Allowed 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 173.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.481 ' HG2' ' HB ' ' A' ' 26' ' ' THR . 25.6 mt-10 -86.11 94.86 9.37 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.066 -171.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.826 HD22 HD21 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -80.78 -37.61 29.97 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.077 -178.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.621 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . 167.26 -159.45 32.8 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 117.87 -2.11 . . . . 0.0 114.855 177.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.701 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 10.5 mtm -151.81 137.52 17.92 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.891 0.876 . . . . 0.0 109.683 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 21' ' ' PHE . 55.7 t -61.83 129.51 24.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 C-N-CA 120.006 -0.677 . . . . 0.0 109.841 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.67 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -130.73 55.02 1.85 Allowed 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.456 173.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.67 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 5.0 t70 148.98 122.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 125.306 1.628 . . . . 0.0 108.198 174.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 52.13 -102.2 0.12 Allowed 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.531 0.52 . . . . 0.0 111.297 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.8 29.34 2.66 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.442 ' CD1' HG12 ' A' ' 10' ' ' ILE . 11.8 tp -103.34 111.15 23.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.419 -0.391 . . . . 0.0 110.044 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.608 ' HB3' HD21 ' A' ' 44' ' ' LEU . . . -101.94 126.61 48.88 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.282 174.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -75.08 88.96 2.44 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.771 ' HB2' HD21 ' A' ' 7' ' ' LEU . 8.1 mt -83.26 177.32 8.58 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 117.403 -1.719 . . . . 0.0 110.079 -171.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.714 ' HA ' ' HB2' ' A' ' 6' ' ' ARG . 41.8 m -138.84 85.72 2.1 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.809 ' HA2' HD13 ' A' ' 7' ' ' LEU . . . 75.61 75.93 0.81 Allowed Glycine 0 C--O 1.223 -0.554 0 C-N-CA 119.914 -1.136 . . . . 0.0 115.421 174.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.464 HG13 HG11 ' A' ' 67' ' ' VAL . 3.9 t -81.65 134.41 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.239 -0.585 . . . . 0.0 109.637 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.541 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -86.55 127.88 58.98 Favored Pre-proline 0 C--N 1.326 -0.45 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.737 179.176 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.728 ' HB2' ' HA ' ' A' ' 69' ' ' GLU . 30.9 Cg_endo -64.71 115.21 3.1 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.326 2.018 . . . . 0.0 111.899 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.28 36.24 2.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.748 -1.215 . . . . 0.0 112.697 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.541 ' HG3' ' O ' ' A' ' 48' ' ' THR . 28.5 mt-10 -116.98 176.81 4.95 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 119.146 -1.022 . . . . 0.0 112.142 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 t -127.31 92.42 3.51 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.333 168.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.826 HD21 HD22 ' A' ' 33' ' ' LEU . 9.0 mt -58.86 158.86 7.62 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 114.222 -1.353 . . . . 0.0 111.764 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.577 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 24.8 m -125.23 121.44 34.12 Favored 'General case' 0 C--N 1.317 -0.812 0 O-C-N 123.58 0.55 . . . . 0.0 109.777 168.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.67 ' O ' ' HA ' ' A' ' 61' ' ' ILE . 9.5 t -109.43 122.23 63.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-O 121.212 0.53 . . . . 0.0 111.466 -170.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.664 HD21 ' HB2' ' A' ' 24' ' ' SER . 0.8 OUTLIER -123.77 132.49 53.81 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.708 -170.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.657 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 6.7 p90 -147.23 -142.95 0.13 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 117.957 -1.497 . . . . 0.0 112.63 171.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.657 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 0.9 OUTLIER -37.5 -63.07 0.48 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.853 0.461 . . . . 0.0 111.298 167.596 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.609 ' HA3' ' NE2' ' A' ' 62' ' ' GLN . . . -80.18 0.45 83.81 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 119.126 -1.512 . . . . 0.0 110.691 176.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.619 ' C ' ' HA ' ' A' ' 56' ' ' ASN . 27.1 mttm 74.69 -140.31 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 113.898 -1.151 . . . . 0.0 113.165 173.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.67 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -77.9 98.78 2.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -174.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.609 ' NE2' ' HA3' ' A' ' 59' ' ' GLY . 1.5 mt-30 -118.92 -41.81 2.75 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 114.416 -1.266 . . . . 0.0 110.877 -173.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 17.2 p -118.24 158.1 25.77 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.73 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.706 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 24.0 mt-30 -126.9 156.53 41.3 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.741 HG23 HD11 ' A' ' 11' ' ' LEU . 2.7 t -106.75 131.92 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 114.433 -2.907 . . . . 0.0 112.562 -172.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -90.46 110.81 21.91 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.187 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.464 HG11 HG13 ' A' ' 47' ' ' VAL . 18.8 t -92.56 114.3 62.02 Favored Pre-proline 0 CA--C 1.513 -0.453 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.873 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 4.6 Cg_exo -81.51 172.7 12.2 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 124.324 3.35 . . . . 0.0 111.903 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.728 ' HA ' ' HB2' ' A' ' 49' ' ' PRO . 40.6 mt-10 -72.68 -6.87 47.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.814 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 68' ' ' PRO . 10.7 t -85.07 18.63 2.45 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.929 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.657 ' HA ' HD22 ' A' ' 77' ' ' LEU . . . -66.25 153.5 42.38 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.617 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.25 167.98 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.909 -173.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.63 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 47.5 t -101.29 143.33 31.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.787 -175.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 51.83 23.45 2.08 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -134.05 173.11 11.94 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.322 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.705 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 74.9 mt-30 -86.25 142.0 28.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.701 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.657 HD22 ' HA ' ' A' ' 71' ' ' ALA . 50.9 tp -150.74 116.6 5.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.644 HD11 ' H ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -82.72 141.7 32.2 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 118.332 -1.347 . . . . 0.0 109.454 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.403 ' HB2' ' CD1' ' A' ' 11' ' ' LEU . 95.2 mt -131.46 147.84 67.71 Favored Pre-proline 0 C--O 1.247 0.97 0 CA-C-O 121.109 0.48 . . . . 0.0 111.962 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.0 109.91 2.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.576 2.851 . . . . 0.0 113.309 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.603 ' SG ' HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -91.06 93.46 9.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.279 172.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.5 m -97.3 126.29 42.36 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.397 -175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -61.12 148.68 92.17 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.758 2.305 . . . . 0.0 111.767 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -66.74 -30.64 70.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.561 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.7 mptt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.461 -0.781 . . . . 0.0 110.189 177.254 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 82.7 mt -60.44 117.97 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.514 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . 4.3 mmmm -93.37 53.79 1.97 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -166.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.85 177.11 33.12 Favored Glycine 0 CA--C 1.474 -2.524 0 C-N-CA 117.812 -2.137 . . . . 0.0 113.599 163.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.867 ' HD3' ' HB2' ' A' ' 74' ' ' ASP . 46.8 tttm -155.54 -141.77 0.1 Allowed 'General case' 0 N--CA 1.406 -2.675 0 CA-C-N 110.532 -2.834 . . . . 0.0 103.384 -171.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 1.105 ' HB2' ' HB2' ' A' ' 45' ' ' SER . 0.0 OUTLIER -88.56 -177.5 5.6 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 -175.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.706 ' N ' ' HG3' ' A' ' 6' ' ' ARG . 1.7 tt -141.08 114.3 8.63 Favored 'General case' 0 N--CA 1.387 -3.62 0 C-N-CA 117.126 -1.829 . . . . 0.0 114.761 -144.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.688 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 2.1 m-85 -119.27 88.77 3.0 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.56 ' HB3' HD21 ' A' ' 79' ' ' LEU . . . -100.38 102.11 13.26 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -170.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 51.5 mt -80.93 98.28 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.565 HD12 ' HG2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -114.41 146.04 41.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.861 -172.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -137.11 147.93 46.36 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.104 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.525 HD12 ' SG ' ' A' ' 81' ' ' CYS . 4.5 mm? -66.15 146.85 54.17 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.71 -27.34 67.82 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.757 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.18 -18.84 63.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.536 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.17 -6.24 25.22 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.8 -163.65 0.75 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.153 -0.524 . . . . 0.0 110.741 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.55 ' HG2' ' HA3' ' A' ' 40' ' ' GLY . 2.8 mt-30 -136.81 145.24 50.06 Favored Pre-proline 0 CA--C 1.506 -0.747 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -172.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.672 ' O ' HG23 ' A' ' 36' ' ' VAL . 6.2 Cg_exo -74.53 103.62 1.73 Allowed 'Trans proline' 0 N--CA 1.431 -2.188 0 N-CA-C 104.796 -2.809 . . . . 0.0 104.796 148.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 19.4 Cg_endo -103.13 -177.69 0.11 Allowed 'Trans proline' 0 N--CA 1.43 -2.236 0 C-N-CA 123.277 2.651 . . . . 0.0 111.99 -165.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.655 ' HA ' HG13 ' A' ' 36' ' ' VAL . 31.0 t80 -41.65 117.43 0.92 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -168.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.67 8.46 57.19 Favored Glycine 0 N--CA 1.436 -1.367 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.74 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -59.0 94.76 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.789 -0.706 . . . . 0.0 109.393 171.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.781 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 3.8 m -57.46 93.01 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 113.341 -1.754 . . . . 0.0 111.546 172.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.973 HG23 ' C ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -89.04 95.18 5.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.634 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.722 ' HB ' ' HG2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -128.33 130.94 48.53 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.66 -174.021 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.5 p -65.42 172.07 3.51 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 118.567 -1.253 . . . . 0.0 109.553 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.61 -18.23 51.78 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.912 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -93.71 -8.79 39.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.839 0.352 . . . . 0.0 110.87 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.444 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 102.12 23.92 8.82 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.164 174.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.648 ' O ' ' HA ' ' A' ' 26' ' ' THR . 39.7 mtm105 -73.73 88.51 1.75 Allowed 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 118.212 -1.395 . . . . 0.0 108.57 170.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.722 ' HG2' ' HB ' ' A' ' 26' ' ' THR . 15.8 mt-10 -83.52 77.9 9.75 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.636 HD11 HH11 ' A' ' 31' ' ' ARG . 96.2 mt -121.11 12.39 11.08 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.816 -167.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 1.03 ' HA2' ' HB2' ' A' ' 44' ' ' LEU . . . -138.02 149.82 20.63 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.468 163.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.74 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 30.9 mtm -154.14 126.28 7.85 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 160.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 19' ' ' PRO . 32.3 t -60.89 135.32 25.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 O-C-N 123.649 0.593 . . . . 0.0 111.518 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -136.59 116.91 13.59 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 172.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 20.5 m-20 72.41 116.91 0.05 OUTLIER 'General case' 0 C--O 1.234 0.255 0 O-C-N 124.199 0.937 . . . . 0.0 111.101 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 62.87 -95.23 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.857 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.55 ' HA3' ' HG2' ' A' ' 18' ' ' GLN . . . -160.94 53.1 0.33 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 118.807 -1.663 . . . . 0.0 114.001 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.637 HD12 ' HE1' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -141.74 139.48 32.86 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.416 170.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.669 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -84.83 122.94 29.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.342 0.592 . . . . 0.0 111.719 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.637 ' HE1' HD12 ' A' ' 41' ' ' LEU . 58.9 m95 -97.03 88.13 4.42 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.268 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 1.03 ' HB2' ' HA2' ' A' ' 34' ' ' GLY . 1.2 mt -156.94 -166.65 2.14 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -169.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 1.105 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 1.1 t -153.57 106.38 2.91 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.281 -171.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.565 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 140.36 76.17 0.05 OUTLIER Glycine 0 CA--C 1.521 0.449 0 C-N-CA 119.707 -1.235 . . . . 0.0 113.93 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.552 ' HB ' HD12 ' A' ' 7' ' ' LEU . 12.9 p -120.84 143.64 32.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.895 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.2 m -117.08 129.48 25.29 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.82 0.343 . . . . 0.0 110.332 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.556 ' HA ' HG13 ' A' ' 67' ' ' VAL . 44.1 Cg_endo -68.56 129.01 18.07 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.569 2.179 . . . . 0.0 112.136 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.47 36.38 5.91 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.155 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -128.02 173.3 10.16 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 118.055 -1.458 . . . . 0.0 113.731 -170.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 p -121.09 89.8 3.2 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.089 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.559 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 25.6 mt -68.1 151.92 46.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.075 174.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.483 ' HB2' HD12 ' A' ' 61' ' ' ILE . 34.5 p -122.88 121.95 37.43 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.938 0.875 . . . . 0.0 110.593 170.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.781 ' HA ' ' O ' ' A' ' 24' ' ' SER . 4.8 t -120.08 117.95 55.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.465 -162.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.653 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 35.0 m-80 -103.51 148.75 25.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.922 -173.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 6.2 p90 -161.84 -138.21 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 120.263 -0.575 . . . . 0.0 112.528 161.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.676 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 30.8 t70 -41.72 -58.12 2.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.277 0.631 . . . . 0.0 111.495 168.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA3' ' NE2' ' A' ' 62' ' ' GLN . . . -80.55 -1.47 88.9 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 119.288 -1.434 . . . . 0.0 110.302 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 37.8 mtmt 71.18 -142.26 0.06 Allowed 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 113.938 -1.131 . . . . 0.0 110.74 173.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.483 HD12 ' HB2' ' A' ' 54' ' ' SER . 0.5 OUTLIER -67.98 95.35 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-O 123.414 1.578 . . . . 0.0 107.937 -177.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.554 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 4.7 pt20 -139.04 -37.3 0.52 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.434 -1.712 . . . . 0.0 111.129 -170.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.656 ' SG ' ' HG3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -87.56 142.85 27.54 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 166.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -140.09 124.64 18.07 Favored 'General case' 0 CA--C 1.478 -1.789 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.559 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 22.2 t -98.93 132.1 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.111 0 C-N-CA 114.639 -2.824 . . . . 0.0 112.278 -168.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -101.05 102.48 13.46 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 118.039 -1.464 . . . . 0.0 110.279 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.556 HG13 ' HA ' ' A' ' 49' ' ' PRO . 40.6 t -75.25 126.57 87.71 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.025 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.515 ' HB2' HG23 ' A' ' 70' ' ' THR . 9.8 Cg_endo -90.16 171.02 3.92 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.663 2.909 . . . . 0.0 111.93 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.32 0.26 22.92 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 111.596 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.515 HG23 ' HB2' ' A' ' 68' ' ' PRO . 8.8 t -93.42 16.03 14.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.192 0.52 . . . . 0.0 110.326 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.09 152.92 38.54 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.712 0.768 . . . . 0.0 111.711 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 59.1 mt -121.12 137.67 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.91 -174.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -88.53 140.39 29.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.382 -173.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.867 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 23.0 t70 71.76 -4.22 1.97 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.217 0.532 . . . . 0.0 112.246 170.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.857 HE21 ' HA ' ' A' ' 75' ' ' GLN . 0.0 OUTLIER -112.7 -166.05 1.05 Allowed 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.34 0.591 . . . . 0.0 110.829 -177.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.688 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 30.0 pt20 -97.69 134.84 40.33 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.921 173.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 78' ' ' LEU . 1.6 tm? -142.9 141.91 31.62 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -88.16 132.81 34.19 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.393 -177.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.56 HD21 ' HB3' ' A' ' 9' ' ' ALA . 3.4 mm? -117.98 139.62 26.78 Favored Pre-proline 0 C--O 1.241 0.657 0 CA-C-O 121.233 0.539 . . . . 0.0 111.496 -176.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 73.3 Cg_endo -87.99 120.27 1.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.051 2.501 . . . . 0.0 112.278 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.525 ' SG ' HD12 ' A' ' 13' ' ' LEU . 8.8 t -89.04 120.31 30.33 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.853 176.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 m -97.52 134.78 22.14 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 170.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -63.17 152.14 81.2 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.46 2.107 . . . . 0.0 112.732 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.447 HE21 ' HB3' ' A' ' 84' ' ' GLN . 3.4 tt0 -60.53 127.62 32.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.17 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.454 175.206 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.848 HG11 ' H ' ' A' ' 2' ' ' LEU . 2.5 p . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.848 ' H ' HG11 ' A' ' 1' ' ' VAL . 3.8 tt -101.77 -56.57 2.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 170.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -91.23 157.6 17.07 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 163.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.458 ' HA3' ' HB2' ' A' ' 73' ' ' SER . . . -77.9 160.42 48.5 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.072 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.901 ' HG2' ' HA3' ' A' ' 46' ' ' GLY . 20.7 mtpp -154.1 72.03 0.87 Allowed 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.861 ' C ' HD22 ' A' ' 7' ' ' LEU . 90.7 mtt-85 -177.2 114.73 0.09 Allowed 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 165.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.861 HD22 ' C ' ' A' ' 6' ' ' ARG . 0.9 OUTLIER -123.01 172.02 8.82 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 115.737 -2.385 . . . . 0.0 109.006 -170.476 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.786 ' HB2' ' HA ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -92.24 87.13 5.96 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.524 -1.67 . . . . 0.0 108.095 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.822 ' HB1' HD12 ' A' ' 44' ' ' LEU . . . -98.32 112.08 24.2 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 118.969 -1.093 . . . . 0.0 111.462 -173.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.43 HG12 ' HG ' ' A' ' 41' ' ' LEU . 59.2 mt -100.65 90.67 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.476 171.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.444 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -103.06 132.27 49.45 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.426 -175.335 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.78 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 58.7 mtm-85 -141.67 155.09 45.7 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.265 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.644 HD23 ' HD3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -89.99 135.23 33.77 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 117.888 -1.525 . . . . 0.0 109.028 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.53 -11.64 3.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.797 -169.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -67.29 -19.0 65.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.433 0.635 . . . . 0.0 110.596 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.7 -8.98 21.79 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -174.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.478 ' CB ' ' HG ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -82.61 -177.9 6.87 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 113.922 -1.139 . . . . 0.0 111.824 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.697 ' NE2' ' HB2' ' A' ' 39' ' ' GLU . 1.2 mt-30 -135.4 142.65 42.15 Favored Pre-proline 0 CA--C 1.503 -0.857 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.949 -176.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.78 ' HD3' ' HA ' ' A' ' 12' ' ' ARG . 3.6 Cg_endo -80.37 102.72 1.45 Allowed 'Trans proline' 0 N--CA 1.423 -2.668 0 N-CA-C 104.848 -2.789 . . . . 0.0 104.848 156.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.694 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 1.9 Cg_endo -101.63 175.76 0.23 Allowed 'Trans proline' 0 N--CA 1.422 -2.715 0 C-N-CA 122.836 2.357 . . . . 0.0 111.047 -162.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 37' ' ' ALA . 82.5 t80 -30.42 99.74 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 124.231 0.957 . . . . 0.0 113.306 -169.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.72 10.85 8.17 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.663 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.9 ' HB2' HG13 ' A' ' 36' ' ' VAL . . . -58.94 95.86 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.227 175.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.613 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -77.8 98.41 5.54 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.714 -1.585 . . . . 0.0 112.117 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.509 HG11 HG23 ' A' ' 55' ' ' VAL . 11.8 m -103.68 115.19 45.16 Favored 'Isoleucine or valine' 0 C--O 1.259 1.563 0 CA-C-O 121.319 0.581 . . . . 0.0 111.85 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.638 ' OG1' ' HA2' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -147.21 125.98 12.65 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.257 175.853 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.608 ' CB ' ' HE2' ' A' ' 29' ' ' LYS . 27.2 m -53.07 168.48 0.13 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 123.17 0.293 . . . . 0.0 111.385 -173.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.437 ' CD ' ' HG3' ' A' ' 29' ' ' LYS . 5.9 pm0 -59.75 -20.31 55.78 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.982 -0.448 . . . . 0.0 112.048 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.608 ' HE2' ' CB ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -103.03 4.55 37.38 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.686 176.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.638 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 86.15 43.06 6.42 Favored Glycine 0 N--CA 1.418 -2.541 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 174.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.966 ' HE ' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -94.7 97.34 10.0 Favored 'General case' 0 N--CA 1.421 -1.897 0 C-N-CA 117.521 -1.672 . . . . 0.0 107.12 166.028 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -96.15 111.18 23.3 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.16 -159.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.737 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 5.9 mp -84.64 -49.94 8.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.383 -174.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.6 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . 168.86 -155.93 26.84 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 117.041 -2.504 . . . . 0.0 114.888 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.797 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 17.1 mtp -149.84 128.28 12.22 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -173.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.9 HG13 ' HB2' ' A' ' 23' ' ' ALA . 6.3 m -71.37 130.04 35.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.105 -173.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.42 ' HA ' ' HD1' ' A' ' 21' ' ' PHE . . . -121.64 55.85 1.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.807 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 20.6 t0 150.31 139.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 O-C-N 125.36 1.662 . . . . 0.0 107.572 176.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.697 ' HB2' ' NE2' ' A' ' 18' ' ' GLN . 0.5 OUTLIER 28.12 -100.26 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 O-C-N 124.757 1.285 . . . . 0.0 111.781 -167.379 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.659 ' H ' ' CG ' ' A' ' 39' ' ' GLU . . . -136.07 48.84 0.9 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 173.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.43 ' HG ' HG12 ' A' ' 10' ' ' ILE . 2.6 tt -116.42 117.48 30.05 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.984 0.421 . . . . 0.0 111.039 -178.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.567 ' HB3' ' CD1' ' A' ' 44' ' ' LEU . . . -125.57 154.75 41.74 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 171.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.588 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 64.6 m95 -84.21 88.11 7.2 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.822 HD12 ' HB1' ' A' ' 9' ' ' ALA . 6.3 mp -73.68 102.26 3.89 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.873 -169.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.798 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 6.4 m -56.71 87.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.086 0.866 . . . . 0.0 111.919 -176.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.901 ' HA3' ' HG2' ' A' ' 5' ' ' LYS . . . 56.58 91.35 0.01 OUTLIER Glycine 0 C--N 1.339 0.722 0 CA-C-N 114.683 -1.144 . . . . 0.0 114.341 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.751 HG22 HD12 ' A' ' 7' ' ' LEU . 4.6 t -72.02 145.72 11.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.569 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.3 118.52 72.26 Favored Pre-proline 0 N--CA 1.442 -0.847 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.967 ' HB2' ' HA ' ' A' ' 69' ' ' GLU . 73.1 Cg_endo -71.48 109.37 2.6 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.451 2.101 . . . . 0.0 112.197 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.44 34.95 1.04 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.098 -1.525 . . . . 0.0 113.524 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -164.66 179.99 6.26 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 117.477 -1.689 . . . . 0.0 114.121 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.813 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 21.0 p -111.63 124.98 53.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.823 -174.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.602 ' H ' HD23 ' A' ' 53' ' ' LEU . 1.1 mm? -83.14 134.79 34.98 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.57 ' HB3' HD13 ' A' ' 61' ' ' ILE . 3.1 m -72.33 103.51 3.44 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.613 ' HA ' ' O ' ' A' ' 24' ' ' SER . 46.3 t -103.18 94.42 3.2 Favored 'Isoleucine or valine' 0 C--O 1.249 1.058 0 CA-C-O 122.145 0.974 . . . . 0.0 111.278 -172.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.623 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 43.0 m-80 -73.65 131.67 41.91 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.271 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.64 ' HB3' ' HG3' ' A' ' 62' ' ' GLN . 1.7 t90 -148.39 134.56 19.34 Favored 'General case' 0 C--O 1.208 -1.125 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.666 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.614 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 2.6 p30 -12.58 -58.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -173.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.487 ' N ' ' NE2' ' A' ' 62' ' ' GLN . . . -61.05 -23.79 62.16 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 118.397 -1.859 . . . . 0.0 114.282 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.996 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 11.1 pttt 173.36 -141.83 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.732 0.777 . . . . 0.0 110.265 -170.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.623 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 11.8 tt -115.1 93.95 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 162.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.996 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 6.6 mt-30 -92.15 -19.51 22.2 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 117.289 -1.764 . . . . 0.0 113.285 -150.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.554 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 23.7 p -147.92 159.92 43.36 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.915 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.599 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 47.5 mt-30 -129.82 119.42 23.33 Favored 'General case' 0 CA--C 1.478 -1.824 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.813 ' O ' ' HA ' ' A' ' 52' ' ' THR . 2.6 t -78.19 123.47 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 C-N-CA 116.804 -1.958 . . . . 0.0 112.025 -167.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -91.32 133.21 35.62 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.023 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.691 HG23 HG11 ' A' ' 47' ' ' VAL . 62.1 t -121.53 134.54 24.59 Favored Pre-proline 0 N--CA 1.44 -0.966 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.768 -173.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 6.5 Cg_endo -92.26 172.76 2.38 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.393 3.395 . . . . 0.0 111.798 171.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.967 ' HA ' ' HB2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -63.6 -14.95 56.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.149 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.5 p -62.42 -21.55 65.49 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.27 138.71 33.47 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.366 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 mm -130.48 -82.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.888 -170.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.86 ' HA ' HD23 ' A' ' 7' ' ' LEU . 24.0 p -172.05 137.67 0.96 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.511 -175.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.795 ' N ' HD23 ' A' ' 7' ' ' LEU . 5.2 m-20 55.89 -163.23 0.15 Allowed 'General case' 0 C--N 1.362 1.142 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -172.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 8' ' ' PHE . 42.4 mt-30 65.73 150.3 0.05 OUTLIER 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.649 0.738 . . . . 0.0 112.3 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.786 ' HA ' ' HB2' ' A' ' 8' ' ' PHE . 22.1 mp0 -76.75 124.12 27.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.464 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.77 116.88 10.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.7 tt -85.98 127.13 34.57 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.018 -177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 81.9 mt -113.61 141.86 26.7 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 121.108 0.48 . . . . 0.0 111.704 -174.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 67.7 Cg_endo -91.38 120.39 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.349 2.699 . . . . 0.0 113.196 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.663 ' SG ' ' HG3' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -82.58 116.24 21.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.384 175.057 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.3 m -82.85 117.1 67.47 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.155 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.48 158.82 22.47 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.814 2.343 . . . . 0.0 112.268 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -134.37 -76.28 0.47 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.421 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.573 179.041 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 111.324 0.12 . . . . 0.0 111.324 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.28 -52.26 66.03 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.215 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -104.96 21.07 17.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.653 0.74 . . . . 0.0 109.893 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.546 ' HA3' ' OG ' ' A' ' 73' ' ' SER . . . 90.8 -112.48 4.11 Favored Glycine 0 CA--C 1.494 -1.27 0 CA-C-O 122.587 1.104 . . . . 0.0 114.423 173.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.542 ' HG3' ' HB2' ' A' ' 74' ' ' ASP . 33.5 mmtp -150.01 -146.34 0.2 Allowed 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 112.253 -1.974 . . . . 0.0 106.468 -160.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.814 ' C ' HD13 ' A' ' 7' ' ' LEU . 25.7 mtm180 -119.84 165.13 14.98 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 102.389 -3.189 . . . . 0.0 102.389 167.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.931 HD22 ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -149.67 177.68 9.55 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 117.714 -1.594 . . . . 0.0 113.164 -168.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 1.3 m-85 -126.78 89.64 3.02 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.697 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 77' ' ' LEU . . . -93.36 134.33 35.69 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.638 -170.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.589 ' HB ' ' HG ' ' A' ' 78' ' ' LEU . 4.2 mp -96.77 111.79 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.691 173.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.697 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 65.4 mt -92.51 131.29 37.77 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.543 -175.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.516 ' HD3' ' O ' ' A' ' 17' ' ' SER . 6.2 tpp180 -137.81 123.56 19.92 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.477 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.69 HD12 ' SG ' ' A' ' 81' ' ' CYS . 4.2 mm? -53.99 144.27 19.56 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 168.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.07 -30.28 66.08 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.218 -1.356 . . . . 0.0 111.211 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -79.02 -13.01 60.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.668 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.25 -11.71 16.88 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.159 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.516 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 30.9 p -81.83 -164.58 0.82 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.465 0.632 . . . . 0.0 110.108 175.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.631 ' C ' HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -129.93 141.38 41.65 Favored Pre-proline 0 CA--C 1.504 -0.815 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -172.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.697 ' HG2' ' HB3' ' A' ' 11' ' ' LEU . 5.4 Cg_exo -78.41 103.66 1.71 Allowed 'Trans proline' 0 N--CA 1.436 -1.888 0 N-CA-C 105.617 -2.494 . . . . 0.0 105.617 153.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -104.27 -161.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 123.563 2.842 . . . . 0.0 111.799 -163.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.467 ' HA ' HG12 ' A' ' 36' ' ' VAL . 38.2 t80 -48.9 114.83 1.07 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.409 0.623 . . . . 0.0 112.585 -169.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.69 -18.86 14.66 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.653 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -53.3 96.43 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 124.505 0.768 . . . . 0.0 110.975 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.752 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -72.68 88.8 1.3 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.444 -1.707 . . . . 0.0 111.653 175.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.401 ' HB ' HD22 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -74.49 88.99 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.774 169.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.734 ' HB ' ' O ' ' A' ' 31' ' ' ARG . 7.2 p -148.27 143.89 27.26 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.794 ' HG ' ' HB2' ' A' ' 31' ' ' ARG . 96.3 p -71.39 178.3 3.5 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 116.953 -1.899 . . . . 0.0 109.913 -175.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.43 ' H ' ' CD ' ' A' ' 28' ' ' GLU . 2.1 mp0 -56.55 -28.69 60.7 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.849 0.357 . . . . 0.0 111.603 -171.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 29' ' ' LYS . 1.9 mptp? -85.37 -15.48 43.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.197 0.522 . . . . 0.0 110.807 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.53 10.43 35.78 Favored Glycine 0 CA--C 1.485 -1.818 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.794 ' HB2' ' HG ' ' A' ' 27' ' ' SER . 93.2 mtt180 -63.95 -178.3 0.31 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.671 -1.265 . . . . 0.0 109.339 169.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 0.6 OUTLIER 87.27 -158.67 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 164.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.916 HD13 HD23 ' A' ' 53' ' ' LEU . 6.8 mp -83.84 -48.67 9.81 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -144.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.765 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . 154.53 -141.4 8.17 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.988 -175.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.765 ' HG3' ' C ' ' A' ' 34' ' ' GLY . 6.9 mtt -148.6 142.66 25.93 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 117.517 0.658 . . . . 0.0 111.529 -173.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.614 HG21 HD13 ' A' ' 11' ' ' LEU . 55.5 t -66.18 130.61 31.65 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.519 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.463 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . . . -121.17 58.5 0.97 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.635 0.731 . . . . 0.0 109.332 172.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.575 ' CG ' ' H ' ' A' ' 39' ' ' GLU . 25.6 t70 178.68 -167.7 0.07 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.182 -174.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.575 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 10.1 pt-20 -85.51 1.81 47.34 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 122.091 -0.381 . . . . 0.0 111.539 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.45 ' HA3' ' HG2' ' A' ' 18' ' ' GLN . . . 174.72 25.1 0.03 OUTLIER Glycine 0 C--N 1.332 0.31 0 C-N-CA 119.143 -1.503 . . . . 0.0 112.995 175.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.474 ' H ' HG11 ' A' ' 36' ' ' VAL . 35.0 tp -133.19 121.69 22.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.57 0.224 . . . . 0.0 111.017 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.675 ' CB ' HD22 ' A' ' 44' ' ' LEU . . . -111.13 128.93 56.05 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.167 176.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -85.12 100.16 11.54 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.931 ' HB2' HD22 ' A' ' 7' ' ' LEU . 35.7 mt -111.15 178.55 4.31 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 118.467 -1.293 . . . . 0.0 111.657 -163.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.538 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 21.1 p -132.22 88.56 2.56 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.4 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.728 ' CA ' HD12 ' A' ' 7' ' ' LEU . . . 86.78 142.56 7.21 Favored Glycine 0 N--CA 1.464 0.56 0 C-N-CA 119.102 -1.523 . . . . 0.0 113.619 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.618 HG11 HD22 ' A' ' 33' ' ' LEU . 16.2 m -122.3 152.61 26.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 120.575 0.226 . . . . 0.0 110.71 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -111.77 109.98 55.04 Favored Pre-proline 0 C--N 1.324 -0.526 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.741 170.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.6 133.93 27.06 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 123.902 3.068 . . . . 0.0 113.069 -173.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.86 34.9 17.27 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 119.507 -1.33 . . . . 0.0 112.474 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -127.32 -173.13 2.82 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 121.852 0.834 . . . . 0.0 112.476 -175.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 22.7 m -130.94 108.58 9.92 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.986 170.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.916 HD23 HD13 ' A' ' 33' ' ' LEU . 5.0 mt -69.36 158.8 34.37 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.793 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.632 ' HB2' ' O ' ' A' ' 26' ' ' THR . 73.5 m -102.25 154.6 18.88 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 159.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.752 ' HA ' ' O ' ' A' ' 24' ' ' SER . 21.5 t -137.92 92.77 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.925 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.652 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.609 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -82.22 109.61 16.65 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.573 -177.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.858 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 1.2 t90 -119.47 153.34 35.44 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.79 -1.55 . . . . 0.0 110.172 -168.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.858 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 15.6 t70 -15.62 -68.23 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.905 1.282 . . . . 0.0 113.176 169.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.74 -41.49 99.07 Favored Glycine 0 C--N 1.346 1.097 0 C-N-CA 117.966 -2.064 . . . . 0.0 113.68 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 1.057 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 0.1 OUTLIER 172.91 -168.79 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.863 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -170.105 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.609 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -87.99 91.57 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 C-N-CA 117.678 -1.609 . . . . 0.0 107.224 173.791 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 1.057 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 3.7 mt-30 -99.39 -41.44 7.41 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.319 -159.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.583 ' SG ' ' HG3' ' A' ' 19' ' ' PRO . 9.1 m -94.95 152.45 18.33 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.239 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.418 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 89.4 mt-30 -133.48 134.8 43.96 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 161.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.6 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 78.2 t -100.0 143.56 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 C-N-CA 114.28 -2.968 . . . . 0.0 112.391 -168.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.401 HD21 ' HA ' ' A' ' 66' ' ' ASN . 0.5 OUTLIER -94.35 110.01 21.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 117.651 -1.619 . . . . 0.0 110.665 171.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.432 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 4.6 t -86.54 117.22 68.33 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.604 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 71' ' ' ALA . 6.0 Cg_exo -79.36 163.27 24.85 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.942 2.428 . . . . 0.0 111.839 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -80.16 -6.2 57.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.177 0.513 . . . . 0.0 110.398 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 p -92.16 -4.3 54.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.984 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . . . -74.21 157.24 36.25 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.221 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.4 tp -144.42 149.43 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.569 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.546 ' OG ' ' HA3' ' A' ' 4' ' ' GLY . 33.4 m -86.53 170.05 12.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.177 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.542 ' HB2' ' HG3' ' A' ' 5' ' ' LYS . 28.1 t0 70.91 147.72 0.08 Allowed 'General case' 0 C--N 1.348 0.52 0 O-C-N 123.671 0.607 . . . . 0.0 109.557 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.413 ' HB3' ' H ' ' A' ' 76' ' ' GLN . 25.5 mp0 62.73 -166.96 0.22 Allowed 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.55 0.691 . . . . 0.0 111.824 -174.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 4.4 pt20 -90.88 143.56 26.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.692 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 39.6 tp -141.58 117.36 10.42 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -175.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.589 ' HG ' ' HB ' ' A' ' 10' ' ' ILE . 6.0 mp -84.79 128.72 34.75 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 118.864 -1.134 . . . . 0.0 109.8 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.582 ' HB3' HG12 ' A' ' 65' ' ' VAL . 83.2 mt -112.84 132.19 22.41 Favored Pre-proline 0 C--O 1.246 0.906 0 CA-C-O 121.212 0.53 . . . . 0.0 111.915 -176.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.435 ' O ' HG13 ' A' ' 65' ' ' VAL . 73.5 Cg_endo -83.57 113.3 1.96 Allowed 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 123.396 2.731 . . . . 0.0 112.675 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.69 ' SG ' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -80.5 120.47 24.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.681 175.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 64.3 p -95.17 130.73 31.68 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 170.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.455 ' C ' ' H ' ' A' ' 85' ' ' LYS . 11.3 Cg_exo -70.51 114.02 3.69 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.564 2.176 . . . . 0.0 111.264 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.4 HE21 ' HB2' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -75.21 17.72 0.24 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.988 0.423 . . . . 0.0 111.445 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.455 ' H ' ' C ' ' A' ' 83' ' ' PRO . 77.9 mttt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.751 -0.642 . . . . 0.0 109.706 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.12 144.19 33.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.244 -0.983 . . . . 0.0 110.194 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -170.12 179.82 3.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.62 123.97 4.71 Favored Glycine 0 CA--C 1.48 -2.142 0 C-N-CA 118.744 -1.694 . . . . 0.0 111.768 166.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.5 ' HD2' ' OD1' ' A' ' 74' ' ' ASP . 37.5 ttmt -79.61 173.77 12.25 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 151.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.795 ' HG3' ' H ' ' A' ' 45' ' ' SER . 0.6 OUTLIER -54.72 154.68 4.8 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.968 174.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 1.036 ' HG ' ' HB3' ' A' ' 45' ' ' SER . 13.6 mt -114.43 167.56 10.62 Favored 'General case' 0 CA--C 1.483 -1.633 0 C-N-CA 116.668 -2.013 . . . . 0.0 114.676 -167.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 1.082 ' HB3' ' HA ' ' A' ' 76' ' ' GLN . 30.2 t80 -81.69 85.92 6.5 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 170.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.12 106.76 19.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.394 0.616 . . . . 0.0 111.886 -167.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.453 HD13 ' HG ' ' A' ' 78' ' ' LEU . 45.9 mt -98.12 96.88 5.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.246 170.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.755 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 71.6 mt -93.79 148.0 22.54 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.844 -174.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' A' ' 17' ' ' SER . 18.8 ttt180 -160.59 142.49 12.52 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 118.566 -1.254 . . . . 0.0 112.348 172.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.654 HD22 ' C ' ' A' ' 18' ' ' GLN . 4.6 mm? -64.83 142.6 58.38 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.677 0.751 . . . . 0.0 109.209 174.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.71 -28.57 69.51 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.943 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.1 -16.35 61.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.298 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.71 -13.9 20.14 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.395 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.478 ' C ' ' HB2' ' A' ' 13' ' ' LEU . 13.2 t -75.74 -168.54 0.88 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.654 ' C ' HD22 ' A' ' 13' ' ' LEU . 1.4 mm-40 -142.45 148.1 45.82 Favored Pre-proline 0 CA--C 1.5 -0.955 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -173.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.755 ' HG2' ' HB3' ' A' ' 11' ' ' LEU . 1.2 Cg_endo -83.18 100.99 0.95 Allowed 'Trans proline' 0 N--CA 1.433 -2.074 0 N-CA-C 106.551 -2.134 . . . . 0.0 106.551 156.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.571 ' HD2' ' CD2' ' A' ' 57' ' ' TRP . 0.2 OUTLIER -106.75 -172.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.332 0 C-N-CA 124.017 3.145 . . . . 0.0 111.573 -167.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.447 ' HD1' ' H ' ' A' ' 38' ' ' ASP . 69.3 t80 -30.23 107.12 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -167.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.34 10.29 27.77 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.588 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.846 ' HB1' HG13 ' A' ' 36' ' ' VAL . . . -61.84 89.62 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 124.142 0.554 . . . . 0.0 111.615 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.848 ' OG ' ' HB3' ' A' ' 56' ' ' ASN . 48.2 p -62.04 131.68 50.38 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.124 0.89 . . . . 0.0 109.093 175.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.743 ' CG2' ' HA3' ' A' ' 34' ' ' GLY . 19.1 m -113.18 114.27 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 117.718 -1.593 . . . . 0.0 110.299 165.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.814 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 1.2 t -140.54 118.55 11.88 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.113 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.569 ' OG ' ' HB2' ' A' ' 31' ' ' ARG . 20.5 p -76.61 -171.69 1.95 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.801 -170.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -34.89 -62.63 0.36 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.087 0.955 . . . . 0.0 113.527 -171.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -75.39 -24.52 57.23 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.932 0.396 . . . . 0.0 111.479 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.645 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 119.88 42.81 0.51 Allowed Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 -172.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.814 ' O ' ' HA ' ' A' ' 26' ' ' THR . 8.8 tpp180 -69.99 99.04 1.37 Allowed 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -91.01 107.85 19.48 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.055 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.94 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -126.28 -16.64 5.4 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.671 -174.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 1.096 ' HA2' ' HB3' ' A' ' 44' ' ' LEU . . . -137.62 152.9 21.83 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 119.062 -1.542 . . . . 0.0 116.646 -169.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.784 ' N ' HD13 ' A' ' 44' ' ' LEU . 13.8 mtt -163.62 99.82 0.9 Allowed 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 125.446 1.499 . . . . 0.0 107.189 172.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.846 HG13 ' HB1' ' A' ' 23' ' ' ALA . 5.6 m -67.84 140.44 19.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 C-N-CA 118.616 -1.234 . . . . 0.0 110.811 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.88 113.67 19.44 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.441 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.447 ' H ' ' HD1' ' A' ' 21' ' ' PHE . 38.9 t70 72.81 125.38 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 O-C-N 124.371 1.044 . . . . 0.0 110.717 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 65.8 -85.14 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.684 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.516 ' HA3' ' OE1' ' A' ' 18' ' ' GLN . . . -174.0 37.67 0.12 Allowed Glycine 0 C--O 1.239 0.451 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.436 HD12 ' CH2' ' A' ' 43' ' ' TRP . 1.4 mm? -120.66 112.14 18.5 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.241 -0.479 . . . . 0.0 111.929 -172.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.584 ' HB1' ' HA ' ' A' ' 36' ' ' VAL . . . -116.53 125.93 52.6 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 171.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.692 ' CE3' ' HA ' ' A' ' 8' ' ' PHE . 8.9 m95 -86.68 81.51 8.2 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 112.603 -3.639 . . . . 0.0 105.494 167.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 1.096 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -149.7 131.1 14.71 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 -165.489 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 1.036 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . 8.6 t 171.2 -145.86 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.425 177.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.32 -0.47 8.14 Favored Glycine 0 C--N 1.3 -1.471 0 C-N-CA 117.704 -2.189 . . . . 0.0 110.338 -160.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.701 HG21 HG12 ' A' ' 67' ' ' VAL . 7.9 p -72.26 153.09 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.824 -0.688 . . . . 0.0 111.126 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.711 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 6.5 m -98.83 131.47 25.55 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.973 ' HB3' ' HA ' ' A' ' 69' ' ' GLU . 83.3 Cg_exo -41.24 127.98 3.05 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.737 2.958 . . . . 0.0 113.899 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.419 ' H ' HG23 ' A' ' 67' ' ' VAL . . . 97.15 36.27 5.0 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.148 174.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.711 ' HG3' ' O ' ' A' ' 48' ' ' THR . 30.3 mt-10 -122.37 -170.15 2.02 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 118.939 -1.104 . . . . 0.0 113.031 -175.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.4 m -132.83 112.86 12.28 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.89 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.858 HD23 HD12 ' A' ' 33' ' ' LEU . 18.6 mt -78.21 159.23 28.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.053 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.603 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 6.4 m -120.04 119.93 34.82 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 168.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.845 ' HA ' ' O ' ' A' ' 24' ' ' SER . 38.2 t -112.64 124.34 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 121.513 0.673 . . . . 0.0 111.916 -169.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.848 ' HB3' ' OG ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -120.02 146.45 45.86 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.067 -170.191 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.662 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 9.7 p90 -157.92 -139.26 0.07 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 119.499 -0.88 . . . . 0.0 112.754 168.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.662 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 1.5 m-20 -41.49 -60.0 1.43 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.348 0.659 . . . . 0.0 111.558 168.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.653 ' HA3' ' NE2' ' A' ' 62' ' ' GLN . . . -77.33 -3.2 81.82 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 118.882 -1.628 . . . . 0.0 110.581 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 10.7 mttp 76.45 -149.91 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 114.356 -0.922 . . . . 0.0 111.95 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.57 HG13 ' HB2' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -71.78 101.42 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -176.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.653 ' NE2' ' HA3' ' A' ' 59' ' ' GLY . 0.2 OUTLIER -129.65 -46.03 1.18 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.632 -175.055 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.508 ' HB3' HD11 ' A' ' 13' ' ' LEU . 16.3 p -99.66 148.07 24.74 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.658 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 27.7 mt-30 -133.24 141.67 48.15 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.579 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 1.5 t -96.15 146.41 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 C-N-CA 116.276 -2.17 . . . . 0.0 112.564 -164.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -98.3 116.17 29.96 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.1 171.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.701 HG12 HG21 ' A' ' 47' ' ' VAL . 1.0 OUTLIER -93.54 123.14 61.06 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.316 -178.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -92.46 170.83 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.707 2.938 . . . . 0.0 113.268 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.973 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 1.8 mp0 -73.35 -13.34 61.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.52 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.7 p -82.89 24.86 0.72 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.332 0.494 . . . . 0.0 112.332 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.4 159.17 18.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.504 HG13 ' H ' ' A' ' 73' ' ' SER . 7.0 tp -169.08 168.09 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.263 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.504 ' H ' HG13 ' A' ' 72' ' ' ILE . 4.1 p -52.82 135.35 35.98 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.5 ' OD1' ' HD2' ' A' ' 5' ' ' LYS . 20.7 m-20 62.51 4.6 1.39 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.43 ' HG2' ' H ' ' A' ' 76' ' ' GLN . 11.4 tt0 -86.23 155.59 20.64 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 122.19 -0.319 . . . . 0.0 111.324 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 1.082 ' HA ' ' HB3' ' A' ' 8' ' ' PHE . 14.9 pt20 -82.77 130.2 35.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.051 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.634 HD21 HD11 ' A' ' 7' ' ' LEU . 3.0 mm? -137.88 118.45 13.92 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.453 ' HG ' HD13 ' A' ' 10' ' ' ILE . 6.3 mp -86.08 96.63 9.94 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 118.759 -1.176 . . . . 0.0 108.115 174.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.562 HD12 HG12 ' A' ' 65' ' ' VAL . 96.2 mt -90.9 132.13 35.43 Favored Pre-proline 0 C--O 1.249 1.048 0 CA-C-O 121.582 0.706 . . . . 0.0 112.703 -167.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.41 117.99 3.85 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 123.544 2.829 . . . . 0.0 111.784 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.463 ' SG ' HG22 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -99.74 99.13 9.91 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.59 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 93.3 m -90.22 123.03 66.83 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.576 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.25 123.62 10.11 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.361 2.041 . . . . 0.0 111.066 175.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -106.95 98.27 7.95 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.493 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 C--O 1.252 1.201 0 CA-C-O 118.528 -0.748 . . . . 0.0 109.839 173.513 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.811 0.339 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 3' ' ' LYS . 5.5 tt -75.93 112.55 12.45 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.717 ' HE3' ' HD3' ' A' ' 49' ' ' PRO . 19.7 tptp 71.47 -60.02 0.53 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.803 0.689 . . . . 0.0 112.5 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.641 ' HA3' ' HB2' ' A' ' 73' ' ' SER . . . 114.36 118.83 3.36 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -172.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' A' ' 46' ' ' GLY . 28.4 ttpp -166.61 58.34 0.09 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -170.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 1.002 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 0.2 OUTLIER 174.37 138.99 0.04 OUTLIER 'General case' 0 N--CA 1.404 -2.73 1 N-CA-C 99.692 -4.188 . . . . 0.0 99.692 158.468 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.891 HD11 ' HA3' ' A' ' 46' ' ' GLY . 0.4 OUTLIER -168.44 169.28 10.62 Favored 'General case' 0 N--CA 1.408 -2.537 0 C-N-CA 114.803 -2.759 . . . . 0.0 114.295 -159.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.646 ' HB2' ' HA ' ' A' ' 76' ' ' GLN . 77.4 m-85 -98.32 89.58 4.51 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.84 174.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.26 103.92 15.89 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.543 -174.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.1 mt -89.22 102.25 12.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.475 175.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -106.08 126.25 51.98 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.138 0.971 . . . . 0.0 110.559 -173.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -127.31 156.06 42.56 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.91 -1.496 . . . . 0.0 108.479 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.63 HD23 ' C ' ' A' ' 18' ' ' GLN . 1.1 pp -105.97 137.52 43.73 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 117.96 -1.496 . . . . 0.0 109.531 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.27 -9.96 0.78 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -166.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.503 ' HB3' HD13 ' A' ' 13' ' ' LEU . 6.5 t70 -66.74 -22.23 66.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.505 0.669 . . . . 0.0 110.216 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.3 -6.85 32.25 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t -96.91 -175.2 3.2 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.61 -0.795 . . . . 0.0 109.729 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.63 ' C ' HD23 ' A' ' 13' ' ' LEU . 1.6 tt0 -120.31 138.29 27.06 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.631 -171.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.538 ' N ' HD23 ' A' ' 13' ' ' LEU . 2.8 Cg_endo -80.73 103.96 1.54 Allowed 'Trans proline' 0 N--CA 1.428 -2.329 0 N-CA-C 105.646 -2.482 . . . . 0.0 105.646 156.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 1.1 Cg_endo -103.49 175.98 0.16 Allowed 'Trans proline' 0 N--CA 1.431 -2.199 0 C-N-CA 123.111 2.541 . . . . 0.0 112.545 -161.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.577 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 24.8 t80 -23.94 104.48 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -168.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.404 ' H ' HG13 ' A' ' 36' ' ' VAL . . . 113.72 0.23 24.51 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.083 176.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.784 ' HB2' HG11 ' A' ' 36' ' ' VAL . . . -60.69 99.63 0.09 Allowed 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.424 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.924 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 68.4 p -66.82 99.32 0.61 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.418 173.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.8 HG21 ' CA ' ' A' ' 34' ' ' GLY . 5.1 m -82.37 101.41 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 C-N-CA 115.762 -2.375 . . . . 0.0 107.982 166.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.683 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 1.1 t -138.51 120.0 14.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.926 -171.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.1 t -83.15 160.64 21.8 Favored 'General case' 0 C--O 1.211 -0.941 0 C-N-CA 119.317 -0.953 . . . . 0.0 108.988 -171.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -15.6 -70.86 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -164.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -65.47 -20.81 66.51 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.3 0.571 . . . . 0.0 112.069 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.549 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 119.67 40.36 0.62 Allowed Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.683 ' O ' ' HA ' ' A' ' 26' ' ' THR . 0.0 OUTLIER -77.24 93.41 3.97 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.073 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -90.57 95.89 10.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.204 0.526 . . . . 0.0 110.478 -172.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.776 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -106.06 3.71 28.46 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.332 -176.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.868 ' HA2' ' CB ' ' A' ' 44' ' ' LEU . . . -157.13 149.67 20.46 Favored Glycine 0 C--O 1.221 -0.672 0 O-C-N 124.585 1.178 . . . . 0.0 112.884 172.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.763 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 42.8 mtp -150.82 107.91 3.58 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 165.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.784 HG11 ' HB2' ' A' ' 23' ' ' ALA . 1.9 p -60.67 123.89 14.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.567 -170.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.414 ' HA ' ' HD1' ' A' ' 21' ' ' PHE . . . -107.5 129.79 54.92 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 170.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.494 ' OD1' ' HG3' ' A' ' 39' ' ' GLU . 3.4 t0 73.59 -150.44 0.05 Allowed 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.902 0.751 . . . . 0.0 109.418 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HG3' ' OD1' ' A' ' 38' ' ' ASP . 32.6 mt-10 -84.24 81.95 8.59 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -171.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.3 -17.66 46.46 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 114.804 0.681 . . . . 0.0 114.804 165.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.655 HD11 ' H ' ' A' ' 41' ' ' LEU . 0.0 OUTLIER -85.78 113.09 21.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 118.045 0.922 . . . . 0.0 113.101 175.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.54 ' HB3' ' N ' ' A' ' 35' ' ' MET . . . -95.64 103.47 15.34 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.723 ' HA ' ' CE3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -82.83 89.58 6.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.868 ' CB ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -140.29 -165.23 1.87 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -163.126 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 1.002 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.7 p -122.51 113.7 19.67 Favored 'General case' 0 N--CA 1.424 -1.731 0 C-N-CA 117.462 -1.695 . . . . 0.0 109.243 -167.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.891 ' HA3' HD11 ' A' ' 7' ' ' LEU . . . -59.4 173.21 4.33 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 118.829 2.292 . . . . 0.0 118.829 -161.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.431 ' HB ' HD21 ' A' ' 33' ' ' LEU . 8.0 p -121.1 172.78 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 112.984 -1.608 . . . . 0.0 110.577 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.413 HG21 ' HD2' ' A' ' 49' ' ' PRO . 6.4 m -71.29 148.12 93.48 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.257 0.623 . . . . 0.0 110.209 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.717 ' HD3' ' HE3' ' A' ' 3' ' ' LYS . 4.5 Cg_exo -77.82 161.82 30.05 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.479 2.119 . . . . 0.0 112.189 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.27 35.24 27.24 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 119.454 -1.355 . . . . 0.0 112.216 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -132.0 -168.29 2.01 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.818 -175.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.2 m -139.84 99.05 3.6 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.72 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.756 HD12 ' HB ' ' A' ' 25' ' ' VAL . 30.9 mt -57.91 155.44 10.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.015 168.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.545 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 48.8 m -121.75 119.88 33.02 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 170.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.924 ' HA ' ' O ' ' A' ' 24' ' ' SER . 48.8 t -109.55 110.81 33.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-O 122.023 0.916 . . . . 0.0 112.435 -166.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.847 ' HB3' ' OG ' ' A' ' 24' ' ' SER . 0.4 OUTLIER -97.26 149.32 22.18 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.412 -174.876 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.737 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 0.1 OUTLIER -158.71 155.09 27.42 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.918 -167.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.737 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 0.1 OUTLIER -19.78 -57.37 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.721 1.208 . . . . 0.0 114.16 174.596 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.34 -44.4 95.47 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 117.249 -2.405 . . . . 0.0 113.479 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.543 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 1.2 pttt 174.25 -176.25 0.08 Allowed 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -167.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.836 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 4.2 tt -87.9 97.06 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 169.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.543 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -103.92 -50.02 3.49 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 118.938 -1.105 . . . . 0.0 112.795 -158.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 29.0 p -104.87 158.08 16.77 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.567 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 51.0 mt-30 -133.09 138.89 46.87 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 2.7 t -91.44 130.55 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 C-N-CA 115.013 -2.675 . . . . 0.0 112.117 -169.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.435 ' N ' HD21 ' A' ' 66' ' ' ASN . 0.9 OUTLIER -93.29 116.12 28.69 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 118.494 -1.282 . . . . 0.0 110.06 177.134 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.61 HG12 ' HA ' ' A' ' 49' ' ' PRO . 13.8 t -93.55 116.16 66.07 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.585 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -92.03 169.23 2.93 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.051 2.501 . . . . 0.0 111.818 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -90.25 15.05 11.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.192 0.52 . . . . 0.0 110.776 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.5 m -106.78 2.6 25.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.589 0.709 . . . . 0.0 110.1 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.38 174.85 7.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.75 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.653 HG13 ' H ' ' A' ' 73' ' ' SER . 11.1 tp -136.66 170.33 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.111 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.653 ' H ' HG13 ' A' ' 72' ' ' ILE . 15.1 m -146.04 -178.58 6.2 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 23.7 t70 71.33 -41.95 0.52 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.106 0.562 . . . . 0.0 110.645 -173.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -89.73 -163.56 1.02 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.864 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.646 ' HA ' ' HB2' ' A' ' 8' ' ' PHE . 25.6 tt0 -86.55 133.62 33.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.536 174.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.596 ' HG ' ' H ' ' A' ' 72' ' ' ILE . 3.1 tm? -150.87 133.04 15.34 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.617 ' H ' HD22 ' A' ' 78' ' ' LEU . 2.4 pt? -94.41 134.74 36.6 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.557 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 93.5 mt -106.43 137.24 19.37 Favored Pre-proline 0 C--O 1.24 0.557 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.281 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 59.8 Cg_endo -90.28 114.51 0.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.189 2.593 . . . . 0.0 113.027 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.87 107.31 18.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.106 177.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.9 m -78.39 130.5 71.43 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.705 175.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.93 129.55 21.02 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.402 2.068 . . . . 0.0 110.998 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.408 HE21 ' HB2' ' A' ' 84' ' ' GLN . 8.3 tt0 -53.62 131.54 39.04 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.429 0.455 . . . . 0.0 110.938 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.071 -177.078 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.89 -72.43 0.64 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.801 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.595 ' HG3' ' H ' ' A' ' 4' ' ' GLY . 15.9 tptp 60.45 -157.35 0.34 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.151 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.595 ' H ' ' HG3' ' A' ' 3' ' ' LYS . . . 75.2 -153.89 45.53 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-O 118.56 -1.133 . . . . 0.0 110.729 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.509 ' N ' ' HD2' ' A' ' 5' ' ' LYS . 0.2 OUTLIER 18.44 69.23 0.02 OUTLIER 'General case' 0 C--N 1.351 0.655 0 CA-C-O 123.749 1.738 . . . . 0.0 112.704 -177.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.833 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 2.1 tmm_? -175.59 121.07 0.19 Allowed 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 110.094 -3.23 . . . . 0.0 104.25 151.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.761 HD12 ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -140.56 175.41 9.63 Favored 'General case' 0 N--CA 1.403 -2.816 0 CA-C-N 112.312 -2.222 . . . . 0.0 111.007 -158.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.68 ' HD2' ' HB3' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -110.91 87.43 2.53 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 173.415 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 41' ' ' LEU . . . -90.59 115.16 27.49 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.5 -167.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 57.0 mt -95.38 98.4 7.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.932 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 3.4 mm? -90.13 134.29 34.36 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 119.559 -0.857 . . . . 0.0 109.411 -174.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -144.05 126.54 15.9 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.055 175.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.778 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . 0.9 OUTLIER -90.48 113.54 25.52 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 117.347 -1.741 . . . . 0.0 109.602 174.295 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.48 -7.98 1.65 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 113.73 -1.577 . . . . 0.0 113.734 -169.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -63.32 -13.73 42.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.219 0.533 . . . . 0.0 110.668 174.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.51 27.75 2.98 Favored Glycine 0 CA--C 1.502 -0.724 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.694 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.7 m -142.03 170.68 15.26 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 114.906 -0.647 . . . . 0.0 110.219 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.82 142.47 31.85 Favored Pre-proline 0 CA--C 1.495 -1.14 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.657 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.932 ' HG2' ' HB3' ' A' ' 11' ' ' LEU . 5.6 Cg_exo -75.29 105.38 2.07 Favored 'Trans proline' 0 N--CA 1.424 -2.562 0 N-CA-C 105.027 -2.72 . . . . 0.0 105.027 156.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 0.3 OUTLIER -105.96 -165.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.155 0 C-N-CA 123.078 2.519 . . . . 0.0 112.198 -164.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.74 100.16 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -170.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.84 22.8 7.79 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.868 ' HB3' HG13 ' A' ' 36' ' ' VAL . . . -64.94 89.62 0.08 Allowed 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.694 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.702 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -70.45 87.91 0.65 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.578 -1.646 . . . . 0.0 111.622 178.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.781 HG23 ' CA ' ' A' ' 34' ' ' GLY . 3.2 m -82.28 112.36 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.173 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -140.53 121.22 14.32 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.795 -178.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.727 ' OG ' HD21 ' A' ' 53' ' ' LEU . 64.0 m -84.85 -171.98 3.93 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.723 -168.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -23.93 -67.85 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -169.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -88.71 -6.97 57.09 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -171.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.563 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 114.39 35.87 1.39 Allowed Glycine 0 CA--C 1.487 -1.672 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -177.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.697 ' O ' HD23 ' A' ' 33' ' ' LEU . 68.3 mtp180 -76.01 100.06 4.78 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -91.9 96.05 10.17 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.06 -169.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.872 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -109.01 4.42 23.19 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.712 -170.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.891 ' N ' HD11 ' A' ' 44' ' ' LEU . . . -166.72 154.76 25.45 Favored Glycine 0 N--CA 1.467 0.764 0 C-N-CA 119.079 -1.534 . . . . 0.0 114.406 176.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.702 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 31.8 mtt -149.88 99.67 2.87 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 164.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.868 HG13 ' HB3' ' A' ' 23' ' ' ALA . 2.2 m -72.09 106.59 2.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 118.899 -1.121 . . . . 0.0 111.176 -169.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.43 120.84 37.47 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 118.659 -1.216 . . . . 0.0 110.328 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 t70 70.6 119.69 0.04 OUTLIER 'General case' 0 C--O 1.237 0.398 0 O-C-N 124.348 1.03 . . . . 0.0 110.968 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 66.63 -98.93 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.309 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.83 47.65 0.33 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.084 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 9' ' ' ALA . 3.9 tt -133.96 125.07 27.43 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.626 ' HB3' ' H ' ' A' ' 35' ' ' MET . . . -113.08 129.23 56.57 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.75 0.31 . . . . 0.0 110.659 177.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.406 ' O ' HD23 ' A' ' 44' ' ' LEU . 91.2 m95 -90.48 83.46 5.88 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.891 HD11 ' N ' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -145.46 -170.37 3.43 Favored 'General case' 0 C--O 1.195 -1.764 0 CA-C-O 118.973 -0.537 . . . . 0.0 110.002 -157.338 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.833 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 37.3 p -116.76 85.81 2.39 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -163.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.761 ' N ' HD12 ' A' ' 7' ' ' LEU . . . -62.12 -177.82 3.12 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 116.395 1.318 . . . . 0.0 116.395 -162.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.572 HG12 ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -103.78 177.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.153 -0.523 . . . . 0.0 111.79 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.0 m -82.47 139.52 44.58 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.029 176.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.675 ' HA ' HG13 ' A' ' 67' ' ' VAL . 59.0 Cg_exo -52.73 120.91 8.28 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.808 2.338 . . . . 0.0 112.833 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.68 36.3 0.92 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.023 -1.084 . . . . 0.0 112.677 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -138.43 -160.94 1.11 Allowed 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 119.244 -0.982 . . . . 0.0 112.175 -174.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.632 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 58.3 m -142.73 129.78 20.76 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.4 172.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.727 HD21 ' OG ' ' A' ' 27' ' ' SER . 45.3 mt -88.13 151.47 22.69 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 173.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.06 106.93 14.31 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 171.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.702 ' HA ' ' O ' ' A' ' 24' ' ' SER . 20.0 t -112.32 109.69 29.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.892 -159.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.593 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 41.5 m-80 -77.68 146.16 36.19 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.549 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.792 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -150.41 149.82 30.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.415 -174.953 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.792 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 5.2 m-20 -25.18 -55.62 0.05 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 173.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.88 -40.62 98.55 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 117.071 -2.49 . . . . 0.0 113.778 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.775 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER 169.12 -168.96 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -169.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.593 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.4 tt -86.12 115.16 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 169.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.775 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 1.1 mt-30 -130.73 -48.78 1.05 Allowed 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 117.663 -1.615 . . . . 0.0 111.207 -165.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.583 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . 38.1 t -72.95 129.29 37.78 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.343 -1.298 . . . . 0.0 107.772 174.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -136.11 114.66 11.84 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 167.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.726 HG11 ' HB2' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -93.75 147.09 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.167 0 C-N-CA 115.04 -2.664 . . . . 0.0 112.346 -160.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 77.1 m-20 -100.5 108.92 21.0 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.568 174.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.675 HG13 ' HA ' ' A' ' 49' ' ' PRO . 22.1 t -79.99 112.49 30.44 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.074 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 66' ' ' ASN . 94.4 Cg_endo -89.01 171.45 4.7 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.445 2.763 . . . . 0.0 112.141 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.523 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 2.4 mp0 -67.34 -15.37 63.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.72 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.4 m -79.83 -3.89 49.79 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.039 0.447 . . . . 0.0 111.115 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.62 156.87 36.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.4 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.45 HD13 ' H ' ' A' ' 73' ' ' SER . 0.4 OUTLIER -158.93 160.16 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.654 ' CB ' HD11 ' A' ' 7' ' ' LEU . 22.0 p -120.28 174.27 6.61 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.578 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.8 t70 68.78 8.16 6.59 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.371 0.605 . . . . 0.0 110.802 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -138.06 172.5 12.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.797 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.68 ' HB3' ' HD2' ' A' ' 8' ' ' PHE . 11.0 pt20 -94.13 124.74 38.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 172.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.6 tp -150.27 149.04 29.6 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.529 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.0 pt? -98.48 132.27 44.06 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.492 -1.283 . . . . 0.0 109.915 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.576 ' HB2' HD11 ' A' ' 11' ' ' LEU . 3.1 mm? -110.66 143.73 28.8 Favored Pre-proline 0 C--O 1.248 0.994 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.33 -176.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 4.9 Cg_exo -79.8 100.36 1.28 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.727 2.951 . . . . 0.0 112.864 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.778 ' SG ' ' HB3' ' A' ' 13' ' ' LEU . 5.1 t -82.62 146.2 29.26 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.212 173.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.4 m -126.12 136.34 28.39 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.403 ' C ' ' H ' ' A' ' 85' ' ' LYS . 10.6 Cg_endo -55.45 152.67 31.85 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.019 1.813 . . . . 0.0 111.04 174.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -66.33 -3.72 6.52 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.011 0.434 . . . . 0.0 111.717 -176.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.403 ' H ' ' C ' ' A' ' 83' ' ' PRO . 67.2 mttm . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.139 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.401 ' HA ' HD12 ' A' ' 72' ' ' ILE . 4.2 mm? -69.15 -31.99 71.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.028 0.442 . . . . 0.0 110.61 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -80.09 74.77 6.87 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.683 ' HA3' ' HB3' ' A' ' 73' ' ' SER . . . -77.95 111.81 3.34 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.373 -0.831 . . . . 0.0 114.001 -170.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -166.05 68.34 0.12 Allowed 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.8 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -179.9 131.54 0.1 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 153.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 1.04 HD12 ' HG ' ' A' ' 73' ' ' SER . 0.0 OUTLIER -157.99 172.09 19.07 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 115.797 1.776 . . . . 0.0 115.797 -157.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.565 ' HB2' ' HA ' ' A' ' 76' ' ' GLN . 92.4 m-85 -114.65 90.18 3.28 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 112.739 -2.028 . . . . 0.0 107.542 174.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.48 98.55 11.83 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.503 -0.479 . . . . 0.0 112.0 -171.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.594 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 40.5 mt -87.73 103.0 13.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.954 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -117.85 150.33 39.35 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.651 -175.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.497 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 13.8 mmm180 -140.3 155.42 46.84 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.821 HD23 ' SG ' ' A' ' 63' ' ' CYS . 1.8 mt -78.69 151.0 32.43 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 116.87 -1.932 . . . . 0.0 107.092 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.34 -40.34 67.95 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.684 -172.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 -74.68 -10.46 59.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.811 0.339 . . . . 0.0 111.686 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.22 24.72 4.07 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.557 -1.306 . . . . 0.0 111.754 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.64 ' HB2' ' CG ' ' A' ' 13' ' ' LEU . 16.2 m -106.33 -155.32 0.54 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.673 ' C ' HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -140.35 137.82 18.25 Favored Pre-proline 0 CA--C 1.51 -0.564 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -170.466 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.954 ' HG2' ' HB2' ' A' ' 11' ' ' LEU . 3.6 Cg_exo -78.59 102.14 1.52 Allowed 'Trans proline' 0 N--CA 1.438 -1.792 0 N-CA-C 104.773 -2.818 . . . . 0.0 104.773 149.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.534 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . 9.8 Cg_endo -107.78 160.88 0.1 Allowed 'Trans proline' 0 N--CA 1.431 -2.201 0 C-N-CA 123.455 2.77 . . . . 0.0 112.683 -164.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -18.64 103.7 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -168.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.413 ' H ' HG13 ' A' ' 36' ' ' VAL . . . 103.63 4.36 46.12 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.837 ' HA ' ' O ' ' A' ' 56' ' ' ASN . . . -61.78 100.03 0.14 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.851 169.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.756 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -72.57 100.07 2.67 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 112.395 -2.184 . . . . 0.0 111.453 173.243 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.737 HG23 ' CA ' ' A' ' 34' ' ' GLY . 19.9 m -89.61 113.78 26.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 C-N-CA 117.645 -1.622 . . . . 0.0 109.668 174.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.94 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . 3.2 p -148.79 133.83 18.17 Favored 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.081 170.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.593 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -78.52 162.7 26.14 Favored 'General case' 0 C--O 1.207 -1.139 0 C-N-CA 117.221 -1.792 . . . . 0.0 108.181 -172.044 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -18.61 -62.67 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -165.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -87.13 3.49 46.05 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -171.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.89 27.03 5.57 Favored Glycine 0 CA--C 1.488 -1.614 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.906 ' HG3' HG12 ' A' ' 47' ' ' VAL . 8.5 tpt180 -68.15 176.92 2.46 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.94 ' HB3' ' HA ' ' A' ' 26' ' ' THR . 23.2 tp10 82.06 -120.56 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 169.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.683 ' C ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER 98.21 93.01 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.186 0 O-C-N 124.512 1.133 . . . . 0.0 109.623 -159.047 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 1.066 ' HA2' ' HB2' ' A' ' 44' ' ' LEU . . . -159.94 102.19 0.21 Allowed Glycine 0 C--O 1.216 -1.014 0 CA-C-N 112.362 -2.199 . . . . 0.0 112.216 164.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.749 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 14.3 mtm -111.08 125.67 54.01 Favored 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 121.0 -1.294 . . . . 0.0 109.911 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.699 HG11 ' HB1' ' A' ' 23' ' ' ALA . 2.1 p -73.59 139.29 19.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.727 -174.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -112.87 71.14 0.73 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 171.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.3 t70 72.65 151.91 0.12 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.239 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.524 ' HB2' HD21 ' A' ' 41' ' ' LEU . 13.5 mm-40 71.8 -27.65 0.18 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.841 0.857 . . . . 0.0 112.889 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.464 ' HA2' HG22 ' A' ' 36' ' ' VAL . . . 116.99 12.81 8.15 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.354 175.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -90.0 107.31 19.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.678 -0.409 . . . . 0.0 112.002 173.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.716 ' HB3' ' C ' ' A' ' 34' ' ' GLY . . . -95.8 92.45 6.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.499 0.666 . . . . 0.0 110.45 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.579 ' HA ' ' CE3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -83.33 110.85 18.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.424 -177.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 1.066 ' HB2' ' HA2' ' A' ' 34' ' ' GLY . 4.2 mt -167.47 -169.93 1.33 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -167.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.8 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 26.5 p -127.47 79.36 1.88 Allowed 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 -168.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.725 ' H ' ' CD1' ' A' ' 7' ' ' LEU . . . -87.04 -150.49 18.1 Favored Glycine 0 C--N 1.306 -1.111 0 CA-C-N 114.44 -1.255 . . . . 0.0 113.529 -161.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.906 HG12 ' HG3' ' A' ' 31' ' ' ARG . 15.5 m -121.2 174.57 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.503 0.668 . . . . 0.0 112.162 174.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 11.4 t -77.79 139.19 62.08 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.692 -175.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.504 ' HB3' HG23 ' A' ' 67' ' ' VAL . 87.5 Cg_exo -49.06 153.2 4.25 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.941 3.094 . . . . 0.0 114.155 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.884 ' H ' HG11 ' A' ' 67' ' ' VAL . . . 119.44 26.74 2.33 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.332 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.46 ' H ' ' CG1' ' A' ' 67' ' ' VAL . 23.2 mt-10 -143.36 -168.45 2.82 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.763 0.792 . . . . 0.0 112.946 -173.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 16.7 p -126.69 122.36 34.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.912 167.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.7 ' HB2' HG13 ' A' ' 65' ' ' VAL . 19.2 mt -93.37 121.01 34.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.302 -173.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.54 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 13.3 m -77.62 109.37 11.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.607 0.718 . . . . 0.0 110.583 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.756 ' HA ' ' O ' ' A' ' 24' ' ' SER . 59.3 t -116.57 116.72 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.537 -167.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.837 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 37.6 m-80 -99.33 157.53 16.34 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.812 -176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 2.4 p90 -161.62 -144.5 0.1 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.887 159.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.673 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 1.0 OUTLIER -41.49 -55.0 2.98 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.746 0.703 . . . . 0.0 111.076 166.216 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.656 ' HA3' ' NE2' ' A' ' 62' ' ' GLN . . . -80.68 2.3 79.6 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 118.886 -1.626 . . . . 0.0 111.079 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.6 ' C ' ' HA ' ' A' ' 56' ' ' ASN . 11.2 mtpt 67.13 -151.59 0.19 Allowed 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 114.482 -0.859 . . . . 0.0 111.771 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.461 HD11 ' HB3' ' A' ' 54' ' ' SER . 0.1 OUTLIER -64.09 106.97 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-O 122.648 1.213 . . . . 0.0 108.656 -177.001 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.656 ' NE2' ' HA3' ' A' ' 59' ' ' GLY . 2.3 pt20 -146.62 -39.33 0.21 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.759 -1.564 . . . . 0.0 111.614 -174.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.821 ' SG ' HD23 ' A' ' 13' ' ' LEU . 1.6 t -96.75 135.04 39.26 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.528 174.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.613 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 49.7 mt-30 -126.36 137.75 53.49 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 169.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.7 HG13 ' HB2' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -97.41 129.95 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 C-N-CA 115.985 -2.286 . . . . 0.0 110.185 -170.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -89.56 98.46 11.78 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.216 -0.994 . . . . 0.0 109.332 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.884 HG11 ' H ' ' A' ' 50' ' ' GLY . 9.0 p -92.11 115.98 65.64 Favored Pre-proline 0 N--CA 1.44 -0.939 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.525 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.53 152.68 15.47 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.352 2.701 . . . . 0.0 111.565 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -75.84 13.39 0.85 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.828 0.346 . . . . 0.0 111.875 -174.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 m -73.75 -42.45 61.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.986 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.11 -173.14 2.24 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.821 -173.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.409 ' O ' HD11 ' A' ' 77' ' ' LEU . 12.6 tt -140.93 155.68 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.35 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 1.04 ' HG ' HD12 ' A' ' 7' ' ' LEU . 33.3 t -84.85 -166.51 1.5 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.886 -175.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' A' ' 73' ' ' SER . 38.8 t70 75.76 10.07 3.39 Favored 'General case' 0 C--N 1.359 1.012 0 CA-C-O 121.717 0.77 . . . . 0.0 110.195 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -153.24 -171.97 4.09 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.154 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.565 ' HA ' ' HB2' ' A' ' 8' ' ' PHE . 14.1 pt20 -86.11 140.39 30.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.409 HD11 ' O ' ' A' ' 72' ' ' ILE . 96.1 mt -138.47 157.0 47.03 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.594 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -111.03 132.96 53.79 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 117.757 -1.577 . . . . 0.0 109.528 173.46 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.423 HD13 HG22 ' A' ' 67' ' ' VAL . 2.7 mm? -122.9 140.98 34.41 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -169.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 57.8 Cg_endo -88.57 110.01 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.846 3.031 . . . . 0.0 112.467 176.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.512 ' HB3' ' HA ' ' A' ' 13' ' ' LEU . 1.8 t -93.43 122.45 35.86 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.345 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 8.6 t -130.35 133.5 24.98 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.737 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 82' ' ' THR . 5.0 Cg_endo -88.02 98.89 0.42 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.952 2.435 . . . . 0.0 110.823 171.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -149.78 56.25 0.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.715 0.769 . . . . 0.0 109.622 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.579 ' NZ ' ' HB2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.56 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.68 HG13 ' H ' ' A' ' 2' ' ' LEU . 1.8 t . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.68 ' H ' HG13 ' A' ' 1' ' ' VAL . 29.3 tp -80.59 -13.28 59.19 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.196 -0.201 . . . . 0.0 111.035 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.623 ' HB2' ' HZ2' ' A' ' 3' ' ' LYS . 8.5 mtmp? 80.34 88.82 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 124.046 0.841 . . . . 0.0 110.647 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 73' ' ' SER . . . 155.23 162.36 11.23 Favored Glycine 0 CA--C 1.49 -1.525 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.703 -177.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.725 ' O ' HD12 ' A' ' 7' ' ' LEU . 50.4 mttm -114.87 80.6 1.44 Allowed 'General case' 0 N--CA 1.399 -3.0 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 161.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.677 ' O ' ' HA ' ' A' ' 74' ' ' ASP . 0.0 OUTLIER -81.23 146.87 30.24 Favored 'General case' 0 CA--C 1.461 -2.476 0 N-CA-C 101.724 -3.435 . . . . 0.0 101.724 168.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.99 HD12 ' H ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -163.17 -179.32 6.56 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 111.762 -3.975 . . . . 0.0 115.987 -151.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.918 ' HE1' ' HB2' ' A' ' 41' ' ' LEU . 6.2 t80 -127.17 105.39 8.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.41 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 77' ' ' LEU . . . -100.74 131.61 46.55 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.877 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.474 HG22 ' HG2' ' A' ' 12' ' ' ARG . 4.1 mp -100.28 97.02 5.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.865 HD11 HG22 ' A' ' 65' ' ' VAL . 2.7 mm? -85.48 107.57 17.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.359 -173.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.862 ' HD3' ' HG2' ' A' ' 18' ' ' GLN . 18.1 mmt180 -126.47 139.75 53.0 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.063 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.642 ' HG ' ' O ' ' A' ' 17' ' ' SER . 2.3 mt -80.62 144.32 32.43 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 117.774 -1.57 . . . . 0.0 107.694 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 -15.39 59.24 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.673 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -75.17 -30.1 60.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.827 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.16 -11.14 20.06 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -174.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.642 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 8.7 p -87.35 165.26 15.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.939 -0.631 . . . . 0.0 110.834 175.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.862 ' HG2' ' HD3' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -159.01 -91.14 0.0 OUTLIER Pre-proline 0 C--O 1.22 -0.484 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.386 171.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 21.3 Cg_exo -23.64 100.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 124.321 3.347 . . . . 0.0 115.114 -133.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.707 ' HB2' ' HB1' ' A' ' 23' ' ' ALA . 91.4 Cg_endo -111.3 96.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.895 0 C-N-CA 124.678 3.586 . . . . 0.0 111.902 163.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.99 111.4 23.73 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 118.641 -1.224 . . . . 0.0 109.401 -171.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.24 12.86 28.19 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 -163.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.751 ' HA ' ' O ' ' A' ' 56' ' ' ASN . . . -60.14 93.74 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.887 -0.656 . . . . 0.0 110.107 174.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.655 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -68.63 94.62 0.6 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.77 174.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.616 ' HB ' HD13 ' A' ' 53' ' ' LEU . 28.5 m -82.3 108.9 15.71 Favored 'Isoleucine or valine' 0 C--O 1.261 1.662 0 C-N-CA 119.031 -1.068 . . . . 0.0 108.691 173.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.686 ' HB ' ' OE1' ' A' ' 32' ' ' GLU . 5.0 t -134.11 129.7 36.31 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.867 -175.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.64 131.14 35.9 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 117.624 -1.63 . . . . 0.0 108.33 -173.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.527 ' CD ' ' HZ1' ' A' ' 85' ' ' LYS . 30.8 mt-10 -14.72 -52.6 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -158.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -65.83 -17.27 64.52 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.31 0.959 . . . . 0.0 111.885 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.627 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 113.36 36.46 1.46 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.7 mtp85 -81.75 86.97 6.36 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 171.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.686 ' OE1' ' HB ' ' A' ' 26' ' ' THR . 4.9 mm-40 -72.35 104.8 3.85 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.03 -173.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.618 HD21 ' O ' ' A' ' 46' ' ' GLY . 24.7 mt -85.84 -35.05 20.87 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.067 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.667 ' HA3' HD21 ' A' ' 44' ' ' LEU . . . 175.9 -171.29 44.34 Favored Glycine 0 C--N 1.349 1.258 0 C-N-CA 119.258 -1.449 . . . . 0.0 114.209 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.7 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 24.8 mtt -149.0 135.99 19.87 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.854 0.327 . . . . 0.0 111.516 -173.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 41' ' ' LEU . 54.7 t -69.41 148.56 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.238 0.336 . . . . 0.0 111.055 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -138.84 57.28 1.68 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.106 172.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.736 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 9.0 p-10 167.09 -154.32 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.579 -176.3 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.557 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 62.6 mm-40 -49.74 -52.55 30.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.774 169.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.52 57.93 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 118.59 -1.767 . . . . 0.0 113.982 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.918 ' HB2' ' HE1' ' A' ' 8' ' ' PHE . 4.5 pp -132.09 131.71 42.63 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.608 0.718 . . . . 0.0 110.341 169.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB2' HD22 ' A' ' 44' ' ' LEU . . . -124.05 114.87 20.31 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.827 173.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.42 ' CZ3' ' HB2' ' A' ' 8' ' ' PHE . 50.7 m95 -72.97 88.81 1.39 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.699 ' HB2' ' CD1' ' A' ' 7' ' ' LEU . 5.9 mt -79.24 178.06 8.36 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 118.547 -1.261 . . . . 0.0 108.538 -174.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 65.7 p -147.13 88.83 1.75 Allowed 'General case' 0 N--CA 1.427 -1.575 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.387 172.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.99 ' H ' HD12 ' A' ' 7' ' ' LEU . . . 107.33 92.87 2.28 Favored Glycine 0 C--O 1.222 -0.615 0 C-N-CA 119.011 -1.566 . . . . 0.0 112.248 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.512 HG22 HD12 ' A' ' 33' ' ' LEU . 10.3 p -120.39 137.46 54.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.425 ' HB ' ' OE2' ' A' ' 51' ' ' GLU . 28.8 m -101.22 129.44 27.04 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.899 ' HB2' ' HA ' ' A' ' 69' ' ' GLU . 60.3 Cg_endo -72.99 135.38 23.08 Favored 'Trans proline' 0 C--N 1.331 -0.367 0 C-N-CA 122.907 2.405 . . . . 0.0 112.897 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.48 ' H ' HG11 ' A' ' 67' ' ' VAL . . . 96.94 35.66 5.26 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 119.46 -1.352 . . . . 0.0 113.176 174.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HB2' HG12 ' A' ' 67' ' ' VAL . 31.6 mt-10 -121.89 177.69 5.19 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.879 -176.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 p -122.86 90.98 3.39 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.664 165.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.616 HD13 ' HB ' ' A' ' 25' ' ' VAL . 19.6 mt -51.43 152.82 2.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.484 171.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.481 ' HB2' HD11 ' A' ' 61' ' ' ILE . 21.4 p -120.61 125.14 47.01 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 165.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.655 ' HA ' ' O ' ' A' ' 24' ' ' SER . 20.3 t -112.68 107.93 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.497 0.665 . . . . 0.0 111.275 -167.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.751 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 45.8 m-80 -76.42 139.8 41.04 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.624 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.873 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 2.4 t90 -144.59 149.66 36.16 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.503 -166.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.873 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 4.3 m-20 -19.41 -64.74 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.758 1.223 . . . . 0.0 113.243 166.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 60' ' ' LYS . . . -62.76 -36.46 93.36 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 117.719 -2.181 . . . . 0.0 113.864 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.779 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 13.1 pttp 167.77 -169.7 0.02 OUTLIER 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -172.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.645 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.3 tt -81.96 118.31 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 167.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.779 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 1.4 mt-30 -125.18 -63.06 1.18 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 115.555 -2.458 . . . . 0.0 112.511 -166.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.51 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 27.5 p -92.89 149.21 21.41 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 117.304 -1.758 . . . . 0.0 108.116 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.598 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 25.5 mt-30 -127.13 133.82 50.31 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.865 HG22 HD11 ' A' ' 11' ' ' LEU . 4.4 t -94.99 140.74 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 C-N-CA 115.522 -2.471 . . . . 0.0 113.015 -164.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -95.48 113.58 25.25 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 118.736 -1.185 . . . . 0.0 110.261 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.48 HG11 ' H ' ' A' ' 50' ' ' GLY . 8.8 p -101.8 124.22 41.19 Favored Pre-proline 0 C--O 1.219 -0.507 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.823 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 91.8 Cg_endo -88.67 171.8 4.93 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.853 3.035 . . . . 0.0 112.916 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.899 ' HA ' ' HB2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -68.78 -25.19 64.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.651 -177.51 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -76.81 28.7 0.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.127 0.489 . . . . 0.0 111.811 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.54 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -69.36 135.28 50.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.394 0.616 . . . . 0.0 110.908 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.505 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 10.7 tp -96.08 157.92 3.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.067 -173.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.485 ' HA ' ' CB ' ' A' ' 5' ' ' LYS . 3.3 m -107.52 129.92 54.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.442 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.677 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 58.4 m-20 56.08 30.09 15.68 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -146.02 -167.7 2.79 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.282 0.563 . . . . 0.0 112.208 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.578 ' HA ' ' HB3' ' A' ' 8' ' ' PHE . 26.9 tt0 -93.32 140.51 29.47 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.606 -175.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.54 HD23 ' HA ' ' A' ' 71' ' ' ALA . 55.0 tp -153.98 123.01 6.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.655 ' H ' HD22 ' A' ' 78' ' ' LEU . 2.3 pt? -85.5 137.0 33.19 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 118.426 -1.309 . . . . 0.0 109.549 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.544 ' HB2' HD13 ' A' ' 11' ' ' LEU . 55.5 mt -122.81 134.83 25.23 Favored Pre-proline 0 C--O 1.245 0.818 0 CA-C-O 121.7 0.762 . . . . 0.0 111.85 -175.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 92.1 Cg_endo -87.68 121.86 1.6 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.192 2.595 . . . . 0.0 112.846 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.494 ' HB3' ' HB2' ' A' ' 63' ' ' CYS . 1.1 m -81.52 97.82 7.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.054 173.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.426 ' HB ' ' CD ' ' A' ' 83' ' ' PRO . 17.2 p -83.92 171.31 11.6 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.029 176.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.426 ' CD ' ' HB ' ' A' ' 82' ' ' THR . 22.6 Cg_exo -65.69 -172.31 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.564 2.176 . . . . 0.0 112.848 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.471 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 27.2 mt-30 -80.28 175.38 10.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.564 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.527 ' HZ1' ' CD ' ' A' ' 28' ' ' GLU . 19.5 ptpt . . . . . 0 C--O 1.252 1.211 0 CA-C-O 117.305 -1.331 . . . . 0.0 108.746 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 120.653 0.263 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.5 tp -88.4 92.41 9.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -68.81 -48.3 63.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.428 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.984 ' HA3' ' HB2' ' A' ' 74' ' ' ASP . . . -167.81 -123.16 0.65 Allowed Glycine 0 CA--C 1.472 -2.608 0 C-N-CA 119.413 -1.375 . . . . 0.0 113.179 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.883 ' H ' ' HB2' ' A' ' 74' ' ' ASP . 7.8 tptm -137.54 -154.1 0.52 Allowed 'General case' 0 N--CA 1.396 -3.155 0 CA-C-N 112.131 -2.035 . . . . 0.0 106.616 -170.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.811 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 7.7 ptp180 -64.62 158.63 23.88 Favored 'General case' 0 C--N 1.27 -2.865 0 CA-C-N 112.197 -2.274 . . . . 0.0 108.645 169.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.673 HD12 ' HA ' ' A' ' 74' ' ' ASP 0.317 10.6 mt 172.13 -165.36 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 156.294 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 0.7 OUTLIER -66.62 127.76 33.61 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.6 -166.092 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.589 ' HB3' HD11 ' A' ' 44' ' ' LEU . . . -127.19 144.14 51.1 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.587 -175.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.1 mt -90.21 106.67 17.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.555 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.608 ' HA ' ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -102.41 154.65 18.88 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.605 ' HA ' ' HG3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -142.89 154.08 43.76 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.05 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.812 HD23 HE21 ' A' ' 18' ' ' GLN . 1.7 mm? -64.07 -175.8 0.17 Allowed 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.623 0.725 . . . . 0.0 109.748 172.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.2 -27.35 66.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.025 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.95 -20.66 61.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.557 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.38 33.64 7.94 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.732 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.732 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 74.8 p -154.75 148.76 25.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.189 -0.505 . . . . 0.0 110.698 -174.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.812 HE21 HD23 ' A' ' 13' ' ' LEU . 5.6 mt-30 -167.71 132.37 1.53 Allowed Pre-proline 0 CA--C 1.503 -0.843 0 C-N-CA 123.068 0.547 . . . . 0.0 109.782 170.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -113.95 91.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.161 0 CA-C-N 119.382 0.815 . . . . 0.0 111.306 140.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.763 ' HD3' ' CB ' ' A' ' 18' ' ' GLN . 22.0 Cg_endo -116.4 94.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.781 0 C-N-CA 123.291 2.66 . . . . 0.0 113.256 163.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.51 108.57 19.47 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.887 0.851 . . . . 0.0 109.566 -174.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.48 -0.66 12.57 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -169.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -56.75 95.21 0.02 OUTLIER 'General case' 0 C--N 1.345 0.411 0 CA-C-O 121.575 0.702 . . . . 0.0 109.891 174.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -70.98 96.92 1.35 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.423 -1.717 . . . . 0.0 113.082 179.005 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.666 HG21 ' HG ' ' A' ' 44' ' ' LEU . 27.6 m -84.41 113.9 23.9 Favored 'Isoleucine or valine' 0 C--O 1.251 1.183 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.752 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -143.4 130.74 20.95 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.337 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.661 ' HA ' ' HA ' ' A' ' 53' ' ' LEU . 59.7 p -69.96 176.37 3.78 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.437 -173.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.536 ' HG2' HG22 ' A' ' 52' ' ' THR . 11.8 mm-40 -58.79 -20.34 49.09 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.018 0.437 . . . . 0.0 111.393 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.425 ' HZ2' ' CD ' ' A' ' 51' ' ' GLU . 37.5 mtmm -86.98 -17.29 33.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.0 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.448 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 98.99 18.72 23.91 Favored Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.653 ' HB2' ' OG ' ' A' ' 27' ' ' SER . 32.0 mtt180 -63.88 91.17 0.06 Allowed 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 168.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.492 ' HA ' ' HB ' ' A' ' 26' ' ' THR . 19.3 mt-10 -81.32 89.67 6.09 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.192 -177.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.513 HD23 ' HB3' ' A' ' 44' ' ' LEU . 11.1 mp -66.56 -48.79 68.54 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.696 -175.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.537 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . -177.22 -161.77 26.38 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 117.932 -2.08 . . . . 0.0 114.051 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.553 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 19.4 mtt -149.69 140.99 23.17 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -176.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 20' ' ' PRO . 43.8 t -70.03 129.05 34.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.324 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.88 92.89 3.89 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 171.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 74.73 136.22 0.06 Allowed 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.296 0.997 . . . . 0.0 111.316 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 58.24 -145.15 0.58 Allowed 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.425 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.43 61.3 0.32 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.425 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.484 HD22 ' HB2' ' A' ' 8' ' ' PHE . 3.8 tt -134.14 112.01 10.78 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.183 -177.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.42 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -106.87 161.29 14.83 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.392 173.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.51 ' CD2' ' HB3' ' A' ' 8' ' ' PHE . 22.6 m95 -95.71 87.98 4.85 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.486 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.666 ' HG ' HG21 ' A' ' 25' ' ' VAL . 6.6 mp -90.27 88.69 7.32 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 116.857 -1.937 . . . . 0.0 111.191 -167.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.811 ' HA ' ' HB2' ' A' ' 6' ' ' ARG . 6.3 p -86.09 86.91 7.35 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 122.012 0.91 . . . . 0.0 109.179 171.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.564 ' N ' ' HB2' ' A' ' 6' ' ' ARG . . . 150.85 26.59 0.05 OUTLIER Glycine 0 C--N 1.308 -0.976 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.176 176.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.532 HG13 ' HA ' ' A' ' 6' ' ' ARG . 6.2 p -84.72 115.31 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.97 -176.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.0 m -115.8 124.81 29.37 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 172.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.406 ' HA ' HG13 ' A' ' 67' ' ' VAL . 10.2 Cg_endo -53.5 133.94 55.58 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.147 2.565 . . . . 0.0 112.708 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.28 35.8 5.62 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.583 -1.294 . . . . 0.0 112.605 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' CD ' ' HZ2' ' A' ' 29' ' ' LYS . 4.5 mm-40 -116.31 179.4 4.0 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 122.298 1.047 . . . . 0.0 111.943 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.536 HG22 ' HG2' ' A' ' 28' ' ' GLU . 14.3 t -134.12 143.2 47.82 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.352 -1.749 . . . . 0.0 108.548 165.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 4.5 tp -121.72 160.0 25.43 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.065 -166.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.488 ' HB3' HD11 ' A' ' 61' ' ' ILE . 36.8 m -129.55 129.94 45.11 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 123.787 0.679 . . . . 0.0 111.214 172.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.656 HG21 ' SG ' ' A' ' 81' ' ' CYS . 14.4 t -119.33 106.15 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.152 -167.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.621 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 8.5 m-20 -76.92 85.62 3.47 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.55 177.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.806 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -82.24 147.11 29.13 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.899 176.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.806 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 18.1 m-20 -12.08 -64.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 170.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.11 -42.65 99.73 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 117.895 -2.098 . . . . 0.0 114.42 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 1.084 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 9.0 ptpt -178.8 -166.29 0.1 Allowed 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -169.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.621 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 12.7 tt -90.4 87.92 2.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 173.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 1.084 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 2.1 mt-30 -96.2 -51.93 4.21 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.896 -158.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' CYS . . . . . 0.412 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 20.5 p -105.33 158.16 16.82 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 118.185 -1.406 . . . . 0.0 108.145 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.642 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 97.1 mt-30 -132.45 142.5 49.28 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -97.54 151.55 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 C-N-CA 114.825 -2.75 . . . . 0.0 112.196 -169.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.59 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 12.7 m120 -112.09 113.42 25.69 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.357 174.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.406 HG13 ' HA ' ' A' ' 49' ' ' PRO . 56.1 t -96.82 106.75 32.65 Favored Pre-proline 0 C--O 1.224 -0.244 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.075 -177.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -62.22 156.08 52.76 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.208 2.605 . . . . 0.0 112.449 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -77.26 5.98 7.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.62 -170.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.7 t -130.23 -4.08 4.4 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.552 -0.459 . . . . 0.0 112.153 -172.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.557 ' HB1' HD12 ' A' ' 77' ' ' LEU . . . -94.79 152.69 18.21 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.751 -0.779 . . . . 0.0 112.675 -172.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.453 HG13 ' H ' ' A' ' 73' ' ' SER . 10.9 tp -158.16 161.9 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.803 -177.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.453 ' H ' HG13 ' A' ' 72' ' ' ILE . 19.3 m -118.1 -105.34 0.39 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 119.182 -1.007 . . . . 0.0 113.459 -173.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.984 ' HB2' ' HA3' ' A' ' 4' ' ' GLY . 29.1 t70 72.13 8.23 5.86 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.284 1.04 . . . . 0.0 109.092 -165.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -169.87 -146.63 0.05 Allowed 'General case' 0 C--O 1.245 0.816 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.738 -173.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.618 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 24.9 mt-30 -78.93 136.86 37.38 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.086 0.866 . . . . 0.0 110.672 171.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.723 ' HG ' ' H ' ' A' ' 78' ' ' LEU . 37.7 tp -129.96 -179.03 4.98 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 169.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.723 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 3.2 pp -140.81 139.32 34.52 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 117.722 -1.591 . . . . 0.0 110.721 174.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.608 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 2.8 mm? -133.58 142.2 43.04 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-O 121.567 0.699 . . . . 0.0 112.699 -175.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.59 ' HG2' ' HB2' ' A' ' 66' ' ' ASN . 74.2 Cg_endo -82.47 122.13 3.54 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.892 2.394 . . . . 0.0 111.594 171.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.656 ' SG ' HG21 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -106.67 87.65 2.58 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.2 t -68.79 143.91 95.36 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.983 -175.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.34 152.39 67.34 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.725 2.283 . . . . 0.0 111.939 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.455 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 4.1 pt20 -67.19 -39.28 86.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.536 -177.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.886 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.65 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.782 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.42 -1.955 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.805 HD23 ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -144.6 -177.41 5.48 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.566 -1.253 . . . . 0.0 113.78 -162.13 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.723 ' HB2' ' HG2' ' A' ' 76' ' ' GLN . 1.2 m-85 -118.21 104.13 10.51 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.535 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.532 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . . . -102.91 143.34 32.64 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.955 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.456 HG12 ' CD1' ' A' ' 41' ' ' LEU . 10.1 mt -112.82 99.79 9.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.277 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.718 HD12 HG21 ' A' ' 65' ' ' VAL . 2.4 mm? -93.38 128.66 39.53 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.407 -173.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -135.44 131.59 36.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.188 -0.605 . . . . 0.0 112.37 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.628 HD22 ' SG ' ' A' ' 81' ' ' CYS . 3.3 mm? -53.96 142.08 25.83 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 167.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.92 -26.37 67.43 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.057 -1.428 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -65.79 -25.55 67.3 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.223 0.535 . . . . 0.0 110.842 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.23 10.97 19.26 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.464 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 22.9 t -97.16 -160.61 0.81 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.473 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.518 ' C ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -139.25 134.82 16.82 Favored Pre-proline 0 CA--C 1.5 -0.96 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -172.402 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.537 ' O ' HG21 ' A' ' 36' ' ' VAL . 42.3 Cg_endo -76.38 103.27 1.72 Allowed 'Trans proline' 0 N--CA 1.429 -2.303 0 N-CA-C 104.301 -3.0 . . . . 0.0 104.301 148.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 17.6 Cg_endo -98.65 -163.75 0.07 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.276 0 C-N-CA 122.773 2.315 . . . . 0.0 111.51 -161.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.553 ' HA ' HG12 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -48.56 109.61 0.26 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.079 0.466 . . . . 0.0 111.986 -172.304 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.9 3.17 26.7 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.701 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -65.29 95.73 0.2 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.214 0.531 . . . . 0.0 109.983 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.577 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.0 m -67.62 105.61 1.93 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.301 -1.772 . . . . 0.0 110.686 173.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.693 HG12 HG22 ' A' ' 55' ' ' VAL . 26.9 m -100.52 112.24 32.64 Favored 'Isoleucine or valine' 0 C--O 1.26 1.614 0 CA-C-O 121.857 0.837 . . . . 0.0 110.204 174.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -149.5 128.96 13.01 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.574 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . 7.1 p -62.83 171.3 2.18 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.594 -175.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -68.39 -7.59 32.85 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.942 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 48.5 tptt -93.72 -14.03 26.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.267 0.556 . . . . 0.0 109.65 172.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.441 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 100.7 31.57 5.71 Favored Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' A' ' 26' ' ' THR . 26.6 tpt180 -73.9 89.22 1.86 Allowed 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 173.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.478 ' HA ' ' HB ' ' A' ' 26' ' ' THR . 25.6 mt-10 -86.11 94.86 9.37 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.066 -171.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.865 HD23 HD21 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -80.78 -37.61 29.97 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.077 -178.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.592 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . 167.26 -159.45 32.8 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 117.87 -2.11 . . . . 0.0 114.855 177.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.701 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 10.5 mtm -151.81 137.52 17.92 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.891 0.876 . . . . 0.0 109.683 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.595 HG23 ' HB3' ' A' ' 23' ' ' ALA . 55.7 t -61.83 129.51 24.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 C-N-CA 120.006 -0.677 . . . . 0.0 109.841 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -130.73 55.02 1.85 Allowed 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.456 173.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 5.0 t70 148.98 122.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 125.306 1.628 . . . . 0.0 108.198 174.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 20' ' ' PRO . 24.0 mt-10 52.13 -102.2 0.12 Allowed 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.531 0.52 . . . . 0.0 111.297 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.8 29.34 2.66 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.456 ' CD1' HG12 ' A' ' 10' ' ' ILE . 11.8 tp -103.34 111.15 23.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.419 -0.391 . . . . 0.0 110.044 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -101.94 126.61 48.88 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.282 174.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -75.08 88.96 2.44 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.805 ' HB2' HD23 ' A' ' 7' ' ' LEU . 8.1 mt -83.26 177.32 8.58 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 117.403 -1.719 . . . . 0.0 110.079 -171.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 41.8 m -138.84 85.72 2.1 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.796 ' HA2' HD11 ' A' ' 7' ' ' LEU . . . 75.61 75.93 0.81 Allowed Glycine 0 C--O 1.223 -0.554 0 C-N-CA 119.914 -1.136 . . . . 0.0 115.421 174.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.49 HG12 HG11 ' A' ' 67' ' ' VAL . 3.9 t -81.65 134.41 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.239 -0.585 . . . . 0.0 109.637 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.542 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -86.55 127.88 58.98 Favored Pre-proline 0 C--N 1.326 -0.45 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.737 179.176 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.747 ' HB2' ' HA ' ' A' ' 69' ' ' GLU . 30.9 Cg_endo -64.71 115.21 3.1 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.326 2.018 . . . . 0.0 111.899 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.28 36.24 2.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.748 -1.215 . . . . 0.0 112.697 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.652 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 28.5 mt-10 -116.98 176.81 4.95 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 119.146 -1.022 . . . . 0.0 112.142 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 t -127.31 92.42 3.51 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.333 168.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.865 HD21 HD23 ' A' ' 33' ' ' LEU . 9.0 mt -58.86 158.86 7.62 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 114.222 -1.353 . . . . 0.0 111.764 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.63 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 24.8 m -125.23 121.44 34.12 Favored 'General case' 0 C--N 1.317 -0.812 0 O-C-N 123.58 0.55 . . . . 0.0 109.777 168.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.693 HG22 HG12 ' A' ' 25' ' ' VAL . 9.5 t -109.43 122.23 63.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-O 121.212 0.53 . . . . 0.0 111.466 -170.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.638 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 0.9 OUTLIER -123.77 132.49 53.81 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.708 -170.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.657 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 6.7 p90 -147.23 -142.95 0.13 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 117.957 -1.497 . . . . 0.0 112.63 171.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.657 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 0.9 OUTLIER -37.5 -63.07 0.48 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.853 0.461 . . . . 0.0 111.298 167.596 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.445 ' HA3' ' OE1' ' A' ' 62' ' ' GLN . . . -80.18 0.45 83.81 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 119.126 -1.512 . . . . 0.0 110.691 176.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.638 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 27.1 mttm 74.69 -140.31 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 113.898 -1.151 . . . . 0.0 113.165 173.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.674 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -77.9 98.78 2.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -174.66 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.445 ' OE1' ' HA3' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -118.92 -41.81 2.75 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 114.416 -1.266 . . . . 0.0 110.877 -173.695 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 17.2 p -118.24 158.1 25.77 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.73 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.697 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 76.5 mt-30 -126.9 156.53 41.3 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.718 HG21 HD12 ' A' ' 11' ' ' LEU . 2.7 t -106.75 131.92 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 114.433 -2.907 . . . . 0.0 112.562 -172.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -90.46 110.81 21.91 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.187 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.652 ' HB ' ' H ' ' A' ' 51' ' ' GLU . 18.8 t -92.56 114.3 62.02 Favored Pre-proline 0 CA--C 1.513 -0.453 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.873 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 4.6 Cg_exo -81.51 172.7 12.2 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 124.324 3.35 . . . . 0.0 111.903 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.747 ' HA ' ' HB2' ' A' ' 49' ' ' PRO . 40.6 mt-10 -72.68 -6.87 47.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.814 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.452 HG22 ' HB2' ' A' ' 68' ' ' PRO . 10.7 t -85.07 18.63 2.45 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.929 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.656 ' HA ' HD22 ' A' ' 77' ' ' LEU . . . -66.25 153.5 42.38 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.617 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.25 167.98 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.909 -173.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.485 ' HA ' HD12 ' A' ' 7' ' ' LEU . 47.5 t -101.29 143.33 31.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.787 -175.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 51.83 23.45 2.08 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -134.05 173.11 11.94 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.322 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.723 ' HG2' ' HB2' ' A' ' 8' ' ' PHE . 74.9 mt-30 -86.25 142.0 28.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.701 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.656 HD22 ' HA ' ' A' ' 71' ' ' ALA . 50.9 tp -150.74 116.6 5.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.591 ' H ' HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -82.72 141.7 32.2 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 118.332 -1.347 . . . . 0.0 109.454 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.415 ' HB2' ' CD1' ' A' ' 11' ' ' LEU . 95.2 mt -131.46 147.84 67.71 Favored Pre-proline 0 C--O 1.247 0.97 0 CA-C-O 121.109 0.48 . . . . 0.0 111.962 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.429 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 65.9 Cg_endo -76.0 109.91 2.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.576 2.851 . . . . 0.0 113.309 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.628 ' SG ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -91.06 93.46 9.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.279 172.092 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 23.5 m -97.3 126.29 42.36 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.397 -175.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 82' ' ' THR . 39.2 Cg_exo -61.12 148.68 92.17 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.758 2.305 . . . . 0.0 111.767 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.561 179.031 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 1.118 ' HB2' ' HB2' ' A' ' 45' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.418 -2.074 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.672 ' N ' ' HG3' ' A' ' 6' ' ' ARG . 1.7 tt -141.08 114.3 8.63 Favored 'General case' 0 N--CA 1.387 -3.62 0 C-N-CA 117.126 -1.829 . . . . 0.0 114.761 -144.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.707 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 2.1 m-85 -119.27 88.77 3.0 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.641 ' HB2' HD21 ' A' ' 7' ' ' LEU . . . -100.38 102.11 13.26 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -170.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 51.5 mt -80.93 98.28 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.55 HD13 ' HG2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -114.41 146.04 41.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.861 -172.093 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -137.11 147.93 46.36 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.104 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.498 HD13 ' SG ' ' A' ' 81' ' ' CYS . 4.5 mm? -66.15 146.85 54.17 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.71 -27.34 67.82 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.757 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.18 -18.84 63.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.536 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.17 -6.24 25.22 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.8 -163.65 0.75 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.153 -0.524 . . . . 0.0 110.741 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.565 ' HG2' ' HA3' ' A' ' 40' ' ' GLY . 2.8 mt-30 -136.81 145.24 50.06 Favored Pre-proline 0 CA--C 1.506 -0.747 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -172.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.684 ' O ' HG21 ' A' ' 36' ' ' VAL . 6.2 Cg_exo -74.53 103.62 1.73 Allowed 'Trans proline' 0 N--CA 1.431 -2.188 0 N-CA-C 104.796 -2.809 . . . . 0.0 104.796 148.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 19.4 Cg_endo -103.13 -177.69 0.11 Allowed 'Trans proline' 0 N--CA 1.43 -2.236 0 C-N-CA 123.277 2.651 . . . . 0.0 111.99 -165.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.641 ' HA ' HG12 ' A' ' 36' ' ' VAL . 31.0 t80 -41.65 117.43 0.92 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -168.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.67 8.46 57.19 Favored Glycine 0 N--CA 1.436 -1.367 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.727 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -59.0 94.76 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.789 -0.706 . . . . 0.0 109.393 171.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.797 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 3.8 m -57.46 93.01 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 113.341 -1.754 . . . . 0.0 111.546 172.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.898 HG23 ' C ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -89.04 95.18 5.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.634 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.716 ' HB ' ' HG2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -128.33 130.94 48.53 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.66 -174.021 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.5 p -65.42 172.07 3.51 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 118.567 -1.253 . . . . 0.0 109.553 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.61 -18.23 51.78 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.912 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -93.71 -8.79 39.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.839 0.352 . . . . 0.0 110.87 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.431 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 102.12 23.92 8.82 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.164 174.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.663 HH11 HD12 ' A' ' 33' ' ' LEU . 39.7 mtm105 -73.73 88.51 1.75 Allowed 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 118.212 -1.395 . . . . 0.0 108.57 170.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.716 ' HG2' ' HB ' ' A' ' 26' ' ' THR . 15.8 mt-10 -83.52 77.9 9.75 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.674 HD13 ' HA3' ' A' ' 46' ' ' GLY . 96.2 mt -121.11 12.39 11.08 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.816 -167.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 1.042 ' HA2' ' HB2' ' A' ' 44' ' ' LEU . . . -138.02 149.82 20.63 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.468 163.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.727 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 30.9 mtm -154.14 126.28 7.85 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 160.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.713 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 32.3 t -60.89 135.32 25.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 O-C-N 123.649 0.593 . . . . 0.0 111.518 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -136.59 116.91 13.59 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 172.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 20.5 m-20 72.41 116.91 0.05 OUTLIER 'General case' 0 C--O 1.234 0.255 0 O-C-N 124.199 0.937 . . . . 0.0 111.101 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 62.87 -95.23 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.857 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.565 ' HA3' ' HG2' ' A' ' 18' ' ' GLN . . . -160.94 53.1 0.33 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 118.807 -1.663 . . . . 0.0 114.001 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.656 HD11 ' HE1' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -141.74 139.48 32.86 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.416 170.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.713 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -84.83 122.94 29.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.342 0.592 . . . . 0.0 111.719 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.656 ' HE1' HD11 ' A' ' 41' ' ' LEU . 58.9 m95 -97.03 88.13 4.42 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.268 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.042 ' HB2' ' HA2' ' A' ' 34' ' ' GLY . 1.2 mt -156.94 -166.65 2.14 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -169.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 1.118 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 1.1 t -153.57 106.38 2.91 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.281 -171.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.674 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 140.36 76.17 0.05 OUTLIER Glycine 0 CA--C 1.521 0.449 0 C-N-CA 119.707 -1.235 . . . . 0.0 113.93 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.568 ' HB ' HD11 ' A' ' 7' ' ' LEU . 12.9 p -120.84 143.64 32.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.895 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.2 m -117.08 129.48 25.29 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.82 0.343 . . . . 0.0 110.332 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.578 ' HA ' HG12 ' A' ' 67' ' ' VAL . 44.1 Cg_endo -68.56 129.01 18.07 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.569 2.179 . . . . 0.0 112.136 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.47 36.38 5.91 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.155 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -128.02 173.3 10.16 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 118.055 -1.458 . . . . 0.0 113.731 -170.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 p -121.09 89.8 3.2 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.089 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 25.6 mt -68.1 151.92 46.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.075 174.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.503 ' HB2' HD11 ' A' ' 61' ' ' ILE . 34.5 p -122.88 121.95 37.43 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.938 0.875 . . . . 0.0 110.593 170.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.797 ' HA ' ' O ' ' A' ' 24' ' ' SER . 4.8 t -120.08 117.95 55.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.465 -162.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.723 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 35.0 m-80 -103.51 148.75 25.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.922 -173.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 6.2 p90 -161.84 -138.21 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 120.263 -0.575 . . . . 0.0 112.528 161.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.676 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 30.8 t70 -41.72 -58.12 2.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.277 0.631 . . . . 0.0 111.495 168.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.55 -1.47 88.9 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 119.288 -1.434 . . . . 0.0 110.302 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.655 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 37.8 mtmt 71.18 -142.26 0.06 Allowed 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 113.938 -1.131 . . . . 0.0 110.74 173.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.503 HD11 ' HB2' ' A' ' 54' ' ' SER . 0.5 OUTLIER -67.98 95.35 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-O 123.414 1.578 . . . . 0.0 107.937 -177.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.597 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -139.04 -37.3 0.52 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.434 -1.712 . . . . 0.0 111.129 -170.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.646 ' SG ' ' HG3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -87.56 142.85 27.54 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 166.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -140.09 124.64 18.07 Favored 'General case' 0 CA--C 1.478 -1.789 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 22.2 t -98.93 132.1 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.111 0 C-N-CA 114.639 -2.824 . . . . 0.0 112.278 -168.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -101.05 102.48 13.46 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 118.039 -1.464 . . . . 0.0 110.279 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 49' ' ' PRO . 40.6 t -75.25 126.57 87.71 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.025 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.537 ' HB2' HG22 ' A' ' 70' ' ' THR . 9.8 Cg_endo -90.16 171.02 3.92 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.663 2.909 . . . . 0.0 111.93 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.32 0.26 22.92 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 111.596 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 68' ' ' PRO . 8.8 t -93.42 16.03 14.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.192 0.52 . . . . 0.0 110.326 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.09 152.92 38.54 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.712 0.768 . . . . 0.0 111.711 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.439 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 59.1 mt -121.12 137.67 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.91 -174.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -88.53 140.39 29.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.382 -173.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.0 t70 71.76 -4.22 1.97 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.217 0.532 . . . . 0.0 112.246 170.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -112.7 -166.05 1.05 Allowed 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.34 0.591 . . . . 0.0 110.829 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.707 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 30.0 pt20 -97.69 134.84 40.33 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.921 173.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 78' ' ' LEU . 1.6 tm? -142.9 141.91 31.62 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -88.16 132.81 34.19 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.393 -177.334 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 3.4 mm? -117.98 139.62 26.78 Favored Pre-proline 0 C--O 1.241 0.657 0 CA-C-O 121.233 0.539 . . . . 0.0 111.496 -176.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 73.3 Cg_endo -87.99 120.27 1.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.051 2.501 . . . . 0.0 112.278 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.498 ' SG ' HD13 ' A' ' 13' ' ' LEU . 8.8 t -89.04 120.31 30.33 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.853 176.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 m -97.52 134.78 22.14 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 170.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -63.17 152.14 81.2 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.46 2.107 . . . . 0.0 112.732 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.17 178.166 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.857 ' C ' HD23 ' A' ' 7' ' ' LEU . 90.7 mtt-85 . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.964 HD22 ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -123.01 172.02 8.82 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 115.737 -2.385 . . . . 0.0 109.006 -170.476 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.819 ' HB2' ' HA ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -92.24 87.13 5.96 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.524 -1.67 . . . . 0.0 108.095 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.839 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -98.32 112.08 24.2 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 118.969 -1.093 . . . . 0.0 111.462 -173.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.456 HG12 ' HG ' ' A' ' 41' ' ' LEU . 59.2 mt -100.65 90.67 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.476 171.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -103.06 132.27 49.45 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.426 -175.335 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.819 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 58.7 mtm-85 -141.67 155.09 45.7 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.265 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.642 HD23 ' HD3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -89.99 135.23 33.77 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 117.888 -1.525 . . . . 0.0 109.028 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.53 -11.64 3.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.797 -169.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -67.29 -19.0 65.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.433 0.635 . . . . 0.0 110.596 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.7 -8.98 21.79 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -174.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.441 ' CB ' ' HG ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -82.61 -177.9 6.87 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 113.922 -1.139 . . . . 0.0 111.824 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.552 ' OE1' ' HB2' ' A' ' 39' ' ' GLU . 0.5 OUTLIER -135.4 142.65 42.15 Favored Pre-proline 0 CA--C 1.503 -0.857 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.949 -176.008 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.819 ' HD3' ' HA ' ' A' ' 12' ' ' ARG . 3.6 Cg_endo -80.37 102.72 1.45 Allowed 'Trans proline' 0 N--CA 1.423 -2.668 0 N-CA-C 104.848 -2.789 . . . . 0.0 104.848 156.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.718 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 1.9 Cg_endo -101.63 175.76 0.23 Allowed 'Trans proline' 0 N--CA 1.422 -2.715 0 C-N-CA 122.836 2.357 . . . . 0.0 111.047 -162.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.445 ' HD1' ' HA ' ' A' ' 37' ' ' ALA . 82.5 t80 -30.42 99.74 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 124.231 0.957 . . . . 0.0 113.306 -169.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.72 10.85 8.17 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.663 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.96 ' HB3' HG13 ' A' ' 36' ' ' VAL . . . -58.94 95.86 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.227 175.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.656 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 0.6 OUTLIER -77.8 98.41 5.54 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.714 -1.585 . . . . 0.0 112.117 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.688 HG12 HG22 ' A' ' 55' ' ' VAL . 11.8 m -103.68 115.19 45.16 Favored 'Isoleucine or valine' 0 C--O 1.259 1.563 0 CA-C-O 121.319 0.581 . . . . 0.0 111.85 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.628 ' OG1' ' HA2' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -147.21 125.98 12.65 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.257 175.853 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.623 ' CB ' ' HE2' ' A' ' 29' ' ' LYS . 27.2 m -53.07 168.48 0.13 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 123.17 0.293 . . . . 0.0 111.385 -173.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.453 ' CD ' ' HG3' ' A' ' 29' ' ' LYS . 5.9 pm0 -59.75 -20.31 55.78 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.982 -0.448 . . . . 0.0 112.048 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.623 ' HE2' ' CB ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -103.03 4.55 37.38 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.686 176.409 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.628 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 86.15 43.06 6.42 Favored Glycine 0 N--CA 1.418 -2.541 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 174.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 1.035 ' HE ' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -94.7 97.34 10.0 Favored 'General case' 0 N--CA 1.421 -1.897 0 C-N-CA 117.521 -1.672 . . . . 0.0 107.12 166.028 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -96.15 111.18 23.3 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.16 -159.446 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.782 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 5.9 mp -84.64 -49.94 8.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.383 -174.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.576 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . 168.86 -155.93 26.84 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 117.041 -2.504 . . . . 0.0 114.888 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.8 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 17.1 mtp -149.84 128.28 12.22 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -173.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.96 HG13 ' HB3' ' A' ' 23' ' ' ALA . 6.3 m -71.37 130.04 35.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.105 -173.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HA ' ' HD1' ' A' ' 21' ' ' PHE . . . -121.64 55.85 1.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.807 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 20.6 t0 150.31 139.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 O-C-N 125.36 1.662 . . . . 0.0 107.572 176.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.718 ' O ' ' HA ' ' A' ' 20' ' ' PRO . 0.5 OUTLIER 28.12 -100.26 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 O-C-N 124.757 1.285 . . . . 0.0 111.781 -167.379 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.697 ' H ' ' HG3' ' A' ' 39' ' ' GLU . . . -136.07 48.84 0.9 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 173.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.456 ' HG ' HG12 ' A' ' 10' ' ' ILE . 2.6 tt -116.42 117.48 30.05 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.984 0.421 . . . . 0.0 111.039 -178.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.562 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . . . -125.57 154.75 41.74 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 171.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.617 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 64.6 m95 -84.21 88.11 7.2 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.847 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 6.3 mp -73.68 102.26 3.89 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.873 -169.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.84 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 6.4 m -56.71 87.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.086 0.866 . . . . 0.0 111.919 -176.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.401 ' HA2' HD21 ' A' ' 7' ' ' LEU . . . 56.58 91.35 0.01 OUTLIER Glycine 0 C--N 1.339 0.722 0 CA-C-N 114.683 -1.144 . . . . 0.0 114.341 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.753 HG23 HD12 ' A' ' 7' ' ' LEU . 4.6 t -72.02 145.72 11.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.569 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.3 118.52 72.26 Favored Pre-proline 0 N--CA 1.442 -0.847 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.98 ' HB2' ' HA ' ' A' ' 69' ' ' GLU . 73.1 Cg_endo -71.48 109.37 2.6 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.451 2.101 . . . . 0.0 112.197 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.44 34.95 1.04 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.098 -1.525 . . . . 0.0 113.524 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -164.66 179.99 6.26 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 117.477 -1.689 . . . . 0.0 114.121 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.828 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 21.0 p -111.63 124.98 53.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.823 -174.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 64' ' ' GLN . 1.1 mm? -83.14 134.79 34.98 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.632 ' HB3' HD11 ' A' ' 61' ' ' ILE . 3.1 m -72.33 103.51 3.44 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.688 HG22 HG12 ' A' ' 25' ' ' VAL . 46.3 t -103.18 94.42 3.2 Favored 'Isoleucine or valine' 0 C--O 1.249 1.058 0 CA-C-O 122.145 0.974 . . . . 0.0 111.278 -172.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.704 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 43.0 m-80 -73.65 131.67 41.91 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.271 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.615 ' HB3' ' HG3' ' A' ' 62' ' ' GLN . 1.7 t90 -148.39 134.56 19.34 Favored 'General case' 0 C--O 1.208 -1.125 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.666 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.574 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 2.6 p30 -12.58 -58.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -173.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -61.05 -23.79 62.16 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 118.397 -1.859 . . . . 0.0 114.282 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 1.023 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 11.1 pttt 173.36 -141.83 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.732 0.777 . . . . 0.0 110.265 -170.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.704 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 11.8 tt -115.1 93.95 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 162.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 1.023 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -92.15 -19.51 22.2 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 117.289 -1.764 . . . . 0.0 113.285 -150.663 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.556 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 23.7 p -147.92 159.92 43.36 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.915 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 47.5 mt-30 -129.82 119.42 23.33 Favored 'General case' 0 CA--C 1.478 -1.824 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.828 ' O ' ' HA ' ' A' ' 52' ' ' THR . 2.6 t -78.19 123.47 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 C-N-CA 116.804 -1.958 . . . . 0.0 112.025 -167.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -91.32 133.21 35.62 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.023 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.731 HG21 HG11 ' A' ' 47' ' ' VAL . 62.1 t -121.53 134.54 24.59 Favored Pre-proline 0 N--CA 1.44 -0.966 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.768 -173.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 6.5 Cg_endo -92.26 172.76 2.38 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.393 3.395 . . . . 0.0 111.798 171.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.98 ' HA ' ' HB2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -63.6 -14.95 56.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.149 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.5 p -62.42 -21.55 65.49 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.27 138.71 33.47 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.366 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 mm -130.48 -82.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.888 -170.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.964 ' HA ' HD22 ' A' ' 7' ' ' LEU . 24.0 p -172.05 137.67 0.96 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.511 -175.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.765 ' H ' HD22 ' A' ' 7' ' ' LEU . 5.2 m-20 55.89 -163.23 0.15 Allowed 'General case' 0 C--N 1.362 1.142 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -172.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 8' ' ' PHE . 42.4 mt-30 65.73 150.3 0.05 OUTLIER 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.649 0.738 . . . . 0.0 112.3 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.819 ' HA ' ' HB2' ' A' ' 8' ' ' PHE . 22.1 mp0 -76.75 124.12 27.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.464 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -140.77 116.88 10.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 7.7 tt -85.98 127.13 34.57 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.018 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 81.9 mt -113.61 141.86 26.7 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 121.108 0.48 . . . . 0.0 111.704 -174.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 67.7 Cg_endo -91.38 120.39 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.349 2.699 . . . . 0.0 113.196 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.678 ' SG ' ' HG3' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -82.58 116.24 21.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.384 175.057 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.3 m -82.85 117.1 67.47 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.155 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.48 158.82 22.47 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.814 2.343 . . . . 0.0 112.268 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.421 178.022 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.841 ' C ' HD13 ' A' ' 7' ' ' LEU . 25.7 mtm180 . . . . . 0 N--CA 1.429 -1.487 0 N-CA-C 102.389 -3.189 . . . . 0.0 102.389 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.906 HD23 ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -149.67 177.68 9.55 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 117.714 -1.594 . . . . 0.0 113.164 -168.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 1.3 m-85 -126.78 89.64 3.02 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.697 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 77' ' ' LEU . . . -93.36 134.33 35.69 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.638 -170.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.619 ' HB ' ' HG ' ' A' ' 78' ' ' LEU . 4.2 mp -96.77 111.79 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.691 173.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.698 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 65.4 mt -92.51 131.29 37.77 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.543 -175.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.533 ' HD3' ' O ' ' A' ' 17' ' ' SER . 6.2 tpp180 -137.81 123.56 19.92 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.477 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.698 HD13 ' SG ' ' A' ' 81' ' ' CYS . 4.2 mm? -53.99 144.27 19.56 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 168.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.07 -30.28 66.08 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.218 -1.356 . . . . 0.0 111.211 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -79.02 -13.01 60.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.668 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.25 -11.71 16.88 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.159 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 30.9 p -81.83 -164.58 0.82 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.465 0.632 . . . . 0.0 110.108 175.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.623 ' C ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -129.93 141.38 41.65 Favored Pre-proline 0 CA--C 1.504 -0.815 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -172.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.698 ' HG2' ' HB3' ' A' ' 11' ' ' LEU . 5.4 Cg_exo -78.41 103.66 1.71 Allowed 'Trans proline' 0 N--CA 1.436 -1.888 0 N-CA-C 105.617 -2.494 . . . . 0.0 105.617 153.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -104.27 -161.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 123.563 2.842 . . . . 0.0 111.799 -163.609 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.471 ' CD2' ' HA ' ' A' ' 37' ' ' ALA . 38.2 t80 -48.9 114.83 1.07 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.409 0.623 . . . . 0.0 112.585 -169.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.69 -18.86 14.66 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.664 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -53.3 96.43 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 124.505 0.768 . . . . 0.0 110.975 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.759 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -72.68 88.8 1.3 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.444 -1.707 . . . . 0.0 111.653 175.358 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.495 ' HB ' HD22 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -74.49 88.99 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.774 169.404 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.738 ' HB ' ' O ' ' A' ' 31' ' ' ARG . 7.2 p -148.27 143.89 27.26 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.71 ' OG ' ' HB2' ' A' ' 31' ' ' ARG . 96.3 p -71.39 178.3 3.5 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 116.953 -1.899 . . . . 0.0 109.913 -175.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.507 ' H ' ' CD ' ' A' ' 28' ' ' GLU . 2.1 mp0 -56.55 -28.69 60.7 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.849 0.357 . . . . 0.0 111.603 -171.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.536 ' H ' ' HD2' ' A' ' 29' ' ' LYS . 1.9 mptp? -85.37 -15.48 43.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.197 0.522 . . . . 0.0 110.807 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.53 10.43 35.78 Favored Glycine 0 CA--C 1.485 -1.818 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.738 ' O ' ' HB ' ' A' ' 26' ' ' THR . 93.2 mtt180 -63.95 -178.3 0.31 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.671 -1.265 . . . . 0.0 109.339 169.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 0.6 OUTLIER 87.27 -158.67 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 164.647 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.945 HD13 HD21 ' A' ' 53' ' ' LEU . 6.8 mp -83.84 -48.67 9.81 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -144.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.725 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . 154.53 -141.4 8.17 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.988 -175.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.725 ' HG3' ' C ' ' A' ' 34' ' ' GLY . 6.9 mtt -148.6 142.66 25.93 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 117.517 0.658 . . . . 0.0 111.529 -173.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.615 HG23 HD12 ' A' ' 11' ' ' LEU . 55.5 t -66.18 130.61 31.65 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.519 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . . . -121.17 58.5 0.97 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.635 0.731 . . . . 0.0 109.332 172.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 39' ' ' GLU . 25.6 t70 178.68 -167.7 0.07 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.182 -174.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.487 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 10.1 pt-20 -85.51 1.81 47.34 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 122.091 -0.381 . . . . 0.0 111.539 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.481 ' HA3' ' HG2' ' A' ' 18' ' ' GLN . . . 174.72 25.1 0.03 OUTLIER Glycine 0 C--N 1.332 0.31 0 C-N-CA 119.143 -1.503 . . . . 0.0 112.995 175.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 9' ' ' ALA . 35.0 tp -133.19 121.69 22.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.57 0.224 . . . . 0.0 111.017 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.858 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -111.13 128.93 56.05 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.167 176.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -85.12 100.16 11.54 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.906 ' HB2' HD23 ' A' ' 7' ' ' LEU . 35.7 mt -111.15 178.55 4.31 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 118.467 -1.293 . . . . 0.0 111.657 -163.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 21.1 p -132.22 88.56 2.56 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.4 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.757 ' CA ' HD11 ' A' ' 7' ' ' LEU . . . 86.78 142.56 7.21 Favored Glycine 0 N--CA 1.464 0.56 0 C-N-CA 119.102 -1.523 . . . . 0.0 113.619 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG12 HD21 ' A' ' 33' ' ' LEU . 16.2 m -122.3 152.61 26.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 120.575 0.226 . . . . 0.0 110.71 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -111.77 109.98 55.04 Favored Pre-proline 0 C--N 1.324 -0.526 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.741 170.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.6 133.93 27.06 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 123.902 3.068 . . . . 0.0 113.069 -173.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.86 34.9 17.27 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 119.507 -1.33 . . . . 0.0 112.474 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.54 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 3.6 mm-40 -127.32 -173.13 2.82 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 121.852 0.834 . . . . 0.0 112.476 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 22.7 m -130.94 108.58 9.92 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.986 170.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.945 HD21 HD13 ' A' ' 33' ' ' LEU . 5.0 mt -69.36 158.8 34.37 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.793 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.654 ' HB3' HD11 ' A' ' 61' ' ' ILE . 73.5 m -102.25 154.6 18.88 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 159.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.759 ' HA ' ' O ' ' A' ' 24' ' ' SER . 21.5 t -137.92 92.77 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.925 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.652 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.666 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -82.22 109.61 16.65 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.573 -177.43 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.821 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 1.2 t90 -119.47 153.34 35.44 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.79 -1.55 . . . . 0.0 110.172 -168.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.821 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 15.6 t70 -15.62 -68.23 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.905 1.282 . . . . 0.0 113.176 169.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.74 -41.49 99.07 Favored Glycine 0 C--N 1.346 1.097 0 C-N-CA 117.966 -2.064 . . . . 0.0 113.68 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 1.036 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 0.1 OUTLIER 172.91 -168.79 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.863 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -170.105 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.666 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -87.99 91.57 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 C-N-CA 117.678 -1.609 . . . . 0.0 107.224 173.791 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 1.036 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -99.39 -41.44 7.41 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.319 -159.815 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.585 ' SG ' ' HG3' ' A' ' 19' ' ' PRO . 9.1 m -94.95 152.45 18.33 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.239 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -133.48 134.8 43.96 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 161.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.679 ' HB ' HD12 ' A' ' 53' ' ' LEU . 78.2 t -100.0 143.56 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 C-N-CA 114.28 -2.968 . . . . 0.0 112.391 -168.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -94.35 110.01 21.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 117.651 -1.619 . . . . 0.0 110.665 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.54 ' HB ' ' H ' ' A' ' 51' ' ' GLU . 4.6 t -86.54 117.22 68.33 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.604 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 71' ' ' ALA . 6.0 Cg_exo -79.36 163.27 24.85 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.942 2.428 . . . . 0.0 111.839 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -80.16 -6.2 57.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.177 0.513 . . . . 0.0 110.398 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 p -92.16 -4.3 54.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.984 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . . . -74.21 157.24 36.25 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.221 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.4 tp -144.42 149.43 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.569 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.569 ' HA ' HD12 ' A' ' 7' ' ' LEU . 33.4 m -86.53 170.05 12.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.177 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t0 70.91 147.72 0.08 Allowed 'General case' 0 C--N 1.348 0.52 0 O-C-N 123.671 0.607 . . . . 0.0 109.557 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.401 ' HB3' ' H ' ' A' ' 76' ' ' GLN . 25.5 mp0 62.73 -166.96 0.22 Allowed 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.55 0.691 . . . . 0.0 111.824 -174.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 23.7 pt20 -90.88 143.56 26.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.692 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 39.6 tp -141.58 117.36 10.42 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -175.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.619 ' HG ' ' HB ' ' A' ' 10' ' ' ILE . 6.0 mp -84.79 128.72 34.75 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 118.864 -1.134 . . . . 0.0 109.8 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.606 ' HB3' HG11 ' A' ' 65' ' ' VAL . 83.2 mt -112.84 132.19 22.41 Favored Pre-proline 0 C--O 1.246 0.906 0 CA-C-O 121.212 0.53 . . . . 0.0 111.915 -176.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.446 ' O ' HG13 ' A' ' 65' ' ' VAL . 73.5 Cg_endo -83.57 113.3 1.96 Allowed 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 123.396 2.731 . . . . 0.0 112.675 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.698 ' SG ' HD13 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -80.5 120.47 24.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.681 175.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 64.3 p -95.17 130.73 31.68 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 170.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.51 114.02 3.69 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.564 2.176 . . . . 0.0 111.264 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.45 ' H ' ' HG3' ' A' ' 84' ' ' GLN . 4.2 pp0? . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 120.988 0.423 . . . . 0.0 111.445 -178.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.875 ' HG3' ' H ' ' A' ' 45' ' ' SER . 0.6 OUTLIER . . . . . 0 C--O 1.259 1.553 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.977 ' HG ' ' HB3' ' A' ' 45' ' ' SER . 13.6 mt -114.43 167.56 10.62 Favored 'General case' 0 CA--C 1.483 -1.633 0 C-N-CA 116.668 -2.013 . . . . 0.0 114.676 -167.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 1.086 ' HB3' ' HA ' ' A' ' 76' ' ' GLN . 30.2 t80 -81.69 85.92 6.5 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 170.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.12 106.76 19.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.394 0.616 . . . . 0.0 111.886 -167.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.444 HD12 ' HG ' ' A' ' 78' ' ' LEU . 45.9 mt -98.12 96.88 5.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.246 170.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.789 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 71.6 mt -93.79 148.0 22.54 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.844 -174.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.481 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 ttt180 -160.59 142.49 12.52 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 118.566 -1.254 . . . . 0.0 112.348 172.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.638 HD23 ' C ' ' A' ' 18' ' ' GLN . 4.6 mm? -64.83 142.6 58.38 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.677 0.751 . . . . 0.0 109.209 174.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.71 -28.57 69.51 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.943 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.1 -16.35 61.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.298 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.71 -13.9 20.14 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.395 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.488 ' C ' ' HB2' ' A' ' 13' ' ' LEU . 13.2 t -75.74 -168.54 0.88 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.638 ' C ' HD23 ' A' ' 13' ' ' LEU . 1.4 mm-40 -142.45 148.1 45.82 Favored Pre-proline 0 CA--C 1.5 -0.955 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -173.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.789 ' HG2' ' HB3' ' A' ' 11' ' ' LEU . 1.2 Cg_endo -83.18 100.99 0.95 Allowed 'Trans proline' 0 N--CA 1.433 -2.074 0 N-CA-C 106.551 -2.134 . . . . 0.0 106.551 156.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.603 ' HD2' ' CD2' ' A' ' 57' ' ' TRP . 0.2 OUTLIER -106.75 -172.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.332 0 C-N-CA 124.017 3.145 . . . . 0.0 111.573 -167.637 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.527 ' HD1' ' H ' ' A' ' 38' ' ' ASP . 69.3 t80 -30.23 107.12 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -167.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.34 10.29 27.77 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.588 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.839 ' HB3' HG13 ' A' ' 36' ' ' VAL . . . -61.84 89.62 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 124.142 0.554 . . . . 0.0 111.615 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.864 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 48.2 p -62.04 131.68 50.38 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.124 0.89 . . . . 0.0 109.093 175.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.957 HG22 ' HA3' ' A' ' 34' ' ' GLY . 19.1 m -113.18 114.27 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 117.718 -1.593 . . . . 0.0 110.299 165.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 1.2 t -140.54 118.55 11.88 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.113 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.569 ' OG ' ' HB2' ' A' ' 31' ' ' ARG . 20.5 p -76.61 -171.69 1.95 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.801 -170.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -34.89 -62.63 0.36 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.087 0.955 . . . . 0.0 113.527 -171.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -75.39 -24.52 57.23 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.932 0.396 . . . . 0.0 111.479 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.641 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 119.88 42.81 0.51 Allowed Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 -172.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.821 ' O ' ' HA ' ' A' ' 26' ' ' THR . 8.8 tpp180 -69.99 99.04 1.37 Allowed 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -91.01 107.85 19.48 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.055 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.874 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -126.28 -16.64 5.4 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.671 -174.566 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 1.102 ' HA2' ' HB3' ' A' ' 44' ' ' LEU . . . -137.62 152.9 21.83 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 119.062 -1.542 . . . . 0.0 116.646 -169.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.788 ' N ' HD12 ' A' ' 44' ' ' LEU . 13.8 mtt -163.62 99.82 0.9 Allowed 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 125.446 1.499 . . . . 0.0 107.189 172.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.871 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 5.6 m -67.84 140.44 19.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 C-N-CA 118.616 -1.234 . . . . 0.0 110.811 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.88 113.67 19.44 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.441 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.527 ' H ' ' HD1' ' A' ' 21' ' ' PHE . 38.9 t70 72.81 125.38 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 O-C-N 124.371 1.044 . . . . 0.0 110.717 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 65.8 -85.14 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.684 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.543 ' HA3' ' OE1' ' A' ' 18' ' ' GLN . . . -174.0 37.67 0.12 Allowed Glycine 0 C--O 1.239 0.451 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.447 HD12 ' CH2' ' A' ' 43' ' ' TRP . 1.4 mm? -120.66 112.14 18.5 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.241 -0.479 . . . . 0.0 111.929 -172.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.871 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . . . -116.53 125.93 52.6 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 171.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.714 ' CE3' ' HA ' ' A' ' 8' ' ' PHE . 8.9 m95 -86.68 81.51 8.2 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 112.603 -3.639 . . . . 0.0 105.494 167.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.102 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -149.7 131.1 14.71 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 -165.489 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.977 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . 8.6 t 171.2 -145.86 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.425 177.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.32 -0.47 8.14 Favored Glycine 0 C--N 1.3 -1.471 0 C-N-CA 117.704 -2.189 . . . . 0.0 110.338 -160.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.712 HG21 HG11 ' A' ' 67' ' ' VAL . 7.9 p -72.26 153.09 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.824 -0.688 . . . . 0.0 111.126 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.725 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 6.5 m -98.83 131.47 25.55 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 1.013 ' HB3' ' HA ' ' A' ' 69' ' ' GLU . 83.3 Cg_exo -41.24 127.98 3.05 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.737 2.958 . . . . 0.0 113.899 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.15 36.27 5.0 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.148 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.964 ' H ' HG22 ' A' ' 67' ' ' VAL . 30.3 mt-10 -122.37 -170.15 2.02 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 118.939 -1.104 . . . . 0.0 113.031 -175.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.4 m -132.83 112.86 12.28 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.89 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.834 HD21 HD11 ' A' ' 33' ' ' LEU . 18.6 mt -78.21 159.23 28.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.053 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.637 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 6.4 m -120.04 119.93 34.82 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 168.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.864 ' HA ' ' O ' ' A' ' 24' ' ' SER . 38.2 t -112.64 124.34 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 121.513 0.673 . . . . 0.0 111.916 -169.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.846 ' HB3' ' OG ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -120.02 146.45 45.86 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.067 -170.191 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.662 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 9.7 p90 -157.92 -139.26 0.07 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 119.499 -0.88 . . . . 0.0 112.754 168.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.662 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 1.5 m-20 -41.49 -60.0 1.43 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.348 0.659 . . . . 0.0 111.558 168.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.638 ' HA3' ' NE2' ' A' ' 62' ' ' GLN . . . -77.33 -3.2 81.82 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 118.882 -1.628 . . . . 0.0 110.581 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 10.7 mttp 76.45 -149.91 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 114.356 -0.922 . . . . 0.0 111.95 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.606 HG13 ' HB2' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -71.78 101.42 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -176.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.638 ' NE2' ' HA3' ' A' ' 59' ' ' GLY . 0.2 OUTLIER -129.65 -46.03 1.18 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.632 -175.055 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.52 ' HB3' HD11 ' A' ' 13' ' ' LEU . 16.3 p -99.66 148.07 24.74 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.651 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 78.5 mt-30 -133.24 141.67 48.15 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.64 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 1.5 t -96.15 146.41 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 C-N-CA 116.276 -2.17 . . . . 0.0 112.564 -164.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -98.3 116.17 29.96 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.1 171.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.964 HG22 ' H ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -93.54 123.14 61.06 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.316 -178.207 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 97.7 Cg_endo -92.46 170.83 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.707 2.938 . . . . 0.0 113.268 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 1.013 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 1.8 mp0 -73.35 -13.34 61.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.52 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.7 p -82.89 24.86 0.72 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.332 0.494 . . . . 0.0 112.332 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.4 159.17 18.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.454 HG22 ' HB2' ' A' ' 75' ' ' GLN . 7.0 tp -169.08 168.09 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.263 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.404 ' H ' HG13 ' A' ' 72' ' ' ILE . 4.1 p -52.82 135.35 35.98 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 62.51 4.6 1.39 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.454 ' HB2' HG22 ' A' ' 72' ' ' ILE . 11.4 tt0 -86.23 155.59 20.64 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 122.19 -0.319 . . . . 0.0 111.324 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 1.086 ' HA ' ' HB3' ' A' ' 8' ' ' PHE . 14.9 pt20 -82.77 130.2 35.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.051 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.682 HD23 HD13 ' A' ' 7' ' ' LEU . 3.0 mm? -137.88 118.45 13.92 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.444 ' HG ' HD12 ' A' ' 10' ' ' ILE . 6.3 mp -86.08 96.63 9.94 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 118.759 -1.176 . . . . 0.0 108.115 174.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.588 HD13 HG11 ' A' ' 65' ' ' VAL . 96.2 mt -90.9 132.13 35.43 Favored Pre-proline 0 C--O 1.249 1.048 0 CA-C-O 121.582 0.706 . . . . 0.0 112.703 -167.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.41 117.99 3.85 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 123.544 2.829 . . . . 0.0 111.784 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.466 ' SG ' HG23 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -99.74 99.13 9.91 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.59 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 93.3 m -90.22 123.03 66.83 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.576 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 62' ' ' GLN . 55.4 Cg_endo -70.25 123.62 10.11 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.361 2.041 . . . . 0.0 111.066 175.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 . . . . . 0 C--N 1.323 -0.562 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.493 -177.503 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 1.114 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.404 -2.73 1 N-CA-C 99.692 -4.188 . . . . 0.0 99.692 . . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.926 HD13 ' HA3' ' A' ' 46' ' ' GLY . 0.4 OUTLIER -168.44 169.28 10.62 Favored 'General case' 0 N--CA 1.408 -2.537 0 C-N-CA 114.803 -2.759 . . . . 0.0 114.295 -159.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.665 ' HB2' ' HA ' ' A' ' 76' ' ' GLN . 77.4 m-85 -98.32 89.58 4.51 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.84 174.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.26 103.92 15.89 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.543 -174.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 54.1 mt -89.22 102.25 12.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.475 175.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.83 HD13 ' H ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -106.08 126.25 51.98 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.138 0.971 . . . . 0.0 110.559 -173.732 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -127.31 156.06 42.56 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.91 -1.496 . . . . 0.0 108.479 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.57 HD23 ' C ' ' A' ' 18' ' ' GLN . 1.1 pp -105.97 137.52 43.73 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 117.96 -1.496 . . . . 0.0 109.531 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.27 -9.96 0.78 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -166.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' HB3' HD12 ' A' ' 13' ' ' LEU . 6.5 t70 -66.74 -22.23 66.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.505 0.669 . . . . 0.0 110.216 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.3 -6.85 32.25 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t -96.91 -175.2 3.2 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.61 -0.795 . . . . 0.0 109.729 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.57 ' C ' HD23 ' A' ' 13' ' ' LEU . 1.6 tt0 -120.31 138.29 27.06 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.631 -171.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.545 ' N ' HD23 ' A' ' 13' ' ' LEU . 2.8 Cg_endo -80.73 103.96 1.54 Allowed 'Trans proline' 0 N--CA 1.428 -2.329 0 N-CA-C 105.646 -2.482 . . . . 0.0 105.646 156.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 1.1 Cg_endo -103.49 175.98 0.16 Allowed 'Trans proline' 0 N--CA 1.431 -2.199 0 C-N-CA 123.111 2.541 . . . . 0.0 112.545 -161.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.627 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 24.8 t80 -23.94 104.48 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -168.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.72 0.23 24.51 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.083 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.851 ' HB3' HG12 ' A' ' 36' ' ' VAL . . . -60.69 99.63 0.09 Allowed 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.424 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.94 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 68.4 p -66.82 99.32 0.61 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.418 173.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.888 HG22 ' HA3' ' A' ' 34' ' ' GLY . 5.1 m -82.37 101.41 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 C-N-CA 115.762 -2.375 . . . . 0.0 107.982 166.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 1.1 t -138.51 120.0 14.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.926 -171.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.1 t -83.15 160.64 21.8 Favored 'General case' 0 C--O 1.211 -0.941 0 C-N-CA 119.317 -0.953 . . . . 0.0 108.988 -171.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -15.6 -70.86 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -164.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -65.47 -20.81 66.51 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.3 0.571 . . . . 0.0 112.069 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.533 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 119.67 40.36 0.62 Allowed Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.692 ' HD2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -77.24 93.41 3.97 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.073 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -90.57 95.89 10.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.204 0.526 . . . . 0.0 110.478 -172.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.791 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -106.06 3.71 28.46 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.332 -176.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.888 ' HA3' HG22 ' A' ' 25' ' ' VAL . . . -157.13 149.67 20.46 Favored Glycine 0 C--O 1.221 -0.672 0 O-C-N 124.585 1.178 . . . . 0.0 112.884 172.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.749 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 42.8 mtp -150.82 107.91 3.58 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 165.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.851 HG12 ' HB3' ' A' ' 23' ' ' ALA . 1.9 p -60.67 123.89 14.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.567 -170.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.434 ' HA ' ' HD1' ' A' ' 21' ' ' PHE . . . -107.5 129.79 54.92 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 170.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 39' ' ' GLU . 3.4 t0 73.59 -150.44 0.05 Allowed 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.902 0.751 . . . . 0.0 109.418 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.502 ' HG3' ' OD1' ' A' ' 38' ' ' ASP . 32.6 mt-10 -84.24 81.95 8.59 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -171.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.3 -17.66 46.46 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 114.804 0.681 . . . . 0.0 114.804 165.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.801 ' H ' HD22 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -85.78 113.09 21.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 118.045 0.922 . . . . 0.0 113.101 175.726 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -95.64 103.47 15.34 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.673 ' HA ' ' CE3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -82.83 89.58 6.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.811 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.865 ' CB ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -140.29 -165.23 1.87 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -163.126 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 1.114 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.7 p -122.51 113.7 19.67 Favored 'General case' 0 N--CA 1.424 -1.731 0 C-N-CA 117.462 -1.695 . . . . 0.0 109.243 -167.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.926 ' HA3' HD13 ' A' ' 7' ' ' LEU . . . -59.4 173.21 4.33 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 118.829 2.292 . . . . 0.0 118.829 -161.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.448 ' HB ' HD23 ' A' ' 33' ' ' LEU . 8.0 p -121.1 172.78 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 112.984 -1.608 . . . . 0.0 110.577 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.445 ' H ' HG22 ' A' ' 47' ' ' VAL . 6.4 m -71.29 148.12 93.48 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.257 0.623 . . . . 0.0 110.209 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.624 ' HA ' HG12 ' A' ' 67' ' ' VAL . 4.5 Cg_exo -77.82 161.82 30.05 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.479 2.119 . . . . 0.0 112.189 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.27 35.24 27.24 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 119.454 -1.355 . . . . 0.0 112.216 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.592 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 22.3 mt-10 -132.0 -168.29 2.01 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.818 -175.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.2 m -139.84 99.05 3.6 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.72 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.779 HD13 ' HB ' ' A' ' 25' ' ' VAL . 30.9 mt -57.91 155.44 10.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.015 168.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.593 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 48.8 m -121.75 119.88 33.02 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 170.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.94 ' HA ' ' O ' ' A' ' 24' ' ' SER . 48.8 t -109.55 110.81 33.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-O 122.023 0.916 . . . . 0.0 112.435 -166.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.948 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -97.26 149.32 22.18 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.412 -174.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.702 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 0.1 OUTLIER -158.71 155.09 27.42 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.918 -167.731 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.702 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 0.1 OUTLIER -19.78 -57.37 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.721 1.208 . . . . 0.0 114.16 174.596 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.34 -44.4 95.47 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 117.249 -2.405 . . . . 0.0 113.479 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.704 ' HE2' ' NE2' ' A' ' 62' ' ' GLN . 1.2 pttt 174.25 -176.25 0.08 Allowed 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -167.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.948 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 4.2 tt -87.9 97.06 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 169.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.704 ' NE2' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -103.92 -50.02 3.49 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 118.938 -1.105 . . . . 0.0 112.795 -158.042 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.401 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 29.0 p -104.87 158.08 16.77 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.593 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 51.0 mt-30 -133.09 138.89 46.87 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.669 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 2.7 t -91.44 130.55 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 C-N-CA 115.013 -2.675 . . . . 0.0 112.117 -169.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -93.29 116.12 28.69 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 118.494 -1.282 . . . . 0.0 110.06 177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.624 HG12 ' HA ' ' A' ' 49' ' ' PRO . 13.8 t -93.55 116.16 66.07 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.585 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -92.03 169.23 2.93 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.051 2.501 . . . . 0.0 111.818 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -90.25 15.05 11.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.192 0.52 . . . . 0.0 110.776 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.5 m -106.78 2.6 25.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.589 0.709 . . . . 0.0 110.1 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.38 174.85 7.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.75 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.678 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 11.1 tp -136.66 170.33 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.111 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.458 ' H ' HG13 ' A' ' 72' ' ' ILE . 15.1 m -146.04 -178.58 6.2 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 23.7 t70 71.33 -41.95 0.52 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.106 0.562 . . . . 0.0 110.645 -173.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 73' ' ' SER . 69.1 mt-30 -89.73 -163.56 1.02 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.864 173.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.665 ' HA ' ' HB2' ' A' ' 8' ' ' PHE . 25.6 tt0 -86.55 133.62 33.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.536 174.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.678 ' HG ' ' H ' ' A' ' 72' ' ' ILE . 3.1 tm? -150.87 133.04 15.34 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.772 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.4 pt? -94.41 134.74 36.6 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.557 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 93.5 mt -106.43 137.24 19.37 Favored Pre-proline 0 C--O 1.24 0.557 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.281 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 59.8 Cg_endo -90.28 114.51 0.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.189 2.593 . . . . 0.0 113.027 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.87 107.31 18.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.106 177.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.9 m -78.39 130.5 71.43 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.705 175.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.93 129.55 21.02 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.402 2.068 . . . . 0.0 110.998 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 . . . . . 0 C--N 1.328 -0.343 0 O-C-N 123.429 0.455 . . . . 0.0 110.938 -178.6 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.926 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 2.1 tmm_? . . . . . 0 N--CA 1.42 -1.951 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.859 HD11 ' H ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -140.56 175.41 9.63 Favored 'General case' 0 N--CA 1.403 -2.816 0 CA-C-N 112.312 -2.222 . . . . 0.0 111.007 -158.068 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.673 ' HD2' ' HB3' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -110.91 87.43 2.53 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 173.415 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 41' ' ' LEU . . . -90.59 115.16 27.49 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.5 -167.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 57.0 mt -95.38 98.4 7.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.949 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 3.4 mm? -90.13 134.29 34.36 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 119.559 -0.857 . . . . 0.0 109.411 -174.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -144.05 126.54 15.9 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.055 175.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.785 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . 0.9 OUTLIER -90.48 113.54 25.52 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 117.347 -1.741 . . . . 0.0 109.602 174.295 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.48 -7.98 1.65 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 113.73 -1.577 . . . . 0.0 113.734 -169.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -63.32 -13.73 42.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.219 0.533 . . . . 0.0 110.668 174.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.51 27.75 2.98 Favored Glycine 0 CA--C 1.502 -0.724 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.694 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.7 m -142.03 170.68 15.26 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 114.906 -0.647 . . . . 0.0 110.219 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -118.82 142.47 31.85 Favored Pre-proline 0 CA--C 1.495 -1.14 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.657 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.949 ' HG2' ' HB3' ' A' ' 11' ' ' LEU . 5.6 Cg_exo -75.29 105.38 2.07 Favored 'Trans proline' 0 N--CA 1.424 -2.562 0 N-CA-C 105.027 -2.72 . . . . 0.0 105.027 156.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -105.96 -165.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.155 0 C-N-CA 123.078 2.519 . . . . 0.0 112.198 -164.043 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.74 100.16 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -170.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.84 22.8 7.79 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.873 ' HB3' HG13 ' A' ' 36' ' ' VAL . . . -64.94 89.62 0.08 Allowed 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.694 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.736 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -70.45 87.91 0.65 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.578 -1.646 . . . . 0.0 111.622 178.465 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.867 HG22 ' CA ' ' A' ' 34' ' ' GLY . 3.2 m -82.28 112.36 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.173 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -140.53 121.22 14.32 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.795 -178.613 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.713 ' OG ' HD23 ' A' ' 53' ' ' LEU . 64.0 m -84.85 -171.98 3.93 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.723 -168.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -23.93 -67.85 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -169.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -88.71 -6.97 57.09 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -171.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.554 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 114.39 35.87 1.39 Allowed Glycine 0 CA--C 1.487 -1.672 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -177.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.686 ' O ' HD22 ' A' ' 33' ' ' LEU . 68.3 mtp180 -76.01 100.06 4.78 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -91.9 96.05 10.17 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.06 -169.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.887 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -109.01 4.42 23.19 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.712 -170.563 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.867 ' CA ' HG22 ' A' ' 25' ' ' VAL . . . -166.72 154.76 25.45 Favored Glycine 0 N--CA 1.467 0.764 0 C-N-CA 119.079 -1.534 . . . . 0.0 114.406 176.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.674 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 31.8 mtt -149.88 99.67 2.87 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 164.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.873 HG13 ' HB3' ' A' ' 23' ' ' ALA . 2.2 m -72.09 106.59 2.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 118.899 -1.121 . . . . 0.0 111.176 -169.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.43 120.84 37.47 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 118.659 -1.216 . . . . 0.0 110.328 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 t70 70.6 119.69 0.04 OUTLIER 'General case' 0 C--O 1.237 0.398 0 O-C-N 124.348 1.03 . . . . 0.0 110.968 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 20' ' ' PRO . 7.1 mm-40 66.63 -98.93 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.309 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.83 47.65 0.33 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.084 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 9' ' ' ALA . 3.9 tt -133.96 125.07 27.43 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.533 ' HB1' ' H ' ' A' ' 35' ' ' MET . . . -113.08 129.23 56.57 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.75 0.31 . . . . 0.0 110.659 177.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -90.48 83.46 5.88 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.887 ' HB3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -145.46 -170.37 3.43 Favored 'General case' 0 C--O 1.195 -1.764 0 CA-C-O 118.973 -0.537 . . . . 0.0 110.002 -157.338 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.926 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 37.3 p -116.76 85.81 2.39 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -163.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.859 ' H ' HD11 ' A' ' 7' ' ' LEU . . . -62.12 -177.82 3.12 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 116.395 1.318 . . . . 0.0 116.395 -162.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.6 HG13 ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -103.78 177.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.153 -0.523 . . . . 0.0 111.79 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 7.0 m -82.47 139.52 44.58 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.029 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.727 ' HA ' HG12 ' A' ' 67' ' ' VAL . 59.0 Cg_exo -52.73 120.91 8.28 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.808 2.338 . . . . 0.0 112.833 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.68 36.3 0.92 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.023 -1.084 . . . . 0.0 112.677 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.719 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 24.3 mt-10 -138.43 -160.94 1.11 Allowed 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 119.244 -0.982 . . . . 0.0 112.175 -174.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 58.3 m -142.73 129.78 20.76 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.4 172.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.758 ' HB2' HG13 ' A' ' 65' ' ' VAL . 45.3 mt -88.13 151.47 22.69 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 173.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.06 106.93 14.31 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 171.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.736 ' HA ' ' O ' ' A' ' 24' ' ' SER . 20.0 t -112.32 109.69 29.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.892 -159.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.658 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 41.5 m-80 -77.68 146.16 36.19 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.549 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.756 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -150.41 149.82 30.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.415 -174.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.756 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 5.2 m-20 -25.18 -55.62 0.05 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 173.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.88 -40.62 98.55 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 117.071 -2.49 . . . . 0.0 113.778 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.763 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER 169.12 -168.96 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -169.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.4 tt -86.12 115.16 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 169.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.763 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 1.1 mt-30 -130.73 -48.78 1.05 Allowed 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 117.663 -1.615 . . . . 0.0 111.207 -165.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.616 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . 38.1 t -72.95 129.29 37.78 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.343 -1.298 . . . . 0.0 107.772 174.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -136.11 114.66 11.84 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 167.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.758 HG13 ' HB2' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -93.75 147.09 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.167 0 C-N-CA 115.04 -2.664 . . . . 0.0 112.346 -160.775 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 77.1 m-20 -100.5 108.92 21.0 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.568 174.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 49' ' ' PRO . 22.1 t -79.99 112.49 30.44 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.074 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 66' ' ' ASN . 94.4 Cg_endo -89.01 171.45 4.7 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.445 2.763 . . . . 0.0 112.141 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.522 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 2.4 mp0 -67.34 -15.37 63.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.72 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.4 m -79.83 -3.89 49.79 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.039 0.447 . . . . 0.0 111.115 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.62 156.87 36.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.4 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 73' ' ' SER . 0.4 OUTLIER -158.93 160.16 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.647 ' CB ' HD12 ' A' ' 7' ' ' LEU . 22.0 p -120.28 174.27 6.61 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.578 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.8 t70 68.78 8.16 6.59 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.371 0.605 . . . . 0.0 110.802 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -138.06 172.5 12.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.797 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.673 ' HB3' ' HD2' ' A' ' 8' ' ' PHE . 11.0 pt20 -94.13 124.74 38.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 172.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.6 tp -150.27 149.04 29.6 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.82 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.0 pt? -98.48 132.27 44.06 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.492 -1.283 . . . . 0.0 109.915 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.591 ' HB2' HD13 ' A' ' 11' ' ' LEU . 3.1 mm? -110.66 143.73 28.8 Favored Pre-proline 0 C--O 1.248 0.994 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.33 -176.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 4.9 Cg_exo -79.8 100.36 1.28 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.727 2.951 . . . . 0.0 112.864 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 13' ' ' LEU . 5.1 t -82.62 146.2 29.26 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.212 173.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.4 m -126.12 136.34 28.39 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.45 152.67 31.85 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.019 1.813 . . . . 0.0 111.04 174.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 121.011 0.434 . . . . 0.0 111.717 -176.153 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.953 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.249 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.794 HD13 ' CA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -157.99 172.09 19.07 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 115.797 1.776 . . . . 0.0 115.797 -157.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.589 ' HB2' ' HA ' ' A' ' 76' ' ' GLN . 92.4 m-85 -114.65 90.18 3.28 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 112.739 -2.028 . . . . 0.0 107.542 174.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.48 98.55 11.83 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.503 -0.479 . . . . 0.0 112.0 -171.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 40.5 mt -87.73 103.0 13.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.975 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -117.85 150.33 39.35 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.651 -175.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.506 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 13.8 mmm180 -140.3 155.42 46.84 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.79 HD22 ' SG ' ' A' ' 63' ' ' CYS . 1.8 mt -78.69 151.0 32.43 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 116.87 -1.932 . . . . 0.0 107.092 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.34 -40.34 67.95 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.684 -172.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 -74.68 -10.46 59.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.811 0.339 . . . . 0.0 111.686 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.22 24.72 4.07 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.557 -1.306 . . . . 0.0 111.754 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.66 ' HB2' ' CG ' ' A' ' 13' ' ' LEU . 16.2 m -106.33 -155.32 0.54 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.638 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -140.35 137.82 18.25 Favored Pre-proline 0 CA--C 1.51 -0.564 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -170.466 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.975 ' HG2' ' HB2' ' A' ' 11' ' ' LEU . 3.6 Cg_exo -78.59 102.14 1.52 Allowed 'Trans proline' 0 N--CA 1.438 -1.792 0 N-CA-C 104.773 -2.818 . . . . 0.0 104.773 149.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.522 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . 9.8 Cg_endo -107.78 160.88 0.1 Allowed 'Trans proline' 0 N--CA 1.431 -2.201 0 C-N-CA 123.455 2.77 . . . . 0.0 112.683 -164.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.411 ' CD1' ' HA ' ' A' ' 37' ' ' ALA . 66.5 t80 -18.64 103.7 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -168.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.63 4.36 46.12 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.836 ' HA ' ' O ' ' A' ' 56' ' ' ASN . . . -61.78 100.03 0.14 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.851 169.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.783 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -72.57 100.07 2.67 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 112.395 -2.184 . . . . 0.0 111.453 173.243 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.741 HG22 ' CA ' ' A' ' 34' ' ' GLY . 19.9 m -89.61 113.78 26.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 C-N-CA 117.645 -1.622 . . . . 0.0 109.668 174.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 1.035 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . 3.2 p -148.79 133.83 18.17 Favored 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.081 170.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.604 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -78.52 162.7 26.14 Favored 'General case' 0 C--O 1.207 -1.139 0 C-N-CA 117.221 -1.792 . . . . 0.0 108.181 -172.044 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -18.61 -62.67 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -165.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -87.13 3.49 46.05 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -171.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.89 27.03 5.57 Favored Glycine 0 CA--C 1.488 -1.614 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.948 ' HG3' HG11 ' A' ' 47' ' ' VAL . 8.5 tpt180 -68.15 176.92 2.46 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 1.035 ' HB3' ' HA ' ' A' ' 26' ' ' THR . 23.2 tp10 82.06 -120.56 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 169.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.697 ' C ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER 98.21 93.01 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.186 0 O-C-N 124.512 1.133 . . . . 0.0 109.623 -159.047 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 1.049 ' HA2' ' HB2' ' A' ' 44' ' ' LEU . . . -159.94 102.19 0.21 Allowed Glycine 0 C--O 1.216 -1.014 0 CA-C-N 112.362 -2.199 . . . . 0.0 112.216 164.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.757 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 14.3 mtm -111.08 125.67 54.01 Favored 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 121.0 -1.294 . . . . 0.0 109.911 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.748 HG12 ' HB3' ' A' ' 23' ' ' ALA . 2.1 p -73.59 139.29 19.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.727 -174.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.411 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . . . -112.87 71.14 0.73 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 171.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.3 t70 72.65 151.91 0.12 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.239 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.516 ' HB2' HD21 ' A' ' 41' ' ' LEU . 13.5 mm-40 71.8 -27.65 0.18 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.841 0.857 . . . . 0.0 112.889 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.442 ' HA2' HG21 ' A' ' 36' ' ' VAL . . . 116.99 12.81 8.15 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.354 175.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -90.0 107.31 19.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.678 -0.409 . . . . 0.0 112.002 173.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.737 ' HB1' ' C ' ' A' ' 34' ' ' GLY . . . -95.8 92.45 6.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.499 0.666 . . . . 0.0 110.45 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.521 ' HA ' ' CE3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -83.33 110.85 18.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.424 -177.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.049 ' HB2' ' HA2' ' A' ' 34' ' ' GLY . 4.2 mt -167.47 -169.93 1.33 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -167.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.953 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 26.5 p -127.47 79.36 1.88 Allowed 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 -168.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.775 ' H ' ' CD1' ' A' ' 7' ' ' LEU . . . -87.04 -150.49 18.1 Favored Glycine 0 C--N 1.306 -1.111 0 CA-C-N 114.44 -1.255 . . . . 0.0 113.529 -161.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.948 HG11 ' HG3' ' A' ' 31' ' ' ARG . 15.5 m -121.2 174.57 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.503 0.668 . . . . 0.0 112.162 174.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 11.4 t -77.79 139.19 62.08 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.692 -175.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HB3' HG22 ' A' ' 67' ' ' VAL . 87.5 Cg_exo -49.06 153.2 4.25 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.941 3.094 . . . . 0.0 114.155 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.888 ' H ' HG13 ' A' ' 67' ' ' VAL . . . 119.44 26.74 2.33 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.332 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.715 ' H ' ' CG1' ' A' ' 67' ' ' VAL . 23.2 mt-10 -143.36 -168.45 2.82 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.763 0.792 . . . . 0.0 112.946 -173.076 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 16.7 p -126.69 122.36 34.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.912 167.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.689 ' HB2' HG12 ' A' ' 65' ' ' VAL . 19.2 mt -93.37 121.01 34.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.302 -173.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.626 ' HB3' HD11 ' A' ' 61' ' ' ILE . 13.3 m -77.62 109.37 11.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.607 0.718 . . . . 0.0 110.583 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.783 ' HA ' ' O ' ' A' ' 24' ' ' SER . 59.3 t -116.57 116.72 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.537 -167.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.836 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 37.6 m-80 -99.33 157.53 16.34 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.812 -176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 2.4 p90 -161.62 -144.5 0.1 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.887 159.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.673 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 1.0 OUTLIER -41.49 -55.0 2.98 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.746 0.703 . . . . 0.0 111.076 166.216 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.51 ' HA3' ' OE1' ' A' ' 62' ' ' GLN . . . -80.68 2.3 79.6 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 118.886 -1.626 . . . . 0.0 111.079 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.643 ' CA ' ' H ' ' A' ' 57' ' ' TRP . 11.2 mtpt 67.13 -151.59 0.19 Allowed 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 114.482 -0.859 . . . . 0.0 111.771 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.626 HD11 ' HB3' ' A' ' 54' ' ' SER . 0.1 OUTLIER -64.09 106.97 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-O 122.648 1.213 . . . . 0.0 108.656 -177.001 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.636 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -146.62 -39.33 0.21 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.759 -1.564 . . . . 0.0 111.614 -174.637 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.79 ' SG ' HD22 ' A' ' 13' ' ' LEU . 1.6 t -96.75 135.04 39.26 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.528 174.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.637 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 45.0 mt-30 -126.36 137.75 53.49 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 169.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.689 HG12 ' HB2' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -97.41 129.95 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 C-N-CA 115.985 -2.286 . . . . 0.0 110.185 -170.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -89.56 98.46 11.78 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.216 -0.994 . . . . 0.0 109.332 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.888 HG13 ' H ' ' A' ' 50' ' ' GLY . 9.0 p -92.11 115.98 65.64 Favored Pre-proline 0 N--CA 1.44 -0.939 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.525 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.419 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 2.3 Cg_endo -82.53 152.68 15.47 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.352 2.701 . . . . 0.0 111.565 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -75.84 13.39 0.85 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.828 0.346 . . . . 0.0 111.875 -174.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 m -73.75 -42.45 61.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.986 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.11 -173.14 2.24 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.821 -173.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.415 ' O ' HD11 ' A' ' 77' ' ' LEU . 12.6 tt -140.93 155.68 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.35 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.782 ' OG ' HD12 ' A' ' 7' ' ' LEU . 33.3 t -84.85 -166.51 1.5 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.886 -175.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 73' ' ' SER . 38.8 t70 75.76 10.07 3.39 Favored 'General case' 0 C--N 1.359 1.012 0 CA-C-O 121.717 0.77 . . . . 0.0 110.195 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -153.24 -171.97 4.09 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.154 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.589 ' HA ' ' HB2' ' A' ' 8' ' ' PHE . 14.1 pt20 -86.11 140.39 30.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 72' ' ' ILE . 96.1 mt -138.47 157.0 47.03 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.692 ' H ' HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -111.03 132.96 53.79 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 117.757 -1.577 . . . . 0.0 109.528 173.46 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.446 HD12 HG23 ' A' ' 67' ' ' VAL . 2.7 mm? -122.9 140.98 34.41 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -169.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 57.8 Cg_endo -88.57 110.01 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.846 3.031 . . . . 0.0 112.467 176.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.603 ' HB3' ' HA ' ' A' ' 13' ' ' LEU . 1.8 t -93.43 122.45 35.86 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.345 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.492 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 8.6 t -130.35 133.5 24.98 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.737 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 82' ' ' THR . 5.0 Cg_endo -88.02 98.89 0.42 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.952 2.435 . . . . 0.0 110.823 171.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.427 ' OE1' ' HA ' ' A' ' 84' ' ' GLN . 6.7 tp60 . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 121.715 0.769 . . . . 0.0 109.622 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.688 ' HA ' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.461 -2.476 0 N-CA-C 101.724 -3.435 . . . . 0.0 101.724 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.952 HD12 ' H ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -163.17 -179.32 6.56 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 111.762 -3.975 . . . . 0.0 115.987 -151.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.928 ' HE1' ' HB2' ' A' ' 41' ' ' LEU . 6.2 t80 -127.17 105.39 8.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.41 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 77' ' ' LEU . . . -100.74 131.61 46.55 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.877 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.503 HG22 ' HG2' ' A' ' 12' ' ' ARG . 4.1 mp -100.28 97.02 5.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.879 HD12 HG21 ' A' ' 65' ' ' VAL . 2.7 mm? -85.48 107.57 17.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.359 -173.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.894 ' HD3' ' HG2' ' A' ' 18' ' ' GLN . 18.1 mmt180 -126.47 139.75 53.0 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.063 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 17' ' ' SER . 2.3 mt -80.62 144.32 32.43 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 117.774 -1.57 . . . . 0.0 107.694 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 -15.39 59.24 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.673 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -75.17 -30.1 60.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.827 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.16 -11.14 20.06 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -174.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.661 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 8.7 p -87.35 165.26 15.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.939 -0.631 . . . . 0.0 110.834 175.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.894 ' HG2' ' HD3' ' A' ' 12' ' ' ARG . 12.1 mp0 -159.01 -91.14 0.0 OUTLIER Pre-proline 0 C--O 1.22 -0.484 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.386 171.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.566 ' CD ' ' HB2' ' A' ' 18' ' ' GLN . 21.3 Cg_exo -23.64 100.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 124.321 3.347 . . . . 0.0 115.114 -133.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.736 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 91.4 Cg_endo -111.3 96.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.895 0 C-N-CA 124.678 3.586 . . . . 0.0 111.902 163.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.99 111.4 23.73 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 118.641 -1.224 . . . . 0.0 109.401 -171.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.24 12.86 28.19 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 -163.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.756 ' HA ' ' O ' ' A' ' 56' ' ' ASN . . . -60.14 93.74 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.887 -0.656 . . . . 0.0 110.107 174.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.681 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 0.6 OUTLIER -68.63 94.62 0.6 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.77 174.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.614 ' HB ' HD13 ' A' ' 53' ' ' LEU . 28.5 m -82.3 108.9 15.71 Favored 'Isoleucine or valine' 0 C--O 1.261 1.662 0 C-N-CA 119.031 -1.068 . . . . 0.0 108.691 173.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.709 ' HB ' ' OE1' ' A' ' 32' ' ' GLU . 5.0 t -134.11 129.7 36.31 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.867 -175.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.64 131.14 35.9 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 117.624 -1.63 . . . . 0.0 108.33 -173.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -14.72 -52.6 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -158.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -65.83 -17.27 64.52 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.31 0.959 . . . . 0.0 111.885 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.599 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 113.36 36.46 1.46 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.7 mtp85 -81.75 86.97 6.36 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 171.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.709 ' OE1' ' HB ' ' A' ' 26' ' ' THR . 4.9 mm-40 -72.35 104.8 3.85 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.03 -173.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.636 HD22 ' O ' ' A' ' 46' ' ' GLY . 24.7 mt -85.84 -35.05 20.87 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.067 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.676 ' HA3' HD22 ' A' ' 44' ' ' LEU . . . 175.9 -171.29 44.34 Favored Glycine 0 C--N 1.349 1.258 0 C-N-CA 119.258 -1.449 . . . . 0.0 114.209 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.709 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 24.8 mtt -149.0 135.99 19.87 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.854 0.327 . . . . 0.0 111.516 -173.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 23' ' ' ALA . 54.7 t -69.41 148.56 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.238 0.336 . . . . 0.0 111.055 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -138.84 57.28 1.68 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.106 172.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.746 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 9.0 p-10 167.09 -154.32 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.579 -176.3 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 62.6 mm-40 -49.74 -52.55 30.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.774 169.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.52 57.93 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 118.59 -1.767 . . . . 0.0 113.982 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.928 ' HB2' ' HE1' ' A' ' 8' ' ' PHE . 4.5 pp -132.09 131.71 42.63 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.608 0.718 . . . . 0.0 110.341 169.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.05 114.87 20.31 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.827 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.423 ' CZ3' ' HB2' ' A' ' 8' ' ' PHE . 50.7 m95 -72.97 88.81 1.39 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.717 HD12 HD21 ' A' ' 7' ' ' LEU . 5.9 mt -79.24 178.06 8.36 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 118.547 -1.261 . . . . 0.0 108.538 -174.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 65.7 p -147.13 88.83 1.75 Allowed 'General case' 0 N--CA 1.427 -1.575 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.387 172.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.952 ' H ' HD12 ' A' ' 7' ' ' LEU . . . 107.33 92.87 2.28 Favored Glycine 0 C--O 1.222 -0.615 0 C-N-CA 119.011 -1.566 . . . . 0.0 112.248 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.545 HG12 ' HG ' ' A' ' 7' ' ' LEU . 10.3 p -120.39 137.46 54.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.435 ' HB ' ' OE2' ' A' ' 51' ' ' GLU . 28.8 m -101.22 129.44 27.04 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.929 ' HB2' ' HA ' ' A' ' 69' ' ' GLU . 60.3 Cg_endo -72.99 135.38 23.08 Favored 'Trans proline' 0 C--N 1.331 -0.367 0 C-N-CA 122.907 2.405 . . . . 0.0 112.897 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.94 35.66 5.26 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 119.46 -1.352 . . . . 0.0 113.176 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.714 ' H ' ' CG1' ' A' ' 67' ' ' VAL . 31.6 mt-10 -121.89 177.69 5.19 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.879 -176.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 p -122.86 90.98 3.39 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.664 165.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.633 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 19.6 mt -51.43 152.82 2.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.484 171.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.52 ' HB2' HD11 ' A' ' 61' ' ' ILE . 21.4 p -120.61 125.14 47.01 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 165.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 24' ' ' SER . 20.3 t -112.68 107.93 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.497 0.665 . . . . 0.0 111.275 -167.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.756 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 45.8 m-80 -76.42 139.8 41.04 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.624 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.857 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 2.4 t90 -144.59 149.66 36.16 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.503 -166.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.857 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 4.3 m-20 -19.41 -64.74 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.758 1.223 . . . . 0.0 113.243 166.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.42 ' HA3' HE22 ' A' ' 62' ' ' GLN . . . -62.76 -36.46 93.36 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 117.719 -2.181 . . . . 0.0 113.864 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.746 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 13.1 pttp 167.77 -169.7 0.02 OUTLIER 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -172.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.715 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.3 tt -81.96 118.31 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 167.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.785 ' HG3' ' HB3' ' A' ' 57' ' ' TRP . 1.4 mt-30 -125.18 -63.06 1.18 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 115.555 -2.458 . . . . 0.0 112.511 -166.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 27.5 p -92.89 149.21 21.41 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 117.304 -1.758 . . . . 0.0 108.116 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 96.1 mt-30 -127.13 133.82 50.31 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.879 HG21 HD12 ' A' ' 11' ' ' LEU . 4.4 t -94.99 140.74 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 C-N-CA 115.522 -2.471 . . . . 0.0 113.015 -164.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -95.48 113.58 25.25 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 118.736 -1.185 . . . . 0.0 110.261 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.714 ' CG1' ' H ' ' A' ' 51' ' ' GLU . 8.8 p -101.8 124.22 41.19 Favored Pre-proline 0 C--O 1.219 -0.507 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.823 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 91.8 Cg_endo -88.67 171.8 4.93 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.853 3.035 . . . . 0.0 112.916 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.929 ' HA ' ' HB2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -68.78 -25.19 64.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.651 -177.51 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -76.81 28.7 0.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.127 0.489 . . . . 0.0 111.811 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.536 ' HA ' HD22 ' A' ' 77' ' ' LEU . . . -69.36 135.28 50.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.394 0.616 . . . . 0.0 110.908 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.434 HG22 ' HB2' ' A' ' 77' ' ' LEU . 10.7 tp -96.08 157.92 3.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.067 -173.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.3 m -107.52 129.92 54.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.442 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.675 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 58.4 m-20 56.08 30.09 15.68 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -146.02 -167.7 2.79 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.282 0.563 . . . . 0.0 112.208 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.569 ' HA ' ' HB3' ' A' ' 8' ' ' PHE . 26.9 tt0 -93.32 140.51 29.47 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.606 -175.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.536 HD22 ' HA ' ' A' ' 71' ' ' ALA . 55.0 tp -153.98 123.01 6.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.769 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -85.5 137.0 33.19 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 118.426 -1.309 . . . . 0.0 109.549 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.563 ' HB2' HD13 ' A' ' 11' ' ' LEU . 55.5 mt -122.81 134.83 25.23 Favored Pre-proline 0 C--O 1.245 0.818 0 CA-C-O 121.7 0.762 . . . . 0.0 111.85 -175.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 92.1 Cg_endo -87.68 121.86 1.6 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.192 2.595 . . . . 0.0 112.846 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 63' ' ' CYS . 1.1 m -81.52 97.82 7.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.054 173.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.44 ' HB ' ' CD ' ' A' ' 83' ' ' PRO . 17.2 p -83.92 171.31 11.6 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.029 176.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.44 ' CD ' ' HB ' ' A' ' 82' ' ' THR . 22.6 Cg_exo -65.69 -172.31 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.564 2.176 . . . . 0.0 112.848 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.564 -179.629 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.811 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 7.7 ptp180 . . . . . 0 N--CA 1.448 -0.561 0 CA-C-O 117.299 -1.334 . . . . 0.0 108.645 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 74' ' ' ASP 0.317 10.6 mt 172.13 -165.36 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 156.294 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 0.7 OUTLIER -66.62 127.76 33.61 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.6 -166.092 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.693 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -127.19 144.14 51.1 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.587 -175.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.1 mt -90.21 106.67 17.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.555 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.69 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -102.41 154.65 18.88 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.644 ' HA ' ' HG3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -142.89 154.08 43.76 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.05 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.727 ' HB2' ' O ' ' A' ' 17' ' ' SER . 1.7 mm? -64.07 -175.8 0.17 Allowed 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.623 0.725 . . . . 0.0 109.748 172.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.2 -27.35 66.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.025 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.95 -20.66 61.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.557 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.38 33.64 7.94 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.732 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.727 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 74.8 p -154.75 148.76 25.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.189 -0.505 . . . . 0.0 110.698 -174.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.764 ' CB ' ' HD3' ' A' ' 20' ' ' PRO . 6.1 mt-30 -167.71 132.37 1.53 Allowed Pre-proline 0 CA--C 1.503 -0.843 0 C-N-CA 123.068 0.547 . . . . 0.0 109.782 170.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -113.95 91.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.161 0 CA-C-N 119.382 0.815 . . . . 0.0 111.306 140.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.764 ' HD3' ' CB ' ' A' ' 18' ' ' GLN . 22.0 Cg_endo -116.4 94.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.781 0 C-N-CA 123.291 2.66 . . . . 0.0 113.256 163.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.51 108.57 19.47 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.887 0.851 . . . . 0.0 109.566 -174.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.48 -0.66 12.57 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -169.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -56.75 95.21 0.02 OUTLIER 'General case' 0 C--N 1.345 0.411 0 CA-C-O 121.575 0.702 . . . . 0.0 109.891 174.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . 0.672 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -70.98 96.92 1.35 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.423 -1.717 . . . . 0.0 113.082 179.005 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.648 HG21 ' HG ' ' A' ' 44' ' ' LEU . 27.6 m -84.41 113.9 23.9 Favored 'Isoleucine or valine' 0 C--O 1.251 1.183 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.752 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -143.4 130.74 20.95 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.337 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.685 ' HA ' ' HA ' ' A' ' 53' ' ' LEU . 59.7 p -69.96 176.37 3.78 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.437 -173.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.561 ' HG2' HG23 ' A' ' 52' ' ' THR . 11.8 mm-40 -58.79 -20.34 49.09 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.018 0.437 . . . . 0.0 111.393 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -86.98 -17.29 33.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.0 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.428 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 98.99 18.72 23.91 Favored Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.658 ' HB2' ' OG ' ' A' ' 27' ' ' SER . 32.0 mtt180 -63.88 91.17 0.06 Allowed 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 168.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.522 ' HA ' ' HB ' ' A' ' 26' ' ' THR . 19.3 mt-10 -81.32 89.67 6.09 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.192 -177.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.521 HD23 ' HB3' ' A' ' 44' ' ' LEU . 11.1 mp -66.56 -48.79 68.54 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.696 -175.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.528 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . -177.22 -161.77 26.38 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 117.932 -2.08 . . . . 0.0 114.051 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 19.4 mtt -149.69 140.99 23.17 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -176.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 23' ' ' ALA . 43.8 t -70.03 129.05 34.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.324 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.88 92.89 3.89 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 171.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 74.73 136.22 0.06 Allowed 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.296 0.997 . . . . 0.0 111.316 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 58.24 -145.15 0.58 Allowed 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.425 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.43 61.3 0.32 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.425 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' A' ' 8' ' ' PHE . 3.8 tt -134.14 112.01 10.78 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.183 -177.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.45 ' HB3' HD11 ' A' ' 44' ' ' LEU . . . -106.87 161.29 14.83 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.392 173.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.517 ' CD2' ' HB3' ' A' ' 8' ' ' PHE . 22.6 m95 -95.71 87.98 4.85 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.486 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.693 HD13 ' HB3' ' A' ' 9' ' ' ALA . 6.6 mp -90.27 88.69 7.32 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 116.857 -1.937 . . . . 0.0 111.191 -167.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.811 ' HA ' ' HB2' ' A' ' 6' ' ' ARG . 6.3 p -86.09 86.91 7.35 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 122.012 0.91 . . . . 0.0 109.179 171.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.601 ' H ' ' HB2' ' A' ' 6' ' ' ARG . . . 150.85 26.59 0.05 OUTLIER Glycine 0 C--N 1.308 -0.976 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.176 176.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 6' ' ' ARG . 6.2 p -84.72 115.31 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.97 -176.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.0 m -115.8 124.81 29.37 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 172.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 67' ' ' VAL . 10.2 Cg_endo -53.5 133.94 55.58 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.147 2.565 . . . . 0.0 112.708 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.28 35.8 5.62 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.583 -1.294 . . . . 0.0 112.605 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.572 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 4.5 mm-40 -116.31 179.4 4.0 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 122.298 1.047 . . . . 0.0 111.943 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.561 HG23 ' HG2' ' A' ' 28' ' ' GLU . 14.3 t -134.12 143.2 47.82 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.352 -1.749 . . . . 0.0 108.548 165.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.685 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 4.5 tp -121.72 160.0 25.43 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.065 -166.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.669 ' HB3' HD11 ' A' ' 61' ' ' ILE . 36.8 m -129.55 129.94 45.11 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 123.787 0.679 . . . . 0.0 111.214 172.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.725 HG21 ' SG ' ' A' ' 81' ' ' CYS . 14.4 t -119.33 106.15 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.152 -167.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.65 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 8.5 m-20 -76.92 85.62 3.47 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.55 177.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.777 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -82.24 147.11 29.13 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.899 176.595 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.777 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 18.1 m-20 -12.08 -64.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 170.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.11 -42.65 99.73 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 117.895 -2.098 . . . . 0.0 114.42 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 1.051 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 9.0 ptpt -178.8 -166.29 0.1 Allowed 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -169.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.669 HD11 ' HB3' ' A' ' 54' ' ' SER . 12.7 tt -90.4 87.92 2.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 173.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 1.051 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -96.2 -51.93 4.21 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.896 -158.389 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 82' ' ' THR . 20.5 p -105.33 158.16 16.82 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 118.185 -1.406 . . . . 0.0 108.145 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.626 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 97.1 mt-30 -132.45 142.5 49.28 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -97.54 151.55 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 C-N-CA 114.825 -2.75 . . . . 0.0 112.196 -169.396 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . 0.615 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 90.7 m-20 -112.09 113.42 25.69 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.357 174.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.572 ' HB ' ' H ' ' A' ' 51' ' ' GLU . 56.1 t -96.82 106.75 32.65 Favored Pre-proline 0 C--O 1.224 -0.244 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.075 -177.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 67' ' ' VAL . 27.7 Cg_endo -62.22 156.08 52.76 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.208 2.605 . . . . 0.0 112.449 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -77.26 5.98 7.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.62 -170.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.7 t -130.23 -4.08 4.4 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.552 -0.459 . . . . 0.0 112.153 -172.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.524 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -94.79 152.69 18.21 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.751 -0.779 . . . . 0.0 112.675 -172.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.9 tp -158.16 161.9 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.803 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.462 ' HB2' ' N ' ' A' ' 7' ' ' LEU . 19.3 m -118.1 -105.34 0.39 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 119.182 -1.007 . . . . 0.0 113.459 -173.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.664 ' HA ' HD12 ' A' ' 7' ' ' LEU . 29.1 t70 72.13 8.23 5.86 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.284 1.04 . . . . 0.0 109.092 -165.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -169.87 -146.63 0.05 Allowed 'General case' 0 C--O 1.245 0.816 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.738 -173.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.611 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 81.8 mt-30 -78.93 136.86 37.38 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.086 0.866 . . . . 0.0 110.672 171.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.524 HD11 ' HB1' ' A' ' 71' ' ' ALA . 37.7 tp -129.96 -179.03 4.98 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 169.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.506 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 3.2 pp -140.81 139.32 34.52 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 117.722 -1.591 . . . . 0.0 110.721 174.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 2.8 mm? -133.58 142.2 43.04 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-O 121.567 0.699 . . . . 0.0 112.699 -175.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.615 ' HG2' ' HB2' ' A' ' 66' ' ' ASN . 74.2 Cg_endo -82.47 122.13 3.54 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.892 2.394 . . . . 0.0 111.594 171.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.725 ' SG ' HG21 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -106.67 87.65 2.58 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 63' ' ' CYS . 10.2 t -68.79 143.91 95.36 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.983 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.34 152.39 67.34 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.725 2.283 . . . . 0.0 111.939 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.536 -177.607 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 2' ' ' LEU . 31.2 mt -119.65 66.28 0.8 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.608 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -98.28 -48.26 5.13 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 157.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.685 ' HA2' ' HB2' ' A' ' 73' ' ' SER . . . -168.07 -169.31 31.39 Favored Glycine 0 CA--C 1.48 -2.147 0 CA-C-N 113.477 -1.692 . . . . 0.0 111.287 155.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.53 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 28.8 mmtt -153.73 -140.38 0.09 Allowed 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 111.484 -2.358 . . . . 0.0 104.667 -168.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.782 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -114.66 156.19 25.21 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 -177.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.805 HD23 ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -144.6 -177.41 5.48 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.566 -1.253 . . . . 0.0 113.78 -162.13 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.723 ' HB2' ' HG2' ' A' ' 76' ' ' GLN . 1.2 m-85 -118.21 104.13 10.51 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.535 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.532 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . . . -102.91 143.34 32.64 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.955 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.456 HG12 ' CD1' ' A' ' 41' ' ' LEU . 10.1 mt -112.82 99.79 9.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.277 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.718 HD12 HG21 ' A' ' 65' ' ' VAL . 2.4 mm? -93.38 128.66 39.53 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.407 -173.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -135.44 131.59 36.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.188 -0.605 . . . . 0.0 112.37 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.628 HD22 ' SG ' ' A' ' 81' ' ' CYS . 3.3 mm? -53.96 142.08 25.83 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 167.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.92 -26.37 67.43 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.057 -1.428 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -65.79 -25.55 67.3 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.223 0.535 . . . . 0.0 110.842 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.23 10.97 19.26 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.464 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 22.9 t -97.16 -160.61 0.81 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.473 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.518 ' C ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -139.25 134.82 16.82 Favored Pre-proline 0 CA--C 1.5 -0.96 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -172.402 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.537 ' O ' HG21 ' A' ' 36' ' ' VAL . 42.3 Cg_endo -76.38 103.27 1.72 Allowed 'Trans proline' 0 N--CA 1.429 -2.303 0 N-CA-C 104.301 -3.0 . . . . 0.0 104.301 148.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 17.6 Cg_endo -98.65 -163.75 0.07 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.276 0 C-N-CA 122.773 2.315 . . . . 0.0 111.51 -161.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.553 ' HA ' HG12 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -48.56 109.61 0.26 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.079 0.466 . . . . 0.0 111.986 -172.304 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.9 3.17 26.7 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.701 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -65.29 95.73 0.2 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.214 0.531 . . . . 0.0 109.983 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.577 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 2.0 m -67.62 105.61 1.93 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.301 -1.772 . . . . 0.0 110.686 173.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.693 HG12 HG22 ' A' ' 55' ' ' VAL . 26.9 m -100.52 112.24 32.64 Favored 'Isoleucine or valine' 0 C--O 1.26 1.614 0 CA-C-O 121.857 0.837 . . . . 0.0 110.204 174.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -149.5 128.96 13.01 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.574 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . 7.1 p -62.83 171.3 2.18 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.594 -175.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -68.39 -7.59 32.85 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.942 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HA ' ' HD2' ' A' ' 29' ' ' LYS . 48.5 tptt -93.72 -14.03 26.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.267 0.556 . . . . 0.0 109.65 172.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.441 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 100.7 31.57 5.71 Favored Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' A' ' 26' ' ' THR . 26.6 tpt180 -73.9 89.22 1.86 Allowed 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 173.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.478 ' HA ' ' HB ' ' A' ' 26' ' ' THR . 25.6 mt-10 -86.11 94.86 9.37 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.066 -171.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.865 HD23 HD21 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -80.78 -37.61 29.97 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.077 -178.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.592 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . 167.26 -159.45 32.8 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 117.87 -2.11 . . . . 0.0 114.855 177.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.701 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 10.5 mtm -151.81 137.52 17.92 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.891 0.876 . . . . 0.0 109.683 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.595 HG23 ' HB3' ' A' ' 23' ' ' ALA . 55.7 t -61.83 129.51 24.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 C-N-CA 120.006 -0.677 . . . . 0.0 109.841 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -130.73 55.02 1.85 Allowed 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.456 173.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 5.0 t70 148.98 122.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 125.306 1.628 . . . . 0.0 108.198 174.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 20' ' ' PRO . 24.0 mt-10 52.13 -102.2 0.12 Allowed 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.531 0.52 . . . . 0.0 111.297 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.8 29.34 2.66 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.456 ' CD1' HG12 ' A' ' 10' ' ' ILE . 11.8 tp -103.34 111.15 23.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.419 -0.391 . . . . 0.0 110.044 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -101.94 126.61 48.88 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.282 174.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -75.08 88.96 2.44 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.805 ' HB2' HD23 ' A' ' 7' ' ' LEU . 8.1 mt -83.26 177.32 8.58 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 117.403 -1.719 . . . . 0.0 110.079 -171.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 41.8 m -138.84 85.72 2.1 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.796 ' HA2' HD11 ' A' ' 7' ' ' LEU . . . 75.61 75.93 0.81 Allowed Glycine 0 C--O 1.223 -0.554 0 C-N-CA 119.914 -1.136 . . . . 0.0 115.421 174.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.49 HG12 HG11 ' A' ' 67' ' ' VAL . 3.9 t -81.65 134.41 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.239 -0.585 . . . . 0.0 109.637 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.542 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -86.55 127.88 58.98 Favored Pre-proline 0 C--N 1.326 -0.45 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.737 179.176 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.747 ' HB2' ' HA ' ' A' ' 69' ' ' GLU . 30.9 Cg_endo -64.71 115.21 3.1 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.326 2.018 . . . . 0.0 111.899 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.28 36.24 2.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.748 -1.215 . . . . 0.0 112.697 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.652 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 28.5 mt-10 -116.98 176.81 4.95 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 119.146 -1.022 . . . . 0.0 112.142 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 t -127.31 92.42 3.51 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.333 168.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.865 HD21 HD23 ' A' ' 33' ' ' LEU . 9.0 mt -58.86 158.86 7.62 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 114.222 -1.353 . . . . 0.0 111.764 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.63 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 24.8 m -125.23 121.44 34.12 Favored 'General case' 0 C--N 1.317 -0.812 0 O-C-N 123.58 0.55 . . . . 0.0 109.777 168.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.693 HG22 HG12 ' A' ' 25' ' ' VAL . 9.5 t -109.43 122.23 63.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-O 121.212 0.53 . . . . 0.0 111.466 -170.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.638 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 0.9 OUTLIER -123.77 132.49 53.81 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.708 -170.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.657 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 6.7 p90 -147.23 -142.95 0.13 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 117.957 -1.497 . . . . 0.0 112.63 171.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.657 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 0.9 OUTLIER -37.5 -63.07 0.48 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.853 0.461 . . . . 0.0 111.298 167.596 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.445 ' HA3' ' OE1' ' A' ' 62' ' ' GLN . . . -80.18 0.45 83.81 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 119.126 -1.512 . . . . 0.0 110.691 176.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.638 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 27.1 mttm 74.69 -140.31 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 113.898 -1.151 . . . . 0.0 113.165 173.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.674 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -77.9 98.78 2.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -174.66 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.445 ' OE1' ' HA3' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -118.92 -41.81 2.75 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 114.416 -1.266 . . . . 0.0 110.877 -173.695 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 17.2 p -118.24 158.1 25.77 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.73 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.697 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 76.5 mt-30 -126.9 156.53 41.3 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.718 HG21 HD12 ' A' ' 11' ' ' LEU . 2.7 t -106.75 131.92 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 114.433 -2.907 . . . . 0.0 112.562 -172.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -90.46 110.81 21.91 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.187 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.652 ' HB ' ' H ' ' A' ' 51' ' ' GLU . 18.8 t -92.56 114.3 62.02 Favored Pre-proline 0 CA--C 1.513 -0.453 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.873 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 4.6 Cg_exo -81.51 172.7 12.2 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 124.324 3.35 . . . . 0.0 111.903 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.747 ' HA ' ' HB2' ' A' ' 49' ' ' PRO . 40.6 mt-10 -72.68 -6.87 47.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.814 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.452 HG22 ' HB2' ' A' ' 68' ' ' PRO . 10.7 t -85.07 18.63 2.45 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.929 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.656 ' HA ' HD22 ' A' ' 77' ' ' LEU . . . -66.25 153.5 42.38 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.617 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.25 167.98 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.909 -173.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.685 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 47.5 t -101.29 143.33 31.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.787 -175.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 51.83 23.45 2.08 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -134.05 173.11 11.94 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.322 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.723 ' HG2' ' HB2' ' A' ' 8' ' ' PHE . 74.9 mt-30 -86.25 142.0 28.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.701 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.656 HD22 ' HA ' ' A' ' 71' ' ' ALA . 50.9 tp -150.74 116.6 5.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.591 ' H ' HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -82.72 141.7 32.2 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 118.332 -1.347 . . . . 0.0 109.454 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.415 ' HB2' ' CD1' ' A' ' 11' ' ' LEU . 95.2 mt -131.46 147.84 67.71 Favored Pre-proline 0 C--O 1.247 0.97 0 CA-C-O 121.109 0.48 . . . . 0.0 111.962 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.429 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 65.9 Cg_endo -76.0 109.91 2.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.576 2.851 . . . . 0.0 113.309 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.628 ' SG ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -91.06 93.46 9.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.279 172.092 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 23.5 m -97.3 126.29 42.36 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.397 -175.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 82' ' ' THR . 39.2 Cg_exo -61.12 148.68 92.17 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.758 2.305 . . . . 0.0 111.767 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -66.74 -30.64 70.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.561 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.7 mptt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.461 -0.781 . . . . 0.0 110.189 177.254 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 82.7 mt -60.44 117.97 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.559 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . 4.3 mmmm -93.37 53.79 1.97 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -166.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.85 177.11 33.12 Favored Glycine 0 CA--C 1.474 -2.524 0 C-N-CA 117.812 -2.137 . . . . 0.0 113.599 163.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.873 ' HD3' ' HB2' ' A' ' 74' ' ' ASP . 46.8 tttm -155.54 -141.77 0.1 Allowed 'General case' 0 N--CA 1.406 -2.675 0 CA-C-N 110.532 -2.834 . . . . 0.0 103.384 -171.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 1.118 ' HB2' ' HB2' ' A' ' 45' ' ' SER . 0.0 OUTLIER -88.56 -177.5 5.6 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 -175.706 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.672 ' N ' ' HG3' ' A' ' 6' ' ' ARG . 1.7 tt -141.08 114.3 8.63 Favored 'General case' 0 N--CA 1.387 -3.62 0 C-N-CA 117.126 -1.829 . . . . 0.0 114.761 -144.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.707 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 2.1 m-85 -119.27 88.77 3.0 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.641 ' HB2' HD21 ' A' ' 7' ' ' LEU . . . -100.38 102.11 13.26 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -170.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 51.5 mt -80.93 98.28 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.55 HD13 ' HG2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -114.41 146.04 41.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.861 -172.093 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -137.11 147.93 46.36 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.104 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.498 HD13 ' SG ' ' A' ' 81' ' ' CYS . 4.5 mm? -66.15 146.85 54.17 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.71 -27.34 67.82 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.757 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.18 -18.84 63.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.536 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.17 -6.24 25.22 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.8 -163.65 0.75 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.153 -0.524 . . . . 0.0 110.741 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.565 ' HG2' ' HA3' ' A' ' 40' ' ' GLY . 2.8 mt-30 -136.81 145.24 50.06 Favored Pre-proline 0 CA--C 1.506 -0.747 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -172.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.684 ' O ' HG21 ' A' ' 36' ' ' VAL . 6.2 Cg_exo -74.53 103.62 1.73 Allowed 'Trans proline' 0 N--CA 1.431 -2.188 0 N-CA-C 104.796 -2.809 . . . . 0.0 104.796 148.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 19.4 Cg_endo -103.13 -177.69 0.11 Allowed 'Trans proline' 0 N--CA 1.43 -2.236 0 C-N-CA 123.277 2.651 . . . . 0.0 111.99 -165.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.641 ' HA ' HG12 ' A' ' 36' ' ' VAL . 31.0 t80 -41.65 117.43 0.92 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -168.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.67 8.46 57.19 Favored Glycine 0 N--CA 1.436 -1.367 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.727 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -59.0 94.76 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.789 -0.706 . . . . 0.0 109.393 171.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.797 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 3.8 m -57.46 93.01 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 113.341 -1.754 . . . . 0.0 111.546 172.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.898 HG23 ' C ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -89.04 95.18 5.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.634 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.716 ' HB ' ' HG2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -128.33 130.94 48.53 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.66 -174.021 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.5 p -65.42 172.07 3.51 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 118.567 -1.253 . . . . 0.0 109.553 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.61 -18.23 51.78 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.912 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -93.71 -8.79 39.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.839 0.352 . . . . 0.0 110.87 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.431 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 102.12 23.92 8.82 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.164 174.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.663 HH11 HD12 ' A' ' 33' ' ' LEU . 39.7 mtm105 -73.73 88.51 1.75 Allowed 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 118.212 -1.395 . . . . 0.0 108.57 170.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.716 ' HG2' ' HB ' ' A' ' 26' ' ' THR . 15.8 mt-10 -83.52 77.9 9.75 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.674 HD13 ' HA3' ' A' ' 46' ' ' GLY . 96.2 mt -121.11 12.39 11.08 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.816 -167.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 1.042 ' HA2' ' HB2' ' A' ' 44' ' ' LEU . . . -138.02 149.82 20.63 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.468 163.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.727 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 30.9 mtm -154.14 126.28 7.85 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 160.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.713 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 32.3 t -60.89 135.32 25.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 O-C-N 123.649 0.593 . . . . 0.0 111.518 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -136.59 116.91 13.59 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 172.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 20.5 m-20 72.41 116.91 0.05 OUTLIER 'General case' 0 C--O 1.234 0.255 0 O-C-N 124.199 0.937 . . . . 0.0 111.101 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 62.87 -95.23 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.857 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.565 ' HA3' ' HG2' ' A' ' 18' ' ' GLN . . . -160.94 53.1 0.33 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 118.807 -1.663 . . . . 0.0 114.001 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.656 HD11 ' HE1' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -141.74 139.48 32.86 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.416 170.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.713 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -84.83 122.94 29.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.342 0.592 . . . . 0.0 111.719 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.656 ' HE1' HD11 ' A' ' 41' ' ' LEU . 58.9 m95 -97.03 88.13 4.42 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.268 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.042 ' HB2' ' HA2' ' A' ' 34' ' ' GLY . 1.2 mt -156.94 -166.65 2.14 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -169.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 1.118 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 1.1 t -153.57 106.38 2.91 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.281 -171.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.674 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 140.36 76.17 0.05 OUTLIER Glycine 0 CA--C 1.521 0.449 0 C-N-CA 119.707 -1.235 . . . . 0.0 113.93 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.568 ' HB ' HD11 ' A' ' 7' ' ' LEU . 12.9 p -120.84 143.64 32.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.895 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.2 m -117.08 129.48 25.29 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.82 0.343 . . . . 0.0 110.332 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.578 ' HA ' HG12 ' A' ' 67' ' ' VAL . 44.1 Cg_endo -68.56 129.01 18.07 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.569 2.179 . . . . 0.0 112.136 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.47 36.38 5.91 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.155 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -128.02 173.3 10.16 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 118.055 -1.458 . . . . 0.0 113.731 -170.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 p -121.09 89.8 3.2 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.089 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 25.6 mt -68.1 151.92 46.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.075 174.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.503 ' HB2' HD11 ' A' ' 61' ' ' ILE . 34.5 p -122.88 121.95 37.43 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.938 0.875 . . . . 0.0 110.593 170.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.797 ' HA ' ' O ' ' A' ' 24' ' ' SER . 4.8 t -120.08 117.95 55.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.465 -162.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.723 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 35.0 m-80 -103.51 148.75 25.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.922 -173.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 6.2 p90 -161.84 -138.21 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 120.263 -0.575 . . . . 0.0 112.528 161.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.676 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 30.8 t70 -41.72 -58.12 2.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.277 0.631 . . . . 0.0 111.495 168.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.55 -1.47 88.9 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 119.288 -1.434 . . . . 0.0 110.302 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.655 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 37.8 mtmt 71.18 -142.26 0.06 Allowed 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 113.938 -1.131 . . . . 0.0 110.74 173.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.503 HD11 ' HB2' ' A' ' 54' ' ' SER . 0.5 OUTLIER -67.98 95.35 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-O 123.414 1.578 . . . . 0.0 107.937 -177.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.597 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -139.04 -37.3 0.52 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.434 -1.712 . . . . 0.0 111.129 -170.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.646 ' SG ' ' HG3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -87.56 142.85 27.54 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 166.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -140.09 124.64 18.07 Favored 'General case' 0 CA--C 1.478 -1.789 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 22.2 t -98.93 132.1 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.111 0 C-N-CA 114.639 -2.824 . . . . 0.0 112.278 -168.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -101.05 102.48 13.46 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 118.039 -1.464 . . . . 0.0 110.279 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 49' ' ' PRO . 40.6 t -75.25 126.57 87.71 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.025 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.537 ' HB2' HG22 ' A' ' 70' ' ' THR . 9.8 Cg_endo -90.16 171.02 3.92 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.663 2.909 . . . . 0.0 111.93 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.32 0.26 22.92 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 111.596 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 68' ' ' PRO . 8.8 t -93.42 16.03 14.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.192 0.52 . . . . 0.0 110.326 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.09 152.92 38.54 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.712 0.768 . . . . 0.0 111.711 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.439 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 59.1 mt -121.12 137.67 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.91 -174.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -88.53 140.39 29.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.382 -173.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.873 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 23.0 t70 71.76 -4.22 1.97 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.217 0.532 . . . . 0.0 112.246 170.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 16.2 mm-40 -112.7 -166.05 1.05 Allowed 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.34 0.591 . . . . 0.0 110.829 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.707 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 30.0 pt20 -97.69 134.84 40.33 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.921 173.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 78' ' ' LEU . 1.6 tm? -142.9 141.91 31.62 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -88.16 132.81 34.19 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.393 -177.334 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 3.4 mm? -117.98 139.62 26.78 Favored Pre-proline 0 C--O 1.241 0.657 0 CA-C-O 121.233 0.539 . . . . 0.0 111.496 -176.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 73.3 Cg_endo -87.99 120.27 1.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.051 2.501 . . . . 0.0 112.278 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.498 ' SG ' HD13 ' A' ' 13' ' ' LEU . 8.8 t -89.04 120.31 30.33 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.853 176.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 m -97.52 134.78 22.14 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 170.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -63.17 152.14 81.2 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.46 2.107 . . . . 0.0 112.732 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -60.53 127.62 32.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.17 178.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.454 175.206 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.883 HG13 ' H ' ' A' ' 2' ' ' LEU . 2.5 p . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.883 ' H ' HG13 ' A' ' 1' ' ' VAL . 3.8 tt -101.77 -56.57 2.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 170.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -91.23 157.6 17.07 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 163.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 73' ' ' SER . . . -77.9 160.42 48.5 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.072 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.909 ' HG2' ' HA3' ' A' ' 46' ' ' GLY . 20.7 mtpp -154.1 72.03 0.87 Allowed 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.857 ' C ' HD23 ' A' ' 7' ' ' LEU . 90.7 mtt-85 -177.2 114.73 0.09 Allowed 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 165.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.964 HD22 ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -123.01 172.02 8.82 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 115.737 -2.385 . . . . 0.0 109.006 -170.476 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.819 ' HB2' ' HA ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -92.24 87.13 5.96 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.524 -1.67 . . . . 0.0 108.095 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.839 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -98.32 112.08 24.2 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 118.969 -1.093 . . . . 0.0 111.462 -173.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.456 HG12 ' HG ' ' A' ' 41' ' ' LEU . 59.2 mt -100.65 90.67 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.476 171.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -103.06 132.27 49.45 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.426 -175.335 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.819 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 58.7 mtm-85 -141.67 155.09 45.7 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.265 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.642 HD23 ' HD3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -89.99 135.23 33.77 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 117.888 -1.525 . . . . 0.0 109.028 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.53 -11.64 3.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.797 -169.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -67.29 -19.0 65.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.433 0.635 . . . . 0.0 110.596 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.7 -8.98 21.79 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -174.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.441 ' CB ' ' HG ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -82.61 -177.9 6.87 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 113.922 -1.139 . . . . 0.0 111.824 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.552 ' OE1' ' HB2' ' A' ' 39' ' ' GLU . 0.5 OUTLIER -135.4 142.65 42.15 Favored Pre-proline 0 CA--C 1.503 -0.857 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.949 -176.008 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.819 ' HD3' ' HA ' ' A' ' 12' ' ' ARG . 3.6 Cg_endo -80.37 102.72 1.45 Allowed 'Trans proline' 0 N--CA 1.423 -2.668 0 N-CA-C 104.848 -2.789 . . . . 0.0 104.848 156.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.718 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 1.9 Cg_endo -101.63 175.76 0.23 Allowed 'Trans proline' 0 N--CA 1.422 -2.715 0 C-N-CA 122.836 2.357 . . . . 0.0 111.047 -162.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.445 ' HD1' ' HA ' ' A' ' 37' ' ' ALA . 82.5 t80 -30.42 99.74 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 124.231 0.957 . . . . 0.0 113.306 -169.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.72 10.85 8.17 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.663 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.96 ' HB3' HG13 ' A' ' 36' ' ' VAL . . . -58.94 95.86 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.227 175.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.656 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 0.6 OUTLIER -77.8 98.41 5.54 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.714 -1.585 . . . . 0.0 112.117 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.688 HG12 HG22 ' A' ' 55' ' ' VAL . 11.8 m -103.68 115.19 45.16 Favored 'Isoleucine or valine' 0 C--O 1.259 1.563 0 CA-C-O 121.319 0.581 . . . . 0.0 111.85 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.628 ' OG1' ' HA2' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -147.21 125.98 12.65 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.257 175.853 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.623 ' CB ' ' HE2' ' A' ' 29' ' ' LYS . 27.2 m -53.07 168.48 0.13 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 123.17 0.293 . . . . 0.0 111.385 -173.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.453 ' CD ' ' HG3' ' A' ' 29' ' ' LYS . 5.9 pm0 -59.75 -20.31 55.78 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.982 -0.448 . . . . 0.0 112.048 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.623 ' HE2' ' CB ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -103.03 4.55 37.38 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.686 176.409 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.628 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 86.15 43.06 6.42 Favored Glycine 0 N--CA 1.418 -2.541 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 174.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 1.035 ' HE ' ' HA ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -94.7 97.34 10.0 Favored 'General case' 0 N--CA 1.421 -1.897 0 C-N-CA 117.521 -1.672 . . . . 0.0 107.12 166.028 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -96.15 111.18 23.3 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.16 -159.446 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.782 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 5.9 mp -84.64 -49.94 8.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.383 -174.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.576 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . 168.86 -155.93 26.84 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 117.041 -2.504 . . . . 0.0 114.888 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.8 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 17.1 mtp -149.84 128.28 12.22 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -173.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.96 HG13 ' HB3' ' A' ' 23' ' ' ALA . 6.3 m -71.37 130.04 35.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.105 -173.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HA ' ' HD1' ' A' ' 21' ' ' PHE . . . -121.64 55.85 1.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.807 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 20.6 t0 150.31 139.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 O-C-N 125.36 1.662 . . . . 0.0 107.572 176.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.718 ' O ' ' HA ' ' A' ' 20' ' ' PRO . 0.5 OUTLIER 28.12 -100.26 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 O-C-N 124.757 1.285 . . . . 0.0 111.781 -167.379 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.697 ' H ' ' HG3' ' A' ' 39' ' ' GLU . . . -136.07 48.84 0.9 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 173.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.456 ' HG ' HG12 ' A' ' 10' ' ' ILE . 2.6 tt -116.42 117.48 30.05 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.984 0.421 . . . . 0.0 111.039 -178.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.562 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . . . -125.57 154.75 41.74 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 171.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.617 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 64.6 m95 -84.21 88.11 7.2 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.847 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 6.3 mp -73.68 102.26 3.89 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.873 -169.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.84 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 6.4 m -56.71 87.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.086 0.866 . . . . 0.0 111.919 -176.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.909 ' HA3' ' HG2' ' A' ' 5' ' ' LYS . . . 56.58 91.35 0.01 OUTLIER Glycine 0 C--N 1.339 0.722 0 CA-C-N 114.683 -1.144 . . . . 0.0 114.341 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.753 HG23 HD12 ' A' ' 7' ' ' LEU . 4.6 t -72.02 145.72 11.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.569 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.3 118.52 72.26 Favored Pre-proline 0 N--CA 1.442 -0.847 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.98 ' HB2' ' HA ' ' A' ' 69' ' ' GLU . 73.1 Cg_endo -71.48 109.37 2.6 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.451 2.101 . . . . 0.0 112.197 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.44 34.95 1.04 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.098 -1.525 . . . . 0.0 113.524 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -164.66 179.99 6.26 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 117.477 -1.689 . . . . 0.0 114.121 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.828 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 21.0 p -111.63 124.98 53.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.823 -174.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 64' ' ' GLN . 1.1 mm? -83.14 134.79 34.98 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.632 ' HB3' HD11 ' A' ' 61' ' ' ILE . 3.1 m -72.33 103.51 3.44 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.688 HG22 HG12 ' A' ' 25' ' ' VAL . 46.3 t -103.18 94.42 3.2 Favored 'Isoleucine or valine' 0 C--O 1.249 1.058 0 CA-C-O 122.145 0.974 . . . . 0.0 111.278 -172.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.704 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 43.0 m-80 -73.65 131.67 41.91 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.271 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.615 ' HB3' ' HG3' ' A' ' 62' ' ' GLN . 1.7 t90 -148.39 134.56 19.34 Favored 'General case' 0 C--O 1.208 -1.125 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.666 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.574 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 2.6 p30 -12.58 -58.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -173.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.423 ' N ' ' OD1' ' A' ' 58' ' ' ASP . . . -61.05 -23.79 62.16 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 118.397 -1.859 . . . . 0.0 114.282 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 1.023 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 11.1 pttt 173.36 -141.83 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.732 0.777 . . . . 0.0 110.265 -170.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.704 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 11.8 tt -115.1 93.95 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 162.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 1.023 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -92.15 -19.51 22.2 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 117.289 -1.764 . . . . 0.0 113.285 -150.663 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.556 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 23.7 p -147.92 159.92 43.36 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.915 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 47.5 mt-30 -129.82 119.42 23.33 Favored 'General case' 0 CA--C 1.478 -1.824 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.828 ' O ' ' HA ' ' A' ' 52' ' ' THR . 2.6 t -78.19 123.47 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 C-N-CA 116.804 -1.958 . . . . 0.0 112.025 -167.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -91.32 133.21 35.62 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.023 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.731 HG21 HG11 ' A' ' 47' ' ' VAL . 62.1 t -121.53 134.54 24.59 Favored Pre-proline 0 N--CA 1.44 -0.966 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.768 -173.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 6.5 Cg_endo -92.26 172.76 2.38 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.393 3.395 . . . . 0.0 111.798 171.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.98 ' HA ' ' HB2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -63.6 -14.95 56.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.149 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.5 p -62.42 -21.55 65.49 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.27 138.71 33.47 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.366 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 mm -130.48 -82.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.888 -170.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.964 ' HA ' HD22 ' A' ' 7' ' ' LEU . 24.0 p -172.05 137.67 0.96 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.511 -175.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.765 ' H ' HD22 ' A' ' 7' ' ' LEU . 5.2 m-20 55.89 -163.23 0.15 Allowed 'General case' 0 C--N 1.362 1.142 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -172.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 8' ' ' PHE . 42.4 mt-30 65.73 150.3 0.05 OUTLIER 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.649 0.738 . . . . 0.0 112.3 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.819 ' HA ' ' HB2' ' A' ' 8' ' ' PHE . 22.1 mp0 -76.75 124.12 27.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.464 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -140.77 116.88 10.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 7.7 tt -85.98 127.13 34.57 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.018 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 81.9 mt -113.61 141.86 26.7 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 121.108 0.48 . . . . 0.0 111.704 -174.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 67.7 Cg_endo -91.38 120.39 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.349 2.699 . . . . 0.0 113.196 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.678 ' SG ' ' HG3' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -82.58 116.24 21.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.384 175.057 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.3 m -82.85 117.1 67.47 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.155 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.48 158.82 22.47 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.814 2.343 . . . . 0.0 112.268 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -134.37 -76.28 0.47 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.421 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.411 ' HD3' ' C ' ' A' ' 85' ' ' LYS . 4.2 tmtt? . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.573 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 111.324 0.12 . . . . 0.0 111.324 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.28 -52.26 66.03 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.215 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -104.96 21.07 17.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.653 0.74 . . . . 0.0 109.893 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.543 ' HA3' ' OG ' ' A' ' 73' ' ' SER . . . 90.8 -112.48 4.11 Favored Glycine 0 CA--C 1.494 -1.27 0 CA-C-O 122.587 1.104 . . . . 0.0 114.423 173.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.549 ' HG3' ' HB2' ' A' ' 74' ' ' ASP . 33.5 mmtp -150.01 -146.34 0.2 Allowed 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 112.253 -1.974 . . . . 0.0 106.468 -160.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.841 ' C ' HD13 ' A' ' 7' ' ' LEU . 25.7 mtm180 -119.84 165.13 14.98 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 102.389 -3.189 . . . . 0.0 102.389 167.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.906 HD23 ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -149.67 177.68 9.55 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 117.714 -1.594 . . . . 0.0 113.164 -168.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 1.3 m-85 -126.78 89.64 3.02 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.697 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 77' ' ' LEU . . . -93.36 134.33 35.69 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.638 -170.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.619 ' HB ' ' HG ' ' A' ' 78' ' ' LEU . 4.2 mp -96.77 111.79 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.691 173.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.698 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 65.4 mt -92.51 131.29 37.77 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.543 -175.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.533 ' HD3' ' O ' ' A' ' 17' ' ' SER . 6.2 tpp180 -137.81 123.56 19.92 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.477 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.698 HD13 ' SG ' ' A' ' 81' ' ' CYS . 4.2 mm? -53.99 144.27 19.56 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 168.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.07 -30.28 66.08 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.218 -1.356 . . . . 0.0 111.211 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -79.02 -13.01 60.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.668 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.25 -11.71 16.88 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.159 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 30.9 p -81.83 -164.58 0.82 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.465 0.632 . . . . 0.0 110.108 175.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.623 ' C ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -129.93 141.38 41.65 Favored Pre-proline 0 CA--C 1.504 -0.815 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -172.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.698 ' HG2' ' HB3' ' A' ' 11' ' ' LEU . 5.4 Cg_exo -78.41 103.66 1.71 Allowed 'Trans proline' 0 N--CA 1.436 -1.888 0 N-CA-C 105.617 -2.494 . . . . 0.0 105.617 153.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -104.27 -161.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 123.563 2.842 . . . . 0.0 111.799 -163.609 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.471 ' CD2' ' HA ' ' A' ' 37' ' ' ALA . 38.2 t80 -48.9 114.83 1.07 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.409 0.623 . . . . 0.0 112.585 -169.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.69 -18.86 14.66 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.664 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -53.3 96.43 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 124.505 0.768 . . . . 0.0 110.975 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.759 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -72.68 88.8 1.3 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.444 -1.707 . . . . 0.0 111.653 175.358 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.495 ' HB ' HD22 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -74.49 88.99 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.774 169.404 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.738 ' HB ' ' O ' ' A' ' 31' ' ' ARG . 7.2 p -148.27 143.89 27.26 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.71 ' OG ' ' HB2' ' A' ' 31' ' ' ARG . 96.3 p -71.39 178.3 3.5 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 116.953 -1.899 . . . . 0.0 109.913 -175.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.507 ' H ' ' CD ' ' A' ' 28' ' ' GLU . 2.1 mp0 -56.55 -28.69 60.7 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.849 0.357 . . . . 0.0 111.603 -171.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.536 ' H ' ' HD2' ' A' ' 29' ' ' LYS . 1.9 mptp? -85.37 -15.48 43.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.197 0.522 . . . . 0.0 110.807 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.53 10.43 35.78 Favored Glycine 0 CA--C 1.485 -1.818 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.738 ' O ' ' HB ' ' A' ' 26' ' ' THR . 93.2 mtt180 -63.95 -178.3 0.31 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.671 -1.265 . . . . 0.0 109.339 169.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 0.6 OUTLIER 87.27 -158.67 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 164.647 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.945 HD13 HD21 ' A' ' 53' ' ' LEU . 6.8 mp -83.84 -48.67 9.81 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -144.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.725 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . 154.53 -141.4 8.17 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.988 -175.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.725 ' HG3' ' C ' ' A' ' 34' ' ' GLY . 6.9 mtt -148.6 142.66 25.93 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 117.517 0.658 . . . . 0.0 111.529 -173.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.615 HG23 HD12 ' A' ' 11' ' ' LEU . 55.5 t -66.18 130.61 31.65 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.519 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . . . -121.17 58.5 0.97 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.635 0.731 . . . . 0.0 109.332 172.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 39' ' ' GLU . 25.6 t70 178.68 -167.7 0.07 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.182 -174.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.487 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 10.1 pt-20 -85.51 1.81 47.34 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 122.091 -0.381 . . . . 0.0 111.539 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.481 ' HA3' ' HG2' ' A' ' 18' ' ' GLN . . . 174.72 25.1 0.03 OUTLIER Glycine 0 C--N 1.332 0.31 0 C-N-CA 119.143 -1.503 . . . . 0.0 112.995 175.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 9' ' ' ALA . 35.0 tp -133.19 121.69 22.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.57 0.224 . . . . 0.0 111.017 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.858 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -111.13 128.93 56.05 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.167 176.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -85.12 100.16 11.54 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.906 ' HB2' HD23 ' A' ' 7' ' ' LEU . 35.7 mt -111.15 178.55 4.31 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 118.467 -1.293 . . . . 0.0 111.657 -163.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 21.1 p -132.22 88.56 2.56 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.4 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.757 ' CA ' HD11 ' A' ' 7' ' ' LEU . . . 86.78 142.56 7.21 Favored Glycine 0 N--CA 1.464 0.56 0 C-N-CA 119.102 -1.523 . . . . 0.0 113.619 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG12 HD21 ' A' ' 33' ' ' LEU . 16.2 m -122.3 152.61 26.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 120.575 0.226 . . . . 0.0 110.71 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -111.77 109.98 55.04 Favored Pre-proline 0 C--N 1.324 -0.526 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.741 170.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.6 133.93 27.06 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 123.902 3.068 . . . . 0.0 113.069 -173.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.86 34.9 17.27 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 119.507 -1.33 . . . . 0.0 112.474 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.54 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 3.6 mm-40 -127.32 -173.13 2.82 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 121.852 0.834 . . . . 0.0 112.476 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 22.7 m -130.94 108.58 9.92 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.986 170.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.945 HD21 HD13 ' A' ' 33' ' ' LEU . 5.0 mt -69.36 158.8 34.37 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.793 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.654 ' HB3' HD11 ' A' ' 61' ' ' ILE . 73.5 m -102.25 154.6 18.88 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 159.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.759 ' HA ' ' O ' ' A' ' 24' ' ' SER . 21.5 t -137.92 92.77 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.925 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.652 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.666 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -82.22 109.61 16.65 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.573 -177.43 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.821 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 1.2 t90 -119.47 153.34 35.44 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.79 -1.55 . . . . 0.0 110.172 -168.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.821 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 15.6 t70 -15.62 -68.23 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.905 1.282 . . . . 0.0 113.176 169.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.74 -41.49 99.07 Favored Glycine 0 C--N 1.346 1.097 0 C-N-CA 117.966 -2.064 . . . . 0.0 113.68 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 1.036 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 0.1 OUTLIER 172.91 -168.79 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.863 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -170.105 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.666 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -87.99 91.57 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 C-N-CA 117.678 -1.609 . . . . 0.0 107.224 173.791 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 1.036 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -99.39 -41.44 7.41 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.319 -159.815 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.585 ' SG ' ' HG3' ' A' ' 19' ' ' PRO . 9.1 m -94.95 152.45 18.33 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.239 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -133.48 134.8 43.96 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 161.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.679 ' HB ' HD12 ' A' ' 53' ' ' LEU . 78.2 t -100.0 143.56 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 C-N-CA 114.28 -2.968 . . . . 0.0 112.391 -168.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.5 m-20 -94.35 110.01 21.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 117.651 -1.619 . . . . 0.0 110.665 171.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.54 ' HB ' ' H ' ' A' ' 51' ' ' GLU . 4.6 t -86.54 117.22 68.33 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.604 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 71' ' ' ALA . 6.0 Cg_exo -79.36 163.27 24.85 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.942 2.428 . . . . 0.0 111.839 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -80.16 -6.2 57.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.177 0.513 . . . . 0.0 110.398 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 p -92.16 -4.3 54.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.984 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . . . -74.21 157.24 36.25 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.221 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.4 tp -144.42 149.43 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.569 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.569 ' HA ' HD12 ' A' ' 7' ' ' LEU . 33.4 m -86.53 170.05 12.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.177 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.549 ' HB2' ' HG3' ' A' ' 5' ' ' LYS . 28.1 t0 70.91 147.72 0.08 Allowed 'General case' 0 C--N 1.348 0.52 0 O-C-N 123.671 0.607 . . . . 0.0 109.557 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.401 ' HB3' ' H ' ' A' ' 76' ' ' GLN . 25.5 mp0 62.73 -166.96 0.22 Allowed 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.55 0.691 . . . . 0.0 111.824 -174.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 23.7 pt20 -90.88 143.56 26.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.692 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 39.6 tp -141.58 117.36 10.42 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -175.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.619 ' HG ' ' HB ' ' A' ' 10' ' ' ILE . 6.0 mp -84.79 128.72 34.75 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 118.864 -1.134 . . . . 0.0 109.8 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.606 ' HB3' HG11 ' A' ' 65' ' ' VAL . 83.2 mt -112.84 132.19 22.41 Favored Pre-proline 0 C--O 1.246 0.906 0 CA-C-O 121.212 0.53 . . . . 0.0 111.915 -176.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.446 ' O ' HG13 ' A' ' 65' ' ' VAL . 73.5 Cg_endo -83.57 113.3 1.96 Allowed 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 123.396 2.731 . . . . 0.0 112.675 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.698 ' SG ' HD13 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -80.5 120.47 24.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.681 175.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 64.3 p -95.17 130.73 31.68 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 170.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 85' ' ' LYS . 11.3 Cg_exo -70.51 114.02 3.69 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.564 2.176 . . . . 0.0 111.264 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.45 ' H ' ' HG3' ' A' ' 84' ' ' GLN . 4.2 pp0? -75.21 17.72 0.24 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.988 0.423 . . . . 0.0 111.445 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 83' ' ' PRO . 77.9 mttt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.751 -0.642 . . . . 0.0 109.706 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.462 ' H ' HD13 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -106.12 144.19 33.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.244 -0.983 . . . . 0.0 110.194 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -170.12 179.82 3.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.62 123.97 4.71 Favored Glycine 0 CA--C 1.48 -2.142 0 C-N-CA 118.744 -1.694 . . . . 0.0 111.768 166.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.631 ' H ' ' HB3' ' A' ' 73' ' ' SER . 37.5 ttmt -79.61 173.77 12.25 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 151.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.875 ' HG3' ' H ' ' A' ' 45' ' ' SER . 0.6 OUTLIER -54.72 154.68 4.8 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.968 174.717 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.977 ' HG ' ' HB3' ' A' ' 45' ' ' SER . 13.6 mt -114.43 167.56 10.62 Favored 'General case' 0 CA--C 1.483 -1.633 0 C-N-CA 116.668 -2.013 . . . . 0.0 114.676 -167.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 1.086 ' HB3' ' HA ' ' A' ' 76' ' ' GLN . 30.2 t80 -81.69 85.92 6.5 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 170.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.12 106.76 19.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.394 0.616 . . . . 0.0 111.886 -167.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.444 HD12 ' HG ' ' A' ' 78' ' ' LEU . 45.9 mt -98.12 96.88 5.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.246 170.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.789 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 71.6 mt -93.79 148.0 22.54 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.844 -174.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.481 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 ttt180 -160.59 142.49 12.52 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 118.566 -1.254 . . . . 0.0 112.348 172.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.638 HD23 ' C ' ' A' ' 18' ' ' GLN . 4.6 mm? -64.83 142.6 58.38 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.677 0.751 . . . . 0.0 109.209 174.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.71 -28.57 69.51 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.943 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.1 -16.35 61.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.298 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.71 -13.9 20.14 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.395 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.488 ' C ' ' HB2' ' A' ' 13' ' ' LEU . 13.2 t -75.74 -168.54 0.88 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.638 ' C ' HD23 ' A' ' 13' ' ' LEU . 1.4 mm-40 -142.45 148.1 45.82 Favored Pre-proline 0 CA--C 1.5 -0.955 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -173.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.789 ' HG2' ' HB3' ' A' ' 11' ' ' LEU . 1.2 Cg_endo -83.18 100.99 0.95 Allowed 'Trans proline' 0 N--CA 1.433 -2.074 0 N-CA-C 106.551 -2.134 . . . . 0.0 106.551 156.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.603 ' HD2' ' CD2' ' A' ' 57' ' ' TRP . 0.2 OUTLIER -106.75 -172.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.332 0 C-N-CA 124.017 3.145 . . . . 0.0 111.573 -167.637 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.527 ' HD1' ' H ' ' A' ' 38' ' ' ASP . 69.3 t80 -30.23 107.12 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -167.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.34 10.29 27.77 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.588 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.839 ' HB3' HG13 ' A' ' 36' ' ' VAL . . . -61.84 89.62 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 124.142 0.554 . . . . 0.0 111.615 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.864 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 48.2 p -62.04 131.68 50.38 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.124 0.89 . . . . 0.0 109.093 175.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.957 HG22 ' HA3' ' A' ' 34' ' ' GLY . 19.1 m -113.18 114.27 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 117.718 -1.593 . . . . 0.0 110.299 165.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 1.2 t -140.54 118.55 11.88 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.113 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.569 ' OG ' ' HB2' ' A' ' 31' ' ' ARG . 20.5 p -76.61 -171.69 1.95 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.801 -170.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -34.89 -62.63 0.36 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.087 0.955 . . . . 0.0 113.527 -171.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -75.39 -24.52 57.23 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.932 0.396 . . . . 0.0 111.479 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.641 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 119.88 42.81 0.51 Allowed Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 -172.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.821 ' O ' ' HA ' ' A' ' 26' ' ' THR . 8.8 tpp180 -69.99 99.04 1.37 Allowed 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -91.01 107.85 19.48 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.055 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.874 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -126.28 -16.64 5.4 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.671 -174.566 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 1.102 ' HA2' ' HB3' ' A' ' 44' ' ' LEU . . . -137.62 152.9 21.83 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 119.062 -1.542 . . . . 0.0 116.646 -169.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.788 ' N ' HD12 ' A' ' 44' ' ' LEU . 13.8 mtt -163.62 99.82 0.9 Allowed 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 125.446 1.499 . . . . 0.0 107.189 172.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.871 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 5.6 m -67.84 140.44 19.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 C-N-CA 118.616 -1.234 . . . . 0.0 110.811 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.88 113.67 19.44 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.441 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.527 ' H ' ' HD1' ' A' ' 21' ' ' PHE . 38.9 t70 72.81 125.38 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 O-C-N 124.371 1.044 . . . . 0.0 110.717 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 65.8 -85.14 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.684 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.543 ' HA3' ' OE1' ' A' ' 18' ' ' GLN . . . -174.0 37.67 0.12 Allowed Glycine 0 C--O 1.239 0.451 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.447 HD12 ' CH2' ' A' ' 43' ' ' TRP . 1.4 mm? -120.66 112.14 18.5 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.241 -0.479 . . . . 0.0 111.929 -172.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.871 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . . . -116.53 125.93 52.6 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 171.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.714 ' CE3' ' HA ' ' A' ' 8' ' ' PHE . 8.9 m95 -86.68 81.51 8.2 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 112.603 -3.639 . . . . 0.0 105.494 167.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.102 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -149.7 131.1 14.71 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 -165.489 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.977 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . 8.6 t 171.2 -145.86 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.425 177.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.32 -0.47 8.14 Favored Glycine 0 C--N 1.3 -1.471 0 C-N-CA 117.704 -2.189 . . . . 0.0 110.338 -160.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.712 HG21 HG11 ' A' ' 67' ' ' VAL . 7.9 p -72.26 153.09 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.824 -0.688 . . . . 0.0 111.126 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.725 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 6.5 m -98.83 131.47 25.55 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 1.013 ' HB3' ' HA ' ' A' ' 69' ' ' GLU . 83.3 Cg_exo -41.24 127.98 3.05 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.737 2.958 . . . . 0.0 113.899 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.15 36.27 5.0 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.148 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.964 ' H ' HG22 ' A' ' 67' ' ' VAL . 30.3 mt-10 -122.37 -170.15 2.02 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 118.939 -1.104 . . . . 0.0 113.031 -175.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.4 m -132.83 112.86 12.28 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.89 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.834 HD21 HD11 ' A' ' 33' ' ' LEU . 18.6 mt -78.21 159.23 28.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.053 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.637 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 6.4 m -120.04 119.93 34.82 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 168.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.864 ' HA ' ' O ' ' A' ' 24' ' ' SER . 38.2 t -112.64 124.34 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 121.513 0.673 . . . . 0.0 111.916 -169.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.846 ' HB3' ' OG ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -120.02 146.45 45.86 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.067 -170.191 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.662 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 9.7 p90 -157.92 -139.26 0.07 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 119.499 -0.88 . . . . 0.0 112.754 168.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.662 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 1.5 m-20 -41.49 -60.0 1.43 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.348 0.659 . . . . 0.0 111.558 168.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.638 ' HA3' ' NE2' ' A' ' 62' ' ' GLN . . . -77.33 -3.2 81.82 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 118.882 -1.628 . . . . 0.0 110.581 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 10.7 mttp 76.45 -149.91 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 114.356 -0.922 . . . . 0.0 111.95 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.606 HG13 ' HB2' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -71.78 101.42 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -176.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.638 ' NE2' ' HA3' ' A' ' 59' ' ' GLY . 0.2 OUTLIER -129.65 -46.03 1.18 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.632 -175.055 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.52 ' HB3' HD11 ' A' ' 13' ' ' LEU . 16.3 p -99.66 148.07 24.74 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.651 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 78.5 mt-30 -133.24 141.67 48.15 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.64 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 1.5 t -96.15 146.41 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 C-N-CA 116.276 -2.17 . . . . 0.0 112.564 -164.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -98.3 116.17 29.96 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.1 171.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.964 HG22 ' H ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -93.54 123.14 61.06 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.316 -178.207 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 97.7 Cg_endo -92.46 170.83 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.707 2.938 . . . . 0.0 113.268 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 1.013 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 1.8 mp0 -73.35 -13.34 61.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.52 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.7 p -82.89 24.86 0.72 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.332 0.494 . . . . 0.0 112.332 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.4 159.17 18.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.454 HG22 ' HB2' ' A' ' 75' ' ' GLN . 7.0 tp -169.08 168.09 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.263 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.631 ' HB3' ' H ' ' A' ' 5' ' ' LYS . 4.1 p -52.82 135.35 35.98 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.511 ' OD1' ' HD2' ' A' ' 5' ' ' LYS . 20.7 m-20 62.51 4.6 1.39 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.454 ' HB2' HG22 ' A' ' 72' ' ' ILE . 11.4 tt0 -86.23 155.59 20.64 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 122.19 -0.319 . . . . 0.0 111.324 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 1.086 ' HA ' ' HB3' ' A' ' 8' ' ' PHE . 14.9 pt20 -82.77 130.2 35.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.051 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.682 HD23 HD13 ' A' ' 7' ' ' LEU . 3.0 mm? -137.88 118.45 13.92 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.444 ' HG ' HD12 ' A' ' 10' ' ' ILE . 6.3 mp -86.08 96.63 9.94 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 118.759 -1.176 . . . . 0.0 108.115 174.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.588 HD13 HG11 ' A' ' 65' ' ' VAL . 96.2 mt -90.9 132.13 35.43 Favored Pre-proline 0 C--O 1.249 1.048 0 CA-C-O 121.582 0.706 . . . . 0.0 112.703 -167.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.41 117.99 3.85 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 123.544 2.829 . . . . 0.0 111.784 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.466 ' SG ' HG23 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -99.74 99.13 9.91 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.59 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 93.3 m -90.22 123.03 66.83 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.576 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 62' ' ' GLN . 55.4 Cg_endo -70.25 123.62 10.11 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.361 2.041 . . . . 0.0 111.066 175.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -106.95 98.27 7.95 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.493 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 C--O 1.252 1.201 0 CA-C-O 118.528 -0.748 . . . . 0.0 109.839 173.513 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.811 0.339 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 3' ' ' LYS . 5.5 tt -75.93 112.55 12.45 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.736 ' HE3' ' HD3' ' A' ' 49' ' ' PRO . 19.7 tptp 71.47 -60.02 0.53 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.803 0.689 . . . . 0.0 112.5 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.647 ' HA3' ' HB2' ' A' ' 73' ' ' SER . . . 114.36 118.83 3.36 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -172.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 46' ' ' GLY . 28.4 ttpp -166.61 58.34 0.09 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -170.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 1.114 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 0.2 OUTLIER 174.37 138.99 0.04 OUTLIER 'General case' 0 N--CA 1.404 -2.73 1 N-CA-C 99.692 -4.188 . . . . 0.0 99.692 158.468 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.926 HD13 ' HA3' ' A' ' 46' ' ' GLY . 0.4 OUTLIER -168.44 169.28 10.62 Favored 'General case' 0 N--CA 1.408 -2.537 0 C-N-CA 114.803 -2.759 . . . . 0.0 114.295 -159.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.665 ' HB2' ' HA ' ' A' ' 76' ' ' GLN . 77.4 m-85 -98.32 89.58 4.51 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.84 174.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.26 103.92 15.89 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.543 -174.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 54.1 mt -89.22 102.25 12.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.475 175.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.83 HD13 ' H ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -106.08 126.25 51.98 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.138 0.971 . . . . 0.0 110.559 -173.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -127.31 156.06 42.56 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.91 -1.496 . . . . 0.0 108.479 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.57 HD23 ' C ' ' A' ' 18' ' ' GLN . 1.1 pp -105.97 137.52 43.73 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 117.96 -1.496 . . . . 0.0 109.531 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.27 -9.96 0.78 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -166.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' HB3' HD12 ' A' ' 13' ' ' LEU . 6.5 t70 -66.74 -22.23 66.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.505 0.669 . . . . 0.0 110.216 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.3 -6.85 32.25 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t -96.91 -175.2 3.2 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.61 -0.795 . . . . 0.0 109.729 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.57 ' C ' HD23 ' A' ' 13' ' ' LEU . 1.6 tt0 -120.31 138.29 27.06 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.631 -171.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.545 ' N ' HD23 ' A' ' 13' ' ' LEU . 2.8 Cg_endo -80.73 103.96 1.54 Allowed 'Trans proline' 0 N--CA 1.428 -2.329 0 N-CA-C 105.646 -2.482 . . . . 0.0 105.646 156.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 1.1 Cg_endo -103.49 175.98 0.16 Allowed 'Trans proline' 0 N--CA 1.431 -2.199 0 C-N-CA 123.111 2.541 . . . . 0.0 112.545 -161.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.627 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 24.8 t80 -23.94 104.48 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -168.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.72 0.23 24.51 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.083 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.851 ' HB3' HG12 ' A' ' 36' ' ' VAL . . . -60.69 99.63 0.09 Allowed 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.424 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.94 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 68.4 p -66.82 99.32 0.61 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.418 173.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.888 HG22 ' HA3' ' A' ' 34' ' ' GLY . 5.1 m -82.37 101.41 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 C-N-CA 115.762 -2.375 . . . . 0.0 107.982 166.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 1.1 t -138.51 120.0 14.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.926 -171.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.1 t -83.15 160.64 21.8 Favored 'General case' 0 C--O 1.211 -0.941 0 C-N-CA 119.317 -0.953 . . . . 0.0 108.988 -171.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -15.6 -70.86 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -164.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -65.47 -20.81 66.51 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.3 0.571 . . . . 0.0 112.069 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.533 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 119.67 40.36 0.62 Allowed Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.692 ' HD2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -77.24 93.41 3.97 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.073 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -90.57 95.89 10.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.204 0.526 . . . . 0.0 110.478 -172.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.791 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -106.06 3.71 28.46 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.332 -176.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.888 ' HA3' HG22 ' A' ' 25' ' ' VAL . . . -157.13 149.67 20.46 Favored Glycine 0 C--O 1.221 -0.672 0 O-C-N 124.585 1.178 . . . . 0.0 112.884 172.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.749 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 42.8 mtp -150.82 107.91 3.58 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 165.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.851 HG12 ' HB3' ' A' ' 23' ' ' ALA . 1.9 p -60.67 123.89 14.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.567 -170.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.434 ' HA ' ' HD1' ' A' ' 21' ' ' PHE . . . -107.5 129.79 54.92 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 170.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 39' ' ' GLU . 3.4 t0 73.59 -150.44 0.05 Allowed 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.902 0.751 . . . . 0.0 109.418 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.502 ' HG3' ' OD1' ' A' ' 38' ' ' ASP . 32.6 mt-10 -84.24 81.95 8.59 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -171.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.3 -17.66 46.46 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 114.804 0.681 . . . . 0.0 114.804 165.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.801 ' H ' HD22 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -85.78 113.09 21.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 118.045 0.922 . . . . 0.0 113.101 175.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -95.64 103.47 15.34 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.673 ' HA ' ' CE3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -82.83 89.58 6.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.865 ' CB ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -140.29 -165.23 1.87 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -163.126 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 1.114 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.7 p -122.51 113.7 19.67 Favored 'General case' 0 N--CA 1.424 -1.731 0 C-N-CA 117.462 -1.695 . . . . 0.0 109.243 -167.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.926 ' HA3' HD13 ' A' ' 7' ' ' LEU . . . -59.4 173.21 4.33 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 118.829 2.292 . . . . 0.0 118.829 -161.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.448 ' HB ' HD23 ' A' ' 33' ' ' LEU . 8.0 p -121.1 172.78 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 112.984 -1.608 . . . . 0.0 110.577 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.445 ' H ' HG22 ' A' ' 47' ' ' VAL . 6.4 m -71.29 148.12 93.48 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.257 0.623 . . . . 0.0 110.209 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.736 ' HD3' ' HE3' ' A' ' 3' ' ' LYS . 4.5 Cg_exo -77.82 161.82 30.05 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.479 2.119 . . . . 0.0 112.189 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.27 35.24 27.24 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 119.454 -1.355 . . . . 0.0 112.216 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.592 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 22.3 mt-10 -132.0 -168.29 2.01 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.818 -175.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.2 m -139.84 99.05 3.6 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.72 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.779 HD13 ' HB ' ' A' ' 25' ' ' VAL . 30.9 mt -57.91 155.44 10.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.015 168.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.593 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 48.8 m -121.75 119.88 33.02 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 170.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.94 ' HA ' ' O ' ' A' ' 24' ' ' SER . 48.8 t -109.55 110.81 33.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-O 122.023 0.916 . . . . 0.0 112.435 -166.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.948 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -97.26 149.32 22.18 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.412 -174.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.702 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 0.1 OUTLIER -158.71 155.09 27.42 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.918 -167.731 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.702 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 0.1 OUTLIER -19.78 -57.37 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.721 1.208 . . . . 0.0 114.16 174.596 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.34 -44.4 95.47 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 117.249 -2.405 . . . . 0.0 113.479 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.704 ' HE2' ' NE2' ' A' ' 62' ' ' GLN . 1.2 pttt 174.25 -176.25 0.08 Allowed 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -167.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.948 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 4.2 tt -87.9 97.06 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 169.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.704 ' NE2' ' HE2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -103.92 -50.02 3.49 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 118.938 -1.105 . . . . 0.0 112.795 -158.042 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.401 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 29.0 p -104.87 158.08 16.77 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.593 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 51.0 mt-30 -133.09 138.89 46.87 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.669 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 2.7 t -91.44 130.55 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 C-N-CA 115.013 -2.675 . . . . 0.0 112.117 -169.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -93.29 116.12 28.69 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 118.494 -1.282 . . . . 0.0 110.06 177.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.624 HG12 ' HA ' ' A' ' 49' ' ' PRO . 13.8 t -93.55 116.16 66.07 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.585 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -92.03 169.23 2.93 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.051 2.501 . . . . 0.0 111.818 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -90.25 15.05 11.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.192 0.52 . . . . 0.0 110.776 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.5 m -106.78 2.6 25.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.589 0.709 . . . . 0.0 110.1 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.38 174.85 7.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.75 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.678 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 11.1 tp -136.66 170.33 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.111 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.647 ' HB2' ' HA3' ' A' ' 4' ' ' GLY . 15.1 m -146.04 -178.58 6.2 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 23.7 t70 71.33 -41.95 0.52 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.106 0.562 . . . . 0.0 110.645 -173.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 73' ' ' SER . 69.1 mt-30 -89.73 -163.56 1.02 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.864 173.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.665 ' HA ' ' HB2' ' A' ' 8' ' ' PHE . 25.6 tt0 -86.55 133.62 33.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.536 174.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.678 ' HG ' ' H ' ' A' ' 72' ' ' ILE . 3.1 tm? -150.87 133.04 15.34 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.772 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.4 pt? -94.41 134.74 36.6 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.557 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 93.5 mt -106.43 137.24 19.37 Favored Pre-proline 0 C--O 1.24 0.557 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.281 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 59.8 Cg_endo -90.28 114.51 0.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.189 2.593 . . . . 0.0 113.027 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.87 107.31 18.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.106 177.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.9 m -78.39 130.5 71.43 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.705 175.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.93 129.55 21.02 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.402 2.068 . . . . 0.0 110.998 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -53.62 131.54 39.04 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.429 0.455 . . . . 0.0 110.938 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.071 -177.078 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.89 -72.43 0.64 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.801 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.5 ' HG3' ' H ' ' A' ' 4' ' ' GLY . 15.9 tptp 60.45 -157.35 0.34 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.151 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.5 ' H ' ' HG3' ' A' ' 3' ' ' LYS . . . 75.2 -153.89 45.53 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-O 118.56 -1.133 . . . . 0.0 110.729 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.747 ' HD2' ' H ' ' A' ' 5' ' ' LYS . 0.2 OUTLIER 18.44 69.23 0.02 OUTLIER 'General case' 0 C--N 1.351 0.655 0 CA-C-O 123.749 1.738 . . . . 0.0 112.704 -177.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.926 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 2.1 tmm_? -175.59 121.07 0.19 Allowed 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 110.094 -3.23 . . . . 0.0 104.25 151.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.859 HD11 ' H ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -140.56 175.41 9.63 Favored 'General case' 0 N--CA 1.403 -2.816 0 CA-C-N 112.312 -2.222 . . . . 0.0 111.007 -158.068 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.673 ' HD2' ' HB3' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -110.91 87.43 2.53 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 173.415 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 41' ' ' LEU . . . -90.59 115.16 27.49 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.5 -167.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 57.0 mt -95.38 98.4 7.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.949 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 3.4 mm? -90.13 134.29 34.36 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 119.559 -0.857 . . . . 0.0 109.411 -174.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -144.05 126.54 15.9 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.055 175.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.785 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . 0.9 OUTLIER -90.48 113.54 25.52 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 117.347 -1.741 . . . . 0.0 109.602 174.295 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.48 -7.98 1.65 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 113.73 -1.577 . . . . 0.0 113.734 -169.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -63.32 -13.73 42.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.219 0.533 . . . . 0.0 110.668 174.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.51 27.75 2.98 Favored Glycine 0 CA--C 1.502 -0.724 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.694 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.7 m -142.03 170.68 15.26 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 114.906 -0.647 . . . . 0.0 110.219 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -118.82 142.47 31.85 Favored Pre-proline 0 CA--C 1.495 -1.14 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.657 -176.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.949 ' HG2' ' HB3' ' A' ' 11' ' ' LEU . 5.6 Cg_exo -75.29 105.38 2.07 Favored 'Trans proline' 0 N--CA 1.424 -2.562 0 N-CA-C 105.027 -2.72 . . . . 0.0 105.027 156.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -105.96 -165.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.155 0 C-N-CA 123.078 2.519 . . . . 0.0 112.198 -164.043 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.74 100.16 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -170.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.84 22.8 7.79 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.873 ' HB3' HG13 ' A' ' 36' ' ' VAL . . . -64.94 89.62 0.08 Allowed 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.694 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.736 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -70.45 87.91 0.65 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.578 -1.646 . . . . 0.0 111.622 178.465 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.867 HG22 ' CA ' ' A' ' 34' ' ' GLY . 3.2 m -82.28 112.36 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.173 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -140.53 121.22 14.32 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.795 -178.613 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.713 ' OG ' HD23 ' A' ' 53' ' ' LEU . 64.0 m -84.85 -171.98 3.93 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.723 -168.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -23.93 -67.85 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -169.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -88.71 -6.97 57.09 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -171.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.554 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 114.39 35.87 1.39 Allowed Glycine 0 CA--C 1.487 -1.672 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -177.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.686 ' O ' HD22 ' A' ' 33' ' ' LEU . 68.3 mtp180 -76.01 100.06 4.78 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -91.9 96.05 10.17 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.06 -169.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.887 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -109.01 4.42 23.19 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.712 -170.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.867 ' CA ' HG22 ' A' ' 25' ' ' VAL . . . -166.72 154.76 25.45 Favored Glycine 0 N--CA 1.467 0.764 0 C-N-CA 119.079 -1.534 . . . . 0.0 114.406 176.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.674 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 31.8 mtt -149.88 99.67 2.87 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 164.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.873 HG13 ' HB3' ' A' ' 23' ' ' ALA . 2.2 m -72.09 106.59 2.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 118.899 -1.121 . . . . 0.0 111.176 -169.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.43 120.84 37.47 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 118.659 -1.216 . . . . 0.0 110.328 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 t70 70.6 119.69 0.04 OUTLIER 'General case' 0 C--O 1.237 0.398 0 O-C-N 124.348 1.03 . . . . 0.0 110.968 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 20' ' ' PRO . 7.1 mm-40 66.63 -98.93 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.309 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.83 47.65 0.33 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.084 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 9' ' ' ALA . 3.9 tt -133.96 125.07 27.43 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.533 ' HB1' ' H ' ' A' ' 35' ' ' MET . . . -113.08 129.23 56.57 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.75 0.31 . . . . 0.0 110.659 177.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -90.48 83.46 5.88 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.887 ' HB3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -145.46 -170.37 3.43 Favored 'General case' 0 C--O 1.195 -1.764 0 CA-C-O 118.973 -0.537 . . . . 0.0 110.002 -157.338 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.926 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 37.3 p -116.76 85.81 2.39 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -163.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.859 ' H ' HD11 ' A' ' 7' ' ' LEU . . . -62.12 -177.82 3.12 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 116.395 1.318 . . . . 0.0 116.395 -162.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.6 HG13 ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -103.78 177.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.153 -0.523 . . . . 0.0 111.79 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 7.0 m -82.47 139.52 44.58 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.029 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.727 ' HA ' HG12 ' A' ' 67' ' ' VAL . 59.0 Cg_exo -52.73 120.91 8.28 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.808 2.338 . . . . 0.0 112.833 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.68 36.3 0.92 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.023 -1.084 . . . . 0.0 112.677 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.719 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 24.3 mt-10 -138.43 -160.94 1.11 Allowed 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 119.244 -0.982 . . . . 0.0 112.175 -174.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 58.3 m -142.73 129.78 20.76 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.4 172.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.758 ' HB2' HG13 ' A' ' 65' ' ' VAL . 45.3 mt -88.13 151.47 22.69 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 173.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.06 106.93 14.31 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 171.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.736 ' HA ' ' O ' ' A' ' 24' ' ' SER . 20.0 t -112.32 109.69 29.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.892 -159.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.658 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 41.5 m-80 -77.68 146.16 36.19 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.549 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.756 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -150.41 149.82 30.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.415 -174.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.756 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 5.2 m-20 -25.18 -55.62 0.05 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 173.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.88 -40.62 98.55 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 117.071 -2.49 . . . . 0.0 113.778 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.763 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER 169.12 -168.96 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -169.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.4 tt -86.12 115.16 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 169.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.763 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 1.1 mt-30 -130.73 -48.78 1.05 Allowed 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 117.663 -1.615 . . . . 0.0 111.207 -165.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.616 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . 38.1 t -72.95 129.29 37.78 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.343 -1.298 . . . . 0.0 107.772 174.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -136.11 114.66 11.84 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 167.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.758 HG13 ' HB2' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -93.75 147.09 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.167 0 C-N-CA 115.04 -2.664 . . . . 0.0 112.346 -160.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 77.1 m-20 -100.5 108.92 21.0 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.568 174.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 49' ' ' PRO . 22.1 t -79.99 112.49 30.44 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.074 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 66' ' ' ASN . 94.4 Cg_endo -89.01 171.45 4.7 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.445 2.763 . . . . 0.0 112.141 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.522 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 2.4 mp0 -67.34 -15.37 63.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.72 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.4 m -79.83 -3.89 49.79 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.039 0.447 . . . . 0.0 111.115 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.62 156.87 36.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.4 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 73' ' ' SER . 0.4 OUTLIER -158.93 160.16 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.647 ' CB ' HD12 ' A' ' 7' ' ' LEU . 22.0 p -120.28 174.27 6.61 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.578 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.8 t70 68.78 8.16 6.59 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.371 0.605 . . . . 0.0 110.802 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -138.06 172.5 12.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.797 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.673 ' HB3' ' HD2' ' A' ' 8' ' ' PHE . 11.0 pt20 -94.13 124.74 38.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 172.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.6 tp -150.27 149.04 29.6 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.82 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.0 pt? -98.48 132.27 44.06 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.492 -1.283 . . . . 0.0 109.915 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.591 ' HB2' HD13 ' A' ' 11' ' ' LEU . 3.1 mm? -110.66 143.73 28.8 Favored Pre-proline 0 C--O 1.248 0.994 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.33 -176.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 4.9 Cg_exo -79.8 100.36 1.28 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.727 2.951 . . . . 0.0 112.864 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 13' ' ' LEU . 5.1 t -82.62 146.2 29.26 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.212 173.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.4 m -126.12 136.34 28.39 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.45 152.67 31.85 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.019 1.813 . . . . 0.0 111.04 174.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -66.33 -3.72 6.52 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.011 0.434 . . . . 0.0 111.717 -176.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.2 mttm . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.139 178.452 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.425 ' HA ' HD11 ' A' ' 72' ' ' ILE . 4.2 mm? -69.15 -31.99 71.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.028 0.442 . . . . 0.0 110.61 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -80.09 74.77 6.87 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.707 ' HA3' ' HB3' ' A' ' 73' ' ' SER . . . -77.95 111.81 3.34 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.373 -0.831 . . . . 0.0 114.001 -170.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -166.05 68.34 0.12 Allowed 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.953 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -179.9 131.54 0.1 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 153.341 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.794 HD13 ' CA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -157.99 172.09 19.07 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 115.797 1.776 . . . . 0.0 115.797 -157.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.589 ' HB2' ' HA ' ' A' ' 76' ' ' GLN . 92.4 m-85 -114.65 90.18 3.28 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 112.739 -2.028 . . . . 0.0 107.542 174.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.48 98.55 11.83 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.503 -0.479 . . . . 0.0 112.0 -171.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 40.5 mt -87.73 103.0 13.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.975 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -117.85 150.33 39.35 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.651 -175.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.506 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 13.8 mmm180 -140.3 155.42 46.84 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.79 HD22 ' SG ' ' A' ' 63' ' ' CYS . 1.8 mt -78.69 151.0 32.43 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 116.87 -1.932 . . . . 0.0 107.092 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.34 -40.34 67.95 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.684 -172.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 -74.68 -10.46 59.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.811 0.339 . . . . 0.0 111.686 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.22 24.72 4.07 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.557 -1.306 . . . . 0.0 111.754 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.66 ' HB2' ' CG ' ' A' ' 13' ' ' LEU . 16.2 m -106.33 -155.32 0.54 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.638 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -140.35 137.82 18.25 Favored Pre-proline 0 CA--C 1.51 -0.564 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -170.466 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.975 ' HG2' ' HB2' ' A' ' 11' ' ' LEU . 3.6 Cg_exo -78.59 102.14 1.52 Allowed 'Trans proline' 0 N--CA 1.438 -1.792 0 N-CA-C 104.773 -2.818 . . . . 0.0 104.773 149.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.522 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . 9.8 Cg_endo -107.78 160.88 0.1 Allowed 'Trans proline' 0 N--CA 1.431 -2.201 0 C-N-CA 123.455 2.77 . . . . 0.0 112.683 -164.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.411 ' CD1' ' HA ' ' A' ' 37' ' ' ALA . 66.5 t80 -18.64 103.7 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -168.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.63 4.36 46.12 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.836 ' HA ' ' O ' ' A' ' 56' ' ' ASN . . . -61.78 100.03 0.14 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.851 169.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.783 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -72.57 100.07 2.67 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 112.395 -2.184 . . . . 0.0 111.453 173.243 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.741 HG22 ' CA ' ' A' ' 34' ' ' GLY . 19.9 m -89.61 113.78 26.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 C-N-CA 117.645 -1.622 . . . . 0.0 109.668 174.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 1.035 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . 3.2 p -148.79 133.83 18.17 Favored 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.081 170.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.604 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -78.52 162.7 26.14 Favored 'General case' 0 C--O 1.207 -1.139 0 C-N-CA 117.221 -1.792 . . . . 0.0 108.181 -172.044 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -18.61 -62.67 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -165.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -87.13 3.49 46.05 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -171.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.89 27.03 5.57 Favored Glycine 0 CA--C 1.488 -1.614 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.948 ' HG3' HG11 ' A' ' 47' ' ' VAL . 8.5 tpt180 -68.15 176.92 2.46 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 1.035 ' HB3' ' HA ' ' A' ' 26' ' ' THR . 23.2 tp10 82.06 -120.56 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 169.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.697 ' C ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER 98.21 93.01 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.186 0 O-C-N 124.512 1.133 . . . . 0.0 109.623 -159.047 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 1.049 ' HA2' ' HB2' ' A' ' 44' ' ' LEU . . . -159.94 102.19 0.21 Allowed Glycine 0 C--O 1.216 -1.014 0 CA-C-N 112.362 -2.199 . . . . 0.0 112.216 164.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.757 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 14.3 mtm -111.08 125.67 54.01 Favored 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 121.0 -1.294 . . . . 0.0 109.911 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.748 HG12 ' HB3' ' A' ' 23' ' ' ALA . 2.1 p -73.59 139.29 19.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.727 -174.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.411 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . . . -112.87 71.14 0.73 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 171.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.3 t70 72.65 151.91 0.12 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.239 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.516 ' HB2' HD21 ' A' ' 41' ' ' LEU . 13.5 mm-40 71.8 -27.65 0.18 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.841 0.857 . . . . 0.0 112.889 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.442 ' HA2' HG21 ' A' ' 36' ' ' VAL . . . 116.99 12.81 8.15 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.354 175.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -90.0 107.31 19.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.678 -0.409 . . . . 0.0 112.002 173.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.737 ' HB1' ' C ' ' A' ' 34' ' ' GLY . . . -95.8 92.45 6.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.499 0.666 . . . . 0.0 110.45 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.521 ' HA ' ' CE3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -83.33 110.85 18.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.424 -177.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.049 ' HB2' ' HA2' ' A' ' 34' ' ' GLY . 4.2 mt -167.47 -169.93 1.33 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -167.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.953 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 26.5 p -127.47 79.36 1.88 Allowed 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 -168.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.775 ' H ' ' CD1' ' A' ' 7' ' ' LEU . . . -87.04 -150.49 18.1 Favored Glycine 0 C--N 1.306 -1.111 0 CA-C-N 114.44 -1.255 . . . . 0.0 113.529 -161.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.948 HG11 ' HG3' ' A' ' 31' ' ' ARG . 15.5 m -121.2 174.57 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.503 0.668 . . . . 0.0 112.162 174.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 11.4 t -77.79 139.19 62.08 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.692 -175.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HB3' HG22 ' A' ' 67' ' ' VAL . 87.5 Cg_exo -49.06 153.2 4.25 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.941 3.094 . . . . 0.0 114.155 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.888 ' H ' HG13 ' A' ' 67' ' ' VAL . . . 119.44 26.74 2.33 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.332 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.715 ' H ' ' CG1' ' A' ' 67' ' ' VAL . 23.2 mt-10 -143.36 -168.45 2.82 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.763 0.792 . . . . 0.0 112.946 -173.076 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 16.7 p -126.69 122.36 34.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.912 167.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.689 ' HB2' HG12 ' A' ' 65' ' ' VAL . 19.2 mt -93.37 121.01 34.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.302 -173.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.626 ' HB3' HD11 ' A' ' 61' ' ' ILE . 13.3 m -77.62 109.37 11.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.607 0.718 . . . . 0.0 110.583 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.783 ' HA ' ' O ' ' A' ' 24' ' ' SER . 59.3 t -116.57 116.72 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.537 -167.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.836 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 37.6 m-80 -99.33 157.53 16.34 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.812 -176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 2.4 p90 -161.62 -144.5 0.1 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.887 159.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.673 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 1.0 OUTLIER -41.49 -55.0 2.98 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.746 0.703 . . . . 0.0 111.076 166.216 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.51 ' HA3' ' OE1' ' A' ' 62' ' ' GLN . . . -80.68 2.3 79.6 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 118.886 -1.626 . . . . 0.0 111.079 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.643 ' CA ' ' H ' ' A' ' 57' ' ' TRP . 11.2 mtpt 67.13 -151.59 0.19 Allowed 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 114.482 -0.859 . . . . 0.0 111.771 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.626 HD11 ' HB3' ' A' ' 54' ' ' SER . 0.1 OUTLIER -64.09 106.97 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-O 122.648 1.213 . . . . 0.0 108.656 -177.001 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.636 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -146.62 -39.33 0.21 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.759 -1.564 . . . . 0.0 111.614 -174.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.79 ' SG ' HD22 ' A' ' 13' ' ' LEU . 1.6 t -96.75 135.04 39.26 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.528 174.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.637 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 49.7 mt-30 -126.36 137.75 53.49 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 169.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.689 HG12 ' HB2' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -97.41 129.95 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 C-N-CA 115.985 -2.286 . . . . 0.0 110.185 -170.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -89.56 98.46 11.78 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.216 -0.994 . . . . 0.0 109.332 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.888 HG13 ' H ' ' A' ' 50' ' ' GLY . 9.0 p -92.11 115.98 65.64 Favored Pre-proline 0 N--CA 1.44 -0.939 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.525 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.419 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 2.3 Cg_endo -82.53 152.68 15.47 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.352 2.701 . . . . 0.0 111.565 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -75.84 13.39 0.85 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.828 0.346 . . . . 0.0 111.875 -174.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 m -73.75 -42.45 61.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.986 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.11 -173.14 2.24 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.821 -173.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.425 HD11 ' HA ' ' A' ' 2' ' ' LEU . 12.6 tt -140.93 155.68 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.35 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.782 ' OG ' HD12 ' A' ' 7' ' ' LEU . 33.3 t -84.85 -166.51 1.5 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.886 -175.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 73' ' ' SER . 38.8 t70 75.76 10.07 3.39 Favored 'General case' 0 C--N 1.359 1.012 0 CA-C-O 121.717 0.77 . . . . 0.0 110.195 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -153.24 -171.97 4.09 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.154 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.589 ' HA ' ' HB2' ' A' ' 8' ' ' PHE . 14.1 pt20 -86.11 140.39 30.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 72' ' ' ILE . 96.1 mt -138.47 157.0 47.03 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.692 ' H ' HD13 ' A' ' 78' ' ' LEU . 0.0 OUTLIER -111.03 132.96 53.79 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 117.757 -1.577 . . . . 0.0 109.528 173.46 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.446 HD12 HG23 ' A' ' 67' ' ' VAL . 2.7 mm? -122.9 140.98 34.41 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -169.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 57.8 Cg_endo -88.57 110.01 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.846 3.031 . . . . 0.0 112.467 176.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.603 ' HB3' ' HA ' ' A' ' 13' ' ' LEU . 1.8 t -93.43 122.45 35.86 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.345 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.492 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 8.6 t -130.35 133.5 24.98 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.737 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 82' ' ' THR . 5.0 Cg_endo -88.02 98.89 0.42 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.952 2.435 . . . . 0.0 110.823 171.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.427 ' OE1' ' HA ' ' A' ' 84' ' ' GLN . 6.7 tp60 -149.78 56.25 0.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.715 0.769 . . . . 0.0 109.622 -176.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.572 ' NZ ' ' HB2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.56 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.641 HG12 ' H ' ' A' ' 2' ' ' LEU . 1.8 t . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.641 ' H ' HG12 ' A' ' 1' ' ' VAL . 29.3 tp -80.59 -13.28 59.19 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.196 -0.201 . . . . 0.0 111.035 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.594 ' NZ ' ' HB2' ' A' ' 3' ' ' LYS . 8.5 mtmp? 80.34 88.82 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 124.046 0.841 . . . . 0.0 110.647 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 73' ' ' SER . . . 155.23 162.36 11.23 Favored Glycine 0 CA--C 1.49 -1.525 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.703 -177.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.746 ' O ' HD12 ' A' ' 7' ' ' LEU . 50.4 mttm -114.87 80.6 1.44 Allowed 'General case' 0 N--CA 1.399 -3.0 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 161.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.688 ' HA ' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -81.23 146.87 30.24 Favored 'General case' 0 CA--C 1.461 -2.476 0 N-CA-C 101.724 -3.435 . . . . 0.0 101.724 168.557 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.952 HD12 ' H ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -163.17 -179.32 6.56 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 111.762 -3.975 . . . . 0.0 115.987 -151.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.928 ' HE1' ' HB2' ' A' ' 41' ' ' LEU . 6.2 t80 -127.17 105.39 8.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.41 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 77' ' ' LEU . . . -100.74 131.61 46.55 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.877 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.503 HG22 ' HG2' ' A' ' 12' ' ' ARG . 4.1 mp -100.28 97.02 5.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.879 HD12 HG21 ' A' ' 65' ' ' VAL . 2.7 mm? -85.48 107.57 17.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.359 -173.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.894 ' HD3' ' HG2' ' A' ' 18' ' ' GLN . 18.1 mmt180 -126.47 139.75 53.0 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.063 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 17' ' ' SER . 2.3 mt -80.62 144.32 32.43 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 117.774 -1.57 . . . . 0.0 107.694 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 -15.39 59.24 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.673 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -75.17 -30.1 60.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.827 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.16 -11.14 20.06 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -174.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.661 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 8.7 p -87.35 165.26 15.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.939 -0.631 . . . . 0.0 110.834 175.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.894 ' HG2' ' HD3' ' A' ' 12' ' ' ARG . 12.1 mp0 -159.01 -91.14 0.0 OUTLIER Pre-proline 0 C--O 1.22 -0.484 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.386 171.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.566 ' CD ' ' HB2' ' A' ' 18' ' ' GLN . 21.3 Cg_exo -23.64 100.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 124.321 3.347 . . . . 0.0 115.114 -133.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.736 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 91.4 Cg_endo -111.3 96.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.895 0 C-N-CA 124.678 3.586 . . . . 0.0 111.902 163.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.99 111.4 23.73 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 118.641 -1.224 . . . . 0.0 109.401 -171.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.24 12.86 28.19 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 -163.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.756 ' HA ' ' O ' ' A' ' 56' ' ' ASN . . . -60.14 93.74 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.887 -0.656 . . . . 0.0 110.107 174.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.681 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 0.6 OUTLIER -68.63 94.62 0.6 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.77 174.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.614 ' HB ' HD13 ' A' ' 53' ' ' LEU . 28.5 m -82.3 108.9 15.71 Favored 'Isoleucine or valine' 0 C--O 1.261 1.662 0 C-N-CA 119.031 -1.068 . . . . 0.0 108.691 173.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.709 ' HB ' ' OE1' ' A' ' 32' ' ' GLU . 5.0 t -134.11 129.7 36.31 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.867 -175.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.64 131.14 35.9 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 117.624 -1.63 . . . . 0.0 108.33 -173.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -14.72 -52.6 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -158.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -65.83 -17.27 64.52 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.31 0.959 . . . . 0.0 111.885 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.599 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 113.36 36.46 1.46 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.7 mtp85 -81.75 86.97 6.36 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 171.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.709 ' OE1' ' HB ' ' A' ' 26' ' ' THR . 4.9 mm-40 -72.35 104.8 3.85 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.03 -173.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.636 HD22 ' O ' ' A' ' 46' ' ' GLY . 24.7 mt -85.84 -35.05 20.87 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.067 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.676 ' HA3' HD22 ' A' ' 44' ' ' LEU . . . 175.9 -171.29 44.34 Favored Glycine 0 C--N 1.349 1.258 0 C-N-CA 119.258 -1.449 . . . . 0.0 114.209 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.709 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 24.8 mtt -149.0 135.99 19.87 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.854 0.327 . . . . 0.0 111.516 -173.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 23' ' ' ALA . 54.7 t -69.41 148.56 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.238 0.336 . . . . 0.0 111.055 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -138.84 57.28 1.68 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.106 172.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.746 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 9.0 p-10 167.09 -154.32 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.579 -176.3 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 62.6 mm-40 -49.74 -52.55 30.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.774 169.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.52 57.93 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 118.59 -1.767 . . . . 0.0 113.982 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.928 ' HB2' ' HE1' ' A' ' 8' ' ' PHE . 4.5 pp -132.09 131.71 42.63 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.608 0.718 . . . . 0.0 110.341 169.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.05 114.87 20.31 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.827 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.423 ' CZ3' ' HB2' ' A' ' 8' ' ' PHE . 50.7 m95 -72.97 88.81 1.39 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.717 HD12 HD21 ' A' ' 7' ' ' LEU . 5.9 mt -79.24 178.06 8.36 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 118.547 -1.261 . . . . 0.0 108.538 -174.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 65.7 p -147.13 88.83 1.75 Allowed 'General case' 0 N--CA 1.427 -1.575 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.387 172.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.952 ' H ' HD12 ' A' ' 7' ' ' LEU . . . 107.33 92.87 2.28 Favored Glycine 0 C--O 1.222 -0.615 0 C-N-CA 119.011 -1.566 . . . . 0.0 112.248 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.545 HG12 ' HG ' ' A' ' 7' ' ' LEU . 10.3 p -120.39 137.46 54.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.435 ' HB ' ' OE2' ' A' ' 51' ' ' GLU . 28.8 m -101.22 129.44 27.04 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.929 ' HB2' ' HA ' ' A' ' 69' ' ' GLU . 60.3 Cg_endo -72.99 135.38 23.08 Favored 'Trans proline' 0 C--N 1.331 -0.367 0 C-N-CA 122.907 2.405 . . . . 0.0 112.897 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.94 35.66 5.26 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 119.46 -1.352 . . . . 0.0 113.176 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.714 ' H ' ' CG1' ' A' ' 67' ' ' VAL . 31.6 mt-10 -121.89 177.69 5.19 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.879 -176.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 p -122.86 90.98 3.39 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.664 165.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.633 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 19.6 mt -51.43 152.82 2.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.484 171.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.52 ' HB2' HD11 ' A' ' 61' ' ' ILE . 21.4 p -120.61 125.14 47.01 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 165.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 24' ' ' SER . 20.3 t -112.68 107.93 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.497 0.665 . . . . 0.0 111.275 -167.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.756 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 45.8 m-80 -76.42 139.8 41.04 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.624 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.857 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 2.4 t90 -144.59 149.66 36.16 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.503 -166.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.857 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 4.3 m-20 -19.41 -64.74 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.758 1.223 . . . . 0.0 113.243 166.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.42 ' HA3' HE22 ' A' ' 62' ' ' GLN . . . -62.76 -36.46 93.36 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 117.719 -2.181 . . . . 0.0 113.864 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.746 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 13.1 pttp 167.77 -169.7 0.02 OUTLIER 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -172.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.715 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.3 tt -81.96 118.31 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 167.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.785 ' HG3' ' HB3' ' A' ' 57' ' ' TRP . 1.4 mt-30 -125.18 -63.06 1.18 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 115.555 -2.458 . . . . 0.0 112.511 -166.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 27.5 p -92.89 149.21 21.41 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 117.304 -1.758 . . . . 0.0 108.116 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 96.1 mt-30 -127.13 133.82 50.31 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.879 HG21 HD12 ' A' ' 11' ' ' LEU . 4.4 t -94.99 140.74 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 C-N-CA 115.522 -2.471 . . . . 0.0 113.015 -164.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -95.48 113.58 25.25 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 118.736 -1.185 . . . . 0.0 110.261 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.714 ' CG1' ' H ' ' A' ' 51' ' ' GLU . 8.8 p -101.8 124.22 41.19 Favored Pre-proline 0 C--O 1.219 -0.507 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.823 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 91.8 Cg_endo -88.67 171.8 4.93 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.853 3.035 . . . . 0.0 112.916 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.929 ' HA ' ' HB2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -68.78 -25.19 64.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.651 -177.51 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -76.81 28.7 0.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.127 0.489 . . . . 0.0 111.811 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.536 ' HA ' HD22 ' A' ' 77' ' ' LEU . . . -69.36 135.28 50.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.394 0.616 . . . . 0.0 110.908 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.508 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 10.7 tp -96.08 157.92 3.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.067 -173.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.49 ' HA ' ' CB ' ' A' ' 5' ' ' LYS . 3.3 m -107.52 129.92 54.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.442 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.675 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 58.4 m-20 56.08 30.09 15.68 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -146.02 -167.7 2.79 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.282 0.563 . . . . 0.0 112.208 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.569 ' HA ' ' HB3' ' A' ' 8' ' ' PHE . 26.9 tt0 -93.32 140.51 29.47 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.606 -175.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.536 HD22 ' HA ' ' A' ' 71' ' ' ALA . 55.0 tp -153.98 123.01 6.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.769 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -85.5 137.0 33.19 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 118.426 -1.309 . . . . 0.0 109.549 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.563 ' HB2' HD13 ' A' ' 11' ' ' LEU . 55.5 mt -122.81 134.83 25.23 Favored Pre-proline 0 C--O 1.245 0.818 0 CA-C-O 121.7 0.762 . . . . 0.0 111.85 -175.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 92.1 Cg_endo -87.68 121.86 1.6 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.192 2.595 . . . . 0.0 112.846 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 63' ' ' CYS . 1.1 m -81.52 97.82 7.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.054 173.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.44 ' HB ' ' CD ' ' A' ' 83' ' ' PRO . 17.2 p -83.92 171.31 11.6 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.029 176.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.44 ' CD ' ' HB ' ' A' ' 82' ' ' THR . 22.6 Cg_exo -65.69 -172.31 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.564 2.176 . . . . 0.0 112.848 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -80.28 175.38 10.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.564 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt . . . . . 0 C--O 1.252 1.211 0 CA-C-O 117.305 -1.331 . . . . 0.0 108.746 178.582 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 120.653 0.263 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.5 tp -88.4 92.41 9.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -68.81 -48.3 63.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.428 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.994 ' HA3' ' HB2' ' A' ' 74' ' ' ASP . . . -167.81 -123.16 0.65 Allowed Glycine 0 CA--C 1.472 -2.608 0 C-N-CA 119.413 -1.375 . . . . 0.0 113.179 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.776 ' H ' ' HB2' ' A' ' 74' ' ' ASP . 7.8 tptm -137.54 -154.1 0.52 Allowed 'General case' 0 N--CA 1.396 -3.155 0 CA-C-N 112.131 -2.035 . . . . 0.0 106.616 -170.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.811 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 7.7 ptp180 -64.62 158.63 23.88 Favored 'General case' 0 C--N 1.27 -2.865 0 CA-C-N 112.197 -2.274 . . . . 0.0 108.645 169.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 74' ' ' ASP 0.317 10.6 mt 172.13 -165.36 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 156.294 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 0.7 OUTLIER -66.62 127.76 33.61 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.6 -166.092 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.693 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -127.19 144.14 51.1 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.587 -175.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.1 mt -90.21 106.67 17.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.555 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.69 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -102.41 154.65 18.88 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.644 ' HA ' ' HG3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -142.89 154.08 43.76 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.05 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.727 ' HB2' ' O ' ' A' ' 17' ' ' SER . 1.7 mm? -64.07 -175.8 0.17 Allowed 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.623 0.725 . . . . 0.0 109.748 172.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.2 -27.35 66.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.025 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.95 -20.66 61.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.557 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.38 33.64 7.94 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.732 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.727 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 74.8 p -154.75 148.76 25.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.189 -0.505 . . . . 0.0 110.698 -174.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.764 ' CB ' ' HD3' ' A' ' 20' ' ' PRO . 6.1 mt-30 -167.71 132.37 1.53 Allowed Pre-proline 0 CA--C 1.503 -0.843 0 C-N-CA 123.068 0.547 . . . . 0.0 109.782 170.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -113.95 91.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.161 0 CA-C-N 119.382 0.815 . . . . 0.0 111.306 140.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.764 ' HD3' ' CB ' ' A' ' 18' ' ' GLN . 22.0 Cg_endo -116.4 94.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.781 0 C-N-CA 123.291 2.66 . . . . 0.0 113.256 163.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.51 108.57 19.47 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.887 0.851 . . . . 0.0 109.566 -174.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.48 -0.66 12.57 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -169.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -56.75 95.21 0.02 OUTLIER 'General case' 0 C--N 1.345 0.411 0 CA-C-O 121.575 0.702 . . . . 0.0 109.891 174.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.672 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -70.98 96.92 1.35 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.423 -1.717 . . . . 0.0 113.082 179.005 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.648 HG21 ' HG ' ' A' ' 44' ' ' LEU . 27.6 m -84.41 113.9 23.9 Favored 'Isoleucine or valine' 0 C--O 1.251 1.183 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.752 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -143.4 130.74 20.95 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.337 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.685 ' HA ' ' HA ' ' A' ' 53' ' ' LEU . 59.7 p -69.96 176.37 3.78 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.437 -173.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.561 ' HG2' HG23 ' A' ' 52' ' ' THR . 11.8 mm-40 -58.79 -20.34 49.09 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.018 0.437 . . . . 0.0 111.393 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -86.98 -17.29 33.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.0 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.428 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 98.99 18.72 23.91 Favored Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.658 ' HB2' ' OG ' ' A' ' 27' ' ' SER . 32.0 mtt180 -63.88 91.17 0.06 Allowed 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 168.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.522 ' HA ' ' HB ' ' A' ' 26' ' ' THR . 19.3 mt-10 -81.32 89.67 6.09 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.192 -177.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.521 HD23 ' HB3' ' A' ' 44' ' ' LEU . 11.1 mp -66.56 -48.79 68.54 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.696 -175.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.528 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . -177.22 -161.77 26.38 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 117.932 -2.08 . . . . 0.0 114.051 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 19.4 mtt -149.69 140.99 23.17 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -176.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 23' ' ' ALA . 43.8 t -70.03 129.05 34.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.324 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.88 92.89 3.89 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 171.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 74.73 136.22 0.06 Allowed 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.296 0.997 . . . . 0.0 111.316 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 58.24 -145.15 0.58 Allowed 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.425 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.43 61.3 0.32 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.425 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' A' ' 8' ' ' PHE . 3.8 tt -134.14 112.01 10.78 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.183 -177.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.45 ' HB3' HD11 ' A' ' 44' ' ' LEU . . . -106.87 161.29 14.83 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.392 173.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.517 ' CD2' ' HB3' ' A' ' 8' ' ' PHE . 22.6 m95 -95.71 87.98 4.85 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.486 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.693 HD13 ' HB3' ' A' ' 9' ' ' ALA . 6.6 mp -90.27 88.69 7.32 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 116.857 -1.937 . . . . 0.0 111.191 -167.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.811 ' HA ' ' HB2' ' A' ' 6' ' ' ARG . 6.3 p -86.09 86.91 7.35 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 122.012 0.91 . . . . 0.0 109.179 171.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.601 ' H ' ' HB2' ' A' ' 6' ' ' ARG . . . 150.85 26.59 0.05 OUTLIER Glycine 0 C--N 1.308 -0.976 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.176 176.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 6' ' ' ARG . 6.2 p -84.72 115.31 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.97 -176.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.0 m -115.8 124.81 29.37 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 172.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 67' ' ' VAL . 10.2 Cg_endo -53.5 133.94 55.58 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.147 2.565 . . . . 0.0 112.708 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.28 35.8 5.62 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.583 -1.294 . . . . 0.0 112.605 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.572 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 4.5 mm-40 -116.31 179.4 4.0 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 122.298 1.047 . . . . 0.0 111.943 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.561 HG23 ' HG2' ' A' ' 28' ' ' GLU . 14.3 t -134.12 143.2 47.82 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.352 -1.749 . . . . 0.0 108.548 165.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.685 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 4.5 tp -121.72 160.0 25.43 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.065 -166.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.669 ' HB3' HD11 ' A' ' 61' ' ' ILE . 36.8 m -129.55 129.94 45.11 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 123.787 0.679 . . . . 0.0 111.214 172.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.725 HG21 ' SG ' ' A' ' 81' ' ' CYS . 14.4 t -119.33 106.15 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.152 -167.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.65 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 8.5 m-20 -76.92 85.62 3.47 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.55 177.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.777 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -82.24 147.11 29.13 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.899 176.595 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.777 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 18.1 m-20 -12.08 -64.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 170.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.11 -42.65 99.73 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 117.895 -2.098 . . . . 0.0 114.42 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 1.051 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 9.0 ptpt -178.8 -166.29 0.1 Allowed 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -169.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.669 HD11 ' HB3' ' A' ' 54' ' ' SER . 12.7 tt -90.4 87.92 2.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 173.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 1.051 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -96.2 -51.93 4.21 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.896 -158.389 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 82' ' ' THR . 20.5 p -105.33 158.16 16.82 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 118.185 -1.406 . . . . 0.0 108.145 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.626 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 97.1 mt-30 -132.45 142.5 49.28 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -97.54 151.55 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 C-N-CA 114.825 -2.75 . . . . 0.0 112.196 -169.396 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.615 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 90.7 m-20 -112.09 113.42 25.69 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.357 174.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.572 ' HB ' ' H ' ' A' ' 51' ' ' GLU . 56.1 t -96.82 106.75 32.65 Favored Pre-proline 0 C--O 1.224 -0.244 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.075 -177.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 67' ' ' VAL . 27.7 Cg_endo -62.22 156.08 52.76 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.208 2.605 . . . . 0.0 112.449 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -77.26 5.98 7.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.62 -170.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.7 t -130.23 -4.08 4.4 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.552 -0.459 . . . . 0.0 112.153 -172.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.524 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -94.79 152.69 18.21 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.751 -0.779 . . . . 0.0 112.675 -172.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.9 tp -158.16 161.9 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.803 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.462 ' HB2' ' N ' ' A' ' 7' ' ' LEU . 19.3 m -118.1 -105.34 0.39 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 119.182 -1.007 . . . . 0.0 113.459 -173.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.994 ' HB2' ' HA3' ' A' ' 4' ' ' GLY . 29.1 t70 72.13 8.23 5.86 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.284 1.04 . . . . 0.0 109.092 -165.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -169.87 -146.63 0.05 Allowed 'General case' 0 C--O 1.245 0.816 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.738 -173.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.611 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 81.8 mt-30 -78.93 136.86 37.38 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.086 0.866 . . . . 0.0 110.672 171.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.524 HD11 ' HB1' ' A' ' 71' ' ' ALA . 37.7 tp -129.96 -179.03 4.98 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 169.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.506 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 3.2 pp -140.81 139.32 34.52 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 117.722 -1.591 . . . . 0.0 110.721 174.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 2.8 mm? -133.58 142.2 43.04 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-O 121.567 0.699 . . . . 0.0 112.699 -175.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.615 ' HG2' ' HB2' ' A' ' 66' ' ' ASN . 74.2 Cg_endo -82.47 122.13 3.54 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.892 2.394 . . . . 0.0 111.594 171.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.725 ' SG ' HG21 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -106.67 87.65 2.58 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 63' ' ' CYS . 10.2 t -68.79 143.91 95.36 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.983 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.34 152.39 67.34 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.725 2.283 . . . . 0.0 111.939 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.459 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 4.1 pt20 -67.19 -39.28 86.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.536 -177.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.91 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.65 -179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.782 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.42 -1.955 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.805 HD23 ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -144.6 -177.41 5.48 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.566 -1.253 . . . . 0.0 113.78 -162.13 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.723 ' HB2' ' HG2' ' A' ' 76' ' ' GLN . 1.2 m-85 -118.21 104.13 10.51 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.535 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.532 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . . . -102.91 143.34 32.64 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.955 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.456 HG12 ' CD1' ' A' ' 41' ' ' LEU . 10.1 mt -112.82 99.79 9.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.277 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.718 HD12 HG21 ' A' ' 65' ' ' VAL . 2.4 mm? -93.38 128.66 39.53 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.407 -173.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -135.44 131.59 36.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.188 -0.605 . . . . 0.0 112.37 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.628 HD22 ' SG ' ' A' ' 81' ' ' CYS . 3.3 mm? -53.96 142.08 25.83 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 167.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.92 -26.37 67.43 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.057 -1.428 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -65.79 -25.55 67.3 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.223 0.535 . . . . 0.0 110.842 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.23 10.97 19.26 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.464 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 22.9 t -97.16 -160.61 0.81 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.473 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.518 ' C ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -139.25 134.82 16.82 Favored Pre-proline 0 CA--C 1.5 -0.96 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -172.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.537 ' O ' HG21 ' A' ' 36' ' ' VAL . 42.3 Cg_endo -76.38 103.27 1.72 Allowed 'Trans proline' 0 N--CA 1.429 -2.303 0 N-CA-C 104.301 -3.0 . . . . 0.0 104.301 148.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 17.6 Cg_endo -98.65 -163.75 0.07 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.276 0 C-N-CA 122.773 2.315 . . . . 0.0 111.51 -161.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.553 ' HA ' HG12 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -48.56 109.61 0.26 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.079 0.466 . . . . 0.0 111.986 -172.304 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.9 3.17 26.7 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.701 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -65.29 95.73 0.2 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.214 0.531 . . . . 0.0 109.983 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.662 ' HB2' HD22 ' A' ' 56' ' ' ASN . 2.0 m -67.62 105.61 1.93 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.301 -1.772 . . . . 0.0 110.686 173.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.693 HG12 HG22 ' A' ' 55' ' ' VAL . 26.9 m -100.52 112.24 32.64 Favored 'Isoleucine or valine' 0 C--O 1.26 1.614 0 CA-C-O 121.857 0.837 . . . . 0.0 110.204 174.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -149.5 128.96 13.01 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.574 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . 7.1 p -62.83 171.3 2.18 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.594 -175.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -68.39 -7.59 32.85 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.942 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HD2' ' HA ' ' A' ' 29' ' ' LYS . 48.5 tptt -93.72 -14.03 26.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.267 0.556 . . . . 0.0 109.65 172.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.441 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 100.7 31.57 5.71 Favored Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' A' ' 26' ' ' THR . 26.6 tpt180 -73.9 89.22 1.86 Allowed 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 173.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.478 ' HA ' ' HB ' ' A' ' 26' ' ' THR . 25.6 mt-10 -86.11 94.86 9.37 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.066 -171.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.865 HD23 HD21 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -80.78 -37.61 29.97 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.077 -178.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.592 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . 167.26 -159.45 32.8 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 117.87 -2.11 . . . . 0.0 114.855 177.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.701 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 10.5 mtm -151.81 137.52 17.92 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.891 0.876 . . . . 0.0 109.683 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.595 HG23 ' HB3' ' A' ' 23' ' ' ALA . 55.7 t -61.83 129.51 24.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 C-N-CA 120.006 -0.677 . . . . 0.0 109.841 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -130.73 55.02 1.85 Allowed 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.456 173.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 5.0 t70 148.98 122.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 125.306 1.628 . . . . 0.0 108.198 174.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 20' ' ' PRO . 24.0 mt-10 52.13 -102.2 0.12 Allowed 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.531 0.52 . . . . 0.0 111.297 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.8 29.34 2.66 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.456 ' CD1' HG12 ' A' ' 10' ' ' ILE . 11.8 tp -103.34 111.15 23.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.419 -0.391 . . . . 0.0 110.044 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -101.94 126.61 48.88 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.282 174.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -75.08 88.96 2.44 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.805 ' HB2' HD23 ' A' ' 7' ' ' LEU . 8.1 mt -83.26 177.32 8.58 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 117.403 -1.719 . . . . 0.0 110.079 -171.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 41.8 m -138.84 85.72 2.1 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.796 ' HA2' HD11 ' A' ' 7' ' ' LEU . . . 75.61 75.93 0.81 Allowed Glycine 0 C--O 1.223 -0.554 0 C-N-CA 119.914 -1.136 . . . . 0.0 115.421 174.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.49 HG12 HG11 ' A' ' 67' ' ' VAL . 3.9 t -81.65 134.41 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.239 -0.585 . . . . 0.0 109.637 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.542 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -86.55 127.88 58.98 Favored Pre-proline 0 C--N 1.326 -0.45 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.737 179.176 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.747 ' HB2' ' HA ' ' A' ' 69' ' ' GLU . 30.9 Cg_endo -64.71 115.21 3.1 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.326 2.018 . . . . 0.0 111.899 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.28 36.24 2.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.748 -1.215 . . . . 0.0 112.697 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.652 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 28.5 mt-10 -116.98 176.81 4.95 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 119.146 -1.022 . . . . 0.0 112.142 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 t -127.31 92.42 3.51 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.333 168.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.865 HD21 HD23 ' A' ' 33' ' ' LEU . 9.0 mt -58.86 158.86 7.62 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 114.222 -1.353 . . . . 0.0 111.764 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.63 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 24.8 m -125.23 121.44 34.12 Favored 'General case' 0 C--N 1.317 -0.812 0 O-C-N 123.58 0.55 . . . . 0.0 109.777 168.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.693 HG22 HG12 ' A' ' 25' ' ' VAL . 9.5 t -109.43 122.23 63.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-O 121.212 0.53 . . . . 0.0 111.466 -170.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.662 HD22 ' HB2' ' A' ' 24' ' ' SER . 0.8 OUTLIER -123.77 132.49 53.81 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.708 -170.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.657 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 6.7 p90 -147.23 -142.95 0.13 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 117.957 -1.497 . . . . 0.0 112.63 171.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.657 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 0.9 OUTLIER -37.5 -63.07 0.48 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.853 0.461 . . . . 0.0 111.298 167.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.595 ' HA3' ' NE2' ' A' ' 62' ' ' GLN . . . -80.18 0.45 83.81 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 119.126 -1.512 . . . . 0.0 110.691 176.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.638 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 27.1 mttm 74.69 -140.31 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 113.898 -1.151 . . . . 0.0 113.165 173.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.674 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -77.9 98.78 2.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -174.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.595 ' NE2' ' HA3' ' A' ' 59' ' ' GLY . 1.5 mt-30 -118.92 -41.81 2.75 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 114.416 -1.266 . . . . 0.0 110.877 -173.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 17.2 p -118.24 158.1 25.77 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.73 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.697 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 24.0 mt-30 -126.9 156.53 41.3 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.718 HG21 HD12 ' A' ' 11' ' ' LEU . 2.7 t -106.75 131.92 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 114.433 -2.907 . . . . 0.0 112.562 -172.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -90.46 110.81 21.91 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.187 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.652 ' HB ' ' H ' ' A' ' 51' ' ' GLU . 18.8 t -92.56 114.3 62.02 Favored Pre-proline 0 CA--C 1.513 -0.453 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.873 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 4.6 Cg_exo -81.51 172.7 12.2 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 124.324 3.35 . . . . 0.0 111.903 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.747 ' HA ' ' HB2' ' A' ' 49' ' ' PRO . 40.6 mt-10 -72.68 -6.87 47.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.814 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.452 HG22 ' HB2' ' A' ' 68' ' ' PRO . 10.7 t -85.07 18.63 2.45 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.929 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.656 ' HA ' HD22 ' A' ' 77' ' ' LEU . . . -66.25 153.5 42.38 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.617 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.25 167.98 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.909 -173.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.485 ' HA ' HD12 ' A' ' 7' ' ' LEU . 47.5 t -101.29 143.33 31.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.787 -175.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 51.83 23.45 2.08 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -134.05 173.11 11.94 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.322 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.723 ' HG2' ' HB2' ' A' ' 8' ' ' PHE . 74.9 mt-30 -86.25 142.0 28.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.701 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.656 HD22 ' HA ' ' A' ' 71' ' ' ALA . 50.9 tp -150.74 116.6 5.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.591 HD13 ' H ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -82.72 141.7 32.2 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 118.332 -1.347 . . . . 0.0 109.454 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.415 ' HB2' ' CD1' ' A' ' 11' ' ' LEU . 95.2 mt -131.46 147.84 67.71 Favored Pre-proline 0 C--O 1.247 0.97 0 CA-C-O 121.109 0.48 . . . . 0.0 111.962 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.429 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 65.9 Cg_endo -76.0 109.91 2.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.576 2.851 . . . . 0.0 113.309 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.628 ' SG ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -91.06 93.46 9.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.279 172.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 23.5 m -97.3 126.29 42.36 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.397 -175.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 82' ' ' THR . 39.2 Cg_exo -61.12 148.68 92.17 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.758 2.305 . . . . 0.0 111.767 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.561 179.031 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 1.118 ' HB2' ' HB2' ' A' ' 45' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.418 -2.074 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.672 ' N ' ' HG3' ' A' ' 6' ' ' ARG . 1.7 tt -141.08 114.3 8.63 Favored 'General case' 0 N--CA 1.387 -3.62 0 C-N-CA 117.126 -1.829 . . . . 0.0 114.761 -144.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.707 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 2.1 m-85 -119.27 88.77 3.0 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.641 ' HB2' HD21 ' A' ' 7' ' ' LEU . . . -100.38 102.11 13.26 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -170.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 51.5 mt -80.93 98.28 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.55 HD13 ' HG2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -114.41 146.04 41.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.861 -172.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -137.11 147.93 46.36 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.104 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.498 HD13 ' SG ' ' A' ' 81' ' ' CYS . 4.5 mm? -66.15 146.85 54.17 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.71 -27.34 67.82 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.757 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.18 -18.84 63.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.536 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.17 -6.24 25.22 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.8 -163.65 0.75 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.153 -0.524 . . . . 0.0 110.741 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.565 ' HG2' ' HA3' ' A' ' 40' ' ' GLY . 2.8 mt-30 -136.81 145.24 50.06 Favored Pre-proline 0 CA--C 1.506 -0.747 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -172.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.684 ' O ' HG21 ' A' ' 36' ' ' VAL . 6.2 Cg_exo -74.53 103.62 1.73 Allowed 'Trans proline' 0 N--CA 1.431 -2.188 0 N-CA-C 104.796 -2.809 . . . . 0.0 104.796 148.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 19.4 Cg_endo -103.13 -177.69 0.11 Allowed 'Trans proline' 0 N--CA 1.43 -2.236 0 C-N-CA 123.277 2.651 . . . . 0.0 111.99 -165.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.641 ' HA ' HG12 ' A' ' 36' ' ' VAL . 31.0 t80 -41.65 117.43 0.92 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -168.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.67 8.46 57.19 Favored Glycine 0 N--CA 1.436 -1.367 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.727 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -59.0 94.76 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.789 -0.706 . . . . 0.0 109.393 171.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.797 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 3.8 m -57.46 93.01 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 113.341 -1.754 . . . . 0.0 111.546 172.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.898 HG23 ' C ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -89.04 95.18 5.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.634 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.716 ' HB ' ' HG2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -128.33 130.94 48.53 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.66 -174.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.5 p -65.42 172.07 3.51 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 118.567 -1.253 . . . . 0.0 109.553 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.61 -18.23 51.78 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.912 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -93.71 -8.79 39.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.839 0.352 . . . . 0.0 110.87 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.431 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 102.12 23.92 8.82 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.164 174.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.663 HH11 HD12 ' A' ' 33' ' ' LEU . 39.7 mtm105 -73.73 88.51 1.75 Allowed 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 118.212 -1.395 . . . . 0.0 108.57 170.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.716 ' HG2' ' HB ' ' A' ' 26' ' ' THR . 15.8 mt-10 -83.52 77.9 9.75 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.674 HD13 ' HA3' ' A' ' 46' ' ' GLY . 96.2 mt -121.11 12.39 11.08 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.816 -167.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 1.042 ' HA2' ' HB2' ' A' ' 44' ' ' LEU . . . -138.02 149.82 20.63 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.468 163.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.727 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 30.9 mtm -154.14 126.28 7.85 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 160.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.713 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 32.3 t -60.89 135.32 25.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 O-C-N 123.649 0.593 . . . . 0.0 111.518 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -136.59 116.91 13.59 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 172.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 20.5 m-20 72.41 116.91 0.05 OUTLIER 'General case' 0 C--O 1.234 0.255 0 O-C-N 124.199 0.937 . . . . 0.0 111.101 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 62.87 -95.23 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.857 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.565 ' HA3' ' HG2' ' A' ' 18' ' ' GLN . . . -160.94 53.1 0.33 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 118.807 -1.663 . . . . 0.0 114.001 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.656 HD11 ' HE1' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -141.74 139.48 32.86 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.416 170.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.713 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -84.83 122.94 29.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.342 0.592 . . . . 0.0 111.719 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.656 ' HE1' HD11 ' A' ' 41' ' ' LEU . 58.9 m95 -97.03 88.13 4.42 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.268 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.042 ' HB2' ' HA2' ' A' ' 34' ' ' GLY . 1.2 mt -156.94 -166.65 2.14 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -169.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 1.118 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 1.1 t -153.57 106.38 2.91 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.281 -171.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.674 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 140.36 76.17 0.05 OUTLIER Glycine 0 CA--C 1.521 0.449 0 C-N-CA 119.707 -1.235 . . . . 0.0 113.93 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.568 ' HB ' HD11 ' A' ' 7' ' ' LEU . 12.9 p -120.84 143.64 32.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.895 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.2 m -117.08 129.48 25.29 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.82 0.343 . . . . 0.0 110.332 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.578 ' HA ' HG12 ' A' ' 67' ' ' VAL . 44.1 Cg_endo -68.56 129.01 18.07 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.569 2.179 . . . . 0.0 112.136 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.47 36.38 5.91 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.155 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -128.02 173.3 10.16 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 118.055 -1.458 . . . . 0.0 113.731 -170.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 p -121.09 89.8 3.2 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.089 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 25.6 mt -68.1 151.92 46.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.075 174.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.503 ' HB2' HD11 ' A' ' 61' ' ' ILE . 34.5 p -122.88 121.95 37.43 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.938 0.875 . . . . 0.0 110.593 170.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.797 ' HA ' ' O ' ' A' ' 24' ' ' SER . 4.8 t -120.08 117.95 55.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.465 -162.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.723 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 35.0 m-80 -103.51 148.75 25.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.922 -173.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 6.2 p90 -161.84 -138.21 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 120.263 -0.575 . . . . 0.0 112.528 161.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.676 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 30.8 t70 -41.72 -58.12 2.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.277 0.631 . . . . 0.0 111.495 168.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.505 ' HA3' ' NE2' ' A' ' 62' ' ' GLN . . . -80.55 -1.47 88.9 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 119.288 -1.434 . . . . 0.0 110.302 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.655 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 37.8 mtmt 71.18 -142.26 0.06 Allowed 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 113.938 -1.131 . . . . 0.0 110.74 173.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.503 HD11 ' HB2' ' A' ' 54' ' ' SER . 0.5 OUTLIER -67.98 95.35 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-O 123.414 1.578 . . . . 0.0 107.937 -177.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.597 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 4.7 pt20 -139.04 -37.3 0.52 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.434 -1.712 . . . . 0.0 111.129 -170.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.646 ' SG ' ' HG3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -87.56 142.85 27.54 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 166.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -140.09 124.64 18.07 Favored 'General case' 0 CA--C 1.478 -1.789 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 22.2 t -98.93 132.1 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.111 0 C-N-CA 114.639 -2.824 . . . . 0.0 112.278 -168.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -101.05 102.48 13.46 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 118.039 -1.464 . . . . 0.0 110.279 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 49' ' ' PRO . 40.6 t -75.25 126.57 87.71 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.025 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.537 ' HB2' HG22 ' A' ' 70' ' ' THR . 9.8 Cg_endo -90.16 171.02 3.92 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.663 2.909 . . . . 0.0 111.93 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.32 0.26 22.92 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 111.596 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 68' ' ' PRO . 8.8 t -93.42 16.03 14.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.192 0.52 . . . . 0.0 110.326 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.09 152.92 38.54 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.712 0.768 . . . . 0.0 111.711 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.439 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 59.1 mt -121.12 137.67 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.91 -174.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -88.53 140.39 29.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.382 -173.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 23.0 t70 71.76 -4.22 1.97 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.217 0.532 . . . . 0.0 112.246 170.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.899 ' HA ' HE21 ' A' ' 75' ' ' GLN . 0.0 OUTLIER -112.7 -166.05 1.05 Allowed 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.34 0.591 . . . . 0.0 110.829 -177.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.707 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 30.0 pt20 -97.69 134.84 40.33 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.921 173.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 78' ' ' LEU . 1.6 tm? -142.9 141.91 31.62 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -88.16 132.81 34.19 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.393 -177.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.539 HD23 ' HB1' ' A' ' 9' ' ' ALA . 3.4 mm? -117.98 139.62 26.78 Favored Pre-proline 0 C--O 1.241 0.657 0 CA-C-O 121.233 0.539 . . . . 0.0 111.496 -176.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 73.3 Cg_endo -87.99 120.27 1.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.051 2.501 . . . . 0.0 112.278 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.498 ' SG ' HD13 ' A' ' 13' ' ' LEU . 8.8 t -89.04 120.31 30.33 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.853 176.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 m -97.52 134.78 22.14 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 170.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -63.17 152.14 81.2 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.46 2.107 . . . . 0.0 112.732 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.434 HE21 ' HB3' ' A' ' 84' ' ' GLN . 3.4 tt0 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.17 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.857 ' C ' HD23 ' A' ' 7' ' ' LEU . 90.7 mtt-85 . . . . . 0 CA--C 1.49 -1.357 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.964 HD22 ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -123.01 172.02 8.82 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 115.737 -2.385 . . . . 0.0 109.006 -170.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.819 ' HB2' ' HA ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -92.24 87.13 5.96 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.524 -1.67 . . . . 0.0 108.095 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.839 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -98.32 112.08 24.2 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 118.969 -1.093 . . . . 0.0 111.462 -173.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.456 HG12 ' HG ' ' A' ' 41' ' ' LEU . 59.2 mt -100.65 90.67 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.476 171.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -103.06 132.27 49.45 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.426 -175.335 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.819 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 58.7 mtm-85 -141.67 155.09 45.7 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.265 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.642 HD23 ' HD3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -89.99 135.23 33.77 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 117.888 -1.525 . . . . 0.0 109.028 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.53 -11.64 3.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.797 -169.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -67.29 -19.0 65.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.433 0.635 . . . . 0.0 110.596 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.7 -8.98 21.79 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -174.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.441 ' CB ' ' HG ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -82.61 -177.9 6.87 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 113.922 -1.139 . . . . 0.0 111.824 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.708 ' NE2' ' HB2' ' A' ' 39' ' ' GLU . 1.2 mt-30 -135.4 142.65 42.15 Favored Pre-proline 0 CA--C 1.503 -0.857 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.949 -176.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.819 ' HD3' ' HA ' ' A' ' 12' ' ' ARG . 3.6 Cg_endo -80.37 102.72 1.45 Allowed 'Trans proline' 0 N--CA 1.423 -2.668 0 N-CA-C 104.848 -2.789 . . . . 0.0 104.848 156.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.718 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 1.9 Cg_endo -101.63 175.76 0.23 Allowed 'Trans proline' 0 N--CA 1.422 -2.715 0 C-N-CA 122.836 2.357 . . . . 0.0 111.047 -162.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.445 ' HD1' ' HA ' ' A' ' 37' ' ' ALA . 82.5 t80 -30.42 99.74 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 124.231 0.957 . . . . 0.0 113.306 -169.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.72 10.85 8.17 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.663 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.96 ' HB3' HG13 ' A' ' 36' ' ' VAL . . . -58.94 95.86 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.227 175.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.656 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 0.6 OUTLIER -77.8 98.41 5.54 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.714 -1.585 . . . . 0.0 112.117 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.688 HG12 HG22 ' A' ' 55' ' ' VAL . 11.8 m -103.68 115.19 45.16 Favored 'Isoleucine or valine' 0 C--O 1.259 1.563 0 CA-C-O 121.319 0.581 . . . . 0.0 111.85 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.628 ' OG1' ' HA2' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -147.21 125.98 12.65 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.257 175.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.623 ' CB ' ' HE2' ' A' ' 29' ' ' LYS . 27.2 m -53.07 168.48 0.13 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 123.17 0.293 . . . . 0.0 111.385 -173.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.453 ' CD ' ' HG3' ' A' ' 29' ' ' LYS . 5.9 pm0 -59.75 -20.31 55.78 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.982 -0.448 . . . . 0.0 112.048 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.623 ' HE2' ' CB ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -103.03 4.55 37.38 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.686 176.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.628 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 86.15 43.06 6.42 Favored Glycine 0 N--CA 1.418 -2.541 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 174.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 1.035 ' HA ' ' HE ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -94.7 97.34 10.0 Favored 'General case' 0 N--CA 1.421 -1.897 0 C-N-CA 117.521 -1.672 . . . . 0.0 107.12 166.028 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -96.15 111.18 23.3 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.16 -159.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.782 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 5.9 mp -84.64 -49.94 8.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.383 -174.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.576 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . 168.86 -155.93 26.84 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 117.041 -2.504 . . . . 0.0 114.888 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.8 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 17.1 mtp -149.84 128.28 12.22 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -173.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.96 HG13 ' HB3' ' A' ' 23' ' ' ALA . 6.3 m -71.37 130.04 35.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.105 -173.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HA ' ' HD1' ' A' ' 21' ' ' PHE . . . -121.64 55.85 1.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.807 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 20.6 t0 150.31 139.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 O-C-N 125.36 1.662 . . . . 0.0 107.572 176.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.718 ' O ' ' HA ' ' A' ' 20' ' ' PRO . 0.5 OUTLIER 28.12 -100.26 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 O-C-N 124.757 1.285 . . . . 0.0 111.781 -167.379 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.697 ' H ' ' HG3' ' A' ' 39' ' ' GLU . . . -136.07 48.84 0.9 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 173.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.456 ' HG ' HG12 ' A' ' 10' ' ' ILE . 2.6 tt -116.42 117.48 30.05 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.984 0.421 . . . . 0.0 111.039 -178.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.562 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . . . -125.57 154.75 41.74 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 171.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.617 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 64.6 m95 -84.21 88.11 7.2 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.847 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 6.3 mp -73.68 102.26 3.89 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.873 -169.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.84 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 6.4 m -56.71 87.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.086 0.866 . . . . 0.0 111.919 -176.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.401 ' HA2' HD21 ' A' ' 7' ' ' LEU . . . 56.58 91.35 0.01 OUTLIER Glycine 0 C--N 1.339 0.722 0 CA-C-N 114.683 -1.144 . . . . 0.0 114.341 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.753 HG23 HD12 ' A' ' 7' ' ' LEU . 4.6 t -72.02 145.72 11.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.569 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.3 118.52 72.26 Favored Pre-proline 0 N--CA 1.442 -0.847 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.98 ' HB2' ' HA ' ' A' ' 69' ' ' GLU . 73.1 Cg_endo -71.48 109.37 2.6 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.451 2.101 . . . . 0.0 112.197 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.44 34.95 1.04 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.098 -1.525 . . . . 0.0 113.524 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -164.66 179.99 6.26 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 117.477 -1.689 . . . . 0.0 114.121 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.828 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 21.0 p -111.63 124.98 53.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.823 -174.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 64' ' ' GLN . 1.1 mm? -83.14 134.79 34.98 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.632 ' HB3' HD11 ' A' ' 61' ' ' ILE . 3.1 m -72.33 103.51 3.44 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.688 HG22 HG12 ' A' ' 25' ' ' VAL . 46.3 t -103.18 94.42 3.2 Favored 'Isoleucine or valine' 0 C--O 1.249 1.058 0 CA-C-O 122.145 0.974 . . . . 0.0 111.278 -172.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.704 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 43.0 m-80 -73.65 131.67 41.91 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.271 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.615 ' HB3' ' HG3' ' A' ' 62' ' ' GLN . 1.7 t90 -148.39 134.56 19.34 Favored 'General case' 0 C--O 1.208 -1.125 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.666 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.574 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 2.6 p30 -12.58 -58.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -173.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.679 ' H ' ' NE2' ' A' ' 62' ' ' GLN . . . -61.05 -23.79 62.16 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 118.397 -1.859 . . . . 0.0 114.282 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 1.023 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 11.1 pttt 173.36 -141.83 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.732 0.777 . . . . 0.0 110.265 -170.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.704 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 11.8 tt -115.1 93.95 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 162.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 1.023 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 6.6 mt-30 -92.15 -19.51 22.2 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 117.289 -1.764 . . . . 0.0 113.285 -150.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.556 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 23.7 p -147.92 159.92 43.36 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.915 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 47.5 mt-30 -129.82 119.42 23.33 Favored 'General case' 0 CA--C 1.478 -1.824 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.828 ' O ' ' HA ' ' A' ' 52' ' ' THR . 2.6 t -78.19 123.47 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 C-N-CA 116.804 -1.958 . . . . 0.0 112.025 -167.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -91.32 133.21 35.62 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.023 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.731 HG21 HG11 ' A' ' 47' ' ' VAL . 62.1 t -121.53 134.54 24.59 Favored Pre-proline 0 N--CA 1.44 -0.966 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.768 -173.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 6.5 Cg_endo -92.26 172.76 2.38 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.393 3.395 . . . . 0.0 111.798 171.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.98 ' HA ' ' HB2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -63.6 -14.95 56.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.149 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.5 p -62.42 -21.55 65.49 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.27 138.71 33.47 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.366 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 mm -130.48 -82.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.888 -170.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.964 ' HA ' HD22 ' A' ' 7' ' ' LEU . 24.0 p -172.05 137.67 0.96 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.511 -175.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.765 ' H ' HD22 ' A' ' 7' ' ' LEU . 5.2 m-20 55.89 -163.23 0.15 Allowed 'General case' 0 C--N 1.362 1.142 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -172.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 8' ' ' PHE . 42.4 mt-30 65.73 150.3 0.05 OUTLIER 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.649 0.738 . . . . 0.0 112.3 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.819 ' HA ' ' HB2' ' A' ' 8' ' ' PHE . 22.1 mp0 -76.75 124.12 27.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.464 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -140.77 116.88 10.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 7.7 tt -85.98 127.13 34.57 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.018 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 81.9 mt -113.61 141.86 26.7 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 121.108 0.48 . . . . 0.0 111.704 -174.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 67.7 Cg_endo -91.38 120.39 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.349 2.699 . . . . 0.0 113.196 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.678 ' SG ' ' HG3' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -82.58 116.24 21.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.384 175.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.3 m -82.85 117.1 67.47 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.155 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.48 158.82 22.47 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.814 2.343 . . . . 0.0 112.268 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.421 178.022 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.841 ' C ' HD13 ' A' ' 7' ' ' LEU . 25.7 mtm180 . . . . . 0 N--CA 1.429 -1.487 0 N-CA-C 102.389 -3.189 . . . . 0.0 102.389 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.906 HD23 ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -149.67 177.68 9.55 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 117.714 -1.594 . . . . 0.0 113.164 -168.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 1.3 m-85 -126.78 89.64 3.02 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.697 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 77' ' ' LEU . . . -93.36 134.33 35.69 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.638 -170.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.619 ' HB ' ' HG ' ' A' ' 78' ' ' LEU . 4.2 mp -96.77 111.79 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.691 173.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.698 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 65.4 mt -92.51 131.29 37.77 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.543 -175.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.533 ' HD3' ' O ' ' A' ' 17' ' ' SER . 6.2 tpp180 -137.81 123.56 19.92 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.477 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.698 HD13 ' SG ' ' A' ' 81' ' ' CYS . 4.2 mm? -53.99 144.27 19.56 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 168.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.07 -30.28 66.08 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.218 -1.356 . . . . 0.0 111.211 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -79.02 -13.01 60.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.668 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.25 -11.71 16.88 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.159 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 30.9 p -81.83 -164.58 0.82 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.465 0.632 . . . . 0.0 110.108 175.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.623 ' C ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -129.93 141.38 41.65 Favored Pre-proline 0 CA--C 1.504 -0.815 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -172.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.698 ' HG2' ' HB3' ' A' ' 11' ' ' LEU . 5.4 Cg_exo -78.41 103.66 1.71 Allowed 'Trans proline' 0 N--CA 1.436 -1.888 0 N-CA-C 105.617 -2.494 . . . . 0.0 105.617 153.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -104.27 -161.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 123.563 2.842 . . . . 0.0 111.799 -163.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.471 ' CD2' ' HA ' ' A' ' 37' ' ' ALA . 38.2 t80 -48.9 114.83 1.07 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.409 0.623 . . . . 0.0 112.585 -169.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.69 -18.86 14.66 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.664 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -53.3 96.43 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 124.505 0.768 . . . . 0.0 110.975 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.759 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -72.68 88.8 1.3 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.444 -1.707 . . . . 0.0 111.653 175.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.495 ' HB ' HD22 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -74.49 88.99 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.774 169.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.738 ' HB ' ' O ' ' A' ' 31' ' ' ARG . 7.2 p -148.27 143.89 27.26 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.71 ' OG ' ' HB2' ' A' ' 31' ' ' ARG . 96.3 p -71.39 178.3 3.5 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 116.953 -1.899 . . . . 0.0 109.913 -175.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 28' ' ' GLU . 2.1 mp0 -56.55 -28.69 60.7 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.849 0.357 . . . . 0.0 111.603 -171.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.536 ' H ' ' HD2' ' A' ' 29' ' ' LYS . 1.9 mptp? -85.37 -15.48 43.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.197 0.522 . . . . 0.0 110.807 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.53 10.43 35.78 Favored Glycine 0 CA--C 1.485 -1.818 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.738 ' O ' ' HB ' ' A' ' 26' ' ' THR . 93.2 mtt180 -63.95 -178.3 0.31 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.671 -1.265 . . . . 0.0 109.339 169.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 0.6 OUTLIER 87.27 -158.67 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 164.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.945 HD13 HD21 ' A' ' 53' ' ' LEU . 6.8 mp -83.84 -48.67 9.81 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -144.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.725 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . 154.53 -141.4 8.17 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.988 -175.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.725 ' HG3' ' C ' ' A' ' 34' ' ' GLY . 6.9 mtt -148.6 142.66 25.93 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 117.517 0.658 . . . . 0.0 111.529 -173.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.615 HG23 HD12 ' A' ' 11' ' ' LEU . 55.5 t -66.18 130.61 31.65 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.519 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . . . -121.17 58.5 0.97 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.635 0.731 . . . . 0.0 109.332 172.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 39' ' ' GLU . 25.6 t70 178.68 -167.7 0.07 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.182 -174.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.487 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 10.1 pt-20 -85.51 1.81 47.34 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 122.091 -0.381 . . . . 0.0 111.539 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.481 ' HA3' ' HG2' ' A' ' 18' ' ' GLN . . . 174.72 25.1 0.03 OUTLIER Glycine 0 C--N 1.332 0.31 0 C-N-CA 119.143 -1.503 . . . . 0.0 112.995 175.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 9' ' ' ALA . 35.0 tp -133.19 121.69 22.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.57 0.224 . . . . 0.0 111.017 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.858 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -111.13 128.93 56.05 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.167 176.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -85.12 100.16 11.54 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.906 ' HB2' HD23 ' A' ' 7' ' ' LEU . 35.7 mt -111.15 178.55 4.31 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 118.467 -1.293 . . . . 0.0 111.657 -163.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 21.1 p -132.22 88.56 2.56 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.4 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.757 ' CA ' HD11 ' A' ' 7' ' ' LEU . . . 86.78 142.56 7.21 Favored Glycine 0 N--CA 1.464 0.56 0 C-N-CA 119.102 -1.523 . . . . 0.0 113.619 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG12 HD21 ' A' ' 33' ' ' LEU . 16.2 m -122.3 152.61 26.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 120.575 0.226 . . . . 0.0 110.71 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -111.77 109.98 55.04 Favored Pre-proline 0 C--N 1.324 -0.526 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.741 170.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.6 133.93 27.06 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 123.902 3.068 . . . . 0.0 113.069 -173.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.86 34.9 17.27 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 119.507 -1.33 . . . . 0.0 112.474 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.54 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 3.6 mm-40 -127.32 -173.13 2.82 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 121.852 0.834 . . . . 0.0 112.476 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 22.7 m -130.94 108.58 9.92 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.986 170.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.945 HD21 HD13 ' A' ' 33' ' ' LEU . 5.0 mt -69.36 158.8 34.37 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.793 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.654 ' HB3' HD11 ' A' ' 61' ' ' ILE . 73.5 m -102.25 154.6 18.88 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 159.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.759 ' HA ' ' O ' ' A' ' 24' ' ' SER . 21.5 t -137.92 92.77 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.925 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.652 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.666 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -82.22 109.61 16.65 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.573 -177.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.821 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 1.2 t90 -119.47 153.34 35.44 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.79 -1.55 . . . . 0.0 110.172 -168.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.821 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 15.6 t70 -15.62 -68.23 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.905 1.282 . . . . 0.0 113.176 169.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.414 ' H ' ' NE2' ' A' ' 62' ' ' GLN . . . -60.74 -41.49 99.07 Favored Glycine 0 C--N 1.346 1.097 0 C-N-CA 117.966 -2.064 . . . . 0.0 113.68 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 1.036 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 0.1 OUTLIER 172.91 -168.79 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.863 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -170.105 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.666 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -87.99 91.57 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 C-N-CA 117.678 -1.609 . . . . 0.0 107.224 173.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 1.036 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 3.7 mt-30 -99.39 -41.44 7.41 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.319 -159.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.585 ' SG ' ' HG3' ' A' ' 19' ' ' PRO . 9.1 m -94.95 152.45 18.33 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.239 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -133.48 134.8 43.96 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 161.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.679 ' HB ' HD12 ' A' ' 53' ' ' LEU . 78.2 t -100.0 143.56 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 C-N-CA 114.28 -2.968 . . . . 0.0 112.391 -168.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.416 HD22 ' HA ' ' A' ' 66' ' ' ASN . 0.5 OUTLIER -94.35 110.01 21.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 117.651 -1.619 . . . . 0.0 110.665 171.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.54 ' HB ' ' H ' ' A' ' 51' ' ' GLU . 4.6 t -86.54 117.22 68.33 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.604 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 71' ' ' ALA . 6.0 Cg_exo -79.36 163.27 24.85 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.942 2.428 . . . . 0.0 111.839 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -80.16 -6.2 57.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.177 0.513 . . . . 0.0 110.398 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 p -92.16 -4.3 54.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.984 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . . . -74.21 157.24 36.25 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.221 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.4 tp -144.42 149.43 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.569 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.569 ' HA ' HD12 ' A' ' 7' ' ' LEU . 33.4 m -86.53 170.05 12.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.177 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.1 t0 70.91 147.72 0.08 Allowed 'General case' 0 C--N 1.348 0.52 0 O-C-N 123.671 0.607 . . . . 0.0 109.557 -176.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.401 ' HB3' ' H ' ' A' ' 76' ' ' GLN . 25.5 mp0 62.73 -166.96 0.22 Allowed 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.55 0.691 . . . . 0.0 111.824 -174.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 4.4 pt20 -90.88 143.56 26.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.692 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 39.6 tp -141.58 117.36 10.42 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -175.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.619 ' HG ' ' HB ' ' A' ' 10' ' ' ILE . 6.0 mp -84.79 128.72 34.75 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 118.864 -1.134 . . . . 0.0 109.8 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.606 ' HB3' HG11 ' A' ' 65' ' ' VAL . 83.2 mt -112.84 132.19 22.41 Favored Pre-proline 0 C--O 1.246 0.906 0 CA-C-O 121.212 0.53 . . . . 0.0 111.915 -176.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.446 ' O ' HG13 ' A' ' 65' ' ' VAL . 73.5 Cg_endo -83.57 113.3 1.96 Allowed 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 123.396 2.731 . . . . 0.0 112.675 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.698 ' SG ' HD13 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -80.5 120.47 24.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.681 175.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 64.3 p -95.17 130.73 31.68 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 170.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.51 114.02 3.69 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.564 2.176 . . . . 0.0 111.264 178.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.45 ' H ' ' HG3' ' A' ' 84' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.425 0 CA-C-O 120.988 0.423 . . . . 0.0 111.445 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.875 ' HG3' ' H ' ' A' ' 45' ' ' SER . 0.6 OUTLIER . . . . . 0 C--O 1.259 1.553 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.977 ' HG ' ' HB3' ' A' ' 45' ' ' SER . 13.6 mt -114.43 167.56 10.62 Favored 'General case' 0 CA--C 1.483 -1.633 0 C-N-CA 116.668 -2.013 . . . . 0.0 114.676 -167.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 1.086 ' HB3' ' HA ' ' A' ' 76' ' ' GLN . 30.2 t80 -81.69 85.92 6.5 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 170.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.12 106.76 19.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.394 0.616 . . . . 0.0 111.886 -167.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.444 HD12 ' HG ' ' A' ' 78' ' ' LEU . 45.9 mt -98.12 96.88 5.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.246 170.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.789 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 71.6 mt -93.79 148.0 22.54 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.844 -174.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.481 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 ttt180 -160.59 142.49 12.52 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 118.566 -1.254 . . . . 0.0 112.348 172.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.638 HD23 ' C ' ' A' ' 18' ' ' GLN . 4.6 mm? -64.83 142.6 58.38 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.677 0.751 . . . . 0.0 109.209 174.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.71 -28.57 69.51 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.943 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.1 -16.35 61.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.298 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.71 -13.9 20.14 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.395 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.488 ' C ' ' HB2' ' A' ' 13' ' ' LEU . 13.2 t -75.74 -168.54 0.88 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.638 ' C ' HD23 ' A' ' 13' ' ' LEU . 1.4 mm-40 -142.45 148.1 45.82 Favored Pre-proline 0 CA--C 1.5 -0.955 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -173.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.789 ' HG2' ' HB3' ' A' ' 11' ' ' LEU . 1.2 Cg_endo -83.18 100.99 0.95 Allowed 'Trans proline' 0 N--CA 1.433 -2.074 0 N-CA-C 106.551 -2.134 . . . . 0.0 106.551 156.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.603 ' HD2' ' CD2' ' A' ' 57' ' ' TRP . 0.2 OUTLIER -106.75 -172.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.332 0 C-N-CA 124.017 3.145 . . . . 0.0 111.573 -167.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.527 ' HD1' ' H ' ' A' ' 38' ' ' ASP . 69.3 t80 -30.23 107.12 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -167.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.34 10.29 27.77 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.588 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.839 ' HB3' HG13 ' A' ' 36' ' ' VAL . . . -61.84 89.62 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 124.142 0.554 . . . . 0.0 111.615 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.864 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 48.2 p -62.04 131.68 50.38 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.124 0.89 . . . . 0.0 109.093 175.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.957 HG22 ' HA3' ' A' ' 34' ' ' GLY . 19.1 m -113.18 114.27 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 117.718 -1.593 . . . . 0.0 110.299 165.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 1.2 t -140.54 118.55 11.88 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.113 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.569 ' OG ' ' HB2' ' A' ' 31' ' ' ARG . 20.5 p -76.61 -171.69 1.95 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.801 -170.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -34.89 -62.63 0.36 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.087 0.955 . . . . 0.0 113.527 -171.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -75.39 -24.52 57.23 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.932 0.396 . . . . 0.0 111.479 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.641 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 119.88 42.81 0.51 Allowed Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 -172.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.821 ' O ' ' HA ' ' A' ' 26' ' ' THR . 8.8 tpp180 -69.99 99.04 1.37 Allowed 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -91.01 107.85 19.48 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.055 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.874 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -126.28 -16.64 5.4 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.671 -174.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 1.102 ' HA2' ' HB3' ' A' ' 44' ' ' LEU . . . -137.62 152.9 21.83 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 119.062 -1.542 . . . . 0.0 116.646 -169.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.788 ' N ' HD12 ' A' ' 44' ' ' LEU . 13.8 mtt -163.62 99.82 0.9 Allowed 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 125.446 1.499 . . . . 0.0 107.189 172.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.871 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 5.6 m -67.84 140.44 19.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 C-N-CA 118.616 -1.234 . . . . 0.0 110.811 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.88 113.67 19.44 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.441 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.527 ' H ' ' HD1' ' A' ' 21' ' ' PHE . 38.9 t70 72.81 125.38 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 O-C-N 124.371 1.044 . . . . 0.0 110.717 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 65.8 -85.14 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.684 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.543 ' HA3' ' OE1' ' A' ' 18' ' ' GLN . . . -174.0 37.67 0.12 Allowed Glycine 0 C--O 1.239 0.451 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.447 HD12 ' CH2' ' A' ' 43' ' ' TRP . 1.4 mm? -120.66 112.14 18.5 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.241 -0.479 . . . . 0.0 111.929 -172.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.871 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . . . -116.53 125.93 52.6 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 171.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.714 ' CE3' ' HA ' ' A' ' 8' ' ' PHE . 8.9 m95 -86.68 81.51 8.2 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 112.603 -3.639 . . . . 0.0 105.494 167.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.102 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -149.7 131.1 14.71 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 -165.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.977 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . 8.6 t 171.2 -145.86 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.425 177.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.32 -0.47 8.14 Favored Glycine 0 C--N 1.3 -1.471 0 C-N-CA 117.704 -2.189 . . . . 0.0 110.338 -160.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.712 HG21 HG11 ' A' ' 67' ' ' VAL . 7.9 p -72.26 153.09 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.824 -0.688 . . . . 0.0 111.126 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.725 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 6.5 m -98.83 131.47 25.55 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 1.013 ' HB3' ' HA ' ' A' ' 69' ' ' GLU . 83.3 Cg_exo -41.24 127.98 3.05 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.737 2.958 . . . . 0.0 113.899 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.15 36.27 5.0 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.148 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.964 ' H ' HG22 ' A' ' 67' ' ' VAL . 30.3 mt-10 -122.37 -170.15 2.02 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 118.939 -1.104 . . . . 0.0 113.031 -175.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.4 m -132.83 112.86 12.28 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.89 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.834 HD21 HD11 ' A' ' 33' ' ' LEU . 18.6 mt -78.21 159.23 28.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.053 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.637 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 6.4 m -120.04 119.93 34.82 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 168.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.864 ' HA ' ' O ' ' A' ' 24' ' ' SER . 38.2 t -112.64 124.34 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 121.513 0.673 . . . . 0.0 111.916 -169.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.846 ' HB3' ' OG ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -120.02 146.45 45.86 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.067 -170.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.662 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 9.7 p90 -157.92 -139.26 0.07 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 119.499 -0.88 . . . . 0.0 112.754 168.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.662 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 1.5 m-20 -41.49 -60.0 1.43 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.348 0.659 . . . . 0.0 111.558 168.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.638 ' HA3' ' NE2' ' A' ' 62' ' ' GLN . . . -77.33 -3.2 81.82 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 118.882 -1.628 . . . . 0.0 110.581 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 10.7 mttp 76.45 -149.91 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 114.356 -0.922 . . . . 0.0 111.95 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.606 HG13 ' HB2' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -71.78 101.42 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -176.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.638 ' NE2' ' HA3' ' A' ' 59' ' ' GLY . 0.2 OUTLIER -129.65 -46.03 1.18 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.632 -175.055 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.52 ' HB3' HD11 ' A' ' 13' ' ' LEU . 16.3 p -99.66 148.07 24.74 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.651 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 27.7 mt-30 -133.24 141.67 48.15 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.64 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 1.5 t -96.15 146.41 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 C-N-CA 116.276 -2.17 . . . . 0.0 112.564 -164.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -98.3 116.17 29.96 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.1 171.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.964 HG22 ' H ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -93.54 123.14 61.06 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.316 -178.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 97.7 Cg_endo -92.46 170.83 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.707 2.938 . . . . 0.0 113.268 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 1.013 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 1.8 mp0 -73.35 -13.34 61.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.52 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.7 p -82.89 24.86 0.72 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.332 0.494 . . . . 0.0 112.332 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.4 159.17 18.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.454 HG22 ' HB2' ' A' ' 75' ' ' GLN . 7.0 tp -169.08 168.09 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.263 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.404 ' H ' HG13 ' A' ' 72' ' ' ILE . 4.1 p -52.82 135.35 35.98 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 62.51 4.6 1.39 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 175.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.454 ' HB2' HG22 ' A' ' 72' ' ' ILE . 11.4 tt0 -86.23 155.59 20.64 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 122.19 -0.319 . . . . 0.0 111.324 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 1.086 ' HA ' ' HB3' ' A' ' 8' ' ' PHE . 14.9 pt20 -82.77 130.2 35.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.051 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.682 HD23 HD13 ' A' ' 7' ' ' LEU . 3.0 mm? -137.88 118.45 13.92 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.444 ' HG ' HD12 ' A' ' 10' ' ' ILE . 6.3 mp -86.08 96.63 9.94 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 118.759 -1.176 . . . . 0.0 108.115 174.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.588 HD13 HG11 ' A' ' 65' ' ' VAL . 96.2 mt -90.9 132.13 35.43 Favored Pre-proline 0 C--O 1.249 1.048 0 CA-C-O 121.582 0.706 . . . . 0.0 112.703 -167.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.41 117.99 3.85 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 123.544 2.829 . . . . 0.0 111.784 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.466 ' SG ' HG23 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -99.74 99.13 9.91 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.59 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 93.3 m -90.22 123.03 66.83 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.576 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 62' ' ' GLN . 55.4 Cg_endo -70.25 123.62 10.11 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.361 2.041 . . . . 0.0 111.066 175.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 . . . . . 0 C--N 1.323 -0.562 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.493 -177.503 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 1.114 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.404 -2.73 1 N-CA-C 99.692 -4.188 . . . . 0.0 99.692 . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.926 HD13 ' HA3' ' A' ' 46' ' ' GLY . 0.4 OUTLIER -168.44 169.28 10.62 Favored 'General case' 0 N--CA 1.408 -2.537 0 C-N-CA 114.803 -2.759 . . . . 0.0 114.295 -159.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.665 ' HB2' ' HA ' ' A' ' 76' ' ' GLN . 77.4 m-85 -98.32 89.58 4.51 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.84 174.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.26 103.92 15.89 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.543 -174.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 54.1 mt -89.22 102.25 12.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.475 175.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.83 ' H ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -106.08 126.25 51.98 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.138 0.971 . . . . 0.0 110.559 -173.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -127.31 156.06 42.56 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.91 -1.496 . . . . 0.0 108.479 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.57 HD23 ' C ' ' A' ' 18' ' ' GLN . 1.1 pp -105.97 137.52 43.73 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 117.96 -1.496 . . . . 0.0 109.531 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.27 -9.96 0.78 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -166.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' HB3' HD12 ' A' ' 13' ' ' LEU . 6.5 t70 -66.74 -22.23 66.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.505 0.669 . . . . 0.0 110.216 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.3 -6.85 32.25 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t -96.91 -175.2 3.2 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.61 -0.795 . . . . 0.0 109.729 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.57 ' C ' HD23 ' A' ' 13' ' ' LEU . 1.6 tt0 -120.31 138.29 27.06 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.631 -171.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.545 ' N ' HD23 ' A' ' 13' ' ' LEU . 2.8 Cg_endo -80.73 103.96 1.54 Allowed 'Trans proline' 0 N--CA 1.428 -2.329 0 N-CA-C 105.646 -2.482 . . . . 0.0 105.646 156.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 1.1 Cg_endo -103.49 175.98 0.16 Allowed 'Trans proline' 0 N--CA 1.431 -2.199 0 C-N-CA 123.111 2.541 . . . . 0.0 112.545 -161.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.627 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 24.8 t80 -23.94 104.48 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -168.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.72 0.23 24.51 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.083 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.851 ' HB3' HG12 ' A' ' 36' ' ' VAL . . . -60.69 99.63 0.09 Allowed 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.424 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.94 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 68.4 p -66.82 99.32 0.61 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.418 173.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.888 HG22 ' HA3' ' A' ' 34' ' ' GLY . 5.1 m -82.37 101.41 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 C-N-CA 115.762 -2.375 . . . . 0.0 107.982 166.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 1.1 t -138.51 120.0 14.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.926 -171.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.1 t -83.15 160.64 21.8 Favored 'General case' 0 C--O 1.211 -0.941 0 C-N-CA 119.317 -0.953 . . . . 0.0 108.988 -171.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -15.6 -70.86 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -164.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -65.47 -20.81 66.51 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.3 0.571 . . . . 0.0 112.069 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.533 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 119.67 40.36 0.62 Allowed Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.692 ' HD2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -77.24 93.41 3.97 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -90.57 95.89 10.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.204 0.526 . . . . 0.0 110.478 -172.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.791 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -106.06 3.71 28.46 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.332 -176.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.888 ' HA3' HG22 ' A' ' 25' ' ' VAL . . . -157.13 149.67 20.46 Favored Glycine 0 C--O 1.221 -0.672 0 O-C-N 124.585 1.178 . . . . 0.0 112.884 172.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.749 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 42.8 mtp -150.82 107.91 3.58 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 165.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.851 HG12 ' HB3' ' A' ' 23' ' ' ALA . 1.9 p -60.67 123.89 14.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.567 -170.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.434 ' HA ' ' HD1' ' A' ' 21' ' ' PHE . . . -107.5 129.79 54.92 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 170.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 39' ' ' GLU . 3.4 t0 73.59 -150.44 0.05 Allowed 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.902 0.751 . . . . 0.0 109.418 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.502 ' HG3' ' OD1' ' A' ' 38' ' ' ASP . 32.6 mt-10 -84.24 81.95 8.59 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -171.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.3 -17.66 46.46 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 114.804 0.681 . . . . 0.0 114.804 165.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.801 ' H ' HD22 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -85.78 113.09 21.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 118.045 0.922 . . . . 0.0 113.101 175.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -95.64 103.47 15.34 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.673 ' HA ' ' CE3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -82.83 89.58 6.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.865 ' CB ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -140.29 -165.23 1.87 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -163.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 1.114 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.7 p -122.51 113.7 19.67 Favored 'General case' 0 N--CA 1.424 -1.731 0 C-N-CA 117.462 -1.695 . . . . 0.0 109.243 -167.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.926 ' HA3' HD13 ' A' ' 7' ' ' LEU . . . -59.4 173.21 4.33 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 118.829 2.292 . . . . 0.0 118.829 -161.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.448 ' HB ' HD23 ' A' ' 33' ' ' LEU . 8.0 p -121.1 172.78 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 112.984 -1.608 . . . . 0.0 110.577 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.445 ' H ' HG22 ' A' ' 47' ' ' VAL . 6.4 m -71.29 148.12 93.48 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.257 0.623 . . . . 0.0 110.209 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.624 ' HA ' HG12 ' A' ' 67' ' ' VAL . 4.5 Cg_exo -77.82 161.82 30.05 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.479 2.119 . . . . 0.0 112.189 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.27 35.24 27.24 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 119.454 -1.355 . . . . 0.0 112.216 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.592 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 22.3 mt-10 -132.0 -168.29 2.01 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.818 -175.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.2 m -139.84 99.05 3.6 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.72 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.779 HD13 ' HB ' ' A' ' 25' ' ' VAL . 30.9 mt -57.91 155.44 10.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.015 168.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.593 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 48.8 m -121.75 119.88 33.02 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 170.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.94 ' HA ' ' O ' ' A' ' 24' ' ' SER . 48.8 t -109.55 110.81 33.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-O 122.023 0.916 . . . . 0.0 112.435 -166.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.948 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -97.26 149.32 22.18 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.412 -174.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.702 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 0.1 OUTLIER -158.71 155.09 27.42 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.918 -167.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.702 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 0.1 OUTLIER -19.78 -57.37 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.721 1.208 . . . . 0.0 114.16 174.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.34 -44.4 95.47 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 117.249 -2.405 . . . . 0.0 113.479 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.56 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 1.2 pttt 174.25 -176.25 0.08 Allowed 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -167.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.948 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 4.2 tt -87.9 97.06 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 169.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -103.92 -50.02 3.49 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 118.938 -1.105 . . . . 0.0 112.795 -158.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.401 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 29.0 p -104.87 158.08 16.77 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.593 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 51.0 mt-30 -133.09 138.89 46.87 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.669 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 2.7 t -91.44 130.55 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 C-N-CA 115.013 -2.675 . . . . 0.0 112.117 -169.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.439 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -93.29 116.12 28.69 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 118.494 -1.282 . . . . 0.0 110.06 177.134 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.624 HG12 ' HA ' ' A' ' 49' ' ' PRO . 13.8 t -93.55 116.16 66.07 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.585 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -92.03 169.23 2.93 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.051 2.501 . . . . 0.0 111.818 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -90.25 15.05 11.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.192 0.52 . . . . 0.0 110.776 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.5 m -106.78 2.6 25.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.589 0.709 . . . . 0.0 110.1 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.38 174.85 7.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.75 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.678 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 11.1 tp -136.66 170.33 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.111 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.458 ' H ' HG13 ' A' ' 72' ' ' ILE . 15.1 m -146.04 -178.58 6.2 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 23.7 t70 71.33 -41.95 0.52 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.106 0.562 . . . . 0.0 110.645 -173.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 73' ' ' SER . 69.1 mt-30 -89.73 -163.56 1.02 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.864 173.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.665 ' HA ' ' HB2' ' A' ' 8' ' ' PHE . 25.6 tt0 -86.55 133.62 33.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.536 174.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.678 ' HG ' ' H ' ' A' ' 72' ' ' ILE . 3.1 tm? -150.87 133.04 15.34 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.772 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.4 pt? -94.41 134.74 36.6 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.557 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 93.5 mt -106.43 137.24 19.37 Favored Pre-proline 0 C--O 1.24 0.557 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.281 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 59.8 Cg_endo -90.28 114.51 0.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.189 2.593 . . . . 0.0 113.027 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.87 107.31 18.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.106 177.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.9 m -78.39 130.5 71.43 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.705 175.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.93 129.55 21.02 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.402 2.068 . . . . 0.0 110.998 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 . . . . . 0 C--N 1.328 -0.343 0 O-C-N 123.429 0.455 . . . . 0.0 110.938 -178.6 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.926 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 2.1 tmm_? . . . . . 0 N--CA 1.42 -1.951 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.859 HD11 ' H ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -140.56 175.41 9.63 Favored 'General case' 0 N--CA 1.403 -2.816 0 CA-C-N 112.312 -2.222 . . . . 0.0 111.007 -158.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.673 ' HD2' ' HB3' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -110.91 87.43 2.53 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 173.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 41' ' ' LEU . . . -90.59 115.16 27.49 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.5 -167.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 57.0 mt -95.38 98.4 7.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.949 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 3.4 mm? -90.13 134.29 34.36 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 119.559 -0.857 . . . . 0.0 109.411 -174.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -144.05 126.54 15.9 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.055 175.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.785 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . 0.9 OUTLIER -90.48 113.54 25.52 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 117.347 -1.741 . . . . 0.0 109.602 174.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.48 -7.98 1.65 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 113.73 -1.577 . . . . 0.0 113.734 -169.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -63.32 -13.73 42.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.219 0.533 . . . . 0.0 110.668 174.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.51 27.75 2.98 Favored Glycine 0 CA--C 1.502 -0.724 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.694 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.7 m -142.03 170.68 15.26 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 114.906 -0.647 . . . . 0.0 110.219 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.82 142.47 31.85 Favored Pre-proline 0 CA--C 1.495 -1.14 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.657 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.949 ' HG2' ' HB3' ' A' ' 11' ' ' LEU . 5.6 Cg_exo -75.29 105.38 2.07 Favored 'Trans proline' 0 N--CA 1.424 -2.562 0 N-CA-C 105.027 -2.72 . . . . 0.0 105.027 156.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -105.96 -165.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.155 0 C-N-CA 123.078 2.519 . . . . 0.0 112.198 -164.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.74 100.16 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -170.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.84 22.8 7.79 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.873 ' HB3' HG13 ' A' ' 36' ' ' VAL . . . -64.94 89.62 0.08 Allowed 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.694 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.736 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -70.45 87.91 0.65 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.578 -1.646 . . . . 0.0 111.622 178.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.867 HG22 ' CA ' ' A' ' 34' ' ' GLY . 3.2 m -82.28 112.36 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.173 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -140.53 121.22 14.32 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.795 -178.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.713 ' OG ' HD23 ' A' ' 53' ' ' LEU . 64.0 m -84.85 -171.98 3.93 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.723 -168.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -23.93 -67.85 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -169.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -88.71 -6.97 57.09 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -171.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.554 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 114.39 35.87 1.39 Allowed Glycine 0 CA--C 1.487 -1.672 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -177.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.686 ' O ' HD22 ' A' ' 33' ' ' LEU . 68.3 mtp180 -76.01 100.06 4.78 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -91.9 96.05 10.17 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.06 -169.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.887 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -109.01 4.42 23.19 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.712 -170.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.867 ' CA ' HG22 ' A' ' 25' ' ' VAL . . . -166.72 154.76 25.45 Favored Glycine 0 N--CA 1.467 0.764 0 C-N-CA 119.079 -1.534 . . . . 0.0 114.406 176.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.674 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 31.8 mtt -149.88 99.67 2.87 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 164.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.873 HG13 ' HB3' ' A' ' 23' ' ' ALA . 2.2 m -72.09 106.59 2.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 118.899 -1.121 . . . . 0.0 111.176 -169.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.43 120.84 37.47 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 118.659 -1.216 . . . . 0.0 110.328 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 t70 70.6 119.69 0.04 OUTLIER 'General case' 0 C--O 1.237 0.398 0 O-C-N 124.348 1.03 . . . . 0.0 110.968 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 20' ' ' PRO . 7.1 mm-40 66.63 -98.93 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.309 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.83 47.65 0.33 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.084 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 9' ' ' ALA . 3.9 tt -133.96 125.07 27.43 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.533 ' HB1' ' H ' ' A' ' 35' ' ' MET . . . -113.08 129.23 56.57 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.75 0.31 . . . . 0.0 110.659 177.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -90.48 83.46 5.88 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.887 ' HB3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -145.46 -170.37 3.43 Favored 'General case' 0 C--O 1.195 -1.764 0 CA-C-O 118.973 -0.537 . . . . 0.0 110.002 -157.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.926 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 37.3 p -116.76 85.81 2.39 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -163.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.859 ' H ' HD11 ' A' ' 7' ' ' LEU . . . -62.12 -177.82 3.12 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 116.395 1.318 . . . . 0.0 116.395 -162.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.6 HG13 ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -103.78 177.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.153 -0.523 . . . . 0.0 111.79 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 7.0 m -82.47 139.52 44.58 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.029 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.727 ' HA ' HG12 ' A' ' 67' ' ' VAL . 59.0 Cg_exo -52.73 120.91 8.28 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.808 2.338 . . . . 0.0 112.833 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.68 36.3 0.92 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.023 -1.084 . . . . 0.0 112.677 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.719 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 24.3 mt-10 -138.43 -160.94 1.11 Allowed 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 119.244 -0.982 . . . . 0.0 112.175 -174.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 58.3 m -142.73 129.78 20.76 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.4 172.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.758 ' HB2' HG13 ' A' ' 65' ' ' VAL . 45.3 mt -88.13 151.47 22.69 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 173.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.06 106.93 14.31 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 171.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.736 ' HA ' ' O ' ' A' ' 24' ' ' SER . 20.0 t -112.32 109.69 29.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.892 -159.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.658 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 41.5 m-80 -77.68 146.16 36.19 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.549 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.756 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -150.41 149.82 30.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.415 -174.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.756 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 5.2 m-20 -25.18 -55.62 0.05 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 173.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.88 -40.62 98.55 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 117.071 -2.49 . . . . 0.0 113.778 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.763 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER 169.12 -168.96 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -169.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.4 tt -86.12 115.16 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 169.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.763 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 1.1 mt-30 -130.73 -48.78 1.05 Allowed 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 117.663 -1.615 . . . . 0.0 111.207 -165.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.616 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . 38.1 t -72.95 129.29 37.78 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.343 -1.298 . . . . 0.0 107.772 174.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -136.11 114.66 11.84 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 167.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.758 HG13 ' HB2' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -93.75 147.09 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.167 0 C-N-CA 115.04 -2.664 . . . . 0.0 112.346 -160.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 77.1 m-20 -100.5 108.92 21.0 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.568 174.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 49' ' ' PRO . 22.1 t -79.99 112.49 30.44 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.074 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 66' ' ' ASN . 94.4 Cg_endo -89.01 171.45 4.7 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.445 2.763 . . . . 0.0 112.141 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' A' ' 69' ' ' GLU . 2.4 mp0 -67.34 -15.37 63.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.72 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.4 m -79.83 -3.89 49.79 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.039 0.447 . . . . 0.0 111.115 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.62 156.87 36.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.4 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 73' ' ' SER . 0.4 OUTLIER -158.93 160.16 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.647 ' CB ' HD12 ' A' ' 7' ' ' LEU . 22.0 p -120.28 174.27 6.61 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.578 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.8 t70 68.78 8.16 6.59 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.371 0.605 . . . . 0.0 110.802 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -138.06 172.5 12.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.797 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.673 ' HB3' ' HD2' ' A' ' 8' ' ' PHE . 11.0 pt20 -94.13 124.74 38.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 172.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.6 tp -150.27 149.04 29.6 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.82 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.0 pt? -98.48 132.27 44.06 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.492 -1.283 . . . . 0.0 109.915 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.591 ' HB2' HD13 ' A' ' 11' ' ' LEU . 3.1 mm? -110.66 143.73 28.8 Favored Pre-proline 0 C--O 1.248 0.994 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.33 -176.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 4.9 Cg_exo -79.8 100.36 1.28 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.727 2.951 . . . . 0.0 112.864 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 13' ' ' LEU . 5.1 t -82.62 146.2 29.26 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.212 173.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.4 m -126.12 136.34 28.39 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.45 152.67 31.85 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.019 1.813 . . . . 0.0 111.04 174.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 121.011 0.434 . . . . 0.0 111.717 -176.153 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.953 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.434 -1.249 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.794 HD13 ' CA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -157.99 172.09 19.07 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 115.797 1.776 . . . . 0.0 115.797 -157.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.589 ' HB2' ' HA ' ' A' ' 76' ' ' GLN . 92.4 m-85 -114.65 90.18 3.28 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 112.739 -2.028 . . . . 0.0 107.542 174.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.48 98.55 11.83 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.503 -0.479 . . . . 0.0 112.0 -171.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 40.5 mt -87.73 103.0 13.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.975 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -117.85 150.33 39.35 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.651 -175.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.506 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 13.8 mmm180 -140.3 155.42 46.84 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.79 HD22 ' SG ' ' A' ' 63' ' ' CYS . 1.8 mt -78.69 151.0 32.43 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 116.87 -1.932 . . . . 0.0 107.092 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.34 -40.34 67.95 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.684 -172.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 -74.68 -10.46 59.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.811 0.339 . . . . 0.0 111.686 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.22 24.72 4.07 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.557 -1.306 . . . . 0.0 111.754 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.66 ' HB2' ' CG ' ' A' ' 13' ' ' LEU . 16.2 m -106.33 -155.32 0.54 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.638 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -140.35 137.82 18.25 Favored Pre-proline 0 CA--C 1.51 -0.564 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -170.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.975 ' HG2' ' HB2' ' A' ' 11' ' ' LEU . 3.6 Cg_exo -78.59 102.14 1.52 Allowed 'Trans proline' 0 N--CA 1.438 -1.792 0 N-CA-C 104.773 -2.818 . . . . 0.0 104.773 149.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.522 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . 9.8 Cg_endo -107.78 160.88 0.1 Allowed 'Trans proline' 0 N--CA 1.431 -2.201 0 C-N-CA 123.455 2.77 . . . . 0.0 112.683 -164.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.411 ' CD1' ' HA ' ' A' ' 37' ' ' ALA . 66.5 t80 -18.64 103.7 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -168.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.63 4.36 46.12 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.836 ' HA ' ' O ' ' A' ' 56' ' ' ASN . . . -61.78 100.03 0.14 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.851 169.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.783 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -72.57 100.07 2.67 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 112.395 -2.184 . . . . 0.0 111.453 173.243 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.741 HG22 ' CA ' ' A' ' 34' ' ' GLY . 19.9 m -89.61 113.78 26.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 C-N-CA 117.645 -1.622 . . . . 0.0 109.668 174.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 1.035 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . 3.2 p -148.79 133.83 18.17 Favored 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.081 170.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.604 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -78.52 162.7 26.14 Favored 'General case' 0 C--O 1.207 -1.139 0 C-N-CA 117.221 -1.792 . . . . 0.0 108.181 -172.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -18.61 -62.67 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -165.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -87.13 3.49 46.05 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -171.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.89 27.03 5.57 Favored Glycine 0 CA--C 1.488 -1.614 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.948 ' HG3' HG11 ' A' ' 47' ' ' VAL . 8.5 tpt180 -68.15 176.92 2.46 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 1.035 ' HB3' ' HA ' ' A' ' 26' ' ' THR . 23.2 tp10 82.06 -120.56 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 169.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.697 ' C ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER 98.21 93.01 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.186 0 O-C-N 124.512 1.133 . . . . 0.0 109.623 -159.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 1.049 ' HA2' ' HB2' ' A' ' 44' ' ' LEU . . . -159.94 102.19 0.21 Allowed Glycine 0 C--O 1.216 -1.014 0 CA-C-N 112.362 -2.199 . . . . 0.0 112.216 164.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.757 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 14.3 mtm -111.08 125.67 54.01 Favored 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 121.0 -1.294 . . . . 0.0 109.911 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.748 HG12 ' HB3' ' A' ' 23' ' ' ALA . 2.1 p -73.59 139.29 19.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.727 -174.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.411 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . . . -112.87 71.14 0.73 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 171.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.3 t70 72.65 151.91 0.12 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.239 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.516 ' HB2' HD21 ' A' ' 41' ' ' LEU . 13.5 mm-40 71.8 -27.65 0.18 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.841 0.857 . . . . 0.0 112.889 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.442 ' HA2' HG21 ' A' ' 36' ' ' VAL . . . 116.99 12.81 8.15 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.354 175.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -90.0 107.31 19.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.678 -0.409 . . . . 0.0 112.002 173.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.737 ' HB1' ' C ' ' A' ' 34' ' ' GLY . . . -95.8 92.45 6.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.499 0.666 . . . . 0.0 110.45 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.521 ' HA ' ' CE3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -83.33 110.85 18.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.424 -177.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.049 ' HB2' ' HA2' ' A' ' 34' ' ' GLY . 4.2 mt -167.47 -169.93 1.33 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -167.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.953 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 26.5 p -127.47 79.36 1.88 Allowed 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 -168.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.775 ' H ' ' CD1' ' A' ' 7' ' ' LEU . . . -87.04 -150.49 18.1 Favored Glycine 0 C--N 1.306 -1.111 0 CA-C-N 114.44 -1.255 . . . . 0.0 113.529 -161.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.948 HG11 ' HG3' ' A' ' 31' ' ' ARG . 15.5 m -121.2 174.57 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.503 0.668 . . . . 0.0 112.162 174.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 11.4 t -77.79 139.19 62.08 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.692 -175.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HB3' HG22 ' A' ' 67' ' ' VAL . 87.5 Cg_exo -49.06 153.2 4.25 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.941 3.094 . . . . 0.0 114.155 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.888 ' H ' HG13 ' A' ' 67' ' ' VAL . . . 119.44 26.74 2.33 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.332 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.715 ' H ' ' CG1' ' A' ' 67' ' ' VAL . 23.2 mt-10 -143.36 -168.45 2.82 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.763 0.792 . . . . 0.0 112.946 -173.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 16.7 p -126.69 122.36 34.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.912 167.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.689 ' HB2' HG12 ' A' ' 65' ' ' VAL . 19.2 mt -93.37 121.01 34.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.302 -173.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.626 ' HB3' HD11 ' A' ' 61' ' ' ILE . 13.3 m -77.62 109.37 11.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.607 0.718 . . . . 0.0 110.583 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.783 ' HA ' ' O ' ' A' ' 24' ' ' SER . 59.3 t -116.57 116.72 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.537 -167.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.836 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 37.6 m-80 -99.33 157.53 16.34 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.812 -176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 2.4 p90 -161.62 -144.5 0.1 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.887 159.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.673 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 1.0 OUTLIER -41.49 -55.0 2.98 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.746 0.703 . . . . 0.0 111.076 166.216 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.645 ' HA3' ' NE2' ' A' ' 62' ' ' GLN . . . -80.68 2.3 79.6 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 118.886 -1.626 . . . . 0.0 111.079 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.643 ' CA ' ' H ' ' A' ' 57' ' ' TRP . 11.2 mtpt 67.13 -151.59 0.19 Allowed 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 114.482 -0.859 . . . . 0.0 111.771 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.626 HD11 ' HB3' ' A' ' 54' ' ' SER . 0.1 OUTLIER -64.09 106.97 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-O 122.648 1.213 . . . . 0.0 108.656 -177.001 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.645 ' NE2' ' HA3' ' A' ' 59' ' ' GLY . 2.3 pt20 -146.62 -39.33 0.21 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.759 -1.564 . . . . 0.0 111.614 -174.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.79 ' SG ' HD22 ' A' ' 13' ' ' LEU . 1.6 t -96.75 135.04 39.26 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.528 174.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.637 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 49.7 mt-30 -126.36 137.75 53.49 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 169.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.689 HG12 ' HB2' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -97.41 129.95 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 C-N-CA 115.985 -2.286 . . . . 0.0 110.185 -170.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -89.56 98.46 11.78 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.216 -0.994 . . . . 0.0 109.332 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.888 HG13 ' H ' ' A' ' 50' ' ' GLY . 9.0 p -92.11 115.98 65.64 Favored Pre-proline 0 N--CA 1.44 -0.939 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.525 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.419 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 2.3 Cg_endo -82.53 152.68 15.47 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.352 2.701 . . . . 0.0 111.565 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -75.84 13.39 0.85 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.828 0.346 . . . . 0.0 111.875 -174.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 m -73.75 -42.45 61.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.986 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.11 -173.14 2.24 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.821 -173.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.415 ' O ' HD11 ' A' ' 77' ' ' LEU . 12.6 tt -140.93 155.68 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.35 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.782 ' OG ' HD12 ' A' ' 7' ' ' LEU . 33.3 t -84.85 -166.51 1.5 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.886 -175.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 73' ' ' SER . 38.8 t70 75.76 10.07 3.39 Favored 'General case' 0 C--N 1.359 1.012 0 CA-C-O 121.717 0.77 . . . . 0.0 110.195 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -153.24 -171.97 4.09 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.154 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.589 ' HA ' ' HB2' ' A' ' 8' ' ' PHE . 14.1 pt20 -86.11 140.39 30.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 72' ' ' ILE . 96.1 mt -138.47 157.0 47.03 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.692 HD13 ' H ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -111.03 132.96 53.79 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 117.757 -1.577 . . . . 0.0 109.528 173.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.446 HD12 HG23 ' A' ' 67' ' ' VAL . 2.7 mm? -122.9 140.98 34.41 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -169.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 57.8 Cg_endo -88.57 110.01 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.846 3.031 . . . . 0.0 112.467 176.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.603 ' HB3' ' HA ' ' A' ' 13' ' ' LEU . 1.8 t -93.43 122.45 35.86 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.345 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.492 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 8.6 t -130.35 133.5 24.98 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.737 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 82' ' ' THR . 5.0 Cg_endo -88.02 98.89 0.42 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.952 2.435 . . . . 0.0 110.823 171.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 84' ' ' GLN . 6.7 tp60 . . . . . 0 C--N 1.328 -0.362 0 CA-C-O 121.715 0.769 . . . . 0.0 109.622 -176.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.688 ' HA ' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.461 -2.476 0 N-CA-C 101.724 -3.435 . . . . 0.0 101.724 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.952 HD12 ' H ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -163.17 -179.32 6.56 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 111.762 -3.975 . . . . 0.0 115.987 -151.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.928 ' HE1' ' HB2' ' A' ' 41' ' ' LEU . 6.2 t80 -127.17 105.39 8.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.41 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 77' ' ' LEU . . . -100.74 131.61 46.55 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.877 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.503 HG22 ' HG2' ' A' ' 12' ' ' ARG . 4.1 mp -100.28 97.02 5.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.879 HD12 HG21 ' A' ' 65' ' ' VAL . 2.7 mm? -85.48 107.57 17.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.359 -173.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.894 ' HD3' ' HG2' ' A' ' 18' ' ' GLN . 18.1 mmt180 -126.47 139.75 53.0 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.063 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 17' ' ' SER . 2.3 mt -80.62 144.32 32.43 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 117.774 -1.57 . . . . 0.0 107.694 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 -15.39 59.24 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.673 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -75.17 -30.1 60.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.827 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.16 -11.14 20.06 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -174.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.661 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 8.7 p -87.35 165.26 15.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.939 -0.631 . . . . 0.0 110.834 175.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.894 ' HG2' ' HD3' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -159.01 -91.14 0.0 OUTLIER Pre-proline 0 C--O 1.22 -0.484 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.386 171.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.566 ' CD ' ' HB2' ' A' ' 18' ' ' GLN . 21.3 Cg_exo -23.64 100.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 124.321 3.347 . . . . 0.0 115.114 -133.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.736 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 91.4 Cg_endo -111.3 96.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.895 0 C-N-CA 124.678 3.586 . . . . 0.0 111.902 163.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.99 111.4 23.73 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 118.641 -1.224 . . . . 0.0 109.401 -171.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.24 12.86 28.19 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 -163.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.756 ' HA ' ' O ' ' A' ' 56' ' ' ASN . . . -60.14 93.74 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.887 -0.656 . . . . 0.0 110.107 174.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.681 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 0.6 OUTLIER -68.63 94.62 0.6 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.77 174.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.614 ' HB ' HD13 ' A' ' 53' ' ' LEU . 28.5 m -82.3 108.9 15.71 Favored 'Isoleucine or valine' 0 C--O 1.261 1.662 0 C-N-CA 119.031 -1.068 . . . . 0.0 108.691 173.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.709 ' HB ' ' OE1' ' A' ' 32' ' ' GLU . 5.0 t -134.11 129.7 36.31 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.867 -175.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.64 131.14 35.9 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 117.624 -1.63 . . . . 0.0 108.33 -173.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -14.72 -52.6 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -158.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -65.83 -17.27 64.52 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.31 0.959 . . . . 0.0 111.885 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.599 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 113.36 36.46 1.46 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.7 mtp85 -81.75 86.97 6.36 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 171.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.709 ' OE1' ' HB ' ' A' ' 26' ' ' THR . 4.9 mm-40 -72.35 104.8 3.85 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.03 -173.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.636 HD22 ' O ' ' A' ' 46' ' ' GLY . 24.7 mt -85.84 -35.05 20.87 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.067 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.676 ' HA3' HD22 ' A' ' 44' ' ' LEU . . . 175.9 -171.29 44.34 Favored Glycine 0 C--N 1.349 1.258 0 C-N-CA 119.258 -1.449 . . . . 0.0 114.209 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.709 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 24.8 mtt -149.0 135.99 19.87 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.854 0.327 . . . . 0.0 111.516 -173.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 23' ' ' ALA . 54.7 t -69.41 148.56 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.238 0.336 . . . . 0.0 111.055 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -138.84 57.28 1.68 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.106 172.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.746 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 9.0 p-10 167.09 -154.32 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.579 -176.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 62.6 mm-40 -49.74 -52.55 30.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.774 169.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.52 57.93 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 118.59 -1.767 . . . . 0.0 113.982 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.928 ' HB2' ' HE1' ' A' ' 8' ' ' PHE . 4.5 pp -132.09 131.71 42.63 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.608 0.718 . . . . 0.0 110.341 169.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.05 114.87 20.31 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.827 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.423 ' CZ3' ' HB2' ' A' ' 8' ' ' PHE . 50.7 m95 -72.97 88.81 1.39 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.717 HD12 HD21 ' A' ' 7' ' ' LEU . 5.9 mt -79.24 178.06 8.36 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 118.547 -1.261 . . . . 0.0 108.538 -174.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 65.7 p -147.13 88.83 1.75 Allowed 'General case' 0 N--CA 1.427 -1.575 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.387 172.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.952 ' H ' HD12 ' A' ' 7' ' ' LEU . . . 107.33 92.87 2.28 Favored Glycine 0 C--O 1.222 -0.615 0 C-N-CA 119.011 -1.566 . . . . 0.0 112.248 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.545 HG12 ' HG ' ' A' ' 7' ' ' LEU . 10.3 p -120.39 137.46 54.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.435 ' HB ' ' OE2' ' A' ' 51' ' ' GLU . 28.8 m -101.22 129.44 27.04 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.929 ' HB2' ' HA ' ' A' ' 69' ' ' GLU . 60.3 Cg_endo -72.99 135.38 23.08 Favored 'Trans proline' 0 C--N 1.331 -0.367 0 C-N-CA 122.907 2.405 . . . . 0.0 112.897 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.94 35.66 5.26 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 119.46 -1.352 . . . . 0.0 113.176 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.714 ' H ' ' CG1' ' A' ' 67' ' ' VAL . 31.6 mt-10 -121.89 177.69 5.19 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.879 -176.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 p -122.86 90.98 3.39 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.664 165.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.633 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 19.6 mt -51.43 152.82 2.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.484 171.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.52 ' HB2' HD11 ' A' ' 61' ' ' ILE . 21.4 p -120.61 125.14 47.01 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 165.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 24' ' ' SER . 20.3 t -112.68 107.93 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.497 0.665 . . . . 0.0 111.275 -167.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.756 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 45.8 m-80 -76.42 139.8 41.04 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.624 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.857 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 2.4 t90 -144.59 149.66 36.16 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.503 -166.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.857 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 4.3 m-20 -19.41 -64.74 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.758 1.223 . . . . 0.0 113.243 166.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.42 ' HA3' HE22 ' A' ' 62' ' ' GLN . . . -62.76 -36.46 93.36 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 117.719 -2.181 . . . . 0.0 113.864 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.746 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 13.1 pttp 167.77 -169.7 0.02 OUTLIER 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -172.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.715 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.3 tt -81.96 118.31 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 167.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.785 ' HG3' ' HB3' ' A' ' 57' ' ' TRP . 1.4 mt-30 -125.18 -63.06 1.18 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 115.555 -2.458 . . . . 0.0 112.511 -166.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 27.5 p -92.89 149.21 21.41 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 117.304 -1.758 . . . . 0.0 108.116 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 25.5 mt-30 -127.13 133.82 50.31 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.879 HG21 HD12 ' A' ' 11' ' ' LEU . 4.4 t -94.99 140.74 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 C-N-CA 115.522 -2.471 . . . . 0.0 113.015 -164.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -95.48 113.58 25.25 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 118.736 -1.185 . . . . 0.0 110.261 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.714 ' CG1' ' H ' ' A' ' 51' ' ' GLU . 8.8 p -101.8 124.22 41.19 Favored Pre-proline 0 C--O 1.219 -0.507 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.823 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 91.8 Cg_endo -88.67 171.8 4.93 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.853 3.035 . . . . 0.0 112.916 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.929 ' HA ' ' HB2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -68.78 -25.19 64.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.651 -177.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -76.81 28.7 0.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.127 0.489 . . . . 0.0 111.811 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.536 ' HA ' HD22 ' A' ' 77' ' ' LEU . . . -69.36 135.28 50.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.394 0.616 . . . . 0.0 110.908 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.434 HG22 ' HB2' ' A' ' 77' ' ' LEU . 10.7 tp -96.08 157.92 3.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.067 -173.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.3 m -107.52 129.92 54.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.442 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.675 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 58.4 m-20 56.08 30.09 15.68 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -146.02 -167.7 2.79 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.282 0.563 . . . . 0.0 112.208 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.569 ' HA ' ' HB3' ' A' ' 8' ' ' PHE . 26.9 tt0 -93.32 140.51 29.47 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.606 -175.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.536 HD22 ' HA ' ' A' ' 71' ' ' ALA . 55.0 tp -153.98 123.01 6.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.769 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -85.5 137.0 33.19 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 118.426 -1.309 . . . . 0.0 109.549 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.563 ' HB2' HD13 ' A' ' 11' ' ' LEU . 55.5 mt -122.81 134.83 25.23 Favored Pre-proline 0 C--O 1.245 0.818 0 CA-C-O 121.7 0.762 . . . . 0.0 111.85 -175.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 92.1 Cg_endo -87.68 121.86 1.6 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.192 2.595 . . . . 0.0 112.846 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 63' ' ' CYS . 1.1 m -81.52 97.82 7.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.054 173.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.44 ' HB ' ' CD ' ' A' ' 83' ' ' PRO . 17.2 p -83.92 171.31 11.6 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.029 176.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.44 ' CD ' ' HB ' ' A' ' 82' ' ' THR . 22.6 Cg_exo -65.69 -172.31 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.564 2.176 . . . . 0.0 112.848 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.479 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 27.2 mt-30 . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.564 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.811 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 7.7 ptp180 . . . . . 0 N--CA 1.448 -0.561 0 CA-C-O 117.299 -1.334 . . . . 0.0 108.645 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 74' ' ' ASP 0.317 10.6 mt 172.13 -165.36 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 156.294 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 0.7 OUTLIER -66.62 127.76 33.61 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.6 -166.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.693 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -127.19 144.14 51.1 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.587 -175.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.1 mt -90.21 106.67 17.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.555 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.69 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -102.41 154.65 18.88 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.644 ' HA ' ' HG3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -142.89 154.08 43.76 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.05 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.852 HD22 HE21 ' A' ' 18' ' ' GLN . 1.7 mm? -64.07 -175.8 0.17 Allowed 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.623 0.725 . . . . 0.0 109.748 172.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.2 -27.35 66.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.025 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.95 -20.66 61.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.557 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.38 33.64 7.94 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.732 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.727 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 74.8 p -154.75 148.76 25.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.189 -0.505 . . . . 0.0 110.698 -174.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.852 HE21 HD22 ' A' ' 13' ' ' LEU . 5.6 mt-30 -167.71 132.37 1.53 Allowed Pre-proline 0 CA--C 1.503 -0.843 0 C-N-CA 123.068 0.547 . . . . 0.0 109.782 170.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -113.95 91.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.161 0 CA-C-N 119.382 0.815 . . . . 0.0 111.306 140.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.764 ' HD3' ' CB ' ' A' ' 18' ' ' GLN . 22.0 Cg_endo -116.4 94.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.781 0 C-N-CA 123.291 2.66 . . . . 0.0 113.256 163.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.51 108.57 19.47 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.887 0.851 . . . . 0.0 109.566 -174.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.48 -0.66 12.57 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -169.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -56.75 95.21 0.02 OUTLIER 'General case' 0 C--N 1.345 0.411 0 CA-C-O 121.575 0.702 . . . . 0.0 109.891 174.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . 0.672 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -70.98 96.92 1.35 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.423 -1.717 . . . . 0.0 113.082 179.005 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.648 HG21 ' HG ' ' A' ' 44' ' ' LEU . 27.6 m -84.41 113.9 23.9 Favored 'Isoleucine or valine' 0 C--O 1.251 1.183 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.752 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -143.4 130.74 20.95 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.337 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.685 ' HA ' ' HA ' ' A' ' 53' ' ' LEU . 59.7 p -69.96 176.37 3.78 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.437 -173.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.561 ' HG2' HG23 ' A' ' 52' ' ' THR . 11.8 mm-40 -58.79 -20.34 49.09 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.018 0.437 . . . . 0.0 111.393 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -86.98 -17.29 33.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.0 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.428 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 98.99 18.72 23.91 Favored Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.658 ' HB2' ' OG ' ' A' ' 27' ' ' SER . 32.0 mtt180 -63.88 91.17 0.06 Allowed 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 168.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.522 ' HA ' ' HB ' ' A' ' 26' ' ' THR . 19.3 mt-10 -81.32 89.67 6.09 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.192 -177.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.521 HD23 ' HB3' ' A' ' 44' ' ' LEU . 11.1 mp -66.56 -48.79 68.54 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.696 -175.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.528 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . -177.22 -161.77 26.38 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 117.932 -2.08 . . . . 0.0 114.051 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 19.4 mtt -149.69 140.99 23.17 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -176.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 23' ' ' ALA . 43.8 t -70.03 129.05 34.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.324 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.88 92.89 3.89 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 171.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 74.73 136.22 0.06 Allowed 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.296 0.997 . . . . 0.0 111.316 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 58.24 -145.15 0.58 Allowed 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.425 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.43 61.3 0.32 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.425 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' A' ' 8' ' ' PHE . 3.8 tt -134.14 112.01 10.78 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.183 -177.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.45 ' HB3' HD11 ' A' ' 44' ' ' LEU . . . -106.87 161.29 14.83 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.392 173.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.517 ' CD2' ' HB3' ' A' ' 8' ' ' PHE . 22.6 m95 -95.71 87.98 4.85 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.486 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.693 HD13 ' HB3' ' A' ' 9' ' ' ALA . 6.6 mp -90.27 88.69 7.32 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 116.857 -1.937 . . . . 0.0 111.191 -167.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.811 ' HA ' ' HB2' ' A' ' 6' ' ' ARG . 6.3 p -86.09 86.91 7.35 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 122.012 0.91 . . . . 0.0 109.179 171.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.601 ' H ' ' HB2' ' A' ' 6' ' ' ARG . . . 150.85 26.59 0.05 OUTLIER Glycine 0 C--N 1.308 -0.976 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.176 176.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 6' ' ' ARG . 6.2 p -84.72 115.31 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.97 -176.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.0 m -115.8 124.81 29.37 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 172.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 67' ' ' VAL . 10.2 Cg_endo -53.5 133.94 55.58 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.147 2.565 . . . . 0.0 112.708 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.28 35.8 5.62 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.583 -1.294 . . . . 0.0 112.605 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.572 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 4.5 mm-40 -116.31 179.4 4.0 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 122.298 1.047 . . . . 0.0 111.943 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.561 HG23 ' HG2' ' A' ' 28' ' ' GLU . 14.3 t -134.12 143.2 47.82 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.352 -1.749 . . . . 0.0 108.548 165.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.685 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 4.5 tp -121.72 160.0 25.43 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.065 -166.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.669 ' HB3' HD11 ' A' ' 61' ' ' ILE . 36.8 m -129.55 129.94 45.11 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 123.787 0.679 . . . . 0.0 111.214 172.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.725 HG21 ' SG ' ' A' ' 81' ' ' CYS . 14.4 t -119.33 106.15 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.152 -167.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.65 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 8.5 m-20 -76.92 85.62 3.47 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.55 177.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.777 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -82.24 147.11 29.13 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.899 176.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.777 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 18.1 m-20 -12.08 -64.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 170.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.11 -42.65 99.73 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 117.895 -2.098 . . . . 0.0 114.42 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 1.051 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 9.0 ptpt -178.8 -166.29 0.1 Allowed 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -169.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.669 HD11 ' HB3' ' A' ' 54' ' ' SER . 12.7 tt -90.4 87.92 2.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 173.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 1.051 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 2.1 mt-30 -96.2 -51.93 4.21 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.896 -158.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 82' ' ' THR . 20.5 p -105.33 158.16 16.82 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 118.185 -1.406 . . . . 0.0 108.145 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.626 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 97.1 mt-30 -132.45 142.5 49.28 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -97.54 151.55 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 C-N-CA 114.825 -2.75 . . . . 0.0 112.196 -169.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.615 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 12.7 m120 -112.09 113.42 25.69 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.357 174.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.572 ' HB ' ' H ' ' A' ' 51' ' ' GLU . 56.1 t -96.82 106.75 32.65 Favored Pre-proline 0 C--O 1.224 -0.244 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.075 -177.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 67' ' ' VAL . 27.7 Cg_endo -62.22 156.08 52.76 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.208 2.605 . . . . 0.0 112.449 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -77.26 5.98 7.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.62 -170.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.7 t -130.23 -4.08 4.4 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.552 -0.459 . . . . 0.0 112.153 -172.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.524 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -94.79 152.69 18.21 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.751 -0.779 . . . . 0.0 112.675 -172.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.9 tp -158.16 161.9 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.803 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.462 ' HB2' ' N ' ' A' ' 7' ' ' LEU . 19.3 m -118.1 -105.34 0.39 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 119.182 -1.007 . . . . 0.0 113.459 -173.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.664 ' HA ' HD12 ' A' ' 7' ' ' LEU . 29.1 t70 72.13 8.23 5.86 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.284 1.04 . . . . 0.0 109.092 -165.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -169.87 -146.63 0.05 Allowed 'General case' 0 C--O 1.245 0.816 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.738 -173.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.611 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 24.9 mt-30 -78.93 136.86 37.38 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.086 0.866 . . . . 0.0 110.672 171.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.524 HD11 ' HB1' ' A' ' 71' ' ' ALA . 37.7 tp -129.96 -179.03 4.98 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 169.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.506 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 3.2 pp -140.81 139.32 34.52 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 117.722 -1.591 . . . . 0.0 110.721 174.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 2.8 mm? -133.58 142.2 43.04 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-O 121.567 0.699 . . . . 0.0 112.699 -175.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.615 ' HG2' ' HB2' ' A' ' 66' ' ' ASN . 74.2 Cg_endo -82.47 122.13 3.54 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.892 2.394 . . . . 0.0 111.594 171.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.725 ' SG ' HG21 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -106.67 87.65 2.58 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 63' ' ' CYS . 10.2 t -68.79 143.91 95.36 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.983 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.34 152.39 67.34 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.725 2.283 . . . . 0.0 111.939 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.536 -177.607 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 111.641 0.237 . . . . 0.0 111.641 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 2' ' ' LEU . 31.2 mt -119.65 66.28 0.8 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 119.584 -0.846 . . . . 0.0 112.608 -178.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -98.28 -48.26 5.13 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 157.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.685 ' HA2' ' HB2' ' A' ' 73' ' ' SER . . . -168.07 -169.31 31.39 Favored Glycine 0 CA--C 1.48 -2.147 0 CA-C-N 113.477 -1.692 . . . . 0.0 111.287 155.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.53 ' HA ' ' HD3' ' A' ' 5' ' ' LYS . 28.8 mmtt -153.73 -140.38 0.09 Allowed 'General case' 0 C--N 1.28 -2.417 0 CA-C-N 111.484 -2.358 . . . . 0.0 104.667 -168.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.782 ' C ' HD13 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -114.66 156.19 25.21 Favored 'General case' 0 C--N 1.268 -2.954 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 -177.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.805 HD23 ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -144.6 -177.41 5.48 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.566 -1.253 . . . . 0.0 113.78 -162.13 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.723 ' HB2' ' HG2' ' A' ' 76' ' ' GLN . 1.2 m-85 -118.21 104.13 10.51 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.535 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.532 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . . . -102.91 143.34 32.64 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 119.175 -1.01 . . . . 0.0 111.955 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.456 HG12 ' CD1' ' A' ' 41' ' ' LEU . 10.1 mt -112.82 99.79 9.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.277 177.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.718 HD12 HG21 ' A' ' 65' ' ' VAL . 2.4 mm? -93.38 128.66 39.53 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.684 -0.806 . . . . 0.0 109.407 -173.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 26.5 mmt180 -135.44 131.59 36.39 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 120.188 -0.605 . . . . 0.0 112.37 -177.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.628 HD22 ' SG ' ' A' ' 81' ' ' CYS . 3.3 mm? -53.96 142.08 25.83 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 167.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.92 -26.37 67.43 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.057 -1.428 . . . . 0.0 110.808 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -65.79 -25.55 67.3 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.223 0.535 . . . . 0.0 110.842 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 111.23 10.97 19.26 Favored Glycine 0 N--CA 1.448 -0.545 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 -169.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.464 ' HB3' ' HB2' ' A' ' 13' ' ' LEU . 22.9 t -97.16 -160.61 0.81 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.666 -0.767 . . . . 0.0 109.473 178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.518 ' C ' HD23 ' A' ' 13' ' ' LEU . 0.3 OUTLIER -139.25 134.82 16.82 Favored Pre-proline 0 CA--C 1.5 -0.96 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -172.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.537 ' O ' HG21 ' A' ' 36' ' ' VAL . 42.3 Cg_endo -76.38 103.27 1.72 Allowed 'Trans proline' 0 N--CA 1.429 -2.303 0 N-CA-C 104.301 -3.0 . . . . 0.0 104.301 148.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 17.6 Cg_endo -98.65 -163.75 0.07 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.276 0 C-N-CA 122.773 2.315 . . . . 0.0 111.51 -161.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.553 ' HA ' HG12 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -48.56 109.61 0.26 Allowed 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.079 0.466 . . . . 0.0 111.986 -172.304 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.9 3.17 26.7 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.701 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -65.29 95.73 0.2 Allowed 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.214 0.531 . . . . 0.0 109.983 176.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.662 ' HB2' HD22 ' A' ' 56' ' ' ASN . 2.0 m -67.62 105.61 1.93 Allowed 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 113.301 -1.772 . . . . 0.0 110.686 173.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.693 HG12 HG22 ' A' ' 55' ' ' VAL . 26.9 m -100.52 112.24 32.64 Favored 'Isoleucine or valine' 0 C--O 1.26 1.614 0 CA-C-O 121.857 0.837 . . . . 0.0 110.204 174.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -149.5 128.96 13.01 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-N 114.109 -1.405 . . . . 0.0 108.574 179.31 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.459 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . 7.1 p -62.83 171.3 2.18 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 119.558 -0.857 . . . . 0.0 109.594 -175.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -68.39 -7.59 32.85 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 119.976 -0.69 . . . . 0.0 111.942 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HD2' ' HA ' ' A' ' 29' ' ' LYS . 48.5 tptt -93.72 -14.03 26.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.267 0.556 . . . . 0.0 109.65 172.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.441 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 100.7 31.57 5.71 Favored Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' A' ' 26' ' ' THR . 26.6 tpt180 -73.9 89.22 1.86 Allowed 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 173.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.478 ' HA ' ' HB ' ' A' ' 26' ' ' THR . 25.6 mt-10 -86.11 94.86 9.37 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.066 -171.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.865 HD23 HD21 ' A' ' 53' ' ' LEU . 0.7 OUTLIER -80.78 -37.61 29.97 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.077 -178.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.592 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . 167.26 -159.45 32.8 Favored Glycine 0 C--N 1.341 0.857 0 C-N-CA 117.87 -2.11 . . . . 0.0 114.855 177.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.701 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 10.5 mtm -151.81 137.52 17.92 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.891 0.876 . . . . 0.0 109.683 -176.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.595 HG23 ' HB3' ' A' ' 23' ' ' ALA . 55.7 t -61.83 129.51 24.94 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 C-N-CA 120.006 -0.677 . . . . 0.0 109.841 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.678 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -130.73 55.02 1.85 Allowed 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.456 173.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.678 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 5.0 t70 148.98 122.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.6 0 O-C-N 125.306 1.628 . . . . 0.0 108.198 174.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 20' ' ' PRO . 24.0 mt-10 52.13 -102.2 0.12 Allowed 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.531 0.52 . . . . 0.0 111.297 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -137.8 29.34 2.66 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.456 ' CD1' HG12 ' A' ' 10' ' ' ILE . 11.8 tp -103.34 111.15 23.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.419 -0.391 . . . . 0.0 110.044 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -101.94 126.61 48.88 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.282 174.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.0 m95 -75.08 88.96 2.44 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.805 ' HB2' HD23 ' A' ' 7' ' ' LEU . 8.1 mt -83.26 177.32 8.58 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 117.403 -1.719 . . . . 0.0 110.079 -171.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 41.8 m -138.84 85.72 2.1 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.796 ' HA2' HD11 ' A' ' 7' ' ' LEU . . . 75.61 75.93 0.81 Allowed Glycine 0 C--O 1.223 -0.554 0 C-N-CA 119.914 -1.136 . . . . 0.0 115.421 174.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.49 HG12 HG11 ' A' ' 67' ' ' VAL . 3.9 t -81.65 134.41 27.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 C-N-CA 120.239 -0.585 . . . . 0.0 109.637 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.542 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -86.55 127.88 58.98 Favored Pre-proline 0 C--N 1.326 -0.45 0 C-N-CA 120.325 -0.55 . . . . 0.0 109.737 179.176 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.747 ' HB2' ' HA ' ' A' ' 69' ' ' GLU . 30.9 Cg_endo -64.71 115.21 3.1 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.326 2.018 . . . . 0.0 111.899 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.28 36.24 2.16 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.748 -1.215 . . . . 0.0 112.697 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.652 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 28.5 mt-10 -116.98 176.81 4.95 Favored 'General case' 0 CA--C 1.501 -0.937 0 C-N-CA 119.146 -1.022 . . . . 0.0 112.142 -175.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.6 t -127.31 92.42 3.51 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 114.513 -1.221 . . . . 0.0 110.333 168.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.865 HD21 HD23 ' A' ' 33' ' ' LEU . 9.0 mt -58.86 158.86 7.62 Favored 'General case' 0 CA--C 1.51 -0.594 0 CA-C-N 114.222 -1.353 . . . . 0.0 111.764 176.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.63 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 24.8 m -125.23 121.44 34.12 Favored 'General case' 0 C--N 1.317 -0.812 0 O-C-N 123.58 0.55 . . . . 0.0 109.777 168.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.693 HG22 HG12 ' A' ' 25' ' ' VAL . 9.5 t -109.43 122.23 63.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 CA-C-O 121.212 0.53 . . . . 0.0 111.466 -170.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.662 HD22 ' HB2' ' A' ' 24' ' ' SER . 0.8 OUTLIER -123.77 132.49 53.81 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.708 -170.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.657 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 6.7 p90 -147.23 -142.95 0.13 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 117.957 -1.497 . . . . 0.0 112.63 171.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.657 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 0.9 OUTLIER -37.5 -63.07 0.48 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.853 0.461 . . . . 0.0 111.298 167.596 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.595 ' HA3' ' NE2' ' A' ' 62' ' ' GLN . . . -80.18 0.45 83.81 Favored Glycine 0 C--N 1.339 0.743 0 C-N-CA 119.126 -1.512 . . . . 0.0 110.691 176.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.638 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 27.1 mttm 74.69 -140.31 0.03 OUTLIER 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 113.898 -1.151 . . . . 0.0 113.165 173.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.674 ' HA ' ' O ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -77.9 98.78 2.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 -174.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.595 ' NE2' ' HA3' ' A' ' 59' ' ' GLY . 1.5 mt-30 -118.92 -41.81 2.75 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 114.416 -1.266 . . . . 0.0 110.877 -173.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . . . . . . . . . 17.2 p -118.24 158.1 25.77 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.73 172.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.697 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 24.0 mt-30 -126.9 156.53 41.3 Favored 'General case' 0 CA--C 1.477 -1.83 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.718 HG21 HD12 ' A' ' 11' ' ' LEU . 2.7 t -106.75 131.92 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.09 0 C-N-CA 114.433 -2.907 . . . . 0.0 112.562 -172.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -90.46 110.81 21.91 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 119.184 -1.006 . . . . 0.0 110.187 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.652 ' HB ' ' H ' ' A' ' 51' ' ' GLU . 18.8 t -92.56 114.3 62.02 Favored Pre-proline 0 CA--C 1.513 -0.453 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.873 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 4.6 Cg_exo -81.51 172.7 12.2 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 124.324 3.35 . . . . 0.0 111.903 177.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.747 ' HA ' ' HB2' ' A' ' 49' ' ' PRO . 40.6 mt-10 -72.68 -6.87 47.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.814 -176.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.452 HG22 ' HB2' ' A' ' 68' ' ' PRO . 10.7 t -85.07 18.63 2.45 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.929 -178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.656 ' HA ' HD22 ' A' ' 77' ' ' LEU . . . -66.25 153.5 42.38 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.617 177.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.25 167.98 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 120.194 -0.603 . . . . 0.0 110.909 -173.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.685 ' HB2' ' HA2' ' A' ' 4' ' ' GLY . 47.5 t -101.29 143.33 31.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.787 -175.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 51.83 23.45 2.08 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 174.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -134.05 173.11 11.94 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.322 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.723 ' HG2' ' HB2' ' A' ' 8' ' ' PHE . 74.9 mt-30 -86.25 142.0 28.88 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.701 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.656 HD22 ' HA ' ' A' ' 71' ' ' ALA . 50.9 tp -150.74 116.6 5.54 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 176.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.591 HD13 ' H ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -82.72 141.7 32.2 Favored 'General case' 0 N--CA 1.441 -0.921 0 C-N-CA 118.332 -1.347 . . . . 0.0 109.454 178.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.415 ' HB2' ' CD1' ' A' ' 11' ' ' LEU . 95.2 mt -131.46 147.84 67.71 Favored Pre-proline 0 C--O 1.247 0.97 0 CA-C-O 121.109 0.48 . . . . 0.0 111.962 -173.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.429 ' O ' ' HA ' ' A' ' 65' ' ' VAL . 65.9 Cg_endo -76.0 109.91 2.98 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.576 2.851 . . . . 0.0 113.309 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.628 ' SG ' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -91.06 93.46 9.18 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 113.906 -1.497 . . . . 0.0 108.279 172.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 23.5 m -97.3 126.29 42.36 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.397 -175.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 82' ' ' THR . 39.2 Cg_exo -61.12 148.68 92.17 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.758 2.305 . . . . 0.0 111.767 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -66.74 -30.64 70.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.561 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.7 mptt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.461 -0.781 . . . . 0.0 110.189 177.254 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 82.7 mt -60.44 117.97 5.91 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 175.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.559 ' HB2' ' HG3' ' A' ' 49' ' ' PRO . 4.3 mmmm -93.37 53.79 1.97 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 -166.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.85 177.11 33.12 Favored Glycine 0 CA--C 1.474 -2.524 0 C-N-CA 117.812 -2.137 . . . . 0.0 113.599 163.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.873 ' HD3' ' HB2' ' A' ' 74' ' ' ASP . 46.8 tttm -155.54 -141.77 0.1 Allowed 'General case' 0 N--CA 1.406 -2.675 0 CA-C-N 110.532 -2.834 . . . . 0.0 103.384 -171.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 1.118 ' HB2' ' HB2' ' A' ' 45' ' ' SER . 0.0 OUTLIER -88.56 -177.5 5.6 Favored 'General case' 0 C--N 1.275 -2.643 0 N-CA-C 106.006 -1.85 . . . . 0.0 106.006 -175.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.672 ' N ' ' HG3' ' A' ' 6' ' ' ARG . 1.7 tt -141.08 114.3 8.63 Favored 'General case' 0 N--CA 1.387 -3.62 0 C-N-CA 117.126 -1.829 . . . . 0.0 114.761 -144.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.707 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 2.1 m-85 -119.27 88.77 3.0 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 165.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.641 ' HB2' HD21 ' A' ' 7' ' ' LEU . . . -100.38 102.11 13.26 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -170.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.541 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 51.5 mt -80.93 98.28 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 175.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.55 HD13 ' HG2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -114.41 146.04 41.09 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 119.33 -0.948 . . . . 0.0 109.861 -172.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 9.9 mmm180 -137.11 147.93 46.36 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.104 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.498 HD13 ' SG ' ' A' ' 81' ' ' CYS . 4.5 mm? -66.15 146.85 54.17 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 166.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.71 -27.34 67.82 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.292 -1.322 . . . . 0.0 110.757 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -70.18 -18.84 63.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.536 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.17 -6.24 25.22 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -176.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.8 -163.65 0.75 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.153 -0.524 . . . . 0.0 110.741 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.565 ' HG2' ' HA3' ' A' ' 40' ' ' GLY . 2.8 mt-30 -136.81 145.24 50.06 Favored Pre-proline 0 CA--C 1.506 -0.747 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -172.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.684 ' O ' HG21 ' A' ' 36' ' ' VAL . 6.2 Cg_exo -74.53 103.62 1.73 Allowed 'Trans proline' 0 N--CA 1.431 -2.188 0 N-CA-C 104.796 -2.809 . . . . 0.0 104.796 148.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 19.4 Cg_endo -103.13 -177.69 0.11 Allowed 'Trans proline' 0 N--CA 1.43 -2.236 0 C-N-CA 123.277 2.651 . . . . 0.0 111.99 -165.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.641 ' HA ' HG12 ' A' ' 36' ' ' VAL . 31.0 t80 -41.65 117.43 0.92 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.863 1.06 . . . . 0.0 113.863 -168.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.67 8.46 57.19 Favored Glycine 0 N--CA 1.436 -1.367 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 177.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.727 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -59.0 94.76 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 114.789 -0.706 . . . . 0.0 109.393 171.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.797 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 3.8 m -57.46 93.01 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 113.341 -1.754 . . . . 0.0 111.546 172.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.898 HG23 ' C ' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -89.04 95.18 5.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.053 0 C-N-CA 120.033 -0.667 . . . . 0.0 109.634 -179.224 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.716 ' HB ' ' HG2' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -128.33 130.94 48.53 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.66 -174.021 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 54.5 p -65.42 172.07 3.51 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 118.567 -1.253 . . . . 0.0 109.553 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.61 -18.23 51.78 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.912 -177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 45.5 mtpt -93.71 -8.79 39.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.839 0.352 . . . . 0.0 110.87 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.431 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 102.12 23.92 8.82 Favored Glycine 0 N--CA 1.425 -2.054 0 C-N-CA 119.737 -1.22 . . . . 0.0 110.164 174.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.663 HH11 HD12 ' A' ' 33' ' ' LEU . 39.7 mtm105 -73.73 88.51 1.75 Allowed 'General case' 0 N--CA 1.427 -1.576 0 C-N-CA 118.212 -1.395 . . . . 0.0 108.57 170.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.716 ' HG2' ' HB ' ' A' ' 26' ' ' THR . 15.8 mt-10 -83.52 77.9 9.75 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.674 HD13 ' HA3' ' A' ' 46' ' ' GLY . 96.2 mt -121.11 12.39 11.08 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 114.68 -1.145 . . . . 0.0 110.816 -167.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 1.042 ' HA2' ' HB2' ' A' ' 44' ' ' LEU . . . -138.02 149.82 20.63 Favored Glycine 0 CA--C 1.528 0.882 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.468 163.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.727 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 30.9 mtm -154.14 126.28 7.85 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 160.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.713 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 32.3 t -60.89 135.32 25.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 O-C-N 123.649 0.593 . . . . 0.0 111.518 -176.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 38' ' ' ASP . . . -136.59 116.91 13.59 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 172.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 20.5 m-20 72.41 116.91 0.05 OUTLIER 'General case' 0 C--O 1.234 0.255 0 O-C-N 124.199 0.937 . . . . 0.0 111.101 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 62.87 -95.23 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.857 177.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.565 ' HA3' ' HG2' ' A' ' 18' ' ' GLN . . . -160.94 53.1 0.33 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 118.807 -1.663 . . . . 0.0 114.001 -174.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.656 HD11 ' HE1' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -141.74 139.48 32.86 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.416 170.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.713 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -84.83 122.94 29.87 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.342 0.592 . . . . 0.0 111.719 -176.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.656 ' HE1' HD11 ' A' ' 41' ' ' LEU . 58.9 m95 -97.03 88.13 4.42 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.268 177.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.042 ' HB2' ' HA2' ' A' ' 34' ' ' GLY . 1.2 mt -156.94 -166.65 2.14 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -169.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 1.118 ' HB2' ' HB2' ' A' ' 6' ' ' ARG . 1.1 t -153.57 106.38 2.91 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 119.831 -0.748 . . . . 0.0 110.281 -171.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.674 ' HA3' HD13 ' A' ' 33' ' ' LEU . . . 140.36 76.17 0.05 OUTLIER Glycine 0 CA--C 1.521 0.449 0 C-N-CA 119.707 -1.235 . . . . 0.0 113.93 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.568 ' HB ' HD11 ' A' ' 7' ' ' LEU . 12.9 p -120.84 143.64 32.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.895 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 12.2 m -117.08 129.48 25.29 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.82 0.343 . . . . 0.0 110.332 176.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.578 ' HA ' HG12 ' A' ' 67' ' ' VAL . 44.1 Cg_endo -68.56 129.01 18.07 Favored 'Trans proline' 0 C--O 1.237 0.437 0 C-N-CA 122.569 2.179 . . . . 0.0 112.136 178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 93.47 36.38 5.91 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.155 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -128.02 173.3 10.16 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 118.055 -1.458 . . . . 0.0 113.731 -170.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 p -121.09 89.8 3.2 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.089 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 25.6 mt -68.1 151.92 46.28 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.075 174.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.503 ' HB2' HD11 ' A' ' 61' ' ' ILE . 34.5 p -122.88 121.95 37.43 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.938 0.875 . . . . 0.0 110.593 170.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.797 ' HA ' ' O ' ' A' ' 24' ' ' SER . 4.8 t -120.08 117.95 55.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 114.436 -1.256 . . . . 0.0 111.465 -162.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.723 ' HB2' ' HB2' ' A' ' 24' ' ' SER . 35.0 m-80 -103.51 148.75 25.58 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.922 -173.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.676 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 6.2 p90 -161.84 -138.21 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 120.263 -0.575 . . . . 0.0 112.528 161.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.676 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 30.8 t70 -41.72 -58.12 2.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.277 0.631 . . . . 0.0 111.495 168.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.505 ' HA3' ' NE2' ' A' ' 62' ' ' GLN . . . -80.55 -1.47 88.9 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 119.288 -1.434 . . . . 0.0 110.302 175.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.655 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 37.8 mtmt 71.18 -142.26 0.06 Allowed 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 113.938 -1.131 . . . . 0.0 110.74 173.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.503 HD11 ' HB2' ' A' ' 54' ' ' SER . 0.5 OUTLIER -67.98 95.35 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 CA-C-O 123.414 1.578 . . . . 0.0 107.937 -177.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.597 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 4.7 pt20 -139.04 -37.3 0.52 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 113.434 -1.712 . . . . 0.0 111.129 -170.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.646 ' SG ' ' HG3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -87.56 142.85 27.54 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 166.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -140.09 124.64 18.07 Favored 'General case' 0 CA--C 1.478 -1.789 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 173.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.583 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 22.2 t -98.93 132.1 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.111 0 C-N-CA 114.639 -2.824 . . . . 0.0 112.278 -168.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -101.05 102.48 13.46 Favored 'General case' 0 C--N 1.313 -0.984 0 C-N-CA 118.039 -1.464 . . . . 0.0 110.279 175.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.578 HG12 ' HA ' ' A' ' 49' ' ' PRO . 40.6 t -75.25 126.57 87.71 Favored Pre-proline 0 C--N 1.318 -0.781 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.025 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.537 ' HB2' HG22 ' A' ' 70' ' ' THR . 9.8 Cg_endo -90.16 171.02 3.92 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.663 2.909 . . . . 0.0 111.93 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -77.32 0.26 22.92 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.888 0.375 . . . . 0.0 111.596 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 68' ' ' PRO . 8.8 t -93.42 16.03 14.42 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.192 0.52 . . . . 0.0 110.326 178.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.09 152.92 38.54 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.712 0.768 . . . . 0.0 111.711 -178.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.439 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 59.1 mt -121.12 137.67 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.162 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.91 -174.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 m -88.53 140.39 29.51 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.382 -173.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.873 ' HB2' ' HD3' ' A' ' 5' ' ' LYS . 23.0 t70 71.76 -4.22 1.97 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-O 121.217 0.532 . . . . 0.0 112.246 170.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.899 ' HA ' HE21 ' A' ' 75' ' ' GLN . 0.0 OUTLIER -112.7 -166.05 1.05 Allowed 'General case' 0 C--O 1.245 0.841 0 CA-C-O 121.34 0.591 . . . . 0.0 110.829 -177.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.707 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 30.0 pt20 -97.69 134.84 40.33 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 114.93 -1.032 . . . . 0.0 108.921 173.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.459 HD13 ' N ' ' A' ' 78' ' ' LEU . 1.6 tm? -142.9 141.91 31.62 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 -177.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.541 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER -88.16 132.81 34.19 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 118.746 -1.182 . . . . 0.0 110.393 -177.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.539 HD23 ' HB1' ' A' ' 9' ' ' ALA . 3.4 mm? -117.98 139.62 26.78 Favored Pre-proline 0 C--O 1.241 0.657 0 CA-C-O 121.233 0.539 . . . . 0.0 111.496 -176.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 73.3 Cg_endo -87.99 120.27 1.34 Allowed 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.051 2.501 . . . . 0.0 112.278 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.498 ' SG ' HD13 ' A' ' 13' ' ' LEU . 8.8 t -89.04 120.31 30.33 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.853 176.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.1 m -97.52 134.78 22.14 Favored Pre-proline 0 C--N 1.316 -0.877 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 170.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -63.17 152.14 81.2 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.46 2.107 . . . . 0.0 112.732 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.434 HE21 ' HB3' ' A' ' 84' ' ' GLN . 3.4 tt0 -60.53 127.62 32.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.17 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.605 -0.712 . . . . 0.0 109.454 175.206 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.883 HG13 ' H ' ' A' ' 2' ' ' LEU . 2.5 p . . . . . 0 N--CA 1.484 1.26 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.883 ' H ' HG13 ' A' ' 1' ' ' VAL . 3.8 tt -101.77 -56.57 2.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 170.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -91.23 157.6 17.07 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 163.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 73' ' ' SER . . . -77.9 160.42 48.5 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.072 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.909 ' HG2' ' HA3' ' A' ' 46' ' ' GLY . 20.7 mtpp -154.1 72.03 0.87 Allowed 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 177.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.857 ' C ' HD23 ' A' ' 7' ' ' LEU . 90.7 mtt-85 -177.2 114.73 0.09 Allowed 'General case' 0 CA--C 1.49 -1.357 0 N-CA-C 102.036 -3.32 . . . . 0.0 102.036 165.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.964 HD22 ' HA ' ' A' ' 73' ' ' SER . 0.9 OUTLIER -123.01 172.02 8.82 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 115.737 -2.385 . . . . 0.0 109.006 -170.476 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.819 ' HB2' ' HA ' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -92.24 87.13 5.96 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.524 -1.67 . . . . 0.0 108.095 -179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.839 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -98.32 112.08 24.2 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 118.969 -1.093 . . . . 0.0 111.462 -173.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.456 HG12 ' HG ' ' A' ' 41' ' ' LEU . 59.2 mt -100.65 90.67 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.476 171.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.514 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.7 OUTLIER -103.06 132.27 49.45 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.426 -175.335 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.819 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 58.7 mtm-85 -141.67 155.09 45.7 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.265 178.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.642 HD23 ' HD3' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -89.99 135.23 33.77 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 117.888 -1.525 . . . . 0.0 109.028 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.53 -11.64 3.17 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 114.509 -1.223 . . . . 0.0 113.797 -169.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -67.29 -19.0 65.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.433 0.635 . . . . 0.0 110.596 175.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.7 -8.98 21.79 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -174.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.441 ' CB ' ' HG ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -82.61 -177.9 6.87 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 113.922 -1.139 . . . . 0.0 111.824 -179.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.708 ' NE2' ' HB2' ' A' ' 39' ' ' GLU . 1.2 mt-30 -135.4 142.65 42.15 Favored Pre-proline 0 CA--C 1.503 -0.857 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.949 -176.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.819 ' HD3' ' HA ' ' A' ' 12' ' ' ARG . 3.6 Cg_endo -80.37 102.72 1.45 Allowed 'Trans proline' 0 N--CA 1.423 -2.668 0 N-CA-C 104.848 -2.789 . . . . 0.0 104.848 156.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.718 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 1.9 Cg_endo -101.63 175.76 0.23 Allowed 'Trans proline' 0 N--CA 1.422 -2.715 0 C-N-CA 122.836 2.357 . . . . 0.0 111.047 -162.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.445 ' HD1' ' HA ' ' A' ' 37' ' ' ALA . 82.5 t80 -30.42 99.74 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 O-C-N 124.231 0.957 . . . . 0.0 113.306 -169.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 118.72 10.85 8.17 Favored Glycine 0 N--CA 1.432 -1.568 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.663 -177.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.96 ' HB3' HG13 ' A' ' 36' ' ' VAL . . . -58.94 95.86 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.638 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.227 175.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.656 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 0.6 OUTLIER -77.8 98.41 5.54 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 113.714 -1.585 . . . . 0.0 112.117 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.688 HG12 HG22 ' A' ' 55' ' ' VAL . 11.8 m -103.68 115.19 45.16 Favored 'Isoleucine or valine' 0 C--O 1.259 1.563 0 CA-C-O 121.319 0.581 . . . . 0.0 111.85 -177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.628 ' OG1' ' HA2' ' A' ' 30' ' ' GLY . 0.0 OUTLIER -147.21 125.98 12.65 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.257 175.853 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.623 ' CB ' ' HE2' ' A' ' 29' ' ' LYS . 27.2 m -53.07 168.48 0.13 Allowed 'General case' 0 CA--C 1.541 0.601 0 O-C-N 123.17 0.293 . . . . 0.0 111.385 -173.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.453 ' CD ' ' HG3' ' A' ' 29' ' ' LYS . 5.9 pm0 -59.75 -20.31 55.78 Favored 'General case' 0 N--CA 1.472 0.669 0 O-C-N 121.982 -0.448 . . . . 0.0 112.048 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.623 ' HE2' ' CB ' ' A' ' 27' ' ' SER . 0.0 OUTLIER -103.03 4.55 37.38 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.686 176.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.628 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 86.15 43.06 6.42 Favored Glycine 0 N--CA 1.418 -2.541 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 174.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 1.035 ' HA ' ' HE ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -94.7 97.34 10.0 Favored 'General case' 0 N--CA 1.421 -1.897 0 C-N-CA 117.521 -1.672 . . . . 0.0 107.12 166.028 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 0.3 OUTLIER -96.15 111.18 23.3 Favored 'General case' 0 N--CA 1.429 -1.477 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.16 -159.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.782 ' HB3' ' HG ' ' A' ' 44' ' ' LEU . 5.9 mp -84.64 -49.94 8.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.383 -174.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.576 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . 168.86 -155.93 26.84 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 117.041 -2.504 . . . . 0.0 114.888 -179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.8 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 17.1 mtp -149.84 128.28 12.22 Favored 'General case' 0 CA--C 1.507 -0.696 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -173.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.96 HG13 ' HB3' ' A' ' 23' ' ' ALA . 6.3 m -71.37 130.04 35.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.105 -173.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HA ' ' HD1' ' A' ' 21' ' ' PHE . . . -121.64 55.85 1.08 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.807 178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 20.6 t0 150.31 139.39 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.548 0 O-C-N 125.36 1.662 . . . . 0.0 107.572 176.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.718 ' O ' ' HA ' ' A' ' 20' ' ' PRO . 0.5 OUTLIER 28.12 -100.26 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.701 0 O-C-N 124.757 1.285 . . . . 0.0 111.781 -167.379 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.697 ' H ' ' HG3' ' A' ' 39' ' ' GLU . . . -136.07 48.84 0.9 Allowed Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 173.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.456 ' HG ' HG12 ' A' ' 10' ' ' ILE . 2.6 tt -116.42 117.48 30.05 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 120.984 0.421 . . . . 0.0 111.039 -178.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.562 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . . . -125.57 154.75 41.74 Favored 'General case' 0 CA--C 1.515 -0.404 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 171.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.617 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 64.6 m95 -84.21 88.11 7.2 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 174.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.847 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 6.3 mp -73.68 102.26 3.89 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 119.23 -0.988 . . . . 0.0 109.873 -169.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.84 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 6.4 m -56.71 87.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.086 0.866 . . . . 0.0 111.919 -176.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.909 ' HA3' ' HG2' ' A' ' 5' ' ' LYS . . . 56.58 91.35 0.01 OUTLIER Glycine 0 C--N 1.339 0.722 0 CA-C-N 114.683 -1.144 . . . . 0.0 114.341 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.753 HG23 HD12 ' A' ' 7' ' ' LEU . 4.6 t -72.02 145.72 11.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.569 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -82.3 118.52 72.26 Favored Pre-proline 0 N--CA 1.442 -0.847 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.98 ' HB2' ' HA ' ' A' ' 69' ' ' GLU . 73.1 Cg_endo -71.48 109.37 2.6 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.451 2.101 . . . . 0.0 112.197 -177.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.44 34.95 1.04 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.098 -1.525 . . . . 0.0 113.524 177.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -164.66 179.99 6.26 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 117.477 -1.689 . . . . 0.0 114.121 -176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.828 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 21.0 p -111.63 124.98 53.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.823 -174.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' A' ' 64' ' ' GLN . 1.1 mm? -83.14 134.79 34.98 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 174.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.632 ' HB3' HD11 ' A' ' 61' ' ' ILE . 3.1 m -72.33 103.51 3.44 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 171.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.688 HG22 HG12 ' A' ' 25' ' ' VAL . 46.3 t -103.18 94.42 3.2 Favored 'Isoleucine or valine' 0 C--O 1.249 1.058 0 CA-C-O 122.145 0.974 . . . . 0.0 111.278 -172.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.704 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 43.0 m-80 -73.65 131.67 41.91 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.357 -1.292 . . . . 0.0 110.271 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.615 ' HB3' ' HG3' ' A' ' 62' ' ' GLN . 1.7 t90 -148.39 134.56 19.34 Favored 'General case' 0 C--O 1.208 -1.125 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.666 -176.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.574 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 2.6 p30 -12.58 -58.52 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 116.396 1.999 . . . . 0.0 116.396 -173.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.679 ' H ' ' NE2' ' A' ' 62' ' ' GLN . . . -61.05 -23.79 62.16 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 118.397 -1.859 . . . . 0.0 114.282 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 1.023 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 11.1 pttt 173.36 -141.83 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.732 0.777 . . . . 0.0 110.265 -170.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.704 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 11.8 tt -115.1 93.95 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 105.587 -2.005 . . . . 0.0 105.587 162.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 1.023 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 6.6 mt-30 -92.15 -19.51 22.2 Favored 'General case' 0 C--N 1.31 -1.109 0 C-N-CA 117.289 -1.764 . . . . 0.0 113.285 -150.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.556 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 23.7 p -147.92 159.92 43.36 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.915 178.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.635 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 47.5 mt-30 -129.82 119.42 23.33 Favored 'General case' 0 CA--C 1.478 -1.824 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.828 ' O ' ' HA ' ' A' ' 52' ' ' THR . 2.6 t -78.19 123.47 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.045 0 C-N-CA 116.804 -1.958 . . . . 0.0 112.025 -167.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -91.32 133.21 35.62 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 118.427 -1.309 . . . . 0.0 110.023 177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.731 HG21 HG11 ' A' ' 47' ' ' VAL . 62.1 t -121.53 134.54 24.59 Favored Pre-proline 0 N--CA 1.44 -0.966 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.768 -173.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 6.5 Cg_endo -92.26 172.76 2.38 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 124.393 3.395 . . . . 0.0 111.798 171.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.98 ' HA ' ' HB2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -63.6 -14.95 56.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.149 -178.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 19.5 p -62.42 -21.55 65.49 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.27 138.71 33.47 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 120.067 -0.653 . . . . 0.0 111.366 -176.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 42.5 mm -130.48 -82.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.888 -170.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.964 ' HA ' HD22 ' A' ' 7' ' ' LEU . 24.0 p -172.05 137.67 0.96 Allowed 'General case' 0 C--O 1.237 0.413 0 CA-C-O 118.783 -0.627 . . . . 0.0 110.511 -175.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.765 ' H ' HD22 ' A' ' 7' ' ' LEU . 5.2 m-20 55.89 -163.23 0.15 Allowed 'General case' 0 C--N 1.362 1.142 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -172.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.498 ' O ' ' HB2' ' A' ' 8' ' ' PHE . 42.4 mt-30 65.73 150.3 0.05 OUTLIER 'General case' 0 C--O 1.243 0.76 0 CA-C-O 121.649 0.738 . . . . 0.0 112.3 174.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.819 ' HA ' ' HB2' ' A' ' 8' ' ' PHE . 22.1 mp0 -76.75 124.12 27.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.464 -179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.43 HD22 ' HA ' ' A' ' 77' ' ' LEU . 0.3 OUTLIER -140.77 116.88 10.55 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 10' ' ' ILE . 7.7 tt -85.98 127.13 34.57 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 119.497 -0.881 . . . . 0.0 109.018 -177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.447 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 81.9 mt -113.61 141.86 26.7 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 121.108 0.48 . . . . 0.0 111.704 -174.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 67.7 Cg_endo -91.38 120.39 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 123.349 2.699 . . . . 0.0 113.196 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.678 ' SG ' ' HG3' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -82.58 116.24 21.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.384 175.057 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.3 m -82.85 117.1 67.47 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.155 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.48 158.82 22.47 Favored 'Trans proline' 0 N--CA 1.462 -0.342 0 C-N-CA 122.814 2.343 . . . . 0.0 112.268 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -134.37 -76.28 0.47 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.421 178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.411 ' HD3' ' C ' ' A' ' 85' ' ' LYS . 4.2 tmtt? . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.389 -0.815 . . . . 0.0 109.573 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 111.324 0.12 . . . . 0.0 111.324 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.28 -52.26 66.03 Favored 'General case' 0 N--CA 1.463 0.195 0 C-N-CA 120.39 -0.524 . . . . 0.0 110.215 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 41.5 pttt -104.96 21.07 17.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.653 0.74 . . . . 0.0 109.893 173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.543 ' HA3' ' OG ' ' A' ' 73' ' ' SER . . . 90.8 -112.48 4.11 Favored Glycine 0 CA--C 1.494 -1.27 0 CA-C-O 122.587 1.104 . . . . 0.0 114.423 173.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.549 ' HG3' ' HB2' ' A' ' 74' ' ' ASP . 33.5 mmtp -150.01 -146.34 0.2 Allowed 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 112.253 -1.974 . . . . 0.0 106.468 -160.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.841 ' C ' HD13 ' A' ' 7' ' ' LEU . 25.7 mtm180 -119.84 165.13 14.98 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 102.389 -3.189 . . . . 0.0 102.389 167.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.906 HD23 ' HB2' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -149.67 177.68 9.55 Favored 'General case' 0 N--CA 1.422 -1.867 0 C-N-CA 117.714 -1.594 . . . . 0.0 113.164 -168.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 1.3 m-85 -126.78 89.64 3.02 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.697 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 77' ' ' LEU . . . -93.36 134.33 35.69 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 119.111 -1.036 . . . . 0.0 112.638 -170.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.619 ' HB ' ' HG ' ' A' ' 78' ' ' LEU . 4.2 mp -96.77 111.79 27.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.04 -0.982 . . . . 0.0 108.691 173.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.698 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 65.4 mt -92.51 131.29 37.77 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.543 -175.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.533 ' HD3' ' O ' ' A' ' 17' ' ' SER . 6.2 tpp180 -137.81 123.56 19.92 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.477 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.698 HD13 ' SG ' ' A' ' 81' ' ' CYS . 4.2 mm? -53.99 144.27 19.56 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 168.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -58.07 -30.28 66.08 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.218 -1.356 . . . . 0.0 111.211 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -79.02 -13.01 60.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.668 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 116.25 -11.71 16.88 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.106 -1.045 . . . . 0.0 113.159 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.533 ' O ' ' HD3' ' A' ' 12' ' ' ARG . 30.9 p -81.83 -164.58 0.82 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 117.465 0.632 . . . . 0.0 110.108 175.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.623 ' C ' HD23 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -129.93 141.38 41.65 Favored Pre-proline 0 CA--C 1.504 -0.815 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -172.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.698 ' HG2' ' HB3' ' A' ' 11' ' ' LEU . 5.4 Cg_exo -78.41 103.66 1.71 Allowed 'Trans proline' 0 N--CA 1.436 -1.888 0 N-CA-C 105.617 -2.494 . . . . 0.0 105.617 153.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -104.27 -161.76 0.04 OUTLIER 'Trans proline' 0 N--CA 1.434 -2.026 0 C-N-CA 123.563 2.842 . . . . 0.0 111.799 -163.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.471 ' CD2' ' HA ' ' A' ' 37' ' ' ALA . 38.2 t80 -48.9 114.83 1.07 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.409 0.623 . . . . 0.0 112.585 -169.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.69 -18.86 14.66 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.664 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -53.3 96.43 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.538 0 O-C-N 124.505 0.768 . . . . 0.0 110.975 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.759 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -72.68 88.8 1.3 Allowed 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.444 -1.707 . . . . 0.0 111.653 175.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.495 ' HB ' HD22 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -74.49 88.99 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 C-N-CA 119.939 -0.704 . . . . 0.0 109.774 169.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.738 ' HB ' ' O ' ' A' ' 31' ' ' ARG . 7.2 p -148.27 143.89 27.26 Favored 'General case' 0 N--CA 1.434 -1.225 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.71 ' OG ' ' HB2' ' A' ' 31' ' ' ARG . 96.3 p -71.39 178.3 3.5 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 116.953 -1.899 . . . . 0.0 109.913 -175.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 28' ' ' GLU . 2.1 mp0 -56.55 -28.69 60.7 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.849 0.357 . . . . 0.0 111.603 -171.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.536 ' H ' ' HD2' ' A' ' 29' ' ' LYS . 1.9 mptp? -85.37 -15.48 43.04 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.197 0.522 . . . . 0.0 110.807 -177.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.53 10.43 35.78 Favored Glycine 0 CA--C 1.485 -1.818 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.738 ' O ' ' HB ' ' A' ' 26' ' ' THR . 93.2 mtt180 -63.95 -178.3 0.31 Allowed 'General case' 0 N--CA 1.43 -1.438 0 CA-C-N 113.671 -1.265 . . . . 0.0 109.339 169.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 0.6 OUTLIER 87.27 -158.67 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 114.726 1.38 . . . . 0.0 114.726 164.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.945 HD13 HD21 ' A' ' 53' ' ' LEU . 6.8 mp -83.84 -48.67 9.81 Favored 'General case' 0 C--O 1.242 0.701 0 N-CA-C 116.22 1.933 . . . . 0.0 116.22 -144.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.725 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . 154.53 -141.4 8.17 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 120.329 -0.939 . . . . 0.0 112.988 -175.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.725 ' HG3' ' C ' ' A' ' 34' ' ' GLY . 6.9 mtt -148.6 142.66 25.93 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 117.517 0.658 . . . . 0.0 111.529 -173.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.615 HG23 HD12 ' A' ' 11' ' ' LEU . 55.5 t -66.18 130.61 31.65 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.519 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.471 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . . . -121.17 58.5 0.97 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.635 0.731 . . . . 0.0 109.332 172.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.487 ' CG ' ' H ' ' A' ' 39' ' ' GLU . 25.6 t70 178.68 -167.7 0.07 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.182 -174.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.487 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 10.1 pt-20 -85.51 1.81 47.34 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 122.091 -0.381 . . . . 0.0 111.539 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.481 ' HA3' ' HG2' ' A' ' 18' ' ' GLN . . . 174.72 25.1 0.03 OUTLIER Glycine 0 C--N 1.332 0.31 0 C-N-CA 119.143 -1.503 . . . . 0.0 112.995 175.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 9' ' ' ALA . 35.0 tp -133.19 121.69 22.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.57 0.224 . . . . 0.0 111.017 -176.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.858 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -111.13 128.93 56.05 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.167 176.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -85.12 100.16 11.54 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.906 ' HB2' HD23 ' A' ' 7' ' ' LEU . 35.7 mt -111.15 178.55 4.31 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 118.467 -1.293 . . . . 0.0 111.657 -163.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 21.1 p -132.22 88.56 2.56 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.4 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.757 ' CA ' HD11 ' A' ' 7' ' ' LEU . . . 86.78 142.56 7.21 Favored Glycine 0 N--CA 1.464 0.56 0 C-N-CA 119.102 -1.523 . . . . 0.0 113.619 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG12 HD21 ' A' ' 33' ' ' LEU . 16.2 m -122.3 152.61 26.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 120.575 0.226 . . . . 0.0 110.71 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 6.6 m -111.77 109.98 55.04 Favored Pre-proline 0 C--N 1.324 -0.526 0 C-N-CA 120.155 -0.618 . . . . 0.0 109.741 170.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.6 133.93 27.06 Favored 'Trans proline' 0 C--N 1.329 -0.495 0 C-N-CA 123.902 3.068 . . . . 0.0 113.069 -173.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.86 34.9 17.27 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 119.507 -1.33 . . . . 0.0 112.474 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.54 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 3.6 mm-40 -127.32 -173.13 2.82 Favored 'General case' 0 CA--C 1.495 -1.171 0 CA-C-O 121.852 0.834 . . . . 0.0 112.476 -175.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 22.7 m -130.94 108.58 9.92 Favored 'General case' 0 N--CA 1.424 -1.727 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.986 170.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.945 HD21 HD13 ' A' ' 33' ' ' LEU . 5.0 mt -69.36 158.8 34.37 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 114.738 -1.119 . . . . 0.0 111.793 176.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.654 ' HB3' HD11 ' A' ' 61' ' ' ILE . 73.5 m -102.25 154.6 18.88 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 159.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.759 ' HA ' ' O ' ' A' ' 24' ' ' SER . 21.5 t -137.92 92.77 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.925 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.652 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.666 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -82.22 109.61 16.65 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.573 -177.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.821 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 1.2 t90 -119.47 153.34 35.44 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 113.79 -1.55 . . . . 0.0 110.172 -168.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.821 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 15.6 t70 -15.62 -68.23 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.905 1.282 . . . . 0.0 113.176 169.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.414 ' H ' ' NE2' ' A' ' 62' ' ' GLN . . . -60.74 -41.49 99.07 Favored Glycine 0 C--N 1.346 1.097 0 C-N-CA 117.966 -2.064 . . . . 0.0 113.68 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 1.036 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 0.1 OUTLIER 172.91 -168.79 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.863 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 -170.105 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.666 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -87.99 91.57 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 C-N-CA 117.678 -1.609 . . . . 0.0 107.224 173.791 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 1.036 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 3.7 mt-30 -99.39 -41.44 7.41 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 114.219 -1.355 . . . . 0.0 111.319 -159.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.585 ' SG ' ' HG3' ' A' ' 19' ' ' PRO . 9.1 m -94.95 152.45 18.33 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.239 176.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -133.48 134.8 43.96 Favored 'General case' 0 CA--C 1.486 -1.485 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 161.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.679 ' HB ' HD12 ' A' ' 53' ' ' LEU . 78.2 t -100.0 143.56 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 C-N-CA 114.28 -2.968 . . . . 0.0 112.391 -168.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.416 HD22 ' HA ' ' A' ' 66' ' ' ASN . 0.5 OUTLIER -94.35 110.01 21.8 Favored 'General case' 0 N--CA 1.436 -1.173 0 C-N-CA 117.651 -1.619 . . . . 0.0 110.665 171.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.54 ' HB ' ' H ' ' A' ' 51' ' ' GLU . 4.6 t -86.54 117.22 68.33 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.604 178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 71' ' ' ALA . 6.0 Cg_exo -79.36 163.27 24.85 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.942 2.428 . . . . 0.0 111.839 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -80.16 -6.2 57.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.177 0.513 . . . . 0.0 110.398 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.8 p -92.16 -4.3 54.42 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.984 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HB2' ' HD2' ' A' ' 68' ' ' PRO . . . -74.21 157.24 36.25 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.221 -177.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 11.4 tp -144.42 149.43 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.569 -175.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.569 ' HA ' HD12 ' A' ' 7' ' ' LEU . 33.4 m -86.53 170.05 12.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.177 176.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.549 ' HB2' ' HG3' ' A' ' 5' ' ' LYS . 28.1 t0 70.91 147.72 0.08 Allowed 'General case' 0 C--N 1.348 0.52 0 O-C-N 123.671 0.607 . . . . 0.0 109.557 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.401 ' HB3' ' H ' ' A' ' 76' ' ' GLN . 25.5 mp0 62.73 -166.96 0.22 Allowed 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.55 0.691 . . . . 0.0 111.824 -174.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 4.4 pt20 -90.88 143.56 26.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.692 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.49 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 39.6 tp -141.58 117.36 10.42 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -175.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.619 ' HG ' ' HB ' ' A' ' 10' ' ' ILE . 6.0 mp -84.79 128.72 34.75 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 118.864 -1.134 . . . . 0.0 109.8 -178.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.606 ' HB3' HG11 ' A' ' 65' ' ' VAL . 83.2 mt -112.84 132.19 22.41 Favored Pre-proline 0 C--O 1.246 0.906 0 CA-C-O 121.212 0.53 . . . . 0.0 111.915 -176.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.446 ' O ' HG13 ' A' ' 65' ' ' VAL . 73.5 Cg_endo -83.57 113.3 1.96 Allowed 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 123.396 2.731 . . . . 0.0 112.675 177.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.698 ' SG ' HD13 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -80.5 120.47 24.52 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.904 -1.044 . . . . 0.0 110.681 175.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 64.3 p -95.17 130.73 31.68 Favored Pre-proline 0 C--N 1.317 -0.81 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 170.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 85' ' ' LYS . 11.3 Cg_exo -70.51 114.02 3.69 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.564 2.176 . . . . 0.0 111.264 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.45 ' H ' ' HG3' ' A' ' 84' ' ' GLN . 0.0 OUTLIER -75.21 17.72 0.24 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.988 0.423 . . . . 0.0 111.445 -178.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.419 ' H ' ' C ' ' A' ' 83' ' ' PRO . 77.9 mttt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.751 -0.642 . . . . 0.0 109.706 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 111.65 0.241 . . . . 0.0 111.65 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.462 HD13 ' H ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -106.12 144.19 33.17 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 119.244 -0.983 . . . . 0.0 110.194 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -170.12 179.82 3.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -127.62 123.97 4.71 Favored Glycine 0 CA--C 1.48 -2.142 0 C-N-CA 118.744 -1.694 . . . . 0.0 111.768 166.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.631 ' H ' ' HB3' ' A' ' 73' ' ' SER . 37.5 ttmt -79.61 173.77 12.25 Favored 'General case' 0 N--CA 1.413 -2.276 0 N-CA-C 104.239 -2.504 . . . . 0.0 104.239 151.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.875 ' HG3' ' H ' ' A' ' 45' ' ' SER . 0.6 OUTLIER -54.72 154.68 4.8 Favored 'General case' 0 C--N 1.294 -1.828 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.968 174.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.977 ' HG ' ' HB3' ' A' ' 45' ' ' SER . 13.6 mt -114.43 167.56 10.62 Favored 'General case' 0 CA--C 1.483 -1.633 0 C-N-CA 116.668 -2.013 . . . . 0.0 114.676 -167.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 1.086 ' HB3' ' HA ' ' A' ' 76' ' ' GLN . 30.2 t80 -81.69 85.92 6.5 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 170.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -98.12 106.76 19.1 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-O 121.394 0.616 . . . . 0.0 111.886 -167.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.444 HD12 ' HG ' ' A' ' 78' ' ' LEU . 45.9 mt -98.12 96.88 5.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.246 170.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.789 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 71.6 mt -93.79 148.0 22.54 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 119.112 -1.035 . . . . 0.0 108.844 -174.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.481 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.8 ttt180 -160.59 142.49 12.52 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 118.566 -1.254 . . . . 0.0 112.348 172.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.638 HD23 ' C ' ' A' ' 18' ' ' GLN . 4.6 mm? -64.83 142.6 58.38 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.677 0.751 . . . . 0.0 109.209 174.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.71 -28.57 69.51 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.943 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.1 -16.35 61.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.298 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.71 -13.9 20.14 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 119.792 -1.194 . . . . 0.0 111.395 -176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.488 ' C ' ' HB2' ' A' ' 13' ' ' LEU . 13.2 t -75.74 -168.54 0.88 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 175.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.638 ' C ' HD23 ' A' ' 13' ' ' LEU . 1.4 mm-40 -142.45 148.1 45.82 Favored Pre-proline 0 CA--C 1.5 -0.955 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -173.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.789 ' HG2' ' HB3' ' A' ' 11' ' ' LEU . 1.2 Cg_endo -83.18 100.99 0.95 Allowed 'Trans proline' 0 N--CA 1.433 -2.074 0 N-CA-C 106.551 -2.134 . . . . 0.0 106.551 156.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.603 ' HD2' ' CD2' ' A' ' 57' ' ' TRP . 0.2 OUTLIER -106.75 -172.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.428 -2.332 0 C-N-CA 124.017 3.145 . . . . 0.0 111.573 -167.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.527 ' HD1' ' H ' ' A' ' 38' ' ' ASP . 69.3 t80 -30.23 107.12 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 -167.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 107.34 10.29 27.77 Favored Glycine 0 N--CA 1.436 -1.35 0 CA-C-N 114.858 -1.064 . . . . 0.0 110.588 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.839 ' HB3' HG13 ' A' ' 36' ' ' VAL . . . -61.84 89.62 0.03 OUTLIER 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 124.142 0.554 . . . . 0.0 111.615 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.864 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 48.2 p -62.04 131.68 50.38 Favored 'General case' 0 C--N 1.318 -0.776 0 O-C-N 124.124 0.89 . . . . 0.0 109.093 175.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.957 HG22 ' HA3' ' A' ' 34' ' ' GLY . 19.1 m -113.18 114.27 46.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 117.718 -1.593 . . . . 0.0 110.299 165.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.821 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 1.2 t -140.54 118.55 11.88 Favored 'General case' 0 C--O 1.22 -0.48 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.113 -174.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.569 ' OG ' ' HB2' ' A' ' 31' ' ' ARG . 20.5 p -76.61 -171.69 1.95 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.801 -170.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 31.1 mm-40 -34.89 -62.63 0.36 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.087 0.955 . . . . 0.0 113.527 -171.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -75.39 -24.52 57.23 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.932 0.396 . . . . 0.0 111.479 -175.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.641 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 119.88 42.81 0.51 Allowed Glycine 0 N--CA 1.42 -2.386 0 N-CA-C 108.408 -1.877 . . . . 0.0 108.408 -172.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.821 ' O ' ' HA ' ' A' ' 26' ' ' THR . 8.8 tpp180 -69.99 99.04 1.37 Allowed 'General case' 0 N--CA 1.433 -1.29 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 172.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -91.01 107.85 19.48 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.055 -173.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.874 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -126.28 -16.64 5.4 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.111 -0.95 . . . . 0.0 112.671 -174.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 1.102 ' HA2' ' HB3' ' A' ' 44' ' ' LEU . . . -137.62 152.9 21.83 Favored Glycine 0 N--CA 1.469 0.867 0 C-N-CA 119.062 -1.542 . . . . 0.0 116.646 -169.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.788 ' N ' HD12 ' A' ' 44' ' ' LEU . 13.8 mtt -163.62 99.82 0.9 Allowed 'General case' 0 CA--C 1.506 -0.727 0 C-N-CA 125.446 1.499 . . . . 0.0 107.189 172.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.871 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 5.6 m -67.84 140.44 19.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 C-N-CA 118.616 -1.234 . . . . 0.0 110.811 -174.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -122.88 113.67 19.44 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.441 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.527 ' H ' ' HD1' ' A' ' 21' ' ' PHE . 38.9 t70 72.81 125.38 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 O-C-N 124.371 1.044 . . . . 0.0 110.717 -178.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 65.8 -85.14 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.684 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.543 ' HA3' ' OE1' ' A' ' 18' ' ' GLN . . . -174.0 37.67 0.12 Allowed Glycine 0 C--O 1.239 0.451 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 -179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.447 HD12 ' CH2' ' A' ' 43' ' ' TRP . 1.4 mm? -120.66 112.14 18.5 Favored 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 115.241 -0.479 . . . . 0.0 111.929 -172.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.871 ' HB2' ' HA ' ' A' ' 36' ' ' VAL . . . -116.53 125.93 52.6 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 171.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.714 ' CE3' ' HA ' ' A' ' 8' ' ' PHE . 8.9 m95 -86.68 81.51 8.2 Favored 'General case' 0 CA--C 1.499 -1.002 0 C-N-CA 112.603 -3.639 . . . . 0.0 105.494 167.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.102 ' HB3' ' HA2' ' A' ' 34' ' ' GLY . 0.2 OUTLIER -149.7 131.1 14.71 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 -165.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.977 ' HB3' ' HG ' ' A' ' 7' ' ' LEU . 8.6 t 171.2 -145.86 0.0 OUTLIER 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 114.968 -1.015 . . . . 0.0 108.425 177.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.32 -0.47 8.14 Favored Glycine 0 C--N 1.3 -1.471 0 C-N-CA 117.704 -2.189 . . . . 0.0 110.338 -160.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.712 HG21 HG11 ' A' ' 67' ' ' VAL . 7.9 p -72.26 153.09 7.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 114.824 -0.688 . . . . 0.0 111.126 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.725 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 6.5 m -98.83 131.47 25.55 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 1.013 ' HB3' ' HA ' ' A' ' 69' ' ' GLU . 83.3 Cg_exo -41.24 127.98 3.05 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 123.737 2.958 . . . . 0.0 113.899 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 97.15 36.27 5.0 Favored Glycine 0 C--N 1.339 0.713 0 C-N-CA 119.374 -1.393 . . . . 0.0 113.148 174.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.964 ' H ' HG22 ' A' ' 67' ' ' VAL . 30.3 mt-10 -122.37 -170.15 2.02 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 118.939 -1.104 . . . . 0.0 113.031 -175.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.4 m -132.83 112.86 12.28 Favored 'General case' 0 N--CA 1.429 -1.497 0 CA-C-N 114.433 -1.258 . . . . 0.0 110.89 172.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.834 HD21 HD11 ' A' ' 33' ' ' LEU . 18.6 mt -78.21 159.23 28.66 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.053 175.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.637 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 6.4 m -120.04 119.93 34.82 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 168.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.864 ' HA ' ' O ' ' A' ' 24' ' ' SER . 38.2 t -112.64 124.34 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.849 0 CA-C-O 121.513 0.673 . . . . 0.0 111.916 -169.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.846 ' HB3' ' OG ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -120.02 146.45 45.86 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.067 -170.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.662 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 9.7 p90 -157.92 -139.26 0.07 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 119.499 -0.88 . . . . 0.0 112.754 168.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.662 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 1.5 m-20 -41.49 -60.0 1.43 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.348 0.659 . . . . 0.0 111.558 168.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.638 ' HA3' ' NE2' ' A' ' 62' ' ' GLN . . . -77.33 -3.2 81.82 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 118.882 -1.628 . . . . 0.0 110.581 175.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.639 ' O ' ' HA ' ' A' ' 56' ' ' ASN . 10.7 mttp 76.45 -149.91 0.03 OUTLIER 'General case' 0 CA--C 1.495 -1.17 0 CA-C-N 114.356 -0.922 . . . . 0.0 111.95 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.606 HG13 ' HB2' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -71.78 101.42 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -176.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.638 ' NE2' ' HA3' ' A' ' 59' ' ' GLY . 0.2 OUTLIER -129.65 -46.03 1.18 Allowed 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.587 -1.188 . . . . 0.0 111.632 -175.055 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.52 ' HB3' HD11 ' A' ' 13' ' ' LEU . 16.3 p -99.66 148.07 24.74 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 170.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.651 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 27.7 mt-30 -133.24 141.67 48.15 Favored 'General case' 0 CA--C 1.484 -1.578 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.64 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 1.5 t -96.15 146.41 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.968 0 C-N-CA 116.276 -2.17 . . . . 0.0 112.564 -164.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -98.3 116.17 29.96 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 119.84 -0.744 . . . . 0.0 110.1 171.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.964 HG22 ' H ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -93.54 123.14 61.06 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.316 -178.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 97.7 Cg_endo -92.46 170.83 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 123.707 2.938 . . . . 0.0 113.268 -175.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 1.013 ' HA ' ' HB3' ' A' ' 49' ' ' PRO . 1.8 mp0 -73.35 -13.34 61.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.52 -177.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.7 p -82.89 24.86 0.72 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.332 0.494 . . . . 0.0 112.332 -176.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -111.4 159.17 18.27 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.456 0.539 . . . . 0.0 112.456 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.454 HG22 ' HB2' ' A' ' 75' ' ' GLN . 7.0 tp -169.08 168.09 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 CA-C-N 115.327 -0.852 . . . . 0.0 109.263 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.631 ' HB3' ' H ' ' A' ' 5' ' ' LYS . 4.1 p -52.82 135.35 35.98 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -176.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.511 ' OD1' ' HD2' ' A' ' 5' ' ' LYS . 20.7 m-20 62.51 4.6 1.39 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 175.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.454 ' HB2' HG22 ' A' ' 72' ' ' ILE . 11.4 tt0 -86.23 155.59 20.64 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 122.19 -0.319 . . . . 0.0 111.324 -174.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 1.086 ' HA ' ' HB3' ' A' ' 8' ' ' PHE . 14.9 pt20 -82.77 130.2 35.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.051 178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.682 HD23 HD13 ' A' ' 7' ' ' LEU . 3.0 mm? -137.88 118.45 13.92 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.444 ' HG ' HD12 ' A' ' 10' ' ' ILE . 6.3 mp -86.08 96.63 9.94 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 118.759 -1.176 . . . . 0.0 108.115 174.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.588 HD13 HG11 ' A' ' 65' ' ' VAL . 96.2 mt -90.9 132.13 35.43 Favored Pre-proline 0 C--O 1.249 1.048 0 CA-C-O 121.582 0.706 . . . . 0.0 112.703 -167.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -79.41 117.99 3.85 Favored 'Trans proline' 0 C--O 1.247 0.95 0 C-N-CA 123.544 2.829 . . . . 0.0 111.784 176.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.466 ' SG ' HG23 ' A' ' 65' ' ' VAL . 0.1 OUTLIER -99.74 99.13 9.91 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.59 179.412 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 93.3 m -90.22 123.03 66.83 Favored Pre-proline 0 C--N 1.32 -0.716 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.576 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 62' ' ' GLN . 55.4 Cg_endo -70.25 123.62 10.11 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.361 2.041 . . . . 0.0 111.066 175.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -106.95 98.27 7.95 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.493 -177.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 C--O 1.252 1.201 0 CA-C-O 118.528 -0.748 . . . . 0.0 109.839 173.513 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.811 0.339 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 3' ' ' LYS . 5.5 tt -75.93 112.55 12.45 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.736 ' HE3' ' HD3' ' A' ' 49' ' ' PRO . 19.7 tptp 71.47 -60.02 0.53 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.803 0.689 . . . . 0.0 112.5 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.647 ' HA3' ' HB2' ' A' ' 73' ' ' SER . . . 114.36 118.83 3.36 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 -172.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 46' ' ' GLY . 28.4 ttpp -166.61 58.34 0.09 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 -170.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 1.114 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 0.2 OUTLIER 174.37 138.99 0.04 OUTLIER 'General case' 0 N--CA 1.404 -2.73 1 N-CA-C 99.692 -4.188 . . . . 0.0 99.692 158.468 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.926 HD13 ' HA3' ' A' ' 46' ' ' GLY . 0.4 OUTLIER -168.44 169.28 10.62 Favored 'General case' 0 N--CA 1.408 -2.537 0 C-N-CA 114.803 -2.759 . . . . 0.0 114.295 -159.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.665 ' HB2' ' HA ' ' A' ' 76' ' ' GLN . 77.4 m-85 -98.32 89.58 4.51 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 114.729 -1.123 . . . . 0.0 108.84 174.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.26 103.92 15.89 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.543 -174.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 54.1 mt -89.22 102.25 12.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.475 175.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.83 ' H ' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -106.08 126.25 51.98 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.138 0.971 . . . . 0.0 110.559 -173.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -127.31 156.06 42.56 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.91 -1.496 . . . . 0.0 108.479 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.57 HD23 ' C ' ' A' ' 18' ' ' GLN . 1.1 pp -105.97 137.52 43.73 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 117.96 -1.496 . . . . 0.0 109.531 -178.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.27 -9.96 0.78 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -166.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' HB3' HD12 ' A' ' 13' ' ' LEU . 6.5 t70 -66.74 -22.23 66.06 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.505 0.669 . . . . 0.0 110.216 174.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 109.3 -6.85 32.25 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -173.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.7 t -96.91 -175.2 3.2 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.61 -0.795 . . . . 0.0 109.729 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.57 ' C ' HD23 ' A' ' 13' ' ' LEU . 1.6 tt0 -120.31 138.29 27.06 Favored Pre-proline 0 C--N 1.31 -1.124 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.631 -171.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.545 ' N ' HD23 ' A' ' 13' ' ' LEU . 2.8 Cg_endo -80.73 103.96 1.54 Allowed 'Trans proline' 0 N--CA 1.428 -2.329 0 N-CA-C 105.646 -2.482 . . . . 0.0 105.646 156.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 1.1 Cg_endo -103.49 175.98 0.16 Allowed 'Trans proline' 0 N--CA 1.431 -2.199 0 C-N-CA 123.111 2.541 . . . . 0.0 112.545 -161.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.627 ' HA ' ' O ' ' A' ' 36' ' ' VAL . 24.8 t80 -23.94 104.48 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -168.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.72 0.23 24.51 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.083 176.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.851 ' HB3' HG12 ' A' ' 36' ' ' VAL . . . -60.69 99.63 0.09 Allowed 'General case' 0 CA--C 1.509 -0.619 0 C-N-CA 120.256 -0.577 . . . . 0.0 110.424 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.94 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 68.4 p -66.82 99.32 0.61 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 112.897 -1.956 . . . . 0.0 110.418 173.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.888 HG22 ' HA3' ' A' ' 34' ' ' GLY . 5.1 m -82.37 101.41 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.047 0 C-N-CA 115.762 -2.375 . . . . 0.0 107.982 166.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.685 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 1.1 t -138.51 120.0 14.96 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.926 -171.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 26.1 t -83.15 160.64 21.8 Favored 'General case' 0 C--O 1.211 -0.941 0 C-N-CA 119.317 -0.953 . . . . 0.0 108.988 -171.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -15.6 -70.86 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 116.225 1.935 . . . . 0.0 116.225 -164.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -65.47 -20.81 66.51 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.3 0.571 . . . . 0.0 112.069 -172.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.533 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 119.67 40.36 0.62 Allowed Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 109.162 -1.575 . . . . 0.0 109.162 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.692 ' HD2' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -77.24 93.41 3.97 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -90.57 95.89 10.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.204 0.526 . . . . 0.0 110.478 -172.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.791 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 0.9 OUTLIER -106.06 3.71 28.46 Favored 'General case' 0 CA--C 1.496 -1.106 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.332 -176.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.888 ' HA3' HG22 ' A' ' 25' ' ' VAL . . . -157.13 149.67 20.46 Favored Glycine 0 C--O 1.221 -0.672 0 O-C-N 124.585 1.178 . . . . 0.0 112.884 172.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.749 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 42.8 mtp -150.82 107.91 3.58 Favored 'General case' 0 CA--C 1.493 -1.221 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 165.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.851 HG12 ' HB3' ' A' ' 23' ' ' ALA . 1.9 p -60.67 123.89 14.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.567 -170.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.434 ' HA ' ' HD1' ' A' ' 21' ' ' PHE . . . -107.5 129.79 54.92 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 170.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.502 ' OD1' ' HG3' ' A' ' 39' ' ' GLU . 3.4 t0 73.59 -150.44 0.05 Allowed 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.902 0.751 . . . . 0.0 109.418 -175.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.502 ' HG3' ' OD1' ' A' ' 38' ' ' ASP . 32.6 mt-10 -84.24 81.95 8.59 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -171.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.3 -17.66 46.46 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 114.804 0.681 . . . . 0.0 114.804 165.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.801 ' H ' HD22 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -85.78 113.09 21.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 118.045 0.922 . . . . 0.0 113.101 175.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -95.64 103.47 15.34 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 169.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.673 ' HA ' ' CE3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -82.83 89.58 6.83 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 178.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.865 ' CB ' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -140.29 -165.23 1.87 Allowed 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -163.126 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 1.114 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 5.7 p -122.51 113.7 19.67 Favored 'General case' 0 N--CA 1.424 -1.731 0 C-N-CA 117.462 -1.695 . . . . 0.0 109.243 -167.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.926 ' HA3' HD13 ' A' ' 7' ' ' LEU . . . -59.4 173.21 4.33 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 118.829 2.292 . . . . 0.0 118.829 -161.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.448 ' HB ' HD23 ' A' ' 33' ' ' LEU . 8.0 p -121.1 172.78 7.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 112.984 -1.608 . . . . 0.0 110.577 -173.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.445 ' H ' HG22 ' A' ' 47' ' ' VAL . 6.4 m -71.29 148.12 93.48 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.257 0.623 . . . . 0.0 110.209 174.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.736 ' HD3' ' HE3' ' A' ' 3' ' ' LYS . 4.5 Cg_exo -77.82 161.82 30.05 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.479 2.119 . . . . 0.0 112.189 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.27 35.24 27.24 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 119.454 -1.355 . . . . 0.0 112.216 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.592 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 22.3 mt-10 -132.0 -168.29 2.01 Favored 'General case' 0 CA--C 1.501 -0.931 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.818 -175.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.2 m -139.84 99.05 3.6 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.72 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.779 HD13 ' HB ' ' A' ' 25' ' ' VAL . 30.9 mt -57.91 155.44 10.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.015 168.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.593 ' HA ' ' HG2' ' A' ' 64' ' ' GLN . 48.8 m -121.75 119.88 33.02 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 170.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.94 ' HA ' ' O ' ' A' ' 24' ' ' SER . 48.8 t -109.55 110.81 33.49 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 CA-C-O 122.023 0.916 . . . . 0.0 112.435 -166.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.948 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 0.4 OUTLIER -97.26 149.32 22.18 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.412 -174.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.702 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 0.1 OUTLIER -158.71 155.09 27.42 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.918 -167.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.702 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 0.1 OUTLIER -19.78 -57.37 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.721 1.208 . . . . 0.0 114.16 174.596 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.34 -44.4 95.47 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 117.249 -2.405 . . . . 0.0 113.479 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.56 ' O ' ' HG2' ' A' ' 62' ' ' GLN . 1.2 pttt 174.25 -176.25 0.08 Allowed 'General case' 0 C--O 1.221 -0.407 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -167.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.948 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 4.2 tt -87.9 97.06 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 169.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.56 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -103.92 -50.02 3.49 Favored 'General case' 0 CA--C 1.507 -0.686 0 C-N-CA 118.938 -1.105 . . . . 0.0 112.795 -158.042 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.401 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 29.0 p -104.87 158.08 16.77 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 176.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.593 ' HG2' ' HA ' ' A' ' 54' ' ' SER . 51.0 mt-30 -133.09 138.89 46.87 Favored 'General case' 0 CA--C 1.484 -1.56 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 176.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.669 ' HB ' ' HB2' ' A' ' 53' ' ' LEU . 2.7 t -91.44 130.55 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 C-N-CA 115.013 -2.675 . . . . 0.0 112.117 -169.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.439 HD22 ' N ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER -93.29 116.12 28.69 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 118.494 -1.282 . . . . 0.0 110.06 177.134 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.624 HG12 ' HA ' ' A' ' 49' ' ' PRO . 13.8 t -93.55 116.16 66.07 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.585 -177.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -92.03 169.23 2.93 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.051 2.501 . . . . 0.0 111.818 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -90.25 15.05 11.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.192 0.52 . . . . 0.0 110.776 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.5 m -106.78 2.6 25.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.589 0.709 . . . . 0.0 110.1 179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.38 174.85 7.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.75 -175.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.678 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 11.1 tp -136.66 170.33 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.111 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.647 ' HB2' ' HA3' ' A' ' 4' ' ' GLY . 15.1 m -146.04 -178.58 6.2 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.51 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 23.7 t70 71.33 -41.95 0.52 Allowed 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.106 0.562 . . . . 0.0 110.645 -173.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 73' ' ' SER . 69.1 mt-30 -89.73 -163.56 1.02 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.864 173.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.665 ' HA ' ' HB2' ' A' ' 8' ' ' PHE . 25.6 tt0 -86.55 133.62 33.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.536 174.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.678 ' HG ' ' H ' ' A' ' 72' ' ' ILE . 3.1 tm? -150.87 133.04 15.34 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -178.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.772 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.4 pt? -94.41 134.74 36.6 Favored 'General case' 0 C--N 1.318 -0.793 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.557 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.58 ' HB2' ' HB3' ' A' ' 11' ' ' LEU . 93.5 mt -106.43 137.24 19.37 Favored Pre-proline 0 C--O 1.24 0.557 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.281 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 59.8 Cg_endo -90.28 114.51 0.51 Allowed 'Trans proline' 0 N--CA 1.454 -0.85 0 C-N-CA 123.189 2.593 . . . . 0.0 113.027 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.87 107.31 18.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.106 177.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 89.9 m -78.39 130.5 71.43 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.705 175.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -66.93 129.55 21.02 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.402 2.068 . . . . 0.0 110.998 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -53.62 131.54 39.04 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.429 0.455 . . . . 0.0 110.938 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 13.6 tppt? . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.071 -177.078 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.5 mt -96.89 -72.43 0.64 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.801 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.5 ' HG3' ' H ' ' A' ' 4' ' ' GLY . 15.9 tptp 60.45 -157.35 0.34 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.151 -177.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.5 ' H ' ' HG3' ' A' ' 3' ' ' LYS . . . 75.2 -153.89 45.53 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-O 118.56 -1.133 . . . . 0.0 110.729 -175.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.747 ' HD2' ' H ' ' A' ' 5' ' ' LYS . 0.2 OUTLIER 18.44 69.23 0.02 OUTLIER 'General case' 0 C--N 1.351 0.655 0 CA-C-O 123.749 1.738 . . . . 0.0 112.704 -177.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.926 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 2.1 tmm_? -175.59 121.07 0.19 Allowed 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 110.094 -3.23 . . . . 0.0 104.25 151.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.859 HD11 ' H ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -140.56 175.41 9.63 Favored 'General case' 0 N--CA 1.403 -2.816 0 CA-C-N 112.312 -2.222 . . . . 0.0 111.007 -158.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.673 ' HD2' ' HB3' ' A' ' 76' ' ' GLN . 0.3 OUTLIER -110.91 87.43 2.53 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 173.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.555 ' O ' ' HA ' ' A' ' 41' ' ' LEU . . . -90.59 115.16 27.49 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.5 -167.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 57.0 mt -95.38 98.4 7.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.949 ' HB3' ' HG2' ' A' ' 19' ' ' PRO . 3.4 mm? -90.13 134.29 34.36 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 119.559 -0.857 . . . . 0.0 109.411 -174.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.4 ttp180 -144.05 126.54 15.9 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.055 175.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.785 ' HB3' ' SG ' ' A' ' 81' ' ' CYS . 0.9 OUTLIER -90.48 113.54 25.52 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 117.347 -1.741 . . . . 0.0 109.602 174.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.48 -7.98 1.65 Allowed 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 113.73 -1.577 . . . . 0.0 113.734 -169.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -63.32 -13.73 42.02 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.219 0.533 . . . . 0.0 110.668 174.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.51 27.75 2.98 Favored Glycine 0 CA--C 1.502 -0.724 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.694 176.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 73.7 m -142.03 170.68 15.26 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 114.906 -0.647 . . . . 0.0 110.219 -174.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.82 142.47 31.85 Favored Pre-proline 0 CA--C 1.495 -1.14 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.657 -176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.949 ' HG2' ' HB3' ' A' ' 11' ' ' LEU . 5.6 Cg_exo -75.29 105.38 2.07 Favored 'Trans proline' 0 N--CA 1.424 -2.562 0 N-CA-C 105.027 -2.72 . . . . 0.0 105.027 156.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -105.96 -165.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.155 0 C-N-CA 123.078 2.519 . . . . 0.0 112.198 -164.043 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -41.74 100.16 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -170.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.84 22.8 7.79 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 111.034 -0.826 . . . . 0.0 111.034 178.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.873 ' HB3' HG13 ' A' ' 36' ' ' VAL . . . -64.94 89.62 0.08 Allowed 'General case' 0 CA--C 1.503 -0.864 0 C-N-CA 119.608 -0.837 . . . . 0.0 110.694 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.736 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.9 OUTLIER -70.45 87.91 0.65 Allowed 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.578 -1.646 . . . . 0.0 111.622 178.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.867 HG22 ' CA ' ' A' ' 34' ' ' GLY . 3.2 m -82.28 112.36 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 118.653 -1.219 . . . . 0.0 110.173 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -140.53 121.22 14.32 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.795 -178.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.713 ' OG ' HD23 ' A' ' 53' ' ' LEU . 64.0 m -84.85 -171.98 3.93 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.216 -0.994 . . . . 0.0 110.723 -168.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -23.93 -67.85 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 -169.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -88.71 -6.97 57.09 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -171.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.554 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 114.39 35.87 1.39 Allowed Glycine 0 CA--C 1.487 -1.672 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 -177.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.686 ' O ' HD22 ' A' ' 33' ' ' LEU . 68.3 mtp180 -76.01 100.06 4.78 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 174.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -91.9 96.05 10.17 Favored 'General case' 0 C--N 1.314 -0.959 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.06 -169.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.887 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -109.01 4.42 23.19 Favored 'General case' 0 CA--C 1.508 -0.638 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.712 -170.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.867 ' CA ' HG22 ' A' ' 25' ' ' VAL . . . -166.72 154.76 25.45 Favored Glycine 0 N--CA 1.467 0.764 0 C-N-CA 119.079 -1.534 . . . . 0.0 114.406 176.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.674 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 31.8 mtt -149.88 99.67 2.87 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 164.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.873 HG13 ' HB3' ' A' ' 23' ' ' ALA . 2.2 m -72.09 106.59 2.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 C-N-CA 118.899 -1.121 . . . . 0.0 111.176 -169.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -96.43 120.84 37.47 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 118.659 -1.216 . . . . 0.0 110.328 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.9 t70 70.6 119.69 0.04 OUTLIER 'General case' 0 C--O 1.237 0.398 0 O-C-N 124.348 1.03 . . . . 0.0 110.968 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' O ' ' HA ' ' A' ' 20' ' ' PRO . 7.1 mm-40 66.63 -98.93 0.05 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.309 -178.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -162.83 47.65 0.33 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.084 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 9' ' ' ALA . 3.9 tt -133.96 125.07 27.43 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.533 ' HB1' ' H ' ' A' ' 35' ' ' MET . . . -113.08 129.23 56.57 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.75 0.31 . . . . 0.0 110.659 177.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -90.48 83.46 5.88 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 176.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.887 ' HB3' ' O ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -145.46 -170.37 3.43 Favored 'General case' 0 C--O 1.195 -1.764 0 CA-C-O 118.973 -0.537 . . . . 0.0 110.002 -157.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.926 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 37.3 p -116.76 85.81 2.39 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -163.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.859 ' H ' HD11 ' A' ' 7' ' ' LEU . . . -62.12 -177.82 3.12 Favored Glycine 0 N--CA 1.476 1.334 0 N-CA-C 116.395 1.318 . . . . 0.0 116.395 -162.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.6 HG13 ' CD2' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -103.78 177.08 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 CA-C-N 115.153 -0.523 . . . . 0.0 111.79 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.402 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 7.0 m -82.47 139.52 44.58 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.029 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.727 ' HA ' HG12 ' A' ' 67' ' ' VAL . 59.0 Cg_exo -52.73 120.91 8.28 Favored 'Trans proline' 0 CA--C 1.531 0.34 0 C-N-CA 122.808 2.338 . . . . 0.0 112.833 176.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 118.68 36.3 0.92 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.023 -1.084 . . . . 0.0 112.677 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.719 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 24.3 mt-10 -138.43 -160.94 1.11 Allowed 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 119.244 -0.982 . . . . 0.0 112.175 -174.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.655 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 58.3 m -142.73 129.78 20.76 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.4 172.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.758 ' HB2' HG13 ' A' ' 65' ' ' VAL . 45.3 mt -88.13 151.47 22.69 Favored 'General case' 0 C--O 1.22 -0.449 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 173.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.06 106.93 14.31 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 171.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.736 ' HA ' ' O ' ' A' ' 24' ' ' SER . 20.0 t -112.32 109.69 29.48 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.892 -159.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.658 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 41.5 m-80 -77.68 146.16 36.19 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.549 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.756 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -150.41 149.82 30.55 Favored 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.415 -174.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.756 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 5.2 m-20 -25.18 -55.62 0.05 Allowed 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 173.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.88 -40.62 98.55 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 117.071 -2.49 . . . . 0.0 113.778 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.763 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 0.0 OUTLIER 169.12 -168.96 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.475 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -169.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.4 tt -86.12 115.16 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 169.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.763 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 1.1 mt-30 -130.73 -48.78 1.05 Allowed 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 117.663 -1.615 . . . . 0.0 111.207 -165.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.616 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . 38.1 t -72.95 129.29 37.78 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 114.343 -1.298 . . . . 0.0 107.772 174.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 -136.11 114.66 11.84 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 167.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.758 HG13 ' HB2' ' A' ' 53' ' ' LEU . 0.6 OUTLIER -93.75 147.09 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.167 0 C-N-CA 115.04 -2.664 . . . . 0.0 112.346 -160.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.407 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 77.1 m-20 -100.5 108.92 21.0 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 119.175 -1.01 . . . . 0.0 109.568 174.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 49' ' ' PRO . 22.1 t -79.99 112.49 30.44 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.074 -178.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 66' ' ' ASN . 94.4 Cg_endo -89.01 171.45 4.7 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 123.445 2.763 . . . . 0.0 112.141 -178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' A' ' 69' ' ' GLU . 2.4 mp0 -67.34 -15.37 63.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.72 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 2.4 m -79.83 -3.89 49.79 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.039 0.447 . . . . 0.0 111.115 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.62 156.87 36.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.4 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.472 HD13 ' H ' ' A' ' 73' ' ' SER . 0.4 OUTLIER -158.93 160.16 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.647 ' CB ' HD12 ' A' ' 7' ' ' LEU . 22.0 p -120.28 174.27 6.61 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.698 -0.401 . . . . 0.0 110.578 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 28.8 t70 68.78 8.16 6.59 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.371 0.605 . . . . 0.0 110.802 -177.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.7 mt-30 -138.06 172.5 12.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.797 179.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.673 ' HB3' ' HD2' ' A' ' 8' ' ' PHE . 11.0 pt20 -94.13 124.74 38.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 172.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 47.6 tp -150.27 149.04 29.6 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 -176.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.82 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.0 pt? -98.48 132.27 44.06 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.492 -1.283 . . . . 0.0 109.915 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.591 ' HB2' HD13 ' A' ' 11' ' ' LEU . 3.1 mm? -110.66 143.73 28.8 Favored Pre-proline 0 C--O 1.248 0.994 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.33 -176.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 4.9 Cg_exo -79.8 100.36 1.28 Allowed 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 123.727 2.951 . . . . 0.0 112.864 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 13' ' ' LEU . 5.1 t -82.62 146.2 29.26 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.212 173.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.4 m -126.12 136.34 28.39 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -55.45 152.67 31.85 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 122.019 1.813 . . . . 0.0 111.04 174.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -66.33 -3.72 6.52 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.011 0.434 . . . . 0.0 111.717 -176.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 67.2 mttm . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.501 -0.761 . . . . 0.0 110.139 178.452 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.9 m . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 110.392 -0.225 . . . . 0.0 110.392 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.425 ' HA ' HD11 ' A' ' 72' ' ' ILE . 4.2 mm? -69.15 -31.99 71.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.028 0.442 . . . . 0.0 110.61 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -80.09 74.77 6.87 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.707 ' HA3' ' HB3' ' A' ' 73' ' ' SER . . . -77.95 111.81 3.34 Favored Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 115.373 -0.831 . . . . 0.0 114.001 -170.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -166.05 68.34 0.12 Allowed 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.953 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 0.0 OUTLIER -179.9 131.54 0.1 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 104.366 -2.457 . . . . 0.0 104.366 153.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.794 HD13 ' CA ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER -157.99 172.09 19.07 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 115.797 1.776 . . . . 0.0 115.797 -157.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.589 ' HB2' ' HA ' ' A' ' 76' ' ' GLN . 92.4 m-85 -114.65 90.18 3.28 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 112.739 -2.028 . . . . 0.0 107.542 174.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.48 98.55 11.83 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.503 -0.479 . . . . 0.0 112.0 -171.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.623 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 40.5 mt -87.73 103.0 13.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 174.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.975 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -117.85 150.33 39.35 Favored 'General case' 0 N--CA 1.434 -1.273 0 C-N-CA 119.13 -1.028 . . . . 0.0 109.651 -175.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.506 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 13.8 mmm180 -140.3 155.42 46.84 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.79 HD22 ' SG ' ' A' ' 63' ' ' CYS . 1.8 mt -78.69 151.0 32.43 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 116.87 -1.932 . . . . 0.0 107.092 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.34 -40.34 67.95 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.684 -172.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 48.6 p-10 -74.68 -10.46 59.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.811 0.339 . . . . 0.0 111.686 -178.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.22 24.72 4.07 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 119.557 -1.306 . . . . 0.0 111.754 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.66 ' HB2' ' CG ' ' A' ' 13' ' ' LEU . 16.2 m -106.33 -155.32 0.54 Allowed 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.638 ' N ' ' HG ' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -140.35 137.82 18.25 Favored Pre-proline 0 CA--C 1.51 -0.564 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -170.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.975 ' HG2' ' HB2' ' A' ' 11' ' ' LEU . 3.6 Cg_exo -78.59 102.14 1.52 Allowed 'Trans proline' 0 N--CA 1.438 -1.792 0 N-CA-C 104.773 -2.818 . . . . 0.0 104.773 149.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.522 ' HB3' ' HB3' ' A' ' 18' ' ' GLN . 9.8 Cg_endo -107.78 160.88 0.1 Allowed 'Trans proline' 0 N--CA 1.431 -2.201 0 C-N-CA 123.455 2.77 . . . . 0.0 112.683 -164.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.411 ' CD1' ' HA ' ' A' ' 37' ' ' ALA . 66.5 t80 -18.64 103.7 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -168.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.63 4.36 46.12 Favored Glycine 0 N--CA 1.43 -1.702 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.836 ' HA ' ' O ' ' A' ' 56' ' ' ASN . . . -61.78 100.03 0.14 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.851 169.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.783 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -72.57 100.07 2.67 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 112.395 -2.184 . . . . 0.0 111.453 173.243 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.741 HG22 ' CA ' ' A' ' 34' ' ' GLY . 19.9 m -89.61 113.78 26.49 Favored 'Isoleucine or valine' 0 C--O 1.248 1.018 0 C-N-CA 117.645 -1.622 . . . . 0.0 109.668 174.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 1.035 ' HA ' ' HB3' ' A' ' 32' ' ' GLU . 3.2 p -148.79 133.83 18.17 Favored 'General case' 0 CA--C 1.496 -1.113 0 C-N-CA 119.376 -0.929 . . . . 0.0 110.081 170.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.604 ' HB3' ' HB3' ' A' ' 31' ' ' ARG . 0.0 OUTLIER -78.52 162.7 26.14 Favored 'General case' 0 C--O 1.207 -1.139 0 C-N-CA 117.221 -1.792 . . . . 0.0 108.181 -172.044 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -18.61 -62.67 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 116.33 1.974 . . . . 0.0 116.33 -165.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.0 mttm -87.13 3.49 46.05 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -171.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.89 27.03 5.57 Favored Glycine 0 CA--C 1.488 -1.614 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.948 ' HG3' HG11 ' A' ' 47' ' ' VAL . 8.5 tpt180 -68.15 176.92 2.46 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 174.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 1.035 ' HB3' ' HA ' ' A' ' 26' ' ' THR . 23.2 tp10 82.06 -120.56 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 169.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.697 ' C ' ' HB3' ' A' ' 44' ' ' LEU . 0.0 OUTLIER 98.21 93.01 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.186 0 O-C-N 124.512 1.133 . . . . 0.0 109.623 -159.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 1.049 ' HA2' ' HB2' ' A' ' 44' ' ' LEU . . . -159.94 102.19 0.21 Allowed Glycine 0 C--O 1.216 -1.014 0 CA-C-N 112.362 -2.199 . . . . 0.0 112.216 164.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.757 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 14.3 mtm -111.08 125.67 54.01 Favored 'General case' 0 CA--C 1.498 -1.022 0 O-C-N 121.0 -1.294 . . . . 0.0 109.911 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.748 HG12 ' HB3' ' A' ' 23' ' ' ALA . 2.1 p -73.59 139.29 19.65 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.727 -174.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.411 ' HA ' ' CD1' ' A' ' 21' ' ' PHE . . . -112.87 71.14 0.73 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 171.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 36.3 t70 72.65 151.91 0.12 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.239 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.516 ' HB2' HD21 ' A' ' 41' ' ' LEU . 13.5 mm-40 71.8 -27.65 0.18 Allowed 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 123.841 0.857 . . . . 0.0 112.889 177.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.442 ' HA2' HG21 ' A' ' 36' ' ' VAL . . . 116.99 12.81 8.15 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.354 175.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -90.0 107.31 19.04 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 120.678 -0.409 . . . . 0.0 112.002 173.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.737 ' HB1' ' C ' ' A' ' 34' ' ' GLY . . . -95.8 92.45 6.55 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.499 0.666 . . . . 0.0 110.45 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.521 ' HA ' ' CE3' ' A' ' 43' ' ' TRP . 0.0 OUTLIER -83.33 110.85 18.47 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.424 -177.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.049 ' HB2' ' HA2' ' A' ' 34' ' ' GLY . 4.2 mt -167.47 -169.93 1.33 Allowed 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -167.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.953 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 26.5 p -127.47 79.36 1.88 Allowed 'General case' 0 N--CA 1.408 -2.566 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 -168.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.775 ' H ' ' CD1' ' A' ' 7' ' ' LEU . . . -87.04 -150.49 18.1 Favored Glycine 0 C--N 1.306 -1.111 0 CA-C-N 114.44 -1.255 . . . . 0.0 113.529 -161.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.948 HG11 ' HG3' ' A' ' 31' ' ' ARG . 15.5 m -121.2 174.57 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 CA-C-O 121.503 0.668 . . . . 0.0 112.162 174.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 11.4 t -77.79 139.19 62.08 Favored Pre-proline 0 N--CA 1.441 -0.882 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.692 -175.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.486 ' HB3' HG22 ' A' ' 67' ' ' VAL . 87.5 Cg_exo -49.06 153.2 4.25 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 123.941 3.094 . . . . 0.0 114.155 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.888 ' H ' HG13 ' A' ' 67' ' ' VAL . . . 119.44 26.74 2.33 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.332 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.715 ' H ' ' CG1' ' A' ' 67' ' ' VAL . 23.2 mt-10 -143.36 -168.45 2.82 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.763 0.792 . . . . 0.0 112.946 -173.076 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 65' ' ' VAL . 16.7 p -126.69 122.36 34.7 Favored 'General case' 0 N--CA 1.435 -1.181 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.912 167.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.689 ' HB2' HG12 ' A' ' 65' ' ' VAL . 19.2 mt -93.37 121.01 34.31 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.302 -173.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.626 ' HB3' HD11 ' A' ' 61' ' ' ILE . 13.3 m -77.62 109.37 11.53 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.607 0.718 . . . . 0.0 110.583 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.783 ' HA ' ' O ' ' A' ' 24' ' ' SER . 59.3 t -116.57 116.72 53.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.537 -167.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.836 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 37.6 m-80 -99.33 157.53 16.34 Favored 'General case' 0 C--O 1.216 -0.668 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.812 -176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.673 ' CD1' ' N ' ' A' ' 58' ' ' ASP . 2.4 p90 -161.62 -144.5 0.1 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.887 159.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.673 ' N ' ' CD1' ' A' ' 57' ' ' TRP . 1.0 OUTLIER -41.49 -55.0 2.98 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 118.746 0.703 . . . . 0.0 111.076 166.216 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.645 ' HA3' ' NE2' ' A' ' 62' ' ' GLN . . . -80.68 2.3 79.6 Favored Glycine 0 C--N 1.34 0.774 0 C-N-CA 118.886 -1.626 . . . . 0.0 111.079 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.643 ' CA ' ' H ' ' A' ' 57' ' ' TRP . 11.2 mtpt 67.13 -151.59 0.19 Allowed 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 114.482 -0.859 . . . . 0.0 111.771 175.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.626 HD11 ' HB3' ' A' ' 54' ' ' SER . 0.1 OUTLIER -64.09 106.97 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 CA-C-O 122.648 1.213 . . . . 0.0 108.656 -177.001 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.645 ' NE2' ' HA3' ' A' ' 59' ' ' GLY . 2.3 pt20 -146.62 -39.33 0.21 Allowed 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 113.759 -1.564 . . . . 0.0 111.614 -174.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.79 ' SG ' HD22 ' A' ' 13' ' ' LEU . 1.6 t -96.75 135.04 39.26 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.528 174.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.637 ' HA ' ' O ' ' A' ' 53' ' ' LEU . 49.7 mt-30 -126.36 137.75 53.49 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 169.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.689 HG12 ' HB2' ' A' ' 53' ' ' LEU . 0.4 OUTLIER -97.41 129.95 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.532 0 C-N-CA 115.985 -2.286 . . . . 0.0 110.185 -170.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -89.56 98.46 11.78 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 119.216 -0.994 . . . . 0.0 109.332 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.888 HG13 ' H ' ' A' ' 50' ' ' GLY . 9.0 p -92.11 115.98 65.64 Favored Pre-proline 0 N--CA 1.44 -0.939 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.525 -177.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.419 ' O ' ' HB3' ' A' ' 49' ' ' PRO . 2.3 Cg_endo -82.53 152.68 15.47 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.352 2.701 . . . . 0.0 111.565 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -75.84 13.39 0.85 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.828 0.346 . . . . 0.0 111.875 -174.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 m -73.75 -42.45 61.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.986 -175.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -104.11 -173.14 2.24 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.821 -173.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.425 HD11 ' HA ' ' A' ' 2' ' ' LEU . 12.6 tt -140.93 155.68 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.35 -176.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.782 ' OG ' HD12 ' A' ' 7' ' ' LEU . 33.3 t -84.85 -166.51 1.5 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.886 -175.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.438 ' HB3' ' O ' ' A' ' 73' ' ' SER . 38.8 t70 75.76 10.07 3.39 Favored 'General case' 0 C--N 1.359 1.012 0 CA-C-O 121.717 0.77 . . . . 0.0 110.195 -178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -153.24 -171.97 4.09 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.154 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.589 ' HA ' ' HB2' ' A' ' 8' ' ' PHE . 14.1 pt20 -86.11 140.39 30.26 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 176.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 72' ' ' ILE . 96.1 mt -138.47 157.0 47.03 Favored 'General case' 0 CA--C 1.502 -0.899 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.692 HD13 ' H ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -111.03 132.96 53.79 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 117.757 -1.577 . . . . 0.0 109.528 173.46 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.446 HD12 HG23 ' A' ' 67' ' ' VAL . 2.7 mm? -122.9 140.98 34.41 Favored Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -169.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 57.8 Cg_endo -88.57 110.01 0.57 Allowed 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.846 3.031 . . . . 0.0 112.467 176.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.603 ' HB3' ' HA ' ' A' ' 13' ' ' LEU . 1.8 t -93.43 122.45 35.86 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.345 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.492 ' HA ' ' HD3' ' A' ' 83' ' ' PRO . 8.6 t -130.35 133.5 24.98 Favored Pre-proline 0 N--CA 1.445 -0.687 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.737 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 82' ' ' THR . 5.0 Cg_endo -88.02 98.89 0.42 Allowed 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.952 2.435 . . . . 0.0 110.823 171.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.427 ' HA ' ' OE1' ' A' ' 84' ' ' GLN . 6.7 tp60 -149.78 56.25 0.96 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.715 0.769 . . . . 0.0 109.622 -176.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.572 ' NZ ' ' HB2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.56 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.641 HG12 ' H ' ' A' ' 2' ' ' LEU . 1.8 t . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.641 ' H ' HG12 ' A' ' 1' ' ' VAL . 29.3 tp -80.59 -13.28 59.19 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.196 -0.201 . . . . 0.0 111.035 -176.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.594 ' NZ ' ' HB2' ' A' ' 3' ' ' LYS . 8.5 mtmp? 80.34 88.82 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 O-C-N 124.046 0.841 . . . . 0.0 110.647 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 73' ' ' SER . . . 155.23 162.36 11.23 Favored Glycine 0 CA--C 1.49 -1.525 0 CA-C-N 115.047 -0.978 . . . . 0.0 110.703 -177.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.746 ' O ' HD12 ' A' ' 7' ' ' LEU . 50.4 mttm -114.87 80.6 1.44 Allowed 'General case' 0 N--CA 1.399 -3.0 0 N-CA-C 104.725 -2.324 . . . . 0.0 104.725 161.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.688 ' HA ' ' N ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -81.23 146.87 30.24 Favored 'General case' 0 CA--C 1.461 -2.476 0 N-CA-C 101.724 -3.435 . . . . 0.0 101.724 168.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.952 HD12 ' H ' ' A' ' 46' ' ' GLY . 0.0 OUTLIER -163.17 -179.32 6.56 Favored 'General case' 0 N--CA 1.399 -3.003 0 C-N-CA 111.762 -3.975 . . . . 0.0 115.987 -151.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.928 ' HE1' ' HB2' ' A' ' 41' ' ' LEU . 6.2 t80 -127.17 105.39 8.53 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.41 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.525 ' HA ' ' O ' ' A' ' 77' ' ' LEU . . . -100.74 131.61 46.55 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.877 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.503 HG22 ' HG2' ' A' ' 12' ' ' ARG . 4.1 mp -100.28 97.02 5.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 175.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.879 HD12 HG21 ' A' ' 65' ' ' VAL . 2.7 mm? -85.48 107.57 17.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.359 -173.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.894 ' HD3' ' HG2' ' A' ' 18' ' ' GLN . 18.1 mmt180 -126.47 139.75 53.0 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.063 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.661 ' HG ' ' O ' ' A' ' 17' ' ' SER . 2.3 mt -80.62 144.32 32.43 Favored 'General case' 0 N--CA 1.435 -1.216 0 C-N-CA 117.774 -1.57 . . . . 0.0 107.694 178.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.0 -15.39 59.24 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-N 114.281 -1.327 . . . . 0.0 111.673 -176.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -75.17 -30.1 60.6 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.827 177.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.16 -11.14 20.06 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -174.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.661 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 8.7 p -87.35 165.26 15.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.939 -0.631 . . . . 0.0 110.834 175.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.894 ' HG2' ' HD3' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -159.01 -91.14 0.0 OUTLIER Pre-proline 0 C--O 1.22 -0.484 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.386 171.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.566 ' CD ' ' HB2' ' A' ' 18' ' ' GLN . 21.3 Cg_exo -23.64 100.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 124.321 3.347 . . . . 0.0 115.114 -133.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.736 ' HB2' ' HB2' ' A' ' 23' ' ' ALA . 91.4 Cg_endo -111.3 96.16 0.02 OUTLIER 'Trans proline' 0 N--CA 1.436 -1.895 0 C-N-CA 124.678 3.586 . . . . 0.0 111.902 163.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -97.99 111.4 23.73 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 118.641 -1.224 . . . . 0.0 109.401 -171.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.24 12.86 28.19 Favored Glycine 0 N--CA 1.422 -2.241 0 N-CA-C 108.128 -1.989 . . . . 0.0 108.128 -163.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.756 ' HA ' ' O ' ' A' ' 56' ' ' ASN . . . -60.14 93.74 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.887 -0.656 . . . . 0.0 110.107 174.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.681 ' HB2' ' HB2' ' A' ' 56' ' ' ASN . 0.6 OUTLIER -68.63 94.62 0.6 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.51 -1.677 . . . . 0.0 110.77 174.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.614 ' HB ' HD13 ' A' ' 53' ' ' LEU . 28.5 m -82.3 108.9 15.71 Favored 'Isoleucine or valine' 0 C--O 1.261 1.662 0 C-N-CA 119.031 -1.068 . . . . 0.0 108.691 173.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.709 ' HB ' ' OE1' ' A' ' 32' ' ' GLU . 5.0 t -134.11 129.7 36.31 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 114.834 -1.075 . . . . 0.0 109.867 -175.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.64 131.14 35.9 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 117.624 -1.63 . . . . 0.0 108.33 -173.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -14.72 -52.6 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 117.289 2.329 . . . . 0.0 117.289 -158.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -65.83 -17.27 64.52 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.31 0.959 . . . . 0.0 111.885 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.599 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 113.36 36.46 1.46 Allowed Glycine 0 N--CA 1.429 -1.769 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.7 mtp85 -81.75 86.97 6.36 Favored 'General case' 0 N--CA 1.431 -1.378 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 171.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.709 ' OE1' ' HB ' ' A' ' 26' ' ' THR . 4.9 mm-40 -72.35 104.8 3.85 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.03 -173.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.636 HD22 ' O ' ' A' ' 46' ' ' GLY . 24.7 mt -85.84 -35.05 20.87 Favored 'General case' 0 C--O 1.242 0.684 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.067 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.676 ' HA3' HD22 ' A' ' 44' ' ' LEU . . . 175.9 -171.29 44.34 Favored Glycine 0 C--N 1.349 1.258 0 C-N-CA 119.258 -1.449 . . . . 0.0 114.209 177.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.709 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 24.8 mtt -149.0 135.99 19.87 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 116.854 0.327 . . . . 0.0 111.516 -173.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 23' ' ' ALA . 54.7 t -69.41 148.56 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.238 0.336 . . . . 0.0 111.055 -179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 38' ' ' ASP . . . -138.84 57.28 1.68 Allowed 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.878 -0.329 . . . . 0.0 111.106 172.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.746 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 9.0 p-10 167.09 -154.32 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.579 -176.3 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 19' ' ' PRO . 62.6 mm-40 -49.74 -52.55 30.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.774 169.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.52 57.93 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 118.59 -1.767 . . . . 0.0 113.982 -178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.928 ' HB2' ' HE1' ' A' ' 8' ' ' PHE . 4.5 pp -132.09 131.71 42.63 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.608 0.718 . . . . 0.0 110.341 169.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.05 114.87 20.31 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.099 -0.955 . . . . 0.0 108.827 173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.423 ' CZ3' ' HB2' ' A' ' 8' ' ' PHE . 50.7 m95 -72.97 88.81 1.39 Allowed 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 175.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.717 HD12 HD21 ' A' ' 7' ' ' LEU . 5.9 mt -79.24 178.06 8.36 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 118.547 -1.261 . . . . 0.0 108.538 -174.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.633 ' HA ' ' HA ' ' A' ' 6' ' ' ARG . 65.7 p -147.13 88.83 1.75 Allowed 'General case' 0 N--CA 1.427 -1.575 0 C-N-CA 118.758 -1.177 . . . . 0.0 109.387 172.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.952 ' H ' HD12 ' A' ' 7' ' ' LEU . . . 107.33 92.87 2.28 Favored Glycine 0 C--O 1.222 -0.615 0 C-N-CA 119.011 -1.566 . . . . 0.0 112.248 -174.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.545 HG12 ' HG ' ' A' ' 7' ' ' LEU . 10.3 p -120.39 137.46 54.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 177.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.435 ' HB ' ' OE2' ' A' ' 51' ' ' GLU . 28.8 m -101.22 129.44 27.04 Favored Pre-proline 0 C--N 1.322 -0.616 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.929 ' HB2' ' HA ' ' A' ' 69' ' ' GLU . 60.3 Cg_endo -72.99 135.38 23.08 Favored 'Trans proline' 0 C--N 1.331 -0.367 0 C-N-CA 122.907 2.405 . . . . 0.0 112.897 -177.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 96.94 35.66 5.26 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 119.46 -1.352 . . . . 0.0 113.176 174.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.714 ' H ' ' CG1' ' A' ' 67' ' ' VAL . 31.6 mt-10 -121.89 177.69 5.19 Favored 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 119.121 -1.032 . . . . 0.0 111.879 -176.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 p -122.86 90.98 3.39 Favored 'General case' 0 N--CA 1.43 -1.426 0 CA-C-N 114.443 -1.253 . . . . 0.0 110.664 165.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.633 ' HB2' ' HB ' ' A' ' 65' ' ' VAL . 19.6 mt -51.43 152.82 2.42 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.484 171.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.52 ' HB2' HD11 ' A' ' 61' ' ' ILE . 21.4 p -120.61 125.14 47.01 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 165.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.677 ' HA ' ' O ' ' A' ' 24' ' ' SER . 20.3 t -112.68 107.93 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 121.497 0.665 . . . . 0.0 111.275 -167.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.756 ' O ' ' HA ' ' A' ' 23' ' ' ALA . 45.8 m-80 -76.42 139.8 41.04 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.624 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.857 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 2.4 t90 -144.59 149.66 36.16 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.503 -166.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.857 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 4.3 m-20 -19.41 -64.74 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.758 1.223 . . . . 0.0 113.243 166.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.42 ' HA3' HE22 ' A' ' 62' ' ' GLN . . . -62.76 -36.46 93.36 Favored Glycine 0 CA--C 1.536 1.36 0 C-N-CA 117.719 -2.181 . . . . 0.0 113.864 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.746 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 13.1 pttp 167.77 -169.7 0.02 OUTLIER 'General case' 0 C--O 1.211 -0.94 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -172.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.715 ' HA ' ' HA ' ' A' ' 56' ' ' ASN . 7.3 tt -81.96 118.31 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 167.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.785 ' HG3' ' HB3' ' A' ' 57' ' ' TRP . 1.4 mt-30 -125.18 -63.06 1.18 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 115.555 -2.458 . . . . 0.0 112.511 -166.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.506 ' O ' ' HB ' ' A' ' 55' ' ' VAL . 27.5 p -92.89 149.21 21.41 Favored 'General case' 0 N--CA 1.434 -1.263 0 C-N-CA 117.304 -1.758 . . . . 0.0 108.116 -179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.589 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 25.5 mt-30 -127.13 133.82 50.31 Favored 'General case' 0 CA--C 1.485 -1.521 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.879 HG21 HD12 ' A' ' 11' ' ' LEU . 4.4 t -94.99 140.74 16.23 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 C-N-CA 115.522 -2.471 . . . . 0.0 113.015 -164.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -95.48 113.58 25.25 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 118.736 -1.185 . . . . 0.0 110.261 174.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.714 ' CG1' ' H ' ' A' ' 51' ' ' GLU . 8.8 p -101.8 124.22 41.19 Favored Pre-proline 0 C--O 1.219 -0.507 0 C-N-CA 119.51 -0.876 . . . . 0.0 110.823 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 67' ' ' VAL . 91.8 Cg_endo -88.67 171.8 4.93 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 123.853 3.035 . . . . 0.0 112.916 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.929 ' HA ' ' HB2' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -68.78 -25.19 64.58 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.651 -177.51 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -76.81 28.7 0.13 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-O 121.127 0.489 . . . . 0.0 111.811 -177.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.536 ' HA ' HD22 ' A' ' 77' ' ' LEU . . . -69.36 135.28 50.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.394 0.616 . . . . 0.0 110.908 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.508 ' O ' ' HB3' ' A' ' 5' ' ' LYS . 10.7 tp -96.08 157.92 3.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.067 -173.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.49 ' HA ' ' CB ' ' A' ' 5' ' ' LYS . 3.3 m -107.52 129.92 54.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 119.207 -0.425 . . . . 0.0 110.442 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.675 ' HA ' ' O ' ' A' ' 6' ' ' ARG . 58.4 m-20 56.08 30.09 15.68 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -146.02 -167.7 2.79 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.282 0.563 . . . . 0.0 112.208 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.569 ' HA ' ' HB3' ' A' ' 8' ' ' PHE . 26.9 tt0 -93.32 140.51 29.47 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 114.985 -1.007 . . . . 0.0 111.606 -175.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.536 HD22 ' HA ' ' A' ' 71' ' ' ALA . 55.0 tp -153.98 123.01 6.4 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.769 HD23 ' H ' ' A' ' 78' ' ' LEU . 2.3 pt? -85.5 137.0 33.19 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 118.426 -1.309 . . . . 0.0 109.549 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.563 ' HB2' HD13 ' A' ' 11' ' ' LEU . 55.5 mt -122.81 134.83 25.23 Favored Pre-proline 0 C--O 1.245 0.818 0 CA-C-O 121.7 0.762 . . . . 0.0 111.85 -175.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 79' ' ' LEU . 92.1 Cg_endo -87.68 121.86 1.6 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 123.192 2.595 . . . . 0.0 112.846 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.483 ' HB3' ' HB2' ' A' ' 63' ' ' CYS . 1.1 m -81.52 97.82 7.99 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.054 173.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.44 ' HB ' ' CD ' ' A' ' 83' ' ' PRO . 17.2 p -83.92 171.31 11.6 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.029 176.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.44 ' CD ' ' HB ' ' A' ' 82' ' ' THR . 22.6 Cg_exo -65.69 -172.31 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.564 2.176 . . . . 0.0 112.848 177.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.479 ' HA ' ' NE2' ' A' ' 64' ' ' GLN . 27.2 mt-30 -80.28 175.38 10.7 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.564 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt . . . . . 0 C--O 1.252 1.211 0 CA-C-O 117.305 -1.331 . . . . 0.0 108.746 178.582 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 120.653 0.263 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.5 tp -88.4 92.41 9.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -68.81 -48.3 63.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.428 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.994 ' HA3' ' HB2' ' A' ' 74' ' ' ASP . . . -167.81 -123.16 0.65 Allowed Glycine 0 CA--C 1.472 -2.608 0 C-N-CA 119.413 -1.375 . . . . 0.0 113.179 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.776 ' H ' ' HB2' ' A' ' 74' ' ' ASP . 7.8 tptm -137.54 -154.1 0.52 Allowed 'General case' 0 N--CA 1.396 -3.155 0 CA-C-N 112.131 -2.035 . . . . 0.0 106.616 -170.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.811 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 7.7 ptp180 -64.62 158.63 23.88 Favored 'General case' 0 C--N 1.27 -2.865 0 CA-C-N 112.197 -2.274 . . . . 0.0 108.645 169.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 74' ' ' ASP 0.317 10.6 mt 172.13 -165.36 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 156.294 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' A' ' 76' ' ' GLN . 0.7 OUTLIER -66.62 127.76 33.61 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 113.478 -1.692 . . . . 0.0 112.6 -166.092 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.693 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -127.19 144.14 51.1 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.587 -175.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.1 mt -90.21 106.67 17.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.555 176.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.69 ' H ' HD23 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -102.41 154.65 18.88 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.644 ' HA ' ' HG3' ' A' ' 18' ' ' GLN . 0.0 OUTLIER -142.89 154.08 43.76 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 120.225 -0.59 . . . . 0.0 112.05 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.852 HD22 HE21 ' A' ' 18' ' ' GLN . 1.7 mm? -64.07 -175.8 0.17 Allowed 'General case' 0 N--CA 1.432 -1.327 0 CA-C-O 121.623 0.725 . . . . 0.0 109.748 172.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.2 -27.35 66.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.025 179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -72.95 -20.66 61.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.557 177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.38 33.64 7.94 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.732 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.727 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 74.8 p -154.75 148.76 25.76 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.189 -0.505 . . . . 0.0 110.698 -174.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.852 HE21 HD22 ' A' ' 13' ' ' LEU . 5.6 mt-30 -167.71 132.37 1.53 Allowed Pre-proline 0 CA--C 1.503 -0.843 0 C-N-CA 123.068 0.547 . . . . 0.0 109.782 170.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -113.95 91.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.161 0 CA-C-N 119.382 0.815 . . . . 0.0 111.306 140.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.764 ' HD3' ' CB ' ' A' ' 18' ' ' GLN . 22.0 Cg_endo -116.4 94.2 0.01 OUTLIER 'Trans proline' 0 N--CA 1.438 -1.781 0 C-N-CA 123.291 2.66 . . . . 0.0 113.256 163.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.51 108.57 19.47 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-O 121.887 0.851 . . . . 0.0 109.566 -174.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 120.48 -0.66 12.57 Favored Glycine 0 N--CA 1.427 -1.902 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -169.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 35' ' ' MET . . . -56.75 95.21 0.02 OUTLIER 'General case' 0 C--N 1.345 0.411 0 CA-C-O 121.575 0.702 . . . . 0.0 109.891 174.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.672 ' O ' ' HA ' ' A' ' 55' ' ' VAL . 0.4 OUTLIER -70.98 96.92 1.35 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 113.423 -1.717 . . . . 0.0 113.082 179.005 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.648 HG21 ' HG ' ' A' ' 44' ' ' LEU . 27.6 m -84.41 113.9 23.9 Favored 'Isoleucine or valine' 0 C--O 1.251 1.183 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.752 176.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 31' ' ' ARG . 0.1 OUTLIER -143.4 130.74 20.95 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.337 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.685 ' HA ' ' HA ' ' A' ' 53' ' ' LEU . 59.7 p -69.96 176.37 3.78 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.437 -173.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.561 ' HG2' HG23 ' A' ' 52' ' ' THR . 11.8 mm-40 -58.79 -20.34 49.09 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.018 0.437 . . . . 0.0 111.393 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -86.98 -17.29 33.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.0 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.428 ' HA2' ' OG1' ' A' ' 26' ' ' THR . . . 98.99 18.72 23.91 Favored Glycine 0 CA--C 1.482 -1.994 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.658 ' HB2' ' OG ' ' A' ' 27' ' ' SER . 32.0 mtt180 -63.88 91.17 0.06 Allowed 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 168.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.522 ' HA ' ' HB ' ' A' ' 26' ' ' THR . 19.3 mt-10 -81.32 89.67 6.09 Favored 'General case' 0 C--N 1.313 -1.01 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.192 -177.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.521 HD23 ' HB3' ' A' ' 44' ' ' LEU . 11.1 mp -66.56 -48.79 68.54 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.696 -175.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.528 ' C ' ' HG3' ' A' ' 35' ' ' MET . . . -177.22 -161.77 26.38 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 117.932 -2.08 . . . . 0.0 114.051 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.559 ' HA ' ' O ' ' A' ' 23' ' ' ALA . 19.4 mtt -149.69 140.99 23.17 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -176.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.556 HG23 ' HB3' ' A' ' 23' ' ' ALA . 43.8 t -70.03 129.05 34.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.324 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.88 92.89 3.89 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 171.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 74.73 136.22 0.06 Allowed 'General case' 0 N--CA 1.47 0.547 0 O-C-N 124.296 0.997 . . . . 0.0 111.316 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 58.24 -145.15 0.58 Allowed 'General case' 0 C--O 1.226 -0.18 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.425 -178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.43 61.3 0.32 Allowed Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.172 -1.013 . . . . 0.0 111.425 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' A' ' 8' ' ' PHE . 3.8 tt -134.14 112.01 10.78 Favored 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.183 -177.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.45 ' HB3' HD11 ' A' ' 44' ' ' LEU . . . -106.87 161.29 14.83 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.392 173.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.517 ' CD2' ' HB3' ' A' ' 8' ' ' PHE . 22.6 m95 -95.71 87.98 4.85 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.486 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.693 HD13 ' HB3' ' A' ' 9' ' ' ALA . 6.6 mp -90.27 88.69 7.32 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 116.857 -1.937 . . . . 0.0 111.191 -167.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.811 ' HA ' ' HB2' ' A' ' 6' ' ' ARG . 6.3 p -86.09 86.91 7.35 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-O 122.012 0.91 . . . . 0.0 109.179 171.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.601 ' H ' ' HB2' ' A' ' 6' ' ' ARG . . . 150.85 26.59 0.05 OUTLIER Glycine 0 C--N 1.308 -0.976 0 CA-C-N 114.386 -1.279 . . . . 0.0 112.176 176.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.553 HG12 ' HA ' ' A' ' 6' ' ' ARG . 6.2 p -84.72 115.31 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 119.782 -0.767 . . . . 0.0 110.97 -176.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.0 m -115.8 124.81 29.37 Favored Pre-proline 0 C--N 1.317 -0.819 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 172.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 67' ' ' VAL . 10.2 Cg_endo -53.5 133.94 55.58 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.147 2.565 . . . . 0.0 112.708 -176.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 95.28 35.8 5.62 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.583 -1.294 . . . . 0.0 112.605 175.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.572 ' H ' ' HB ' ' A' ' 67' ' ' VAL . 4.5 mm-40 -116.31 179.4 4.0 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-O 122.298 1.047 . . . . 0.0 111.943 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.561 HG23 ' HG2' ' A' ' 28' ' ' GLU . 14.3 t -134.12 143.2 47.82 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.352 -1.749 . . . . 0.0 108.548 165.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.685 ' HA ' ' HA ' ' A' ' 27' ' ' SER . 4.5 tp -121.72 160.0 25.43 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.065 -166.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.669 ' HB3' HD11 ' A' ' 61' ' ' ILE . 36.8 m -129.55 129.94 45.11 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 123.787 0.679 . . . . 0.0 111.214 172.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.725 HG21 ' SG ' ' A' ' 81' ' ' CYS . 14.4 t -119.33 106.15 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.152 -167.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.65 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 8.5 m-20 -76.92 85.62 3.47 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.55 177.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.777 ' HD1' ' N ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -82.24 147.11 29.13 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.604 -1.18 . . . . 0.0 109.899 176.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.777 ' N ' ' HD1' ' A' ' 57' ' ' TRP . 18.1 m-20 -12.08 -64.71 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 170.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.11 -42.65 99.73 Favored Glycine 0 CA--C 1.535 1.306 0 C-N-CA 117.895 -2.098 . . . . 0.0 114.42 -178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 1.051 ' HG2' ' HG2' ' A' ' 62' ' ' GLN . 9.0 ptpt -178.8 -166.29 0.1 Allowed 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -169.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.669 HD11 ' HB3' ' A' ' 54' ' ' SER . 12.7 tt -90.4 87.92 2.77 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 173.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 1.051 ' HG2' ' HG2' ' A' ' 60' ' ' LYS . 2.1 mt-30 -96.2 -51.93 4.21 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.236 -1.347 . . . . 0.0 111.896 -158.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' CYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 82' ' ' THR . 20.5 p -105.33 158.16 16.82 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 118.185 -1.406 . . . . 0.0 108.145 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.626 ' HB3' ' O ' ' A' ' 53' ' ' LEU . 97.1 mt-30 -132.45 142.5 49.28 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.627 ' HB ' ' HB3' ' A' ' 53' ' ' LEU . 1.0 OUTLIER -97.54 151.55 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 C-N-CA 114.825 -2.75 . . . . 0.0 112.196 -169.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.615 ' HB2' ' HG2' ' A' ' 80' ' ' PRO . 12.7 m120 -112.09 113.42 25.69 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.357 174.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.572 ' HB ' ' H ' ' A' ' 51' ' ' GLU . 56.1 t -96.82 106.75 32.65 Favored Pre-proline 0 C--O 1.224 -0.244 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.075 -177.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 67' ' ' VAL . 27.7 Cg_endo -62.22 156.08 52.76 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 123.208 2.605 . . . . 0.0 112.449 -178.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -77.26 5.98 7.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.62 -170.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.7 t -130.23 -4.08 4.4 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 120.552 -0.459 . . . . 0.0 112.153 -172.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.524 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -94.79 152.69 18.21 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 119.751 -0.779 . . . . 0.0 112.675 -172.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 10.9 tp -158.16 161.9 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 115.028 -0.987 . . . . 0.0 108.803 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.462 ' HB2' ' N ' ' A' ' 7' ' ' LEU . 19.3 m -118.1 -105.34 0.39 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 119.182 -1.007 . . . . 0.0 113.459 -173.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.994 ' HB2' ' HA3' ' A' ' 4' ' ' GLY . 29.1 t70 72.13 8.23 5.86 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 122.284 1.04 . . . . 0.0 109.092 -165.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -169.87 -146.63 0.05 Allowed 'General case' 0 C--O 1.245 0.816 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.738 -173.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.611 ' HA ' ' O ' ' A' ' 8' ' ' PHE . 24.9 mt-30 -78.93 136.86 37.38 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.086 0.866 . . . . 0.0 110.672 171.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.524 HD11 ' HB1' ' A' ' 71' ' ' ALA . 37.7 tp -129.96 -179.03 4.98 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 169.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.506 ' H ' ' HG ' ' A' ' 77' ' ' LEU . 3.2 pp -140.81 139.32 34.52 Favored 'General case' 0 C--N 1.311 -1.1 0 C-N-CA 117.722 -1.591 . . . . 0.0 110.721 174.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.63 ' O ' ' HA ' ' A' ' 11' ' ' LEU . 2.8 mm? -133.58 142.2 43.04 Favored Pre-proline 0 C--O 1.242 0.684 0 CA-C-O 121.567 0.699 . . . . 0.0 112.699 -175.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.615 ' HG2' ' HB2' ' A' ' 66' ' ' ASN . 74.2 Cg_endo -82.47 122.13 3.54 Favored 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 122.892 2.394 . . . . 0.0 111.594 171.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.725 ' SG ' HG21 ' A' ' 55' ' ' VAL . 0.3 OUTLIER -106.67 87.65 2.58 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.42 ' O ' ' HA ' ' A' ' 63' ' ' CYS . 10.2 t -68.79 143.91 95.36 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.983 -175.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.34 152.39 67.34 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.725 2.283 . . . . 0.0 111.939 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.459 ' O ' ' HE3' ' A' ' 85' ' ' LYS . 4.1 pt20 -67.19 -39.28 86.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.536 -177.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.91 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.794 -0.622 . . . . 0.0 110.65 -179.455 . . . . . . . . 2 2 . 1 stop_ save_